Cataracts,open-angle glaucoma
{   <Cataracts>and <open-angle glaucoma>}
{<Cataracts>,<and >,<open-angle glaucoma>
primary open angle glaucoma,ocular hypertension
{the treatment of <primary open angle glaucoma>and <ocular hypertension>}
{<primary open angle glaucoma>,<and >,<ocular hypertension>
{  NTG <primary open angle glaucoma>POAG and <ocular hypertension>}
{<primary open angle glaucoma>,<POAG and >,<ocular hypertension>
{primary therapy in <primary open angle glaucoma>and <ocular hypertension>}
{<primary open angle glaucoma>,<and >,<ocular hypertension>
{Patients with untreated <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{patients with bilateral <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{79 eyes with <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{patients with bilateral <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{406 eyes with <primary open angle glaucoma>and <ocular hypertension>}
{<primary open angle glaucoma>,<and >,<ocular hypertension>
{patients with bilateral <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{patients with either <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{patients with bilateral <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{included had either <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{patients with bilateral <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{72 eyes with <primary open angle glaucoma>POAG and <ocular hypertension>}
{<primary open angle glaucoma>,<POAG and >,<ocular hypertension>
{indicates that untreated <primary open angle glaucoma>or untreated <ocular hypertension>}
{<primary open angle glaucoma>,<or untreated >,<ocular hypertension>
{patients treated for <primary open angle glaucoma>POAG or <ocular hypertension>}
{<primary open angle glaucoma>,<POAG or >,<ocular hypertension>
{medical treatment for <primary open angle glaucoma>and <ocular hypertension>}
{<primary open angle glaucoma>,<and >,<ocular hypertension>
{Genetic heterogeneity of <primary open angle glaucoma>and <ocular hypertension>}
{<primary open angle glaucoma>,<and >,<ocular hypertension>
{   <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{tomography OCT among <primary open angle glaucoma>POAG and <ocular hypertension>}
{<primary open angle glaucoma>,<POAG and >,<ocular hypertension>
{95 eyes with <primary open angle glaucoma>37 <ocular hypertension>}
{<primary open angle glaucoma>,<37 >,<ocular hypertension>
{recruiting adults with <primary open angle glaucoma>POAG and/or <ocular hypertension>}
{<primary open angle glaucoma>,<POAG and/or >,<ocular hypertension>
{the epidemiology of <primary open angle glaucoma>and <ocular hypertension>}
{<primary open angle glaucoma>,<and >,<ocular hypertension>
{line therapy for <primary open angle glaucoma>OAG and <ocular hypertension>}
{<primary open angle glaucoma>,<OAG and >,<ocular hypertension>
{diagnosis of either <primary open angle glaucoma>POAG or <ocular hypertension>}
{<primary open angle glaucoma>,<POAG or >,<ocular hypertension>
{who sustain either <primary open angle glaucoma>or <ocular hypertension>}
{<primary open angle glaucoma>,<or >,<ocular hypertension>
{5 groups the <primary open angle glaucoma>group PGOU 54 eyes the preperimetric form of PGOU group 34 eyes the <ocular hypertension>}
{<primary open angle glaucoma>,<group PGOU 54 eyes the preperimetric form of PGOU group 34 eyes the >,<ocular hypertension>
{groups 1 the <primary open angle glaucoma>PGOU group and the preperimetric form of PGOU group 88 eyes 2 the <ocular hypertension>}
{<primary open angle glaucoma>,<PGOU group and the preperimetric form of PGOU group 88 eyes 2 the >,<ocular hypertension>
{recent diagnosis of <primary open angle glaucoma>POAG or <ocular hypertension>}
{<primary open angle glaucoma>,<POAG or >,<ocular hypertension>
{prevalence rate of <primary open angle glaucoma>and <ocular hypertension>}
{<primary open angle glaucoma>,<and >,<ocular hypertension>
{patients affected by <primary open angle glaucoma>in 30 patients with isolated <ocular hypertension>}
{<primary open angle glaucoma>,<in 30 patients with isolated >,<ocular hypertension>
Osteogenesis imperfecta,glaucoma
{   <Osteogenesis imperfecta>and <glaucoma>}
{<Osteogenesis imperfecta>,<and >,<glaucoma>
angle recession glaucoma uveitic glaucoma,neovascular glaucoma
{   <angle recession glaucoma uveitic glaucoma>and <neovascular glaucoma>}
{<angle recession glaucoma uveitic glaucoma>,<and >,<neovascular glaucoma>
glaucoma cataract,retinal detachment
{   <glaucoma cataract>and <retinal detachment>}
{<glaucoma cataract>,<and >,<retinal detachment>
otitis hearing loss,sleep apnea
{   <otitis hearing loss>and <sleep apnea>}
{<otitis hearing loss>,<and >,<sleep apnea>
non-alcoholic fatty liver disease,autoimmune diseases
{   <non-alcoholic fatty liver disease>and <autoimmune diseases>}
{<non-alcoholic fatty liver disease>,<and >,<autoimmune diseases>
Hypermature cataract,phacolytic glaucoma
{   <Hypermature cataract>and <phacolytic glaucoma>}
{<Hypermature cataract>,<and >,<phacolytic glaucoma>
diabetic retinopathy,glaucoma
{the treatment of <diabetic retinopathy>and <glaucoma>}
{<diabetic retinopathy>,<and >,<glaucoma>
{ Impact of <diabetic retinopathy>on quantitative retinal nerve fiber layer measurement and <glaucoma>}
{<diabetic retinopathy>,<on quantitative retinal nerve fiber layer measurement and >,<glaucoma>
{any association between <diabetic retinopathy>DR and <glaucoma>}
{<diabetic retinopathy>,<DR and >,<glaucoma>
{three leading causes--AMD <diabetic retinopathy>and <glaucoma>}
{<diabetic retinopathy>,<and >,<glaucoma>
{  AMD <diabetic retinopathy>and <glaucoma>}
{<diabetic retinopathy>,<and >,<glaucoma>
{retinal vein occlusion <diabetic retinopathy>and <glaucoma>}
{<diabetic retinopathy>,<and >,<glaucoma>
{ Unilateral progressive <diabetic retinopathy>following a filtering <glaucoma>}
{<diabetic retinopathy>,<following a filtering >,<glaucoma>
{  AMD <diabetic retinopathy>and <glaucoma>}
{<diabetic retinopathy>,<and >,<glaucoma>
{  AMD <diabetic retinopathy>DR uveoretinitis and <glaucoma>}
{<diabetic retinopathy>,<DR uveoretinitis and >,<glaucoma>
acute angle-closure glaucoma giant cell arteritis,central retinal artery occlusion
{   <acute angle-closure glaucoma giant cell arteritis>and <central retinal artery occlusion>}
{<acute angle-closure glaucoma giant cell arteritis>,<and >,<central retinal artery occlusion>
pressure,glaucoma
{posture on intraocular <pressure>IOP in medically treated patients with open-angle <glaucoma>}
{<pressure>,<IOP in medically treated patients with open-angle >,<glaucoma>
{measures were intraocular <pressure>IOP <glaucoma>}
{<pressure>,<IOP >,<glaucoma>
{change in intraocular <pressure>IOP observed in one eye after starting a <glaucoma>}
{<pressure>,<IOP observed in one eye after starting a >,<glaucoma>
{and ocular perfusion <pressure>OPP in patients with newly diagnosed untreated normal tension <glaucoma>}
{<pressure>,<OPP in patients with newly diagnosed untreated normal tension >,<glaucoma>
{meta-analysis of translaminar <pressure>difference in open-angle <glaucoma>}
{<pressure>,<difference in open-angle >,<glaucoma>
{phacoemulsification on intraocular <pressure>IOP control in <glaucoma>}
{<pressure>,<IOP control in >,<glaucoma>
{and ocular perfusion <pressure>in normal-tension <glaucoma>}
{<pressure>,<in normal-tension >,<glaucoma>
{ in intraocular <pressure>IOP elevation and optic nerve damage has been hypothesized in the pathogenesis of <glaucoma>}
{<pressure>,<IOP elevation and optic nerve damage has been hypothesized in the pathogenesis of >,<glaucoma>
{of lowering intraocular <pressure>have been shown to be unable to prevent progressive vision loss in some <glaucoma>}
{<pressure>,<have been shown to be unable to prevent progressive vision loss in some >,<glaucoma>
{monotherapy on intraocular <pressure>in Japanese <glaucoma>}
{<pressure>,<in Japanese >,<glaucoma>
{had uncontrolled intraocular <pressure>IOP despite prior <glaucoma>}
{<pressure>,<IOP despite prior >,<glaucoma>
{latanoprost on intraocular <pressure>in patients with normal-tension <glaucoma>}
{<pressure>,<in patients with normal-tension >,<glaucoma>
{travoprost on intraocular <pressure>during 12 months of treatment for normal-tension <glaucoma>}
{<pressure>,<during 12 months of treatment for normal-tension >,<glaucoma>
{literature regarding translaminar <pressure>difference's TPD role in the pathophysiology of <glaucoma>}
{<pressure>,<difference's TPD role in the pathophysiology of >,<glaucoma>
{8% had intraocular <pressure>IOP of 20mm Hg or less without <glaucoma>}
{<pressure>,<IOP of 20mm Hg or less without >,<glaucoma>
{by elevated intraocular <pressure>IOP namely high-tension <glaucoma>}
{<pressure>,<IOP namely high-tension >,<glaucoma>
{variation of intraocular <pressure>in patients with open-angle <glaucoma>}
{<pressure>,<in patients with open-angle >,<glaucoma>
{24 h intraocular <pressure>IOP and blood pressure BP with bimatoprost or latanoprost in patients with normal-tension <glaucoma>}
{<pressure>,<IOP and blood pressure BP with bimatoprost or latanoprost in patients with normal-tension >,<glaucoma>
{CAV1-CAV2 affect intraocular <pressure>and high-tension <glaucoma>}
{<pressure>,<and high-tension >,<glaucoma>
{change in intraocular <pressure>IOP leads to measurable changes in axial eye length and whether there is a difference between <glaucoma>}
{<pressure>,<IOP leads to measurable changes in axial eye length and whether there is a difference between >,<glaucoma>
{variation of intraocular <pressure>in suspected <glaucoma>}
{<pressure>,<in suspected >,<glaucoma>
{Although elevated intraocular <pressure>is a major risk factor for the development of glaucoma there is increasing evidence that the immune system may be involved in the development of normal-tension <glaucoma>}
{<pressure>,<is a major risk factor for the development of glaucoma there is increasing evidence that the immune system may be involved in the development of normal-tension >,<glaucoma>
{and ocular perfusion <pressure>after timolol or latanoprost in Caucasians with normal-tension <glaucoma>}
{<pressure>,<after timolol or latanoprost in Caucasians with normal-tension >,<glaucoma>
{1 topical intraocular <pressure>IOP -lowering medication and the control group including 30 patients with no diagnosis of <glaucoma>}
{<pressure>,<IOP -lowering medication and the control group including 30 patients with no diagnosis of >,<glaucoma>
{the elevated intraocular <pressure>IOP associated with <glaucoma>}
{<pressure>,<IOP associated with >,<glaucoma>
{have a positive <pressure>effect in 50% of suspected normal-tension <glaucoma>}
{<pressure>,<effect in 50% of suspected normal-tension >,<glaucoma>
{variation of intraocular <pressure>was measured in 202 eyes of suspected open-angle <glaucoma>}
{<pressure>,<was measured in 202 eyes of suspected open-angle >,<glaucoma>
{of arterial blood <pressure>as a risk factor for the development of glaucomatous damage and progressive visual field loss in <glaucoma>}
{<pressure>,<as a risk factor for the development of glaucomatous damage and progressive visual field loss in >,<glaucoma>
{ Ocular perfusion <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{and a larger <pressure>amplitude eyes with pigmentary <glaucoma>}
{<pressure>,<amplitude eyes with pigmentary >,<glaucoma>
{ Ambulatory blood <pressure>monitoring in <glaucoma>}
{<pressure>,<monitoring in >,<glaucoma>
{reduction of intraocular <pressure>IOP and visual field VF damage in normal-tension <glaucoma>}
{<pressure>,<IOP and visual field VF damage in normal-tension >,<glaucoma>
{of the translaminar <pressure>gradient to be considered in the treatment of <glaucoma>}
{<pressure>,<gradient to be considered in the treatment of >,<glaucoma>
{35 years intraocular <pressure>IOP 22 mm Hg or more in both eyes or 19 mm Hg or more while the patient was taking two <glaucoma>}
{<pressure>,<IOP 22 mm Hg or more in both eyes or 19 mm Hg or more while the patient was taking two >,<glaucoma>
{control of intraocular <pressure>there was recorded a progression of <glaucoma>}
{<pressure>,<there was recorded a progression of >,<glaucoma>
{for lowering intra-ocular <pressure>IOP in patients with open-angle <glaucoma>}
{<pressure>,<IOP in patients with open-angle >,<glaucoma>
{evaluate long-term intraocular <pressure>IOP control and visual outcome of patients with phacolytic <glaucoma>}
{<pressure>,<IOP control and visual outcome of patients with phacolytic >,<glaucoma>
{variations in intraocular <pressure>IOP in patients with normal-tension <glaucoma>}
{<pressure>,<IOP in patients with normal-tension >,<glaucoma>
{PURPOSE Elevated intra-ocular <pressure>IOP has been identified as a major risk factor for <glaucoma>}
{<pressure>,<IOP has been identified as a major risk factor for >,<glaucoma>
{and elevated intraocular <pressure>IOP in both eyes all in the absence of secondary causes of <glaucoma>}
{<pressure>,<IOP in both eyes all in the absence of secondary causes of >,<glaucoma>
{Reduction of intraocular <pressure>in a <glaucoma>}
{<pressure>,<in a >,<glaucoma>
{variation of intraocular <pressure>in normal-tension <glaucoma>}
{<pressure>,<in normal-tension >,<glaucoma>
{ baseline intraocular <pressure>IOP and severity of <glaucoma>}
{<pressure>,<IOP and severity of >,<glaucoma>
{SLT on intraocular <pressure>IOP control and diurnal tension curves of patients with open-angle <glaucoma>}
{<pressure>,<IOP control and diurnal tension curves of patients with open-angle >,<glaucoma>
{Increase of intraocular <pressure>changes of tonographic values accumulation of lipid peroxidation products and alteration of the drainage zone morphology were observed in animals with adrenalin <glaucoma>}
{<pressure>,<changes of tonographic values accumulation of lipid peroxidation products and alteration of the drainage zone morphology were observed in animals with adrenalin >,<glaucoma>
{the target intraocular <pressure>IOP level in normal-tension <glaucoma>}
{<pressure>,<IOP level in normal-tension >,<glaucoma>
{analogs reduce intraocular <pressure>IOP in patients with open-angle <glaucoma>}
{<pressure>,<IOP in patients with open-angle >,<glaucoma>
{surgeon on intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{the diurnal intraocular <pressure>IOP variation in patients with exfoliation <glaucoma>}
{<pressure>,<IOP variation in patients with exfoliation >,<glaucoma>
{ Target intraocular <pressure>for stability of visual field loss progression in normal-tension <glaucoma>}
{<pressure>,<for stability of visual field loss progression in normal-tension >,<glaucoma>
{change in intraocular <pressure>IOP in eyes with pigmentary <glaucoma>}
{<pressure>,<IOP in eyes with pigmentary >,<glaucoma>
{elevation of intraocular <pressure>over time and associated factors in normal-tension <glaucoma>}
{<pressure>,<over time and associated factors in normal-tension >,<glaucoma>
{ in blood <pressure>is protective against systemic end-organ damage but its effects on <glaucoma>}
{<pressure>,<is protective against systemic end-organ damage but its effects on >,<glaucoma>
{  intra-ocular <pressure>IOP Â  Â 21Â mmHg and with no previous filtering <glaucoma>}
{<pressure>,<IOP Â  Â 21Â mmHg and with no previous filtering >,<glaucoma>
{Although increased intraocular <pressure>is a major risk factor of <glaucoma>}
{<pressure>,<is a major risk factor of >,<glaucoma>
{for increased intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{Blood pressure perfusion <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{reduction of intraocular <pressure>IOP in patients with open-angle <glaucoma>}
{<pressure>,<IOP in patients with open-angle >,<glaucoma>
{ Ocular perfusion <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{systemic arterial blood <pressure>associated with progressive visual field loss in <glaucoma>}
{<pressure>,<associated with progressive visual field loss in >,<glaucoma>
{the elevated intraocular <pressure>IOP is thought to be the major risk factor for POAG about 50% of the POAG patients have normal IOP called 'normal-tension' <glaucoma>}
{<pressure>,<IOP is thought to be the major risk factor for POAG about 50% of the POAG patients have normal IOP called 'normal-tension' >,<glaucoma>
{fluctuations in intraocular <pressure>across the spectrum of <glaucoma>}
{<pressure>,<across the spectrum of >,<glaucoma>
{a patient's blood <pressure>as therapy for <glaucoma>}
{<pressure>,<as therapy for >,<glaucoma>
{differences in intraocular <pressure>IOP measurements obtained with Goldmann applanation tonometry GAT and Pascal dynamic contour tonometry DCT in subjects with thin corneas and to correlate these with structural and functional parameters of <glaucoma>}
{<pressure>,<IOP measurements obtained with Goldmann applanation tonometry GAT and Pascal dynamic contour tonometry DCT in subjects with thin corneas and to correlate these with structural and functional parameters of >,<glaucoma>
{study long-term intraocular <pressure>IOP lowering following a switch to bimatoprost in patients with open-angle <glaucoma>}
{<pressure>,<IOP lowering following a switch to bimatoprost in patients with open-angle >,<glaucoma>
{with elevated intraocular <pressure>recent studies have shown a relatively high prevalence of normal tension <glaucoma>}
{<pressure>,<recent studies have shown a relatively high prevalence of normal tension >,<glaucoma>
{differences in intraocular <pressure>reduction and outflow facility due to latanoprost in normal-tension <glaucoma>}
{<pressure>,<reduction and outflow facility due to latanoprost in normal-tension >,<glaucoma>
{sensitivity with intraocular <pressure>lowering in <glaucoma>}
{<pressure>,<lowering in >,<glaucoma>
{latanoprost on intraocular <pressure>during 12 months of treatment for normal-tension <glaucoma>}
{<pressure>,<during 12 months of treatment for normal-tension >,<glaucoma>
{canaloplasty on intra-ocular <pressure>modifications after postural changes in open-angle <glaucoma>}
{<pressure>,<modifications after postural changes in open-angle >,<glaucoma>
{ Target intraocular <pressure>in the management of <glaucoma>}
{<pressure>,<in the management of >,<glaucoma>
{vs multiple intraocular <pressure>measurements in <glaucoma>}
{<pressure>,<measurements in >,<glaucoma>
{ Episcleral venous <pressure>in untreated primary open-angle and normal-tension <glaucoma>}
{<pressure>,<in untreated primary open-angle and normal-tension >,<glaucoma>
{to reduce intraocular <pressure>IOP in eyes with primary angle closure <glaucoma>}
{<pressure>,<IOP in eyes with primary angle closure >,<glaucoma>
{to lower ocular <pressure>are widely used in <glaucoma>}
{<pressure>,<are widely used in >,<glaucoma>
{ Circadian intraocular <pressure>patterns in healthy subjects primary open angle and normal tension <glaucoma>}
{<pressure>,<patterns in healthy subjects primary open angle and normal tension >,<glaucoma>
{the initial intraocular <pressure>or decrease to 18 mmHg in advanced <glaucoma>}
{<pressure>,<or decrease to 18 mmHg in advanced >,<glaucoma>
{strategies for intraocular <pressure>IOP control in Hispanic <glaucoma>}
{<pressure>,<IOP control in Hispanic >,<glaucoma>
{ Sequential office <pressure>measurements in the management of <glaucoma>}
{<pressure>,<measurements in the management of >,<glaucoma>
{addition to intraocular <pressure>IOP may thus play a role in <glaucoma>}
{<pressure>,<IOP may thus play a role in >,<glaucoma>
{patients with raised <pressure>and a reduced effect in normal tension <glaucoma>}
{<pressure>,<and a reduced effect in normal tension >,<glaucoma>
{the circadian intraocular <pressure>IOP patterns in healthy subjects in primary open angle and normal tension <glaucoma>}
{<pressure>,<IOP patterns in healthy subjects in primary open angle and normal tension >,<glaucoma>
{Estimated trans-lamina cribrosa <pressure>difference versus intraocular pressure as biomarker for open-angle <glaucoma>}
{<pressure>,<difference versus intraocular pressure as biomarker for open-angle >,<glaucoma>
{PERG after intraocular <pressure>lowering in <glaucoma>}
{<pressure>,<lowering in >,<glaucoma>
{levels of perfusion <pressure>that lead to optic nerve hypoxia in the laboratory correspond remarkably well to the levels that increase the risk of glaucomatous optic nerve atrophy in human <glaucoma>}
{<pressure>,<that lead to optic nerve hypoxia in the laboratory correspond remarkably well to the levels that increase the risk of glaucomatous optic nerve atrophy in human >,<glaucoma>
{assessment of prostaglandin-induced <pressure>reduction in <glaucoma>}
{<pressure>,<reduction in >,<glaucoma>
{ with high <pressure>high-tension <glaucoma>}
{<pressure>,<high-tension >,<glaucoma>
{and elevated intraocular <pressure>IOP simulating malignant <glaucoma>}
{<pressure>,<IOP simulating malignant >,<glaucoma>
{ Long-term intraocular <pressure>control of trabeculectomy and triple procedure in primary open angle glaucoma and chronic primary angle closure <glaucoma>}
{<pressure>,<control of trabeculectomy and triple procedure in primary open angle glaucoma and chronic primary angle closure >,<glaucoma>
{PURPOSE High intraocular <pressure>IOP and large vertical cup-to-disc ratio VCDR are important risk factors of <glaucoma>}
{<pressure>,<IOP and large vertical cup-to-disc ratio VCDR are important risk factors of >,<glaucoma>
{CONCLUSIONS Ocular perfusion <pressure>is decreased and retrobulbar haemodynamics are worse in pseudoexfoliative <glaucoma>}
{<pressure>,<is decreased and retrobulbar haemodynamics are worse in pseudoexfoliative >,<glaucoma>
{between ocular perfusion <pressure>and visual field damage in normal-tension <glaucoma>}
{<pressure>,<and visual field damage in normal-tension >,<glaucoma>
{for lowering intraocular <pressure>is described with a potential for adding to our armamentarium for treating <glaucoma>}
{<pressure>,<is described with a potential for adding to our armamentarium for treating >,<glaucoma>
{with increased intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{those with normal <pressure>normal-tension <glaucoma>}
{<pressure>,<normal-tension >,<glaucoma>
{change in intraocular <pressure>IOP of the fellow eye after <glaucoma>}
{<pressure>,<IOP of the fellow eye after >,<glaucoma>
{whether greater intraocular <pressure>IOP variation between visits was associated with higher likelihood of <glaucoma>}
{<pressure>,<IOP variation between visits was associated with higher likelihood of >,<glaucoma>
{variation of intraocular <pressure>in suspected normal-tension <glaucoma>}
{<pressure>,<in suspected normal-tension >,<glaucoma>
{control of intraocular <pressure>IOP is essential for the successful management of <glaucoma>}
{<pressure>,<IOP is essential for the successful management of >,<glaucoma>
{of ocular perfusion <pressure>OPP with general and localized visual field damage in normal-tension <glaucoma>}
{<pressure>,<OPP with general and localized visual field damage in normal-tension >,<glaucoma>
{elevation of intraocular <pressure>was not required for the diagnosis of <glaucoma>}
{<pressure>,<was not required for the diagnosis of >,<glaucoma>
{changes in intraocular <pressure>in patients with normal-tension <glaucoma>}
{<pressure>,<in patients with normal-tension >,<glaucoma>
{the elevated intraocular <pressure>characteristic of <glaucoma>}
{<pressure>,<characteristic of >,<glaucoma>
{effectively reduces intraocular <pressure>IOP in patients with open-angle <glaucoma>}
{<pressure>,<IOP in patients with open-angle >,<glaucoma>
{variations of intraocular <pressure>IOP in suspected normal-tension <glaucoma>}
{<pressure>,<IOP in suspected normal-tension >,<glaucoma>
{in lowering intraocular <pressure>compared to phacoemulsification and trabecular aspiration alone in pseudoexfoliation <glaucoma>}
{<pressure>,<compared to phacoemulsification and trabecular aspiration alone in pseudoexfoliation >,<glaucoma>
{state of intraocular <pressure>and visual functions of combined surgery for cataract and <glaucoma>}
{<pressure>,<and visual functions of combined surgery for cataract and >,<glaucoma>
{ Ocular perfusion <pressure>and retrobulbar haemodynamics in pseudoexfoliative <glaucoma>}
{<pressure>,<and retrobulbar haemodynamics in pseudoexfoliative >,<glaucoma>
{further reduce intraocular <pressure>IOP in normal-tension <glaucoma>}
{<pressure>,<IOP in normal-tension >,<glaucoma>
{ Elevated intraocular <pressure>IOP has been associated with <glaucoma>}
{<pressure>,<IOP has been associated with >,<glaucoma>
{reduction in intraocular <pressure>achieved with latanoprost in normal-tension <glaucoma>}
{<pressure>,<achieved with latanoprost in normal-tension >,<glaucoma>
{loteprednol on intraocular <pressure>after selective laser trabeculoplasty for open-angle <glaucoma>}
{<pressure>,<after selective laser trabeculoplasty for open-angle >,<glaucoma>
{reading on intraocular <pressure>for patients sustaining primary <glaucoma>}
{<pressure>,<for patients sustaining primary >,<glaucoma>
{mean ocular perfusion <pressure>a risk factor for normal tension <glaucoma>}
{<pressure>,<a risk factor for normal tension >,<glaucoma>
{variations of intraocular <pressure>in three groups of white individuals healthy young healthy ageing population and <glaucoma>}
{<pressure>,<in three groups of white individuals healthy young healthy ageing population and >,<glaucoma>
{ OBJECTIVE Intraocular <pressure>IOP is a elementary data in diagnosis and therapy of <glaucoma>}
{<pressure>,<IOP is a elementary data in diagnosis and therapy of >,<glaucoma>
{PURPOSE Elevated intraocular <pressure>IOP is a risk factor for <glaucoma>}
{<pressure>,<IOP is a risk factor for >,<glaucoma>
{surgery on intraocular <pressure>and pulsatile ocular blood flow in normal-pressure <glaucoma>}
{<pressure>,<and pulsatile ocular blood flow in normal-pressure >,<glaucoma>
{agonist on intraocular <pressure>in preclinical models of <glaucoma>}
{<pressure>,<in preclinical models of >,<glaucoma>
{Reduction of intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{administration on intraocular <pressure>IOP and visual field damage progression in normal-tension <glaucoma>}
{<pressure>,<IOP and visual field damage progression in normal-tension >,<glaucoma>
{role in intraocular <pressure>in both normal and <glaucoma>}
{<pressure>,<in both normal and >,<glaucoma>
{that reduces intraocular <pressure>IOP by 20-40% in adults with open-angle <glaucoma>}
{<pressure>,<IOP by 20-40% in adults with open-angle >,<glaucoma>
{effect of intraocular <pressure>reduction on the occurrence of <glaucoma>}
{<pressure>,<reduction on the occurrence of >,<glaucoma>
{treating elevated intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{latanoprost on intraocular <pressure>IOP and pulsatile ocular blood flow POBF in patients with normal-pressure <glaucoma>}
{<pressure>,<IOP and pulsatile ocular blood flow POBF in patients with normal-pressure >,<glaucoma>
{by acute intraocular <pressure>reduction in <glaucoma>}
{<pressure>,<reduction in >,<glaucoma>
{and postoperative intraocular <pressure>IOP <glaucoma>}
{<pressure>,<IOP >,<glaucoma>
{0 D intraocular <pressure>â‰ 22 mm Hg and <glaucoma>}
{<pressure>,<â‰ 22 mm Hg and >,<glaucoma>
{between high intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{fluctuations of intraocular <pressure>before and after selective laser trabeculoplasty in normal-tension <glaucoma>}
{<pressure>,<before and after selective laser trabeculoplasty in normal-tension >,<glaucoma>
{ Elevated intraocular <pressure>is a well-known major risk factor for <glaucoma>}
{<pressure>,<is a well-known major risk factor for >,<glaucoma>
{and peak intraocular <pressure>IOP -lowering efficacy of brimonidine and latanoprost as adjunctive therapy in patients with ocular hypertension or <glaucoma>}
{<pressure>,<IOP -lowering efficacy of brimonidine and latanoprost as adjunctive therapy in patients with ocular hypertension or >,<glaucoma>
{reduction of intraocular <pressure>reduces the risk of glaucoma progression covering the whole spectrum of <glaucoma>}
{<pressure>,<reduces the risk of glaucoma progression covering the whole spectrum of >,<glaucoma>
{difference in intraocular <pressure>IOP measurements between dynamic contour tonometry DCT and Goldmann applanation tonometry GAT is correlated with axial length AL and to assess the possible influence of age sex central corneal thickness CCT corneal hysteresis CH ocular pulse amplitude OPA and <glaucoma>}
{<pressure>,<IOP measurements between dynamic contour tonometry DCT and Goldmann applanation tonometry GAT is correlated with axial length AL and to assess the possible influence of age sex central corneal thickness CCT corneal hysteresis CH ocular pulse amplitude OPA and >,<glaucoma>
{level of intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{toward low perfusion <pressure>which is consistent with observations that <glaucoma>}
{<pressure>,<which is consistent with observations that >,<glaucoma>
{relevant to intraocular <pressure>regulation in health and <glaucoma>}
{<pressure>,<regulation in health and >,<glaucoma>
{mm Hg and <pressure>reduction without <glaucoma>}
{<pressure>,<reduction without >,<glaucoma>
{mean ocular perfusion <pressure>MOPP and the rate of paracentral visual field PVF progression in patients with medically treated normal-tension <glaucoma>}
{<pressure>,<MOPP and the rate of paracentral visual field PVF progression in patients with medically treated normal-tension >,<glaucoma>
{NSAIDs on intraocular <pressure>and the hypertensive phase after Ahmed <glaucoma>}
{<pressure>,<and the hypertensive phase after Ahmed >,<glaucoma>
{intraocular pressure blood <pressure>cardiovascular pathology and prior <glaucoma>}
{<pressure>,<cardiovascular pathology and prior >,<glaucoma>
{steeper trans-lamina cribrosa <pressure>gradient are important for glaucomatous optic nerve damage a low orbital CSFP would therefore play a role in the pathogenesis of normal-tension <glaucoma>}
{<pressure>,<gradient are important for glaucomatous optic nerve damage a low orbital CSFP would therefore play a role in the pathogenesis of normal-tension >,<glaucoma>
{relationship with 24-hÂ intraocular <pressure>and blood pressure in <glaucoma>}
{<pressure>,<and blood pressure in >,<glaucoma>
{ Elevated intraocular <pressure>IOP remains the most important risk factor for <glaucoma>}
{<pressure>,<IOP remains the most important risk factor for >,<glaucoma>
{  The <pressure>decays in three out of four eyes with narrow-angle <glaucoma>}
{<pressure>,<decays in three out of four eyes with narrow-angle >,<glaucoma>
{adequately control intraocular <pressure>in a group of patients with refractory <glaucoma>}
{<pressure>,<in a group of patients with refractory >,<glaucoma>
{of lowering intraocular <pressure>in both ocular hypertensive and <glaucoma>}
{<pressure>,<in both ocular hypertensive and >,<glaucoma>
{the diurnal intraocular <pressure>IOP efficacy and safety of timolol vs latanoprost in subjects with exfoliation <glaucoma>}
{<pressure>,<IOP efficacy and safety of timolol vs latanoprost in subjects with exfoliation >,<glaucoma>
{pattern of intraocular <pressure>IOP reduction following selective laser trabeculoplasty SLT versus argon laser trabeculoplasty ALT in open-angle <glaucoma>}
{<pressure>,<IOP reduction following selective laser trabeculoplasty SLT versus argon laser trabeculoplasty ALT in open-angle >,<glaucoma>
{one eye intraocular <pressure>IOP or = 18 mmHg average of the two highest readings of the round-the-clock curve including one reading at midnight in supine position no prior <glaucoma>}
{<pressure>,<IOP or = 18 mmHg average of the two highest readings of the round-the-clock curve including one reading at midnight in supine position no prior >,<glaucoma>
{than average blood <pressure>levels in advance of <glaucoma>}
{<pressure>,<levels in advance of >,<glaucoma>
{Pattern of intraocular <pressure>reduction following laser trabeculoplasty in open-angle <glaucoma>}
{<pressure>,<reduction following laser trabeculoplasty in open-angle >,<glaucoma>
{of lowering intraocular <pressure>in normal-tension <glaucoma>}
{<pressure>,<in normal-tension >,<glaucoma>
{trend in intraocular <pressure>more than placebo after trabeculectomy for open-angle <glaucoma>}
{<pressure>,<more than placebo after trabeculectomy for open-angle >,<glaucoma>
{drops on intraocular <pressure>and aqueous humor flow in healthy volunteers and patients with open-angle <glaucoma>}
{<pressure>,<and aqueous humor flow in healthy volunteers and patients with open-angle >,<glaucoma>
{ Elevated intraocular <pressure>IOP is a strong risk factor although a subset of POAG patients has normal IOP and is designated normal tension <glaucoma>}
{<pressure>,<IOP is a strong risk factor although a subset of POAG patients has normal IOP and is designated normal tension >,<glaucoma>
{and elevated intraocular <pressure>IOP are frequently suspicious for <glaucoma>}
{<pressure>,<IOP are frequently suspicious for >,<glaucoma>
{ Central blood <pressure>arterial waveform analysis and vascular risk factors in <glaucoma>}
{<pressure>,<arterial waveform analysis and vascular risk factors in >,<glaucoma>
{drops on intraocular <pressure>and pulsatile ocular blood flow a 180-day randomized double-masked comparison with latanoprost eye drops in patients with open-angle <glaucoma>}
{<pressure>,<and pulsatile ocular blood flow a 180-day randomized double-masked comparison with latanoprost eye drops in patients with open-angle >,<glaucoma>
{reduction in intraocular <pressure>and in some cases <glaucoma>}
{<pressure>,<and in some cases >,<glaucoma>
{and postoperative intraocular <pressure>reduction in patients with the closed angle <glaucoma>}
{<pressure>,<reduction in patients with the closed angle >,<glaucoma>
{visual acuity intraocular <pressure>IOP measurement using Goldmann tonometry number of <glaucoma>}
{<pressure>,<IOP measurement using Goldmann tonometry number of >,<glaucoma>
{iridotomy on intraocular <pressure>in pigmentary <glaucoma>}
{<pressure>,<in pigmentary >,<glaucoma>
{ Ocular perfusion <pressure>and the incidence of <glaucoma>}
{<pressure>,<and the incidence of >,<glaucoma>
{iridotomy on intraocular <pressure>IOP and the iris morphology in pigmentary <glaucoma>}
{<pressure>,<IOP and the iris morphology in pigmentary >,<glaucoma>
{ Elevated intraocular <pressure>IOP can damage the optic nerve and is a risk factor for <glaucoma>}
{<pressure>,<IOP can damage the optic nerve and is a risk factor for >,<glaucoma>
{4 angle intraocular <pressure>IOP assessed with the Goldmann applanation tonometry optic disc examination results and a visual field test results using frequency-doubling perimetry in cases in which <glaucoma>}
{<pressure>,<IOP assessed with the Goldmann applanation tonometry optic disc examination results and a visual field test results using frequency-doubling perimetry in cases in which >,<glaucoma>
{further help identify <pressure>levels that prevent worsening of <glaucoma>}
{<pressure>,<levels that prevent worsening of >,<glaucoma>
{and ocular perfusion <pressure>OPP measurements in normal volunteers untreated normal-tension <glaucoma>}
{<pressure>,<OPP measurements in normal volunteers untreated normal-tension >,<glaucoma>
{24 h intraocular <pressure>IOP control of morning and evening administered bimatoprost/timolol fixed combination BTFC and evening administered bimatoprost in exfoliative <glaucoma>}
{<pressure>,<IOP control of morning and evening administered bimatoprost/timolol fixed combination BTFC and evening administered bimatoprost in exfoliative >,<glaucoma>
{long-term stable intra-ocular <pressure>with a contemporary low complication rate in the case of primary open angle- and pseudoexfoliative <glaucoma>}
{<pressure>,<with a contemporary low complication rate in the case of primary open angle- and pseudoexfoliative >,<glaucoma>
{long-term elevated intraocular <pressure>IOP <glaucoma>}
{<pressure>,<IOP >,<glaucoma>
{pattern of intraocular <pressure>and visual field damage in eyes with normal-tension <glaucoma>}
{<pressure>,<and visual field damage in eyes with normal-tension >,<glaucoma>
{develop elevated intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{combinations on intraocular <pressure>IOP visual function and retrobulbar blood flow in patients with open-angle <glaucoma>}
{<pressure>,<IOP visual function and retrobulbar blood flow in patients with open-angle >,<glaucoma>
{did not achieve <pressure>control in all patients especially in the low target pressure range the risk profile appears to be more favorable in the trabecular aspiration-treated eyes than in the filtering <glaucoma>}
{<pressure>,<control in all patients especially in the low target pressure range the risk profile appears to be more favorable in the trabecular aspiration-treated eyes than in the filtering >,<glaucoma>
{how systemic blood <pressure>affects waveform variables in <glaucoma>}
{<pressure>,<affects waveform variables in >,<glaucoma>
{PURPOSE Uncontrolled intraocular <pressure>IOP after glaucoma filtration surgery is a challenging problem in the management of <glaucoma>}
{<pressure>,<IOP after glaucoma filtration surgery is a challenging problem in the management of >,<glaucoma>
{latanoprost on intraocular <pressure>in steroid-induced <glaucoma>}
{<pressure>,<in steroid-induced >,<glaucoma>
{level of intraocular <pressure>IOP the open angle glaucoma is arbitrarily divided into high tension <glaucoma>}
{<pressure>,<IOP the open angle glaucoma is arbitrarily divided into high tension >,<glaucoma>
{reduction of intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{obviously an efficient <pressure>reducing drug which can be used in <glaucoma>}
{<pressure>,<reducing drug which can be used in >,<glaucoma>
{endothelin in intraocular <pressure>control its effect on the trabecular meshwork TM and the outflow facility effect on ocular blood flow and vascular regulation and the potential role of endothelin-1 ET-1 antagonism in the therapeutic paradigm of <glaucoma>}
{<pressure>,<control its effect on the trabecular meshwork TM and the outflow facility effect on ocular blood flow and vascular regulation and the potential role of endothelin-1 ET-1 antagonism in the therapeutic paradigm of >,<glaucoma>
{PURPOSE Evaluate the <pressure>tolerance of dexamethasone implants in open-angle <glaucoma>}
{<pressure>,<tolerance of dexamethasone implants in open-angle >,<glaucoma>
{the long-term intraocular <pressure>IOP control and to identify risk factors for failure of repeat trabeculectomy with mitomycin C MMC in patients with open-angle <glaucoma>}
{<pressure>,<IOP control and to identify risk factors for failure of repeat trabeculectomy with mitomycin C MMC in patients with open-angle >,<glaucoma>
{the lower intraocular <pressure>readings found in normal-tension <glaucoma>}
{<pressure>,<readings found in normal-tension >,<glaucoma>
{and diurnal intraocular <pressure>IOP in Chinese healthy volunteers normal tension <glaucoma>}
{<pressure>,<IOP in Chinese healthy volunteers normal tension >,<glaucoma>
{ALT in intraocular <pressure>reduction in patients with open-angle <glaucoma>}
{<pressure>,<reduction in patients with open-angle >,<glaucoma>
{visual acuity intraocular <pressure>IOP visual field indices presence or absence of glaucomatous optic disc changes and diagnosis of <glaucoma>}
{<pressure>,<IOP visual field indices presence or absence of glaucomatous optic disc changes and diagnosis of >,<glaucoma>
{  The <pressure>in the AC is defined as the intraocular pressure IOP which when elevated beyond statistically normal limits is a recognized risk factor for <glaucoma>}
{<pressure>,<in the AC is defined as the intraocular pressure IOP which when elevated beyond statistically normal limits is a recognized risk factor for >,<glaucoma>
{reduction of intraocular <pressure>IOP has been proven beneficial in a large fraction of <glaucoma>}
{<pressure>,<IOP has been proven beneficial in a large fraction of >,<glaucoma>
{in mean intraocular <pressure>IOP from baseline and was more effective than brinzolamide or timolol monotherapy in lowering IOP in a 6-month randomized phase III trial in patients with open-angle <glaucoma>}
{<pressure>,<IOP from baseline and was more effective than brinzolamide or timolol monotherapy in lowering IOP in a 6-month randomized phase III trial in patients with open-angle >,<glaucoma>
{and his intraocular <pressure>was controlled without any <glaucoma>}
{<pressure>,<was controlled without any >,<glaucoma>
{and diurnal intraocular <pressure>in Japanese normal-tension <glaucoma>}
{<pressure>,<in Japanese normal-tension >,<glaucoma>
{ in intraocular <pressure>IOP elevation and optic nerve damage may be involved in the pathogenesis of <glaucoma>}
{<pressure>,<IOP elevation and optic nerve damage may be involved in the pathogenesis of >,<glaucoma>
{interact with intraocular <pressure>IOP elevations in determining the course of <glaucoma>}
{<pressure>,<IOP elevations in determining the course of >,<glaucoma>
{response to intraocular <pressure>IOP -lowering medications as a function of <glaucoma>}
{<pressure>,<IOP -lowering medications as a function of >,<glaucoma>
{between increased intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{control of intraocular <pressure>and systemic risk factor for visual field progression in normal-tension <glaucoma>}
{<pressure>,<and systemic risk factor for visual field progression in normal-tension >,<glaucoma>
{and diurnal intraocular <pressure>IOP in Japanese normal-tension <glaucoma>}
{<pressure>,<IOP in Japanese normal-tension >,<glaucoma>
{symptoms and intraocular <pressure>IOP in newly diagnosed and untreated patients with open-angle <glaucoma>}
{<pressure>,<IOP in newly diagnosed and untreated patients with open-angle >,<glaucoma>
{surgery on intraocular <pressure>control in <glaucoma>}
{<pressure>,<control in >,<glaucoma>
{Viagra on intraocular <pressure>in open-angle <glaucoma>}
{<pressure>,<in open-angle >,<glaucoma>
{and high intraocular <pressure>groups in normal tension <glaucoma>}
{<pressure>,<groups in normal tension >,<glaucoma>
{decrease in intraocular <pressure>IOP of 3 mmHg or more with no additional medications laser or <glaucoma>}
{<pressure>,<IOP of 3 mmHg or more with no additional medications laser or >,<glaucoma>
{to control intraocular <pressure>IOP and visual rehabilitation in patients with cataract and <glaucoma>}
{<pressure>,<IOP and visual rehabilitation in patients with cataract and >,<glaucoma>
{of elevated intraocular <pressure>it is now clear that <glaucoma>}
{<pressure>,<it is now clear that >,<glaucoma>
{Control of intraocular <pressure>is still the main strategy to treat <glaucoma>}
{<pressure>,<is still the main strategy to treat >,<glaucoma>
{the circadian blood <pressure>rhythm and the retrobulbar blood flow in <glaucoma>}
{<pressure>,<rhythm and the retrobulbar blood flow in >,<glaucoma>
{and follow-up intraocular <pressure>in open-angle <glaucoma>}
{<pressure>,<in open-angle >,<glaucoma>
{at controlling intraocular <pressure>and preserving visual function as medical treatment for newly diagnosed <glaucoma>}
{<pressure>,<and preserving visual function as medical treatment for newly diagnosed >,<glaucoma>
{effect on intraocular <pressure>in healthy subjects but induces a significant hypertensive effect in patients with initial <glaucoma>}
{<pressure>,<in healthy subjects but induces a significant hypertensive effect in patients with initial >,<glaucoma>
{and high intraocular <pressure>IOP groups in normal tension <glaucoma>}
{<pressure>,<IOP groups in normal tension >,<glaucoma>
{variability of intraocular <pressure>values has important implications in the scheduling of <glaucoma>}
{<pressure>,<values has important implications in the scheduling of >,<glaucoma>
{preoperative mean intraocular <pressure>mean number of medications and <glaucoma>}
{<pressure>,<mean number of medications and >,<glaucoma>
{amount of intraocular <pressure>IOP reduction with topical medications is associated with the progression of normal-tension <glaucoma>}
{<pressure>,<IOP reduction with topical medications is associated with the progression of normal-tension >,<glaucoma>
{several topical intraocular <pressure>IOP -lowering <glaucoma>}
{<pressure>,<IOP -lowering >,<glaucoma>
{and elevated intraocular <pressure>with subsequent selective loss of retinal ganglion cells and optic nerve head cupping which are the hallmarks of <glaucoma>}
{<pressure>,<with subsequent selective loss of retinal ganglion cells and optic nerve head cupping which are the hallmarks of >,<glaucoma>
{of elevated intraocular <pressure>optic nerve damage and/or visual field loss consistent with <glaucoma>}
{<pressure>,<optic nerve damage and/or visual field loss consistent with >,<glaucoma>
{the follow-up intraocular <pressure>IOP in open-angle <glaucoma>}
{<pressure>,<IOP in open-angle >,<glaucoma>
{of print Translaminar <pressure>in Caucasian normal tension <glaucoma>}
{<pressure>,<in Caucasian normal tension >,<glaucoma>
{better control intraocular <pressure>and to ultimately delay the onset of myocilin <glaucoma>}
{<pressure>,<and to ultimately delay the onset of myocilin >,<glaucoma>
{IOL on intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{level of intraocular <pressure>IOP open angle glaucoma is divided into high tension <glaucoma>}
{<pressure>,<IOP open angle glaucoma is divided into high tension >,<glaucoma>
{ Life under <pressure>The role of ocular cribriform cells in preventing <glaucoma>}
{<pressure>,<The role of ocular cribriform cells in preventing >,<glaucoma>
{fluctuations in intraocular <pressure>in the same day versus over different days in <glaucoma>}
{<pressure>,<in the same day versus over different days in >,<glaucoma>
{lower postoperative intraocular <pressure>and reduced postoperative <glaucoma>}
{<pressure>,<and reduced postoperative >,<glaucoma>
{nocturnal ocular perfusion <pressure>as a risk factor for normal tension <glaucoma>}
{<pressure>,<as a risk factor for normal tension >,<glaucoma>
{implantation on intraocular <pressure>IOP and medication use in open-angle <glaucoma>}
{<pressure>,<IOP and medication use in open-angle >,<glaucoma>
{of systemic blood <pressure>and choroidal blood flow in <glaucoma>}
{<pressure>,<and choroidal blood flow in >,<glaucoma>
{brimonidine on intraocular <pressure>in the treatment of <glaucoma>}
{<pressure>,<in the treatment of >,<glaucoma>
{Reduction of intraocular <pressure>IOP is still the primary goal of <glaucoma>}
{<pressure>,<IOP is still the primary goal of >,<glaucoma>
{and ocular perfusion <pressure>measurements in Chinese volunteers and <glaucoma>}
{<pressure>,<measurements in Chinese volunteers and >,<glaucoma>
{thickness on intraocular <pressure>among Ethiopian <glaucoma>}
{<pressure>,<among Ethiopian >,<glaucoma>
{accurately using intraocular <pressure>measurements in <glaucoma>}
{<pressure>,<measurements in >,<glaucoma>
{outflow elevated intraocular <pressure>IOP and ultimately <glaucoma>}
{<pressure>,<IOP and ultimately >,<glaucoma>
{Highest recorded intraocular <pressure>IOP also was analyzed both with and without correction for central corneal thickness CCT and was dichotomized into high-tension glaucoma and normal-tension <glaucoma>}
{<pressure>,<IOP also was analyzed both with and without correction for central corneal thickness CCT and was dichotomized into high-tension glaucoma and normal-tension >,<glaucoma>
{  this <pressure>is drastically elevated in <glaucoma>}
{<pressure>,<is drastically elevated in >,<glaucoma>
{calculated ocular perfusion <pressure>OPP in patients with open-angle <glaucoma>}
{<pressure>,<OPP in patients with open-angle >,<glaucoma>
{ Lowering intraocular <pressure>a known risk factor for progression has been the mainstay of <glaucoma>}
{<pressure>,<a known risk factor for progression has been the mainstay of >,<glaucoma>
{BP ocular perfusion <pressure>OPP and intraocular pressure IOP in patients with open-angle <glaucoma>}
{<pressure>,<OPP and intraocular pressure IOP in patients with open-angle >,<glaucoma>
{latanoprost induced intraocular <pressure>IOP reduction in <glaucoma>}
{<pressure>,<IOP reduction in >,<glaucoma>
{ Diastolic blood <pressure>and alcohol use appeared to be more strongly associated with <glaucoma>}
{<pressure>,<and alcohol use appeared to be more strongly associated with >,<glaucoma>
{and ocular perfusion <pressure>OPP in patients with normal-tension <glaucoma>}
{<pressure>,<OPP in patients with normal-tension >,<glaucoma>
{their increased intraocular <pressure>IOP anterior segment abnormalities including findings on gonioscopy and the absence of other causes of childhood <glaucoma>}
{<pressure>,<IOP anterior segment abnormalities including findings on gonioscopy and the absence of other causes of childhood >,<glaucoma>
{rise in intraocular <pressure>or change in anterior chamber angle in patients with open-angle <glaucoma>}
{<pressure>,<or change in anterior chamber angle in patients with open-angle >,<glaucoma>
{properties on intraocular <pressure>IOP measured with the ICare and to compare IOP readings obtained with ICare Ocular Response Analyzer ORA and Goldmann applanation tonometry GAT in normal-tension <glaucoma>}
{<pressure>,<IOP measured with the ICare and to compare IOP readings obtained with ICare Ocular Response Analyzer ORA and Goldmann applanation tonometry GAT in normal-tension >,<glaucoma>
{the individual normalocular <pressure>a step forward in the <glaucoma>}
{<pressure>,<a step forward in the >,<glaucoma>
{ elevated intraocular <pressure>and acute closed-angle <glaucoma>}
{<pressure>,<and acute closed-angle >,<glaucoma>
{changes of intraocular <pressure>IOP and mean ocular perfusion pressure MOPP obtained with tafluprost versus travoprost in patients with normal-tension <glaucoma>}
{<pressure>,<IOP and mean ocular perfusion pressure MOPP obtained with tafluprost versus travoprost in patients with normal-tension >,<glaucoma>
{visual acuity intraocular <pressure>measurement using Goldmann tonometry number of <glaucoma>}
{<pressure>,<measurement using Goldmann tonometry number of >,<glaucoma>
{between elevated intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{differences in post-operative <pressure>level existed between the different types of <glaucoma>}
{<pressure>,<level existed between the different types of >,<glaucoma>
{decreases in intraocular <pressure>IOP of 3 mmHg or more with no additional medications laser or <glaucoma>}
{<pressure>,<IOP of 3 mmHg or more with no additional medications laser or >,<glaucoma>
{influences on intraocular <pressure>in patients with chronic <glaucoma>}
{<pressure>,<in patients with chronic >,<glaucoma>
{from uncontrolled intraocular <pressure>is another potential iris finding in pediatric <glaucoma>}
{<pressure>,<is another potential iris finding in pediatric >,<glaucoma>
{travoprost on intraocular <pressure>IOP of chronic open-angle <glaucoma>}
{<pressure>,<IOP of chronic open-angle >,<glaucoma>
{  The <pressure>reducing effect is good both in simple and capsular <glaucoma>}
{<pressure>,<reducing effect is good both in simple and capsular >,<glaucoma>
{response to intraocular <pressure>IOP lowering in patients with open-angle <glaucoma>}
{<pressure>,<IOP lowering in patients with open-angle >,<glaucoma>
{band to lower <pressure>in open-angle <glaucoma>}
{<pressure>,<in open-angle >,<glaucoma>
{reduction of intraocular <pressure>IOP by a single-session 270Â° selective laser trabeculoplasty SLT in pseudoexfoliation <glaucoma>}
{<pressure>,<IOP by a single-session 270Â° selective laser trabeculoplasty SLT in pseudoexfoliation >,<glaucoma>
{shown paradigmatically the <pressure>tolerance test shows to be a valuable tool in the differential diagnosis of <glaucoma>}
{<pressure>,<tolerance test shows to be a valuable tool in the differential diagnosis of >,<glaucoma>
{ lowered intraocular <pressure>significantly in both the <glaucoma>}
{<pressure>,<significantly in both the >,<glaucoma>
{highest known intraocular <pressure>IOP target IOP diagnosis years with glaucoma cup-to-disk ratio CDR mean defect MD pattern standard deviation PSD <glaucoma>}
{<pressure>,<IOP target IOP diagnosis years with glaucoma cup-to-disk ratio CDR mean defect MD pattern standard deviation PSD >,<glaucoma>
{of increased intraocular <pressure>in primary <glaucoma>}
{<pressure>,<in primary >,<glaucoma>
{latanoprost on intraocular <pressure>and ocular symptoms in patients with open-angle <glaucoma>}
{<pressure>,<and ocular symptoms in patients with open-angle >,<glaucoma>
{  The <pressure>increase was higher than in earlier reports on LTP in presurgical <glaucoma>}
{<pressure>,<increase was higher than in earlier reports on LTP in presurgical >,<glaucoma>
{in reducing intraocular <pressure>IOP and are commonly used in the medical treatment of <glaucoma>}
{<pressure>,<IOP and are commonly used in the medical treatment of >,<glaucoma>
{ Long-term intraocular <pressure>change after clear corneal phacoemulsification in Thai <glaucoma>}
{<pressure>,<change after clear corneal phacoemulsification in Thai >,<glaucoma>
{the clinical intraocular <pressure>in pigmentary <glaucoma>}
{<pressure>,<in pigmentary >,<glaucoma>
{PURPOSE High intraocular <pressure>IOP is a major risk factor for <glaucoma>}
{<pressure>,<IOP is a major risk factor for >,<glaucoma>
{exercise on intraocular <pressure>in pigmentary <glaucoma>}
{<pressure>,<in pigmentary >,<glaucoma>
{and less the <pressure>amplitude which has the main influence on the rate of the <glaucoma>}
{<pressure>,<amplitude which has the main influence on the rate of the >,<glaucoma>
{abruptly higher intraocular <pressure>is measurably reduced in <glaucoma>}
{<pressure>,<is measurably reduced in >,<glaucoma>
{ Cornea intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{ Postoperative intraocular <pressure>IOP was measured in patients with open-angle <glaucoma>}
{<pressure>,<IOP was measured in patients with open-angle >,<glaucoma>
{for lowering intraocular <pressure>in Thai patients with open-angle <glaucoma>}
{<pressure>,<in Thai patients with open-angle >,<glaucoma>
{arteries exerting pulsating <pressure>on intracranial portions of the optic tract a basal factor of <glaucoma>}
{<pressure>,<on intracranial portions of the optic tract a basal factor of >,<glaucoma>
{disturbances in intraocular <pressure>regulation using up-to-date adequate methods--ultrasound dopplerography rheography fluorescence angiography electron tonography as well as other traditional methods allow to make a conclusion that glaucoma with low intraocular pressure is a variant of the development of a typical open-angle <glaucoma>}
{<pressure>,<regulation using up-to-date adequate methods--ultrasound dopplerography rheography fluorescence angiography electron tonography as well as other traditional methods allow to make a conclusion that glaucoma with low intraocular pressure is a variant of the development of a typical open-angle >,<glaucoma>
{reduction in intraocular <pressure>in patients with primary open angle glaucoma or normal tension <glaucoma>}
{<pressure>,<in patients with primary open angle glaucoma or normal tension >,<glaucoma>
{the advantages of <pressure>reduction without narrowing of the pupils in the treatment of all types of open-angle <glaucoma>}
{<pressure>,<reduction without narrowing of the pupils in the treatment of all types of open-angle >,<glaucoma>
{BP ocular perfusion <pressure>OPP and diastolic ocular perfusion pressure DOPP in patients with normal-tension <glaucoma>}
{<pressure>,<OPP and diastolic ocular perfusion pressure DOPP in patients with normal-tension >,<glaucoma>
{basis of the <pressure>level required for control of the <glaucoma>}
{<pressure>,<level required for control of the >,<glaucoma>
{CONCLUSION Systemic blood <pressure>and hypertension are associated with IOP and high-tension <glaucoma>}
{<pressure>,<and hypertension are associated with IOP and high-tension >,<glaucoma>
{decreasing elevated intraocular <pressure>IOP in patients with open-angle <glaucoma>}
{<pressure>,<IOP in patients with open-angle >,<glaucoma>
{by maintaining intraocular <pressure>at a low level will protect a <glaucoma>}
{<pressure>,<at a low level will protect a >,<glaucoma>
{insertion for intraocular <pressure>IOP control in eyes with <glaucoma>}
{<pressure>,<IOP control in eyes with >,<glaucoma>
{development of intraocular <pressure>IOP after PK in patients with PEX-keratopathy depending on the presence of pre-existing <glaucoma>}
{<pressure>,<IOP after PK in patients with PEX-keratopathy depending on the presence of pre-existing >,<glaucoma>
{its effects on <pressure>in open-angle <glaucoma>}
{<pressure>,<in open-angle >,<glaucoma>
{  The <pressure>reduction obtained in healthy eyes with this dose of PGF2 alpha-IE was less than one would expect with conventional <glaucoma>}
{<pressure>,<reduction obtained in healthy eyes with this dose of PGF2 alpha-IE was less than one would expect with conventional >,<glaucoma>
{level of intraocular <pressure>and the extent of optic disc and visual field changes in normal-tension <glaucoma>}
{<pressure>,<and the extent of optic disc and visual field changes in normal-tension >,<glaucoma>
{effect on the <pressure>in open-angle <glaucoma>}
{<pressure>,<in open-angle >,<glaucoma>
{ However the <pressure>reduction in response to this dose of PGF2 alpha-IE among <glaucoma>}
{<pressure>,<reduction in response to this dose of PGF2 alpha-IE among >,<glaucoma>
{the postoperative intraocular <pressure>IOP level visual prognosis and complications of trabeculectomy with adjunctive mitomycin C in normal-tension <glaucoma>}
{<pressure>,<IOP level visual prognosis and complications of trabeculectomy with adjunctive mitomycin C in normal-tension >,<glaucoma>
{amount of intraocular <pressure>IOP asymmetry in a large group of ethnically diverse patients with and without glaucoma and to delineate the risk for <glaucoma>}
{<pressure>,<IOP asymmetry in a large group of ethnically diverse patients with and without glaucoma and to delineate the risk for >,<glaucoma>
{ Elevated intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{experiment on intraocular <pressure>in patients with open-angle <glaucoma>}
{<pressure>,<in patients with open-angle >,<glaucoma>
{without increased intraocular <pressure>or visual field loss and early stage normal-tension <glaucoma>}
{<pressure>,<or visual field loss and early stage normal-tension >,<glaucoma>
{involved in intraocular <pressure>IOP elevation in <glaucoma>}
{<pressure>,<IOP elevation in >,<glaucoma>
{reduction of intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{increase in intraocular <pressure>present in the eye with <glaucoma>}
{<pressure>,<present in the eye with >,<glaucoma>
{ Diurnal intraocular <pressure>variation in low-tension <glaucoma>}
{<pressure>,<variation in low-tension >,<glaucoma>
{ Elevated intraocular <pressure>or <glaucoma>}
{<pressure>,<or >,<glaucoma>
{variation of intraocular <pressure>IOP in normal-tension <glaucoma>}
{<pressure>,<IOP in normal-tension >,<glaucoma>
{the initial intraocular <pressure>the horizontal cup/disk ratio and family history of <glaucoma>}
{<pressure>,<the horizontal cup/disk ratio and family history of >,<glaucoma>
{fluctuation of intraocular <pressure>IOP in normal-tension <glaucoma>}
{<pressure>,<IOP in normal-tension >,<glaucoma>
{variation of intraocular <pressure>IOP is indispensable for the diagnosis of normal-tension <glaucoma>}
{<pressure>,<IOP is indispensable for the diagnosis of normal-tension >,<glaucoma>
{trabeculectomy on intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{significantly reduces intraocular <pressure>in patients with open-angle <glaucoma>}
{<pressure>,<in patients with open-angle >,<glaucoma>
{response in applanation <pressure>to intravenous acetazolamide in primary glaucomas and <glaucoma>}
{<pressure>,<to intravenous acetazolamide in primary glaucomas and >,<glaucoma>
{extremely low intraocular <pressure>levels to limit further <glaucoma>}
{<pressure>,<levels to limit further >,<glaucoma>
{and ocular perfusion <pressure>OPP a consistent risk factor for <glaucoma>}
{<pressure>,<OPP a consistent risk factor for >,<glaucoma>
{reductions in intraocular <pressure>may delay or obviate the need for surgery for open-angle <glaucoma>}
{<pressure>,<may delay or obviate the need for surgery for open-angle >,<glaucoma>
{increase in intraocular <pressure>occasionally occurred shortly after treatment but chronic exacerbation of underlying <glaucoma>}
{<pressure>,<occasionally occurred shortly after treatment but chronic exacerbation of underlying >,<glaucoma>
{maleate and intra-ocular <pressure>in low-tension <glaucoma>}
{<pressure>,<in low-tension >,<glaucoma>
{low systolic blood <pressure>was found to be the risk factor more often in patients with low-tension <glaucoma>}
{<pressure>,<was found to be the risk factor more often in patients with low-tension >,<glaucoma>
{ Can intraocular <pressure>asymmetry indicate undiagnosed primary <glaucoma>}
{<pressure>,<asymmetry indicate undiagnosed primary >,<glaucoma>
{ Increased intraocular <pressure>is a common feature of <glaucoma>}
{<pressure>,<is a common feature of >,<glaucoma>
{and ocular perfusion <pressure>in untreated normal-tension <glaucoma>}
{<pressure>,<in untreated normal-tension >,<glaucoma>
{with elevated intraocular <pressure>or symptomatic dellen formation unresponsive to conservative therapy developed in 24 of 222 eyes following <glaucoma>}
{<pressure>,<or symptomatic dellen formation unresponsive to conservative therapy developed in 24 of 222 eyes following >,<glaucoma>
{Central retinal venous <pressure>in eyes of normal-tension <glaucoma>}
{<pressure>,<in eyes of normal-tension >,<glaucoma>
{central retinal venous <pressure>CRVP among eyes with and without optic disc hemorrhage ODH in bilateral normal-tension <glaucoma>}
{<pressure>,<CRVP among eyes with and without optic disc hemorrhage ODH in bilateral normal-tension >,<glaucoma>
{change in intraocular <pressure>autoregulation was studied using the blue field entopic phenomenon in 11 open angle glaucoma patients eight <glaucoma>}
{<pressure>,<autoregulation was studied using the blue field entopic phenomenon in 11 open angle glaucoma patients eight >,<glaucoma>
{a low intraocular <pressure>in all <glaucoma>}
{<pressure>,<in all >,<glaucoma>
{phacoemulsification on intraocular <pressure>in eyes with primary angle closure <glaucoma>}
{<pressure>,<in eyes with primary angle closure >,<glaucoma>
{ frequency intraocular <pressure>IOP <glaucoma>}
{<pressure>,<IOP >,<glaucoma>
{with elevated intraocular <pressure>were commonly seen after Ahmed <glaucoma>}
{<pressure>,<were commonly seen after Ahmed >,<glaucoma>
{significantly higher intraocular <pressure>than eyes with simple glaucoma in corresponding <glaucoma>}
{<pressure>,<than eyes with simple glaucoma in corresponding >,<glaucoma>
{analyze circadian intraocular <pressure>IOP patterns in <glaucoma>}
{<pressure>,<IOP patterns in >,<glaucoma>
{of increased intraocular <pressure>in juvenile <glaucoma>}
{<pressure>,<in juvenile >,<glaucoma>
{estimated trans-lamina cribrosa <pressure>difference TLCPD and prevalence of normal tension <glaucoma>}
{<pressure>,<difference TLCPD and prevalence of normal tension >,<glaucoma>
{that systemic blood <pressure>fundamentally influences ocular circulation and consequently <glaucoma>}
{<pressure>,<fundamentally influences ocular circulation and consequently >,<glaucoma>
{of the intra-ocular <pressure>IOP is the mainstay of treatment for <glaucoma>}
{<pressure>,<IOP is the mainstay of treatment for >,<glaucoma>
{intraocular pressure blood <pressure>and heart rate in 10 <glaucoma>}
{<pressure>,<and heart rate in 10 >,<glaucoma>
{BP ocular perfusion <pressure>OPP and diastolic ocular perfusion pressure DOPP between the latanoprost and DTFC groups in patients with normal-tension <glaucoma>}
{<pressure>,<OPP and diastolic ocular perfusion pressure DOPP between the latanoprost and DTFC groups in patients with normal-tension >,<glaucoma>
{of systemic blood <pressure>with ocular perfusion pressure and intraocular pressure of <glaucoma>}
{<pressure>,<with ocular perfusion pressure and intraocular pressure of >,<glaucoma>
{the long-term intraocular <pressure>course for patients with pigmentary <glaucoma>}
{<pressure>,<course for patients with pigmentary >,<glaucoma>
{The mean intraocular <pressure>IOP reduction was greater in capsular glaucoma 37% than in simple <glaucoma>}
{<pressure>,<IOP reduction was greater in capsular glaucoma 37% than in simple >,<glaucoma>
{changes in blood <pressure>in each <glaucoma>}
{<pressure>,<in each >,<glaucoma>
{ on intraocular <pressure>IOP in patients with open-angle <glaucoma>}
{<pressure>,<IOP in patients with open-angle >,<glaucoma>
{survey for intraocular <pressure>in ocular hypertensive and <glaucoma>}
{<pressure>,<in ocular hypertensive and >,<glaucoma>
{the control of <pressure>if an operation involving iridectomy has not been completely successful in open-angle <glaucoma>}
{<pressure>,<if an operation involving iridectomy has not been completely successful in open-angle >,<glaucoma>
{The median intraocular <pressure>value was lowered in patients with secondary <glaucoma>}
{<pressure>,<value was lowered in patients with secondary >,<glaucoma>
{Although elevated intraocular <pressure>is the major risk factor there is increasing evidence that the pathogenesis of <glaucoma>}
{<pressure>,<is the major risk factor there is increasing evidence that the pathogenesis of >,<glaucoma>
{variations of intraocular <pressure>in open-angle <glaucoma>}
{<pressure>,<in open-angle >,<glaucoma>
{elevation in intraocular <pressure>than GLC1A <glaucoma>}
{<pressure>,<than GLC1A >,<glaucoma>
{evidence for intraocular <pressure>IOP -dependent optic disc cupping change in adult <glaucoma>}
{<pressure>,<IOP -dependent optic disc cupping change in adult >,<glaucoma>
{the high intraocular <pressure>in open-angle <glaucoma>}
{<pressure>,<in open-angle >,<glaucoma>
{differences in intraocular <pressure>IOP level and stability of <glaucoma>}
{<pressure>,<IOP level and stability of >,<glaucoma>
{effectively lower intraocular <pressure>IOP in some normal-tension <glaucoma>}
{<pressure>,<IOP in some normal-tension >,<glaucoma>
{significantly higher intraocular <pressure>peaks in pseudoexfoliative <glaucoma>}
{<pressure>,<peaks in pseudoexfoliative >,<glaucoma>
{to lower intraocular <pressure>IOP in two different rabbit <glaucoma>}
{<pressure>,<IOP in two different rabbit >,<glaucoma>
{Variations in intraocular <pressure>in normal-pressure glaucoma and in hypertensive open-angle <glaucoma>}
{<pressure>,<in normal-pressure glaucoma and in hypertensive open-angle >,<glaucoma>
{  The <pressure>tolerance test--a new technic in the differential diagnosis of <glaucoma>}
{<pressure>,<tolerance test--a new technic in the differential diagnosis of >,<glaucoma>
{increase in intraocular <pressure>IOP associated with enlargement of lens haptic PAS developed in one patient with preoperative chronic open-angle <glaucoma>}
{<pressure>,<IOP associated with enlargement of lens haptic PAS developed in one patient with preoperative chronic open-angle >,<glaucoma>
{rupture on intraocular <pressure>IOP level and the control of previous <glaucoma>}
{<pressure>,<IOP level and the control of previous >,<glaucoma>
{passages on intraocular <pressure>IOP in patients with open-angle <glaucoma>}
{<pressure>,<IOP in patients with open-angle >,<glaucoma>
{of ocular perfusion <pressure>in the pathogenesis of <glaucoma>}
{<pressure>,<in the pathogenesis of >,<glaucoma>
{ Long-term intraocular <pressure>IOP was evaluated in 41 <glaucoma>}
{<pressure>,<IOP was evaluated in 41 >,<glaucoma>
{change in intraocular <pressure>IOP and <glaucoma>}
{<pressure>,<IOP and >,<glaucoma>
{than with intraocular <pressure>it tended to be in the inferior portion of the disc at an early stage of glaucoma and in the superior portion of the disc at a more advanced stage of <glaucoma>}
{<pressure>,<it tended to be in the inferior portion of the disc at an early stage of glaucoma and in the superior portion of the disc at a more advanced stage of >,<glaucoma>
{early morning intraocular <pressure>peaks in <glaucoma>}
{<pressure>,<peaks in >,<glaucoma>
{Fluctuation of intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{25% in intraocular <pressure>in 46 patients with open and closed angle <glaucoma>}
{<pressure>,<in 46 patients with open and closed angle >,<glaucoma>
{and systolic blood <pressure>were significantly increased while finger blood flow was significantly decreased when comparing the nicotine-tested <glaucoma>}
{<pressure>,<were significantly increased while finger blood flow was significantly decreased when comparing the nicotine-tested >,<glaucoma>
{ control intraocular <pressure>or = 15 mm Hg with zero to two <glaucoma>}
{<pressure>,<or = 15 mm Hg with zero to two >,<glaucoma>
{ Elevated intraocular <pressure>and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle <glaucoma>}
{<pressure>,<and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle >,<glaucoma>
{ Ambulatory blood <pressure>monitoring in <glaucoma>}
{<pressure>,<monitoring in >,<glaucoma>
{Increase of intraocular <pressure>in patients with open-angle <glaucoma>}
{<pressure>,<in patients with open-angle >,<glaucoma>
{of mean arterial <pressure>to pulse rate was significantly less for normal subjects than for either <glaucoma>}
{<pressure>,<to pulse rate was significantly less for normal subjects than for either >,<glaucoma>
{decreases in intraocular <pressure>in open-angle <glaucoma>}
{<pressure>,<in open-angle >,<glaucoma>
{control of intraocular <pressure>one year after combined surgery in eyes with open-angle <glaucoma>}
{<pressure>,<one year after combined surgery in eyes with open-angle >,<glaucoma>
{beta-blockers on intraocular <pressure>and visual field sensitivity in ocular hypertension and chronic open-angle <glaucoma>}
{<pressure>,<and visual field sensitivity in ocular hypertension and chronic open-angle >,<glaucoma>
{demonstrated temporary intra-ocular <pressure>decrease in both healthy subjects and <glaucoma>}
{<pressure>,<decrease in both healthy subjects and >,<glaucoma>
{on post-operative intraocular <pressure>IOP and number of topical <glaucoma>}
{<pressure>,<IOP and number of topical >,<glaucoma>
{trabeculoplasty on intraocular <pressure>in pseudoexfoliation <glaucoma>}
{<pressure>,<in pseudoexfoliation >,<glaucoma>
{WMDs for intraocular <pressure>reduction a reduction in <glaucoma>}
{<pressure>,<reduction a reduction in >,<glaucoma>
{2004 for intra-ocular <pressure>lowering in the treatment of primary <glaucoma>}
{<pressure>,<lowering in the treatment of primary >,<glaucoma>
{is elevated eye <pressure>and the current standard approach in <glaucoma>}
{<pressure>,<and the current standard approach in >,<glaucoma>
{ Elevated eye <pressure>is the main risk factor for <glaucoma>}
{<pressure>,<is the main risk factor for >,<glaucoma>
{between ocular perfusion <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{blockers in intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{visual acuity intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{differences for intraocular <pressure>IOP as well as change of number of <glaucoma>}
{<pressure>,<IOP as well as change of number of >,<glaucoma>
{Reduction of intraocular <pressure>IOP by drugs is a major treatment for <glaucoma>}
{<pressure>,<IOP by drugs is a major treatment for >,<glaucoma>
{and function intraocular <pressure>central corneal thickness <glaucoma>}
{<pressure>,<central corneal thickness >,<glaucoma>
{Elevation of intraocular <pressure>IOP is a major risk factor for the development and the progression in <glaucoma>}
{<pressure>,<IOP is a major risk factor for the development and the progression in >,<glaucoma>
{as elevated intraocular <pressure>are significantly more common in eyes with medically treated glaucoma than in eyes with previous <glaucoma>}
{<pressure>,<are significantly more common in eyes with medically treated glaucoma than in eyes with previous >,<glaucoma>
{determination of intraocular <pressure>IOP is essential for correct management of <glaucoma>}
{<pressure>,<IOP is essential for correct management of >,<glaucoma>
{interpretation of intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{ Monitoring intraocular <pressure>IOP is a critically important part of <glaucoma>}
{<pressure>,<IOP is a critically important part of >,<glaucoma>
{on ocular perfu-sion <pressure>as well as an overview of the newly developed imaging technologies used to investigate ocular blood flow in <glaucoma>}
{<pressure>,<as well as an overview of the newly developed imaging technologies used to investigate ocular blood flow in >,<glaucoma>
{by lowering intraocular <pressure>IOP a major risk factor for <glaucoma>}
{<pressure>,<IOP a major risk factor for >,<glaucoma>
{conditions increase intraocular <pressure>which may result in development of <glaucoma>}
{<pressure>,<which may result in development of >,<glaucoma>
{ Lowering intraocular <pressure>IOP remains the guiding principle of <glaucoma>}
{<pressure>,<IOP remains the guiding principle of >,<glaucoma>
{ Mean intraocular <pressure>and mean number of <glaucoma>}
{<pressure>,<and mean number of >,<glaucoma>
{measures were intraocular <pressure>IOP number of glaucoma medications prescribed best corrected visual acuity BCVA <glaucoma>}
{<pressure>,<IOP number of glaucoma medications prescribed best corrected visual acuity BCVA >,<glaucoma>
{Although elevated intraocular <pressure>IOP is one of the most important risk factors and lowering of IOP is the only proven treatment so far the definition of <glaucoma>}
{<pressure>,<IOP is one of the most important risk factors and lowering of IOP is the only proven treatment so far the definition of >,<glaucoma>
{to lower intraocular <pressure>are the mainstay of <glaucoma>}
{<pressure>,<are the mainstay of >,<glaucoma>
{prostaglandin analogues intra-ocular <pressure>lowering in <glaucoma>}
{<pressure>,<lowering in >,<glaucoma>
{difference in intraocular <pressure>control between mitomycin-C trabeculectomy and nonpenetrating <glaucoma>}
{<pressure>,<control between mitomycin-C trabeculectomy and nonpenetrating >,<glaucoma>
{the nocturnal intraocular <pressure>in addition to the diurnal and has been shown to be additive to other <glaucoma>}
{<pressure>,<in addition to the diurnal and has been shown to be additive to other >,<glaucoma>
{an increased intraocular <pressure>in patients with myopia or <glaucoma>}
{<pressure>,<in patients with myopia or >,<glaucoma>
{used to reduce <pressure>in eyes with refractory <glaucoma>}
{<pressure>,<in eyes with refractory >,<glaucoma>
{to elevated intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{ increased intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{of lowering intraocular <pressure>in posttraumatic <glaucoma>}
{<pressure>,<in posttraumatic >,<glaucoma>
{raised episcleral venous <pressure>to be a possible mechanism of <glaucoma>}
{<pressure>,<to be a possible mechanism of >,<glaucoma>
{it Lowering intra-ocular <pressure>either medically or surgically is the proven strategy to control <glaucoma>}
{<pressure>,<either medically or surgically is the proven strategy to control >,<glaucoma>
{to reduce intraocular <pressure>IOP or when the offset is unpredictable phacoemulsification associated with <glaucoma>}
{<pressure>,<IOP or when the offset is unpredictable phacoemulsification associated with >,<glaucoma>
{DSAEK on intraocular <pressure>IOP and corneal graft survival in eyes with pre-existing <glaucoma>}
{<pressure>,<IOP and corneal graft survival in eyes with pre-existing >,<glaucoma>
{with increased intraocular <pressure>which is also the most important risk factor for <glaucoma>}
{<pressure>,<which is also the most important risk factor for >,<glaucoma>
{device median intraocular <pressure>IOP was 29 mmHg in the congenital <glaucoma>}
{<pressure>,<IOP was 29 mmHg in the congenital >,<glaucoma>
{with increased intraocular <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{ Steroid-induced intraocular <pressure>elevation or <glaucoma>}
{<pressure>,<elevation or >,<glaucoma>
{glaucoma and perfusion <pressure>and <glaucoma>}
{<pressure>,<and >,<glaucoma>
{24 h intraocular <pressure>IOP on the management of <glaucoma>}
{<pressure>,<IOP on the management of >,<glaucoma>
{hospitalization on intraocular <pressure>IOP in patients with normal-tension <glaucoma>}
{<pressure>,<IOP in patients with normal-tension >,<glaucoma>
{hospitalization on intraocular <pressure>in patients with normal-tension <glaucoma>}
{<pressure>,<in patients with normal-tension >,<glaucoma>
{systemic arterial blood <pressure>BP and nocturnal hypotension in patients with normal-tension <glaucoma>}
{<pressure>,<BP and nocturnal hypotension in patients with normal-tension >,<glaucoma>
{variation of intraocular <pressure>IOP is important for precise diagnosis of normal-tension <glaucoma>}
{<pressure>,<IOP is important for precise diagnosis of normal-tension >,<glaucoma>
{history baseline intraocular <pressure>IOP access to health-care socio-economic status and <glaucoma>}
{<pressure>,<IOP access to health-care socio-economic status and >,<glaucoma>
{level of intraocular <pressure>IOP and mean months of duration of encountering <glaucoma>}
{<pressure>,<IOP and mean months of duration of encountering >,<glaucoma>
{phacoemulsification on intraocular <pressure>in medically controlled open-angle <glaucoma>}
{<pressure>,<in medically controlled open-angle >,<glaucoma>
{variations of intraocular <pressure>in normal-tension <glaucoma>}
{<pressure>,<in normal-tension >,<glaucoma>
{and ocular perfusion <pressure>accompanying successful <glaucoma>}
{<pressure>,<accompanying successful >,<glaucoma>
{the peak intraocular <pressure>IOP in patients with normal-tension <glaucoma>}
{<pressure>,<IOP in patients with normal-tension >,<glaucoma>
{the peak intraocular <pressure>in patients with normal-tension <glaucoma>}
{<pressure>,<in patients with normal-tension >,<glaucoma>
{reduction of intraocular <pressure>in unilateral high-tension <glaucoma>}
{<pressure>,<in unilateral high-tension >,<glaucoma>
{IMPORTANCE Elevated intraocular <pressure>IOP and decreased ocular perfusion pressure OPP are risk factors for <glaucoma>}
{<pressure>,<IOP and decreased ocular perfusion pressure OPP are risk factors for >,<glaucoma>
{ Nocturnal blood <pressure>drops relative day-night differences may play a more important role in the pathogenesis of normal tension <glaucoma>}
{<pressure>,<drops relative day-night differences may play a more important role in the pathogenesis of normal tension >,<glaucoma>
{ALT on intraocular <pressure>IOP of normal-tension <glaucoma>}
{<pressure>,<IOP of normal-tension >,<glaucoma>
{the postoperative intraocular <pressure>level visual function changes and postoperative complications of trabeculectomy with adjunctive mitomycin C in normal-tension <glaucoma>}
{<pressure>,<level visual function changes and postoperative complications of trabeculectomy with adjunctive mitomycin C in normal-tension >,<glaucoma>
{effect of intraocular <pressure>reduction on progression of visual change in normal-tension <glaucoma>}
{<pressure>,<reduction on progression of visual change in normal-tension >,<glaucoma>
{Because ocular perfusion <pressure>may be important in some glaucomatous patients latanoprost appears to affect ocular perfusion pressure more favorably than timolol does in patients with normal-tension <glaucoma>}
{<pressure>,<may be important in some glaucomatous patients latanoprost appears to affect ocular perfusion pressure more favorably than timolol does in patients with normal-tension >,<glaucoma>
{calculated ocular perfusion <pressure>in patients with normal-tension <glaucoma>}
{<pressure>,<in patients with normal-tension >,<glaucoma>
retinopathy of prematurity,neovascular glaucoma
{   <retinopathy of prematurity>and <neovascular glaucoma>}
{<retinopathy of prematurity>,<and >,<neovascular glaucoma>
left ventricular hypertrophy,heart failure
{   <left ventricular hypertrophy>and <heart failure>}
{<left ventricular hypertrophy>,<and >,<heart failure>
{high prevalence of <left ventricular hypertrophy><heart failure>}
{<left ventricular hypertrophy>,<>,<heart failure>
{enlargement valvular calcification <left ventricular hypertrophy><heart failure>}
{<left ventricular hypertrophy>,<>,<heart failure>
Cystic fibrosis,abdominal pain
{   <Cystic fibrosis>and <abdominal pain>}
{<Cystic fibrosis>,<and >,<abdominal pain>
Recurrent abdominal pain,chronic appendicitis
{   <Recurrent abdominal pain>and <chronic appendicitis>}
{<Recurrent abdominal pain>,<and >,<chronic appendicitis>
retinopathy of prematurity,glaucoma
{   <retinopathy of prematurity>and <glaucoma>}
{<retinopathy of prematurity>,<and >,<glaucoma>
glaucoma,open-angle glaucoma
{frequently in low-tension <glaucoma>stage II compared to primary <open-angle glaucoma>}
{<glaucoma>,<stage II compared to primary >,<open-angle glaucoma>
{trabeculectomy for open-angle <glaucoma>were investigated by clinical examination biomicroscopy and gonioscopy and classified into three categories exfoliation glaucoma possible exfoliation glaucoma and primary <open-angle glaucoma>}
{<glaucoma>,<were investigated by clinical examination biomicroscopy and gonioscopy and classified into three categories exfoliation glaucoma possible exfoliation glaucoma and primary >,<open-angle glaucoma>
{patients with open-angle <glaucoma>was conducted to evaluate conformance with recommendations from the American Academy of Ophthalmology's Preferred Practice Pattern for <open-angle glaucoma>}
{<glaucoma>,<was conducted to evaluate conformance with recommendations from the American Academy of Ophthalmology's Preferred Practice Pattern for >,<open-angle glaucoma>
{of the participants <glaucoma>had been diagnosed before this survey non-exfoliative <open-angle glaucoma>}
{<glaucoma>,<had been diagnosed before this survey non-exfoliative >,<open-angle glaucoma>
{patients with normotensive <glaucoma>exhibited significantly better color vision than did patients with primary <open-angle glaucoma>}
{<glaucoma>,<exhibited significantly better color vision than did patients with primary >,<open-angle glaucoma>
{eyes with normal-pressure <glaucoma>have an unusually large parapapillary atrophy as compared to eyes with primary <open-angle glaucoma>}
{<glaucoma>,<have an unusually large parapapillary atrophy as compared to eyes with primary >,<open-angle glaucoma>
{Eyes with normal-pressure <glaucoma>do not have an abnormally large parapapillary atrophy as compared to eyes with primary <open-angle glaucoma>}
{<glaucoma>,<do not have an abnormally large parapapillary atrophy as compared to eyes with primary >,<open-angle glaucoma>
{of tardive congenital <glaucoma>which were unknown or known as <open-angle glaucoma>}
{<glaucoma>,<which were unknown or known as >,<open-angle glaucoma>
{calcium blocker' in <glaucoma>patients 6 with primary <open-angle glaucoma>}
{<glaucoma>,<patients 6 with primary >,<open-angle glaucoma>
{various stages of <glaucoma>were studied including 23 patients with primary <open-angle glaucoma>}
{<glaucoma>,<were studied including 23 patients with primary >,<open-angle glaucoma>
{Different types of <glaucoma>were present <open-angle glaucoma>}
{<glaucoma>,<were present >,<open-angle glaucoma>
{history of low-tension <glaucoma>differs from high-tension <open-angle glaucoma>}
{<glaucoma>,<differs from high-tension >,<open-angle glaucoma>
{to CLV in <glaucoma>suspects and 17 patients with visual-field defects due to chronic <open-angle glaucoma>}
{<glaucoma>,<suspects and 17 patients with visual-field defects due to chronic >,<open-angle glaucoma>
{follow-up study on <glaucoma>patients of whom 19 patients received laser trabeculoplasty and 20 patients medication therapy as primary treatment of their newly detected <open-angle glaucoma>}
{<glaucoma>,<patients of whom 19 patients received laser trabeculoplasty and 20 patients medication therapy as primary treatment of their newly detected >,<open-angle glaucoma>
{with primary closed-angle <glaucoma>20 patients with primary <open-angle glaucoma>}
{<glaucoma>,<20 patients with primary >,<open-angle glaucoma>
{of normal subjects <glaucoma>suspects and patients with primary <open-angle glaucoma>}
{<glaucoma>,<suspects and patients with primary >,<open-angle glaucoma>
{that the closed-angle <glaucoma>may have a subacute course leading finally to the quasiabsolute stage with large scleral ectasias like in the <open-angle glaucoma>}
{<glaucoma>,<may have a subacute course leading finally to the quasiabsolute stage with large scleral ectasias like in the >,<open-angle glaucoma>
{eyes with low-tension <glaucoma>49 with primary <open-angle glaucoma>}
{<glaucoma>,<49 with primary >,<open-angle glaucoma>
{ three narrow-angle <glaucoma>three primary <open-angle glaucoma>}
{<glaucoma>,<three primary >,<open-angle glaucoma>
{either bilateral low-tension <glaucoma>or advanced chronic <open-angle glaucoma>}
{<glaucoma>,<or advanced chronic >,<open-angle glaucoma>
{the iStent Â® <glaucoma>device in patients with secondary <open-angle glaucoma>}
{<glaucoma>,<device in patients with secondary >,<open-angle glaucoma>
{patients with suspected <glaucoma>normal subjects and patients with early <open-angle glaucoma>}
{<glaucoma>,<normal subjects and patients with early >,<open-angle glaucoma>
{the management of <glaucoma>especially in primary <open-angle glaucoma>}
{<glaucoma>,<especially in primary >,<open-angle glaucoma>
{patients with low-tension <glaucoma>did not comprise a homogeneous population but contained one group of patients with evidence of reduced choroidal blood flow and another group with pulse amplitudes similar to those found in primary <open-angle glaucoma>}
{<glaucoma>,<did not comprise a homogeneous population but contained one group of patients with evidence of reduced choroidal blood flow and another group with pulse amplitudes similar to those found in primary >,<open-angle glaucoma>
{the EX-PRESS Â® <glaucoma>filtration device and trabeculectomy in primary <open-angle glaucoma>}
{<glaucoma>,<filtration device and trabeculectomy in primary >,<open-angle glaucoma>
{ in open-angle <glaucoma>the disc stereophotographs of one hundred consecutive patients with bilateral <open-angle glaucoma>}
{<glaucoma>,<the disc stereophotographs of one hundred consecutive patients with bilateral >,<open-angle glaucoma>
{patients with exfoliative <glaucoma>XFG group II comprised 30 patients with primary <open-angle glaucoma>}
{<glaucoma>,<XFG group II comprised 30 patients with primary >,<open-angle glaucoma>
{curves of our <glaucoma>patients which we interpret as indicating a lack of vascular autoregulation in primary <open-angle glaucoma>}
{<glaucoma>,<patients which we interpret as indicating a lack of vascular autoregulation in primary >,<open-angle glaucoma>
{patients with pseudoexfoliation <glaucoma>15 patients with primary <open-angle glaucoma>}
{<glaucoma>,<15 patients with primary >,<open-angle glaucoma>
{cupping in low-tension <glaucoma>compared with primary <open-angle glaucoma>}
{<glaucoma>,<compared with primary >,<open-angle glaucoma>
{treatment of pseudoexfoliation <glaucoma>compared with primary <open-angle glaucoma>}
{<glaucoma>,<compared with primary >,<open-angle glaucoma>
{advantages of full-thickness <glaucoma>filtration surgery 43 eyes of 38 patients with chronic <open-angle glaucoma>}
{<glaucoma>,<filtration surgery 43 eyes of 38 patients with chronic >,<open-angle glaucoma>
{wound healing after <glaucoma>filtration surgery in primary <open-angle glaucoma>}
{<glaucoma>,<filtration surgery in primary >,<open-angle glaucoma>
{different types of <glaucoma>autosomal-dominant <open-angle glaucoma>}
{<glaucoma>,<autosomal-dominant >,<open-angle glaucoma>
{comparing the EX-PRESS <glaucoma>filtration device and trabeculectomy in primary <open-angle glaucoma>}
{<glaucoma>,<filtration device and trabeculectomy in primary >,<open-angle glaucoma>
{patients with low-tension <glaucoma>182 patients with primary <open-angle glaucoma>}
{<glaucoma>,<182 patients with primary >,<open-angle glaucoma>
{30 adult bilateral <glaucoma>patients who had been receiving PG analogues for primary <open-angle glaucoma>}
{<glaucoma>,<patients who had been receiving PG analogues for primary >,<open-angle glaucoma>
{patients with low-tension <glaucoma>LTG 316 patients with primary <open-angle glaucoma>}
{<glaucoma>,<LTG 316 patients with primary >,<open-angle glaucoma>
{81 eyes pigmentary <glaucoma>34 eyes primary <open-angle glaucoma>}
{<glaucoma>,<34 eyes primary >,<open-angle glaucoma>
{eyes with narrow-angle <glaucoma>were treated by laser iridotomy 21 eyes with <open-angle glaucoma>}
{<glaucoma>,<were treated by laser iridotomy 21 eyes with >,<open-angle glaucoma>
{late-age-onset chronic open-angle <glaucoma>COAG diagnosed after age 40 and 2 the less common form juvenile <open-angle glaucoma>}
{<glaucoma>,<COAG diagnosed after age 40 and 2 the less common form juvenile >,<open-angle glaucoma>
{observers for low-tension <glaucoma>subjects but not for primary <open-angle glaucoma>}
{<glaucoma>,<subjects but not for primary >,<open-angle glaucoma>
{in 22 normal-tension <glaucoma>patients 27 <open-angle glaucoma>}
{<glaucoma>,<patients 27 >,<open-angle glaucoma>
{= 130 normal-pressure <glaucoma>n = 75 and high myopia combined with <open-angle glaucoma>}
{<glaucoma>,<n = 75 and high myopia combined with >,<open-angle glaucoma>
{normal-tension and high-tension <glaucoma>the differences may provide an insight for discriminating between the pressure-dependent and the pressure-independent damage in <open-angle glaucoma>}
{<glaucoma>,<the differences may provide an insight for discriminating between the pressure-dependent and the pressure-independent damage in >,<open-angle glaucoma>
{perimetry in open-angle <glaucoma>eyes with hemifield visual field damage and to compare it between <open-angle glaucoma>}
{<glaucoma>,<eyes with hemifield visual field damage and to compare it between >,<open-angle glaucoma>
{patients with normal-tension <glaucoma>NTG 76 with ocular hypertension OHT and 89 with primary <open-angle glaucoma>}
{<glaucoma>,<NTG 76 with ocular hypertension OHT and 89 with primary >,<open-angle glaucoma>
{rate in pseudoexfoliation <glaucoma>than in primary <open-angle glaucoma>}
{<glaucoma>,<than in primary >,<open-angle glaucoma>
{233 with normal-tension <glaucoma>NTG and 111 with primary <open-angle glaucoma>}
{<glaucoma>,<NTG and 111 with primary >,<open-angle glaucoma>
{ five neovascular <glaucoma>four secondary <open-angle glaucoma>}
{<glaucoma>,<four secondary >,<open-angle glaucoma>
{HTG 100 normal-tension <glaucoma>NTG and 50 juvenile-onset <open-angle glaucoma>}
{<glaucoma>,<NTG and 50 juvenile-onset >,<open-angle glaucoma>
{  The <glaucoma>normal-tension glaucoma and primary <open-angle glaucoma>}
{<glaucoma>,<normal-tension glaucoma and primary >,<open-angle glaucoma>
{who had normal-tension <glaucoma>6 eyes and primary <open-angle glaucoma>}
{<glaucoma>,<6 eyes and primary >,<open-angle glaucoma>
{overexpression of the <glaucoma>gene MYOC is involved in the development of <open-angle glaucoma>}
{<glaucoma>,<gene MYOC is involved in the development of >,<open-angle glaucoma>
{patients with open-angle <glaucoma>OAG including both primary <open-angle glaucoma>}
{<glaucoma>,<OAG including both primary >,<open-angle glaucoma>
{patients with normal-tension <glaucoma>selected from 60 consecutive newly diagnosed patients with primary <open-angle glaucoma>}
{<glaucoma>,<selected from 60 consecutive newly diagnosed patients with primary >,<open-angle glaucoma>
{Patients with normal-tension <glaucoma>had lower coverage rates than patients with primary <open-angle glaucoma>}
{<glaucoma>,<had lower coverage rates than patients with primary >,<open-angle glaucoma>
{candidate genes of <glaucoma>between the D14S261 and D14S121 markers of chromosome 14q11 a critical region previously linked to primary <open-angle glaucoma>}
{<glaucoma>,<between the D14S261 and D14S121 markers of chromosome 14q11 a critical region previously linked to primary >,<open-angle glaucoma>
{includes the GLC1B <glaucoma>locus for association with primary <open-angle glaucoma>}
{<glaucoma>,<locus for association with primary >,<open-angle glaucoma>
{patients with normal-tension <glaucoma>13 patients with primary <open-angle glaucoma>}
{<glaucoma>,<13 patients with primary >,<open-angle glaucoma>
{patients with normal-tension <glaucoma>NTG was compared with that in patients with primary <open-angle glaucoma>}
{<glaucoma>,<NTG was compared with that in patients with primary >,<open-angle glaucoma>
{patients had normal-tension <glaucoma>5 had primary <open-angle glaucoma>}
{<glaucoma>,<5 had primary >,<open-angle glaucoma>
{Since normal tension <glaucoma>NTG is thought to be more related to vascular factor than in primary <open-angle glaucoma>}
{<glaucoma>,<NTG is thought to be more related to vascular factor than in primary >,<open-angle glaucoma>
{subgroup analysis by <glaucoma>type OSAHS patients showed increased primary <open-angle glaucoma>}
{<glaucoma>,<type OSAHS patients showed increased primary >,<open-angle glaucoma>
{patients with normal-pressure <glaucoma>had clinically relevant intracranial compressive lesions involving the anterior visual pathway compared with none of the 70 patients with primary <open-angle glaucoma>}
{<glaucoma>,<had clinically relevant intracranial compressive lesions involving the anterior visual pathway compared with none of the 70 patients with primary >,<open-angle glaucoma>
{patients with pigmentary <glaucoma>were significantly lower than the mean ratios of the controls the patients with primary <open-angle glaucoma>}
{<glaucoma>,<were significantly lower than the mean ratios of the controls the patients with primary >,<open-angle glaucoma>
{consecutively diagnosed normal-pressure <glaucoma>n = 62 and progressive primary <open-angle glaucoma>}
{<glaucoma>,<n = 62 and progressive primary >,<open-angle glaucoma>
{patients with normal-tension <glaucoma>compared with patients with primary <open-angle glaucoma>}
{<glaucoma>,<compared with patients with primary >,<open-angle glaucoma>
{visit to a <glaucoma>specialist by consecutive patients with primary <open-angle glaucoma>}
{<glaucoma>,<specialist by consecutive patients with primary >,<open-angle glaucoma>
{ METHODS The <glaucoma>patients 7 with primary <open-angle glaucoma>}
{<glaucoma>,<patients 7 with primary >,<open-angle glaucoma>
{tested 113 controls <glaucoma>suspects 270 with primary <open-angle glaucoma>}
{<glaucoma>,<suspects 270 with primary >,<open-angle glaucoma>
{Patients with exfoliative <glaucoma>XFG and those with primary <open-angle glaucoma>}
{<glaucoma>,<XFG and those with primary >,<open-angle glaucoma>
{patients with normal-tension <glaucoma>were compared with 25 patients with primary <open-angle glaucoma>}
{<glaucoma>,<were compared with 25 patients with primary >,<open-angle glaucoma>
{patients with exfoliative <glaucoma>XFG and those with primary <open-angle glaucoma>}
{<glaucoma>,<XFG and those with primary >,<open-angle glaucoma>
{subjects 296 low-tension <glaucoma>patients 98 and <open-angle glaucoma>}
{<glaucoma>,<patients 98 and >,<open-angle glaucoma>
{patients with normal-tension <glaucoma>NTG cardiovascular autoregulation may also be defective in primary <open-angle glaucoma>}
{<glaucoma>,<NTG cardiovascular autoregulation may also be defective in primary >,<open-angle glaucoma>
{16 without glaucoma <glaucoma>suspects 25 with primary <open-angle glaucoma>}
{<glaucoma>,<suspects 25 with primary >,<open-angle glaucoma>
{common form of <glaucoma>was primary <open-angle glaucoma>}
{<glaucoma>,<was primary >,<open-angle glaucoma>
{sclerectomy in capsular <glaucoma>CG with those in primary <open-angle glaucoma>}
{<glaucoma>,<CG with those in primary >,<open-angle glaucoma>
{76 with normal-tension <glaucoma>26 with primary <open-angle glaucoma>}
{<glaucoma>,<26 with primary >,<open-angle glaucoma>
{associated with normal-tension <glaucoma>are not associated with adult-onset primary <open-angle glaucoma>}
{<glaucoma>,<are not associated with adult-onset primary >,<open-angle glaucoma>
{of all normal-tension <glaucoma>patients and about one third of all primary <open-angle glaucoma>}
{<glaucoma>,<patients and about one third of all primary >,<open-angle glaucoma>
{  and <glaucoma>1 with bilateral <open-angle glaucoma>}
{<glaucoma>,<1 with bilateral >,<open-angle glaucoma>
{with low-tension normal-tension <glaucoma>compared with those with chronic <open-angle glaucoma>}
{<glaucoma>,<compared with those with chronic >,<open-angle glaucoma>
{layer in normal-tension <glaucoma>NTG differs from that in chronic <open-angle glaucoma>}
{<glaucoma>,<NTG differs from that in chronic >,<open-angle glaucoma>
{30 degrees in <glaucoma>patients 74 with primary <open-angle glaucoma>}
{<glaucoma>,<patients 74 with primary >,<open-angle glaucoma>
{patients with normal-pressure <glaucoma>NPG 68 patients with primary <open-angle glaucoma>}
{<glaucoma>,<NPG 68 patients with primary >,<open-angle glaucoma>
{CONCLUSIONS With standard <glaucoma>therapy the rate of visual field loss in primary <open-angle glaucoma>}
{<glaucoma>,<therapy the rate of visual field loss in primary >,<open-angle glaucoma>
{ IOP and <glaucoma>medication in <open-angle glaucoma>}
{<glaucoma>,<medication in >,<open-angle glaucoma>
{patients with open-angle <glaucoma>including both primary <open-angle glaucoma>}
{<glaucoma>,<including both primary >,<open-angle glaucoma>
{8 patients the <glaucoma>suspect converted into a primary <open-angle glaucoma>}
{<glaucoma>,<suspect converted into a primary >,<open-angle glaucoma>
{eyes with normal-pressure <glaucoma>538 +/- 51 microm highest in eyes with ocular hypertension 570 +/- 32 microm and intermediate and similar in eyes with primary <open-angle glaucoma>}
{<glaucoma>,<538 +/- 51 microm highest in eyes with ocular hypertension 570 +/- 32 microm and intermediate and similar in eyes with primary >,<open-angle glaucoma>
{investigated in normal-tension <glaucoma>NTG patients in comparison with primary <open-angle glaucoma>}
{<glaucoma>,<NTG patients in comparison with primary >,<open-angle glaucoma>
{8 patients the <glaucoma>suspect associated with central retinal vein occlusion converted to primary <open-angle glaucoma>}
{<glaucoma>,<suspect associated with central retinal vein occlusion converted to primary >,<open-angle glaucoma>
{  NTG <glaucoma>suspects GS and 28 patients with primary <open-angle glaucoma>}
{<glaucoma>,<suspects GS and 28 patients with primary >,<open-angle glaucoma>
{patients with suspected <glaucoma>by disc those with ocular hypertension and those with primary <open-angle glaucoma>}
{<glaucoma>,<by disc those with ocular hypertension and those with primary >,<open-angle glaucoma>
{patients with suspected <glaucoma>by disc n = 28 patients with ocular hypertension n = 18 and patients with primary <open-angle glaucoma>}
{<glaucoma>,<by disc n = 28 patients with ocular hypertension n = 18 and patients with primary >,<open-angle glaucoma>
{RNFL in normal <glaucoma>suspect and <open-angle glaucoma>}
{<glaucoma>,<suspect and >,<open-angle glaucoma>
{patients with normal-pressure <glaucoma>than that in control subjects and approximately 50% higher than that in patients with primary <open-angle glaucoma>}
{<glaucoma>,<than that in control subjects and approximately 50% higher than that in patients with primary >,<open-angle glaucoma>
{patients with normal-pressure <glaucoma>10 eyes 10 patients with primary <open-angle glaucoma>}
{<glaucoma>,<10 eyes 10 patients with primary >,<open-angle glaucoma>
{83 with normal-tension <glaucoma>NTG and 68 with primary <open-angle glaucoma>}
{<glaucoma>,<NTG and 68 with primary >,<open-angle glaucoma>
{patients with pigmentary <glaucoma>were compared with those of 501 patients with primary <open-angle glaucoma>}
{<glaucoma>,<were compared with those of 501 patients with primary >,<open-angle glaucoma>
{eyes had closed-angle <glaucoma>CAG and the other 23 eyes had <open-angle glaucoma>}
{<glaucoma>,<CAG and the other 23 eyes had >,<open-angle glaucoma>
{In normal IOP <glaucoma>papillary lesions and visual field impairments may differ from those occurring in primary <open-angle glaucoma>}
{<glaucoma>,<papillary lesions and visual field impairments may differ from those occurring in primary >,<open-angle glaucoma>
{patients with normal-pressure <glaucoma>36 patients with primary <open-angle glaucoma>}
{<glaucoma>,<36 patients with primary >,<open-angle glaucoma>
{cataracts spontaneous closed-angle <glaucoma>developed in two of nine patients and <open-angle glaucoma>}
{<glaucoma>,<developed in two of nine patients and >,<open-angle glaucoma>
{into two groups <glaucoma>suspects without any treatment 30 patients 60 eyes and early <open-angle glaucoma>}
{<glaucoma>,<suspects without any treatment 30 patients 60 eyes and early >,<open-angle glaucoma>
{from each of <glaucoma>suspects n = 58 and patients with established <open-angle glaucoma>}
{<glaucoma>,<suspects n = 58 and patients with established >,<open-angle glaucoma>
{patients with normal-pressure <glaucoma>retinal circulation is delayed in patients with primary <open-angle glaucoma>}
{<glaucoma>,<retinal circulation is delayed in patients with primary >,<open-angle glaucoma>
{  Normal-tension <glaucoma>NTG is a type of <open-angle glaucoma>}
{<glaucoma>,<NTG is a type of >,<open-angle glaucoma>
{Hg without additional <glaucoma>medication were 62% for primary <open-angle glaucoma>}
{<glaucoma>,<medication were 62% for primary >,<open-angle glaucoma>
{outcome of primary <glaucoma>triple procedure PGTP in primary <open-angle glaucoma>}
{<glaucoma>,<triple procedure PGTP in primary >,<open-angle glaucoma>
{C on primary <glaucoma>triple procedure in patients with primary <open-angle glaucoma>}
{<glaucoma>,<triple procedure in patients with primary >,<open-angle glaucoma>
{type of normal-pressure <glaucoma>17 eyes with the highly myopic type of normal-pressure glaucoma and 36 eyes with the age-related atrophic type of primary <open-angle glaucoma>}
{<glaucoma>,<17 eyes with the highly myopic type of normal-pressure glaucoma and 36 eyes with the age-related atrophic type of primary >,<open-angle glaucoma>
{ was suspected <glaucoma>suspects and 17 patients with primary <open-angle glaucoma>}
{<glaucoma>,<suspects and 17 patients with primary >,<open-angle glaucoma>
{patients with early <glaucoma>or suspected primary <open-angle glaucoma>}
{<glaucoma>,<or suspected primary >,<open-angle glaucoma>
{2 groups the <glaucoma>group with 31 patients diagnosed with primary <open-angle glaucoma>}
{<glaucoma>,<group with 31 patients diagnosed with primary >,<open-angle glaucoma>
{and chronic open-angle <glaucoma>has been tested only in a small case-control study of uncontrolled chronic <open-angle glaucoma>}
{<glaucoma>,<has been tested only in a small case-control study of uncontrolled chronic >,<open-angle glaucoma>
{patients with pseudoexfoliation <glaucoma>PXFG compared with primary <open-angle glaucoma>}
{<glaucoma>,<PXFG compared with primary >,<open-angle glaucoma>
{ and pseudoexfoliation--favor <glaucoma>manifestation in cases disposed to primary <open-angle glaucoma>}
{<glaucoma>,<manifestation in cases disposed to primary >,<open-angle glaucoma>
{progression diagnosis of <glaucoma>for a group with <open-angle glaucoma>}
{<glaucoma>,<for a group with >,<open-angle glaucoma>
{ INTRODUCTION Micro-invasive <glaucoma>surgical implantation of trabecular micro-bypass stents previously shown to be safe and effective for <open-angle glaucoma>}
{<glaucoma>,<surgical implantation of trabecular micro-bypass stents previously shown to be safe and effective for >,<open-angle glaucoma>
{evaluation of microinvasive <glaucoma>surgery with trabecular microbypass stents and prostaglandin in <open-angle glaucoma>}
{<glaucoma>,<surgery with trabecular microbypass stents and prostaglandin in >,<open-angle glaucoma>
{optic disc in <glaucoma>pathogenetic correlation of five patterns of cupping in chronic <open-angle glaucoma>}
{<glaucoma>,<pathogenetic correlation of five patterns of cupping in chronic >,<open-angle glaucoma>
{The influence of <glaucoma>medications on ocular surface disease in primary <open-angle glaucoma>}
{<glaucoma>,<medications on ocular surface disease in primary >,<open-angle glaucoma>
{ethnic differences of <glaucoma>risk and be a new risk factor to consider in primary <open-angle glaucoma>}
{<glaucoma>,<risk and be a new risk factor to consider in primary >,<open-angle glaucoma>
{phacoviscocanalostomy in pseudoexfoliation <glaucoma>PEXG versus that in primary <open-angle glaucoma>}
{<glaucoma>,<PEXG versus that in primary >,<open-angle glaucoma>
{of chronic open-angle <glaucoma>surgery for chronic <open-angle glaucoma>}
{<glaucoma>,<surgery for chronic >,<open-angle glaucoma>
{Grouping within the <glaucoma>cohort was based on SAP-performance 33 preperimetric <open-angle glaucoma>}
{<glaucoma>,<cohort was based on SAP-performance 33 preperimetric >,<open-angle glaucoma>
{been suggested in <glaucoma>we examined peripapillary choroidal thickness CT in patients with and without primary <open-angle glaucoma>}
{<glaucoma>,<we examined peripapillary choroidal thickness CT in patients with and without primary >,<open-angle glaucoma>
{differentiate mild angle-closure <glaucoma>from <open-angle glaucoma>}
{<glaucoma>,<from >,<open-angle glaucoma>
{tolerability of nonpenetrating <glaucoma>surgery augmented with mitomycin C in treatment of <open-angle glaucoma>}
{<glaucoma>,<surgery augmented with mitomycin C in treatment of >,<open-angle glaucoma>
{the pathogenesis of <glaucoma>that require different therapeutic strategies 1 overfill with total anterior chamber fill leads to an <open-angle glaucoma>}
{<glaucoma>,<that require different therapeutic strategies 1 overfill with total anterior chamber fill leads to an >,<open-angle glaucoma>
{ Angle closure <glaucoma>is related to a blockade of aqueous humor to the trabecular meshwork whereas <open-angle glaucoma>}
{<glaucoma>,<is related to a blockade of aqueous humor to the trabecular meshwork whereas >,<open-angle glaucoma>
{22 had normal-tension <glaucoma>NTG and 18 had primary <open-angle glaucoma>}
{<glaucoma>,<NTG and 18 had primary >,<open-angle glaucoma>
{72 early normal-tension <glaucoma>NTG patients and 34 early primary <open-angle glaucoma>}
{<glaucoma>,<NTG patients and 34 early primary >,<open-angle glaucoma>
{of normal tension <glaucoma>NTG patients with primary <open-angle glaucoma>}
{<glaucoma>,<NTG patients with primary >,<open-angle glaucoma>
{children were included <glaucoma>eyes 25 with primary congenital and 12 with juvenile <open-angle glaucoma>}
{<glaucoma>,<eyes 25 with primary congenital and 12 with juvenile >,<open-angle glaucoma>
{in an ongoing <glaucoma>research study at our institution we identified 354 eyes in 180 subjects 97 with primary <open-angle glaucoma>}
{<glaucoma>,<research study at our institution we identified 354 eyes in 180 subjects 97 with primary >,<open-angle glaucoma>
{Ilan Israel mini <glaucoma>shunt in <open-angle glaucoma>}
{<glaucoma>,<shunt in >,<open-angle glaucoma>
{ PURPOSE Mucogenic <glaucoma>is an unusual form of secondary <open-angle glaucoma>}
{<glaucoma>,<is an unusual form of secondary >,<open-angle glaucoma>
{bevacizumab IVB before <glaucoma>surgery eight were from patients with primary <open-angle glaucoma>}
{<glaucoma>,<surgery eight were from patients with primary >,<open-angle glaucoma>
{of resident and <glaucoma>faculty practice patterns in the care of <open-angle glaucoma>}
{<glaucoma>,<faculty practice patterns in the care of >,<open-angle glaucoma>
{high prevalence of <glaucoma>which is largely <open-angle glaucoma>}
{<glaucoma>,<which is largely >,<open-angle glaucoma>
{between AD and <glaucoma>since it has been shown that mean CSFP is lower in subjects with primary <open-angle glaucoma>}
{<glaucoma>,<since it has been shown that mean CSFP is lower in subjects with primary >,<open-angle glaucoma>
{subjects 28 preperimetric <glaucoma>PPG patients and 100 <open-angle glaucoma>}
{<glaucoma>,<PPG patients and 100 >,<open-angle glaucoma>
{SDOCT images from <glaucoma>eyes 4 patients with varying stages of <open-angle glaucoma>}
{<glaucoma>,<eyes 4 patients with varying stages of >,<open-angle glaucoma>
{implantation in uveitic <glaucoma>versus <open-angle glaucoma>}
{<glaucoma>,<versus >,<open-angle glaucoma>
{worse in pseudoexfoliative <glaucoma>patients than in primary <open-angle glaucoma>}
{<glaucoma>,<patients than in primary >,<open-angle glaucoma>
{tertiary care academic <glaucoma>center 92 eyes of 92 subjects 46 with early perimetric <open-angle glaucoma>}
{<glaucoma>,<center 92 eyes of 92 subjects 46 with early perimetric >,<open-angle glaucoma>
{field loss and <glaucoma>risk factors in primary <open-angle glaucoma>}
{<glaucoma>,<risk factors in primary >,<open-angle glaucoma>
{previous diagnosis of <glaucoma>6 having primary <open-angle glaucoma>}
{<glaucoma>,<6 having primary >,<open-angle glaucoma>
{whom had undergone <glaucoma>surgery and 2 of whom had been diagnosed to have <open-angle glaucoma>}
{<glaucoma>,<surgery and 2 of whom had been diagnosed to have >,<open-angle glaucoma>
{medical treatment of <glaucoma>nearly all respondents 98% or greater confirmed that medical treatment as first-line therapy is preferred to surgery prostaglandin analogs are the medication of first choice for primary <open-angle glaucoma>}
{<glaucoma>,<nearly all respondents 98% or greater confirmed that medical treatment as first-line therapy is preferred to surgery prostaglandin analogs are the medication of first choice for primary >,<open-angle glaucoma>
{the diagnosis of <glaucoma>section all respondents confirmed that after initial examination gonioscopy should be repeated over time standard automated perimetry is the most important functional examination for diagnosis and monitoring of primary <open-angle glaucoma>}
{<glaucoma>,<section all respondents confirmed that after initial examination gonioscopy should be repeated over time standard automated perimetry is the most important functional examination for diagnosis and monitoring of primary >,<open-angle glaucoma>
{corneas with pseudoexfoliative <glaucoma>PEXG and to compare them with those of patients with primary <open-angle glaucoma>}
{<glaucoma>,<PEXG and to compare them with those of patients with primary >,<open-angle glaucoma>
{phaco-trab-5-Fu in Asian <glaucoma>patients with primary <open-angle glaucoma>}
{<glaucoma>,<patients with primary >,<open-angle glaucoma>
{persons with suspected <glaucoma>or patients with primary <open-angle glaucoma>}
{<glaucoma>,<or patients with primary >,<open-angle glaucoma>
{hyperplasia BPH and <glaucoma>simplex <open-angle glaucoma>}
{<glaucoma>,<simplex >,<open-angle glaucoma>
{were recruited from <glaucoma>clinics in Singapore with diagnoses of primary angle closure primary <open-angle glaucoma>}
{<glaucoma>,<clinics in Singapore with diagnoses of primary angle closure primary >,<open-angle glaucoma>
{the diabetic open-angle <glaucoma>patients whereas positive correlations between retinal flow and non-flow were only found in non-diabetic <open-angle glaucoma>}
{<glaucoma>,<patients whereas positive correlations between retinal flow and non-flow were only found in non-diabetic >,<open-angle glaucoma>
{102 with preperimetric <glaucoma>PPG and 164 with primary <open-angle glaucoma>}
{<glaucoma>,<PPG and 164 with primary >,<open-angle glaucoma>
{patients with pseudoexfoliative <glaucoma>PXE and 31 eyes from 31 patients with primary <open-angle glaucoma>}
{<glaucoma>,<PXE and 31 eyes from 31 patients with primary >,<open-angle glaucoma>
{normal 37 pre-perimetric <glaucoma>PPG and 29 early stage of primary <open-angle glaucoma>}
{<glaucoma>,<PPG and 29 early stage of primary >,<open-angle glaucoma>
{recently developed non-penetrating <glaucoma>surgical approach may restore physiological outflow routes in primary <open-angle glaucoma>}
{<glaucoma>,<surgical approach may restore physiological outflow routes in primary >,<open-angle glaucoma>
{medically uncontrolled open-angle <glaucoma>or <open-angle glaucoma>}
{<glaucoma>,<or >,<open-angle glaucoma>
viral pneumonias croup,bronchiolitis dengue
{   <viral pneumonias croup>and <bronchiolitis dengue>}
{<viral pneumonias croup>,<and >,<bronchiolitis dengue>
Primary open-angle glaucoma,systemic diseases
{   <Primary open-angle glaucoma>and <systemic diseases>}
{<Primary open-angle glaucoma>,<and >,<systemic diseases>
age-related macular degeneration hemianopia,diabetic retinopathy
{   <age-related macular degeneration hemianopia>and <diabetic retinopathy>}
{<age-related macular degeneration hemianopia>,<and >,<diabetic retinopathy>
related autoimmune haemolytic anaemia,lymphadenopathy
{   <related autoimmune haemolytic anaemia>and <lymphadenopathy>}
{<related autoimmune haemolytic anaemia>,<and >,<lymphadenopathy>
{  SLE <related autoimmune haemolytic anaemia>AIHA and <lymphadenopathy>}
{<related autoimmune haemolytic anaemia>,<AIHA and >,<lymphadenopathy>
Malignant glaucoma,severe myopia
{   <Malignant glaucoma>and <severe myopia>}
{<Malignant glaucoma>,<and >,<severe myopia>
optic neuropathy,retinopathy
{   <optic neuropathy>and <retinopathy>}
{<optic neuropathy>,<and >,<retinopathy>
{to moderate glaucomatous <optic neuropathy>can be highly discriminated by the two imaging devices in eyes with diabetic <retinopathy>}
{<optic neuropathy>,<can be highly discriminated by the two imaging devices in eyes with diabetic >,<retinopathy>
Acute pancreatitis,afferent loop syndrome
{   <Acute pancreatitis>and <afferent loop syndrome>}
{<Acute pancreatitis>,<and >,<afferent loop syndrome>
primary open-angle glaucoma,ocular hypertension
{the treatment of <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{and timolol in <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{risk factors in <primary open-angle glaucoma>normal-pressure glaucoma and simple <ocular hypertension>}
{<primary open-angle glaucoma>,<normal-pressure glaucoma and simple >,<ocular hypertension>
{detect whether untreated <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{who had NPG <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{in eyes with <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{in 10 patients <primary open-angle glaucoma>and 4 <ocular hypertension>}
{<primary open-angle glaucoma>,<and 4 >,<ocular hypertension>
{control subjects n <primary open-angle glaucoma>n = 111 <ocular hypertension>}
{<primary open-angle glaucoma>,<n = 111 >,<ocular hypertension>
{clinical trials evaluating <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{topical treatments for <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{newly detected untreated <primary open-angle glaucoma>and 29 patients with untreated <ocular hypertension>}
{<primary open-angle glaucoma>,<and 29 patients with untreated >,<ocular hypertension>
{50 high tension <primary open-angle glaucoma>exfoliative glaucoma and <ocular hypertension>}
{<primary open-angle glaucoma>,<exfoliative glaucoma and >,<ocular hypertension>
{whether eyes with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{control patients n <primary open-angle glaucoma>n=45 <ocular hypertension>}
{<primary open-angle glaucoma>,<n=45 >,<ocular hypertension>
{20 eyes of <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{  NTG <primary open-angle glaucoma>POAG <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG >,<ocular hypertension>
{recent diagnosis of <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{and older with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{newly diagnosed with <primary open-angle glaucoma>POAG or <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG or >,<ocular hypertension>
{times daily for <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{patients with either <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{flow in untreated <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{flow in untreated <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{newly diagnosed with <primary open-angle glaucoma>POAG or <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG or >,<ocular hypertension>
{medical treatment of <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{topical management of <primary open-angle glaucoma>POAG and <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG and >,<ocular hypertension>
{Thirty-four subjects with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{concomitant therapy in <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients affected by <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{a diagnosis of <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{41 eyes with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{the subjects had <primary open-angle glaucoma>and four had <ocular hypertension>}
{<primary open-angle glaucoma>,<and four had >,<ocular hypertension>
{141 eyes with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{with newly diagnosed <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{fixed-combination therapy in <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{long treatment periods <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{180 eyes with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients affected with <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{once daily in <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{a diagnosis of <primary open-angle glaucoma>n = 28 or <ocular hypertension>}
{<primary open-angle glaucoma>,<n = 28 or >,<ocular hypertension>
{with diagnoses of <primary open-angle glaucoma>POAG and <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG and >,<ocular hypertension>
{US who had <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{with newly diagnosed <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with either <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients with early <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients with bilateral <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{for treatment of <primary open-angle glaucoma>POAG and <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG and >,<ocular hypertension>
{patients with bilateral <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{  NTG <primary open-angle glaucoma>POAG pseudoexfoliation-glaucoma PEX and <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG pseudoexfoliation-glaucoma PEX and >,<ocular hypertension>
{randomized subjects with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{ocular hypotensives in <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients with predominantly <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{medical management of <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{First-line therapy for <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{patients with predominantly <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients with either <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{diagnosed with either <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{with previously untreated <primary open-angle glaucoma>POAG or <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG or >,<ocular hypertension>
{dose-finding trial in <primary open-angle glaucoma>POAG or <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG or >,<ocular hypertension>
{80 eyes with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{newly diagnosed with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients with either <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{main glaucoma subtype <primary open-angle glaucoma>POAG and <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG and >,<ocular hypertension>
{eyes eyes with <primary open-angle glaucoma>and eyes with <ocular hypertension>}
{<primary open-angle glaucoma>,<and eyes with >,<ocular hypertension>
{patients with either <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients with either <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{capability to differentiate <primary open-angle glaucoma>POAG from <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG from >,<ocular hypertension>
{Patients treated for <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{the control of <primary open-angle glaucoma>POAG and <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG and >,<ocular hypertension>
{30 subjects with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{patients with bilateral <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{03% therapy for <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{or older with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{retina of untreated <primary open-angle glaucoma>POAG and <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG and >,<ocular hypertension>
{respects in untreated <primary open-angle glaucoma>POAG and <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG and >,<ocular hypertension>
{1 eye of <primary open-angle glaucoma>POAG 30 <ocular hypertension>}
{<primary open-angle glaucoma>,<POAG 30 >,<ocular hypertension>
{white subjects with <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
{-lowering medications for <primary open-angle glaucoma>and <ocular hypertension>}
{<primary open-angle glaucoma>,<and >,<ocular hypertension>
{a diagnosis of <primary open-angle glaucoma>and 10 eyes had <ocular hypertension>}
{<primary open-angle glaucoma>,<and 10 eyes had >,<ocular hypertension>
{patients with early <primary open-angle glaucoma>or <ocular hypertension>}
{<primary open-angle glaucoma>,<or >,<ocular hypertension>
infections,deaths
{   <infections>or <deaths>}
{<infections>,<or >,<deaths>
{C virus HCV <infections>account for 57% of cases of liver cirrhosis and 78% of cases of primary liver cancer worldwide and cause a million <deaths>}
{<infections>,<account for 57% of cases of liver cirrhosis and 78% of cases of primary liver cancer worldwide and cause a million >,<deaths>
vitreous hemorrhage neovascular glaucoma,retinal detachment
{   <vitreous hemorrhage neovascular glaucoma>and <retinal detachment>}
{<vitreous hemorrhage neovascular glaucoma>,<and >,<retinal detachment>
glaucoma age-related macular degeneration,high altitude retinopathy
{   <glaucoma age-related macular degeneration>or <high altitude retinopathy>}
{<glaucoma age-related macular degeneration>,<or >,<high altitude retinopathy>
dry mouth,glaucoma
{the treatment of <dry mouth>and <glaucoma>}
{<dry mouth>,<and >,<glaucoma>
pallor hepatosplenomegaly,lymphadenopathy
{   <pallor hepatosplenomegaly>and <lymphadenopathy>}
{<pallor hepatosplenomegaly>,<and >,<lymphadenopathy>
Appendicitis,peritonitis
{   <Appendicitis>or <peritonitis>}
{<Appendicitis>,<or >,<peritonitis>
{   <Appendicitis>is uncommon in children under the age of 5 but the proportion of cases complicated by <peritonitis>}
{<Appendicitis>,<is uncommon in children under the age of 5 but the proportion of cases complicated by >,<peritonitis>
{   <Appendicitis>is very common in adolescents but here the proportion of cases complicated by <peritonitis>}
{<Appendicitis>,<is very common in adolescents but here the proportion of cases complicated by >,<peritonitis>
{   <Appendicitis>cases among very young and older patients were more likely to be associated with peritoneal abscess <peritonitis>}
{<Appendicitis>,<cases among very young and older patients were more likely to be associated with peritoneal abscess >,<peritonitis>
{  it <Appendicitis>is a frequent clinical condition in normal children that may be complicated by community-acquired secondary <peritonitis>}
{<Appendicitis>,<is a frequent clinical condition in normal children that may be complicated by community-acquired secondary >,<peritonitis>
Myopia,glaucoma
{   <Myopia>and <glaucoma>}
{<Myopia>,<and >,<glaucoma>
{   <Myopia>and <glaucoma>}
{<Myopia>,<and >,<glaucoma>
{   <Myopia>and <glaucoma>}
{<Myopia>,<and >,<glaucoma>
Splenic infarction,malaria
{   <Splenic infarction>and <malaria>}
{<Splenic infarction>,<and >,<malaria>
autoimmune enteropathy,ulcerative colitis
{   <autoimmune enteropathy>and <ulcerative colitis>}
{<autoimmune enteropathy>,<and >,<ulcerative colitis>
{  and <autoimmune enteropathy>and mucosal ulceration of the colon in <ulcerative colitis>}
{<autoimmune enteropathy>,<and mucosal ulceration of the colon in >,<ulcerative colitis>
Ischemia,hypoxia
{   <Ischemia>and <hypoxia>}
{<Ischemia>,<and >,<hypoxia>
diarrhea fever,malaise
{   <diarrhea fever>and <malaise>}
{<diarrhea fever>,<and >,<malaise>
non-alcoholic fatty liver disease,metabolic syndrome
{   <non-alcoholic fatty liver disease>and <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<and >,<metabolic syndrome>
{ Liver steatosis <non-alcoholic fatty liver disease>NAFLD is deemed as the hepatic face of the <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<NAFLD is deemed as the hepatic face of the >,<metabolic syndrome>
{progressive phenotype of <non-alcoholic fatty liver disease>associated with the <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<associated with the >,<metabolic syndrome>
{disease CVD and <non-alcoholic fatty liver disease>NAFLD are manifestations of the <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<NAFLD are manifestations of the >,<metabolic syndrome>
{  CKD <non-alcoholic fatty liver disease>NAFLD <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<NAFLD >,<metabolic syndrome>
{disorders such as <non-alcoholic fatty liver disease>NAFLD <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<NAFLD >,<metabolic syndrome>
{Diet strongly influences <non-alcoholic fatty liver disease>which is associated with oxidative stress and is considered the hepatic manifestation of the <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<which is associated with oxidative stress and is considered the hepatic manifestation of the >,<metabolic syndrome>
{combination of keywords <non-alcoholic fatty liver disease>OR hepatic steatosis OR <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<OR hepatic steatosis OR >,<metabolic syndrome>
{with a clinically-proven <non-alcoholic fatty liver disease>which is currently recognized as the hepatic component of <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<which is currently recognized as the hepatic component of >,<metabolic syndrome>
{ Rates of <non-alcoholic fatty liver disease>NAFLD are increasing worldwide in tandem with the <metabolic syndrome>}
{<non-alcoholic fatty liver disease>,<NAFLD are increasing worldwide in tandem with the >,<metabolic syndrome>
hepatorenal syndrome hepatopulmonary syndrome,portopulmonary hypertension
{   <hepatorenal syndrome hepatopulmonary syndrome>and <portopulmonary hypertension>}
{<hepatorenal syndrome hepatopulmonary syndrome>,<and >,<portopulmonary hypertension>
End stage renal disease,ventricular arrhythmia
{   <End stage renal disease>and <ventricular arrhythmia>}
{<End stage renal disease>,<and >,<ventricular arrhythmia>
Primary hyperparathyroidism,vitamin D deficiency
{   <Primary hyperparathyroidism>and <vitamin D deficiency>}
{<Primary hyperparathyroidism>,<and >,<vitamin D deficiency>
cataract diabetic retinopathy,glaucoma
{   <cataract diabetic retinopathy>and <glaucoma>}
{<cataract diabetic retinopathy>,<and >,<glaucoma>
{morbidity caused by <cataract diabetic retinopathy>and <glaucoma>}
{<cataract diabetic retinopathy>,<and >,<glaucoma>
Parkinson's disease essential tremor,neuropathic pain
{   <Parkinson's disease essential tremor>and <neuropathic pain>}
{<Parkinson's disease essential tremor>,<and >,<neuropathic pain>
chronic viral hepatitis hereditary hemochromatosis,autoimmune liver diseases
{   <chronic viral hepatitis hereditary hemochromatosis>and <autoimmune liver diseases>}
{<chronic viral hepatitis hereditary hemochromatosis>,<and >,<autoimmune liver diseases>
diabetic retinopathy,kidney diseases
{   <diabetic retinopathy>and <kidney diseases>}
{<diabetic retinopathy>,<and >,<kidney diseases>
chronic kidney disease thalassaemia,arthritis
{   <chronic kidney disease thalassaemia>and <arthritis>}
{<chronic kidney disease thalassaemia>,<and >,<arthritis>
Episcleritis,scleritis
{   <Episcleritis>and <scleritis>}
{<Episcleritis>,<and >,<scleritis>
{   <Episcleritis>and <scleritis>}
{<Episcleritis>,<and >,<scleritis>
Anterior uveitis,juvenile idiopathic arthritis
{   <Anterior uveitis>and <juvenile idiopathic arthritis>}
{<Anterior uveitis>,<and >,<juvenile idiopathic arthritis>
{ es PURPOSE <Anterior uveitis>is one of the most important extraarticular manifestations of <juvenile idiopathic arthritis>}
{<Anterior uveitis>,<is one of the most important extraarticular manifestations of >,<juvenile idiopathic arthritis>
primary open-angle glaucoma age-related macular degeneration,trachoma
{   <primary open-angle glaucoma age-related macular degeneration>and <trachoma>}
{<primary open-angle glaucoma age-related macular degeneration>,<and >,<trachoma>
Pigment dispersion syndrome,pigmentary glaucoma
{   <Pigment dispersion syndrome>and <pigmentary glaucoma>}
{<Pigment dispersion syndrome>,<and >,<pigmentary glaucoma>
{  PURPOSE <Pigment dispersion syndrome>and <pigmentary glaucoma>}
{<Pigment dispersion syndrome>,<and >,<pigmentary glaucoma>
{   <Pigment dispersion syndrome>and <pigmentary glaucoma>}
{<Pigment dispersion syndrome>,<and >,<pigmentary glaucoma>
{  PURPOSE <Pigment dispersion syndrome>PDS and <pigmentary glaucoma>}
{<Pigment dispersion syndrome>,<PDS and >,<pigmentary glaucoma>
{   <Pigment dispersion syndrome>and <pigmentary glaucoma>}
{<Pigment dispersion syndrome>,<and >,<pigmentary glaucoma>
Human immunodeficiency virus infection,kidney disease
{   <Human immunodeficiency virus infection>and <kidney disease>}
{<Human immunodeficiency virus infection>,<and >,<kidney disease>
kidney disease,metabolic syndrome
{   <kidney disease>and the <metabolic syndrome>}
{<kidney disease>,<and the >,<metabolic syndrome>
{many with chronic <kidney disease>according to the advantages associated with attenuation of <metabolic syndrome>}
{<kidney disease>,<according to the advantages associated with attenuation of >,<metabolic syndrome>
{to insulin and <kidney disease>in the cardiorenal <metabolic syndrome>}
{<kidney disease>,<in the cardiorenal >,<metabolic syndrome>
{carotid stenosis chronic <kidney disease>and <metabolic syndrome>}
{<kidney disease>,<and >,<metabolic syndrome>
pheochromocytoma afibrinogenemia,ruptured ectopic pregnancy
{   <pheochromocytoma afibrinogenemia>and <ruptured ectopic pregnancy>}
{<pheochromocytoma afibrinogenemia>,<and >,<ruptured ectopic pregnancy>
Hypoglycemia chronic kidney disease,diabetes mellitus
{   <Hypoglycemia chronic kidney disease>and <diabetes mellitus>}
{<Hypoglycemia chronic kidney disease>,<and >,<diabetes mellitus>
infection Meckel's diverticulum,mesenteric adenitis
{   <infection Meckel's diverticulum>and <mesenteric adenitis>}
{<infection Meckel's diverticulum>,<and >,<mesenteric adenitis>
lymphocytopenia malabsorption,intestinal obstruction
{   <lymphocytopenia malabsorption>and <intestinal obstruction>}
{<lymphocytopenia malabsorption>,<and >,<intestinal obstruction>
glaucoma diabetic retinopathy,dry eye
{   <glaucoma diabetic retinopathy>and <dry eye>}
{<glaucoma diabetic retinopathy>,<and >,<dry eye>
systemic sclerosis,myelofibrosis
{patients with either <systemic sclerosis>or <myelofibrosis>}
{<systemic sclerosis>,<or >,<myelofibrosis>
Periumbilical pain,fever
{   <Periumbilical pain>and <fever>}
{<Periumbilical pain>,<and >,<fever>
infection intra-abdominal collection,ileus
{   <infection intra-abdominal collection>and <ileus>}
{<infection intra-abdominal collection>,<and >,<ileus>
Acute appendicitis,measles
{   <Acute appendicitis>and <measles>}
{<Acute appendicitis>,<and >,<measles>
{   <Acute appendicitis>during <measles>}
{<Acute appendicitis>,<during >,<measles>
nonalcoholic fatty liver disease,metabolic syndrome
{   <nonalcoholic fatty liver disease>and <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<and >,<metabolic syndrome>
{conventional paradigm of <nonalcoholic fatty liver disease>representing the hepatic manifestation of the <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<representing the hepatic manifestation of the >,<metabolic syndrome>
{a stage of <nonalcoholic fatty liver disease>NAFLD and in most patients is associated with obesity and the <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<NAFLD and in most patients is associated with obesity and the >,<metabolic syndrome>
{the pathogenesis of <nonalcoholic fatty liver disease>a component of the <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<a component of the >,<metabolic syndrome>
{   <nonalcoholic fatty liver disease>and the <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<and the >,<metabolic syndrome>
{longitudinal reported that <nonalcoholic fatty liver disease>precedes and is a risk factor for the future development of the <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<precedes and is a risk factor for the future development of the >,<metabolic syndrome>
{cross-sectional studies linked <nonalcoholic fatty liver disease>to either diabetes and other components of the <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<to either diabetes and other components of the >,<metabolic syndrome>
{The relationship between <nonalcoholic fatty liver disease>and colorectal cancer the future challenges and outcomes of the <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<and colorectal cancer the future challenges and outcomes of the >,<metabolic syndrome>
{novel paradigm of <nonalcoholic fatty liver disease>as a strong determinant for the development of the <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<as a strong determinant for the development of the >,<metabolic syndrome>
{The incidences of <nonalcoholic fatty liver disease>continuously increase due to high prevalence of <metabolic syndrome>}
{<nonalcoholic fatty liver disease>,<continuously increase due to high prevalence of >,<metabolic syndrome>
back pain hypotension,tachycardia
{   <back pain hypotension>and <tachycardia>}
{<back pain hypotension>,<and >,<tachycardia>
cerebrovascular disease,systolic heart failure
{   <cerebrovascular disease>and <systolic heart failure>}
{<cerebrovascular disease>,<and >,<systolic heart failure>
anaemia,infection
{the relationship between <anaemia>and <infection>}
{<anaemia>,<and >,<infection>
atherosclerosis,related diseases
{the treatment of <atherosclerosis>and <related diseases>}
{<atherosclerosis>,<and >,<related diseases>
vomiting epigastric pain,weight loss
{   <vomiting epigastric pain>and <weight loss>}
{<vomiting epigastric pain>,<and >,<weight loss>
hyperbilirubinemia,appendicitis
{the relationship between <hyperbilirubinemia>and <appendicitis>}
{<hyperbilirubinemia>,<and >,<appendicitis>
{of reports on <hyperbilirubinemia>in acute <appendicitis>}
{<hyperbilirubinemia>,<in acute >,<appendicitis>
{diagnostic value of <hyperbilirubinemia>as a preoperative laboratory marker for appendiceal perforation in patients with acute <appendicitis>}
{<hyperbilirubinemia>,<as a preoperative laboratory marker for appendiceal perforation in patients with acute >,<appendicitis>
{Diagnostic value of <hyperbilirubinemia>as a predictive factor for appendiceal perforation in acute <appendicitis>}
{<hyperbilirubinemia>,<as a predictive factor for appendiceal perforation in acute >,<appendicitis>
rheumatoid arthritis fibromyalgia,giant cell arteritis
{   <rheumatoid arthritis fibromyalgia>and <giant cell arteritis>}
{<rheumatoid arthritis fibromyalgia>,<and >,<giant cell arteritis>
glaucoma,disease
{cause of open-angle <glaucoma>is a kind of clinically systemic <disease>}
{<glaucoma>,<is a kind of clinically systemic >,<disease>
{and normal tension <glaucoma>patients may suggest a different role of the lamina cribrosa to the <disease>}
{<glaucoma>,<patients may suggest a different role of the lamina cribrosa to the >,<disease>
{the magnitude of <glaucoma>globally and the need for a greater understanding of this <disease>}
{<glaucoma>,<globally and the need for a greater understanding of this >,<disease>
{PACG or PEX <glaucoma>eyes had stage 3 or 4 <disease>}
{<glaucoma>,<eyes had stage 3 or 4 >,<disease>
{association with open-angle <glaucoma>progression were an advanced stage of the <disease>}
{<glaucoma>,<progression were an advanced stage of the >,<disease>
{Open angle chronic <glaucoma>tends to progress at a slower rate and patients may not notice loss of vision until the <disease>}
{<glaucoma>,<tends to progress at a slower rate and patients may not notice loss of vision until the >,<disease>
{with glaucoma pathophysiology <glaucoma>treatment perspectives and the possibility of future prevention of irreversible visual loss caused by the <disease>}
{<glaucoma>,<treatment perspectives and the possibility of future prevention of irreversible visual loss caused by the >,<disease>
{ BACKGROUND Open-angle <glaucoma>OAG is a progressive neurodegenerative <disease>}
{<glaucoma>,<OAG is a progressive neurodegenerative >,<disease>
{other indicators of <glaucoma>to build the pretest probability of the <disease>}
{<glaucoma>,<to build the pretest probability of the >,<disease>
{genetic pathophysiology of <glaucoma>mutations in known genes account for less than 15% of <disease>}
{<glaucoma>,<mutations in known genes account for less than 15% of >,<disease>
{the pathophysiology of <glaucoma>through loss of neurotrophic function and may eventually open the possibility of using ligands activating TrkB to prevent the progression of the <disease>}
{<glaucoma>,<through loss of neurotrophic function and may eventually open the possibility of using ligands activating TrkB to prevent the progression of the >,<disease>
{patients with familial <glaucoma>than in people with sporadic <disease>}
{<glaucoma>,<than in people with sporadic >,<disease>
{family history of <glaucoma>history of ocular trauma hypertension diabetes vascular <disease>}
{<glaucoma>,<history of ocular trauma hypertension diabetes vascular >,<disease>
{changes observed as <glaucoma>progresses and discusses <disease>}
{<glaucoma>,<progresses and discusses >,<disease>
{fixed combinations in <glaucoma>patients whose <disease>}
{<glaucoma>,<patients whose >,<disease>
{early stages of <glaucoma>the ROP worsened as the severity increased but in later stages of the <disease>}
{<glaucoma>,<the ROP worsened as the severity increased but in later stages of the >,<disease>
{that noncompliance to <glaucoma>treatment is one of the risk factors associated with disease s progression the purpose of the present study was to evaluate 1 knowledge and feelings about the <disease>}
{<glaucoma>,<treatment is one of the risk factors associated with disease s progression the purpose of the present study was to evaluate 1 knowledge and feelings about the >,<disease>
{studies suggest that <glaucoma>is a neurodegenerative <disease>}
{<glaucoma>,<is a neurodegenerative >,<disease>
{loss suggestive of <glaucoma>but did not show progression characteristic of this <disease>}
{<glaucoma>,<but did not show progression characteristic of this >,<disease>
{patients with exfoliation <glaucoma>XFG with cardiovascular <disease>}
{<glaucoma>,<XFG with cardiovascular >,<disease>
{in terms of <glaucoma>risk factors may have a significant impact in elucidating the mechanisms behind the <disease>}
{<glaucoma>,<risk factors may have a significant impact in elucidating the mechanisms behind the >,<disease>
{the notion that <glaucoma>is a neurodegenerative <disease>}
{<glaucoma>,<is a neurodegenerative >,<disease>
{major concern among <glaucoma>patients in Southwest Nigeria and there is a need to intensify present efforts aimed at increasing public awareness emphasising the irreversible nature of the <disease>}
{<glaucoma>,<patients in Southwest Nigeria and there is a need to intensify present efforts aimed at increasing public awareness emphasising the irreversible nature of the >,<disease>
{presentation pattern of <glaucoma>helps in providing more understanding of the <disease>}
{<glaucoma>,<helps in providing more understanding of the >,<disease>
{4 groups unaffected <glaucoma>suspect glaucoma advanced glaucoma according to the severity of <disease>}
{<glaucoma>,<suspect glaucoma advanced glaucoma according to the severity of >,<disease>
{Health Problems ICD <glaucoma>staging codes to predict <disease>}
{<glaucoma>,<staging codes to predict >,<disease>
{evidence indicates that <glaucoma>is a multifactorial neurodegenerative <disease>}
{<glaucoma>,<is a multifactorial neurodegenerative >,<disease>
{patients with advanced <glaucoma>does not agree with the Russian glaucoma society recommendations which accounts for progression of the <disease>}
{<glaucoma>,<does not agree with the Russian glaucoma society recommendations which accounts for progression of the >,<disease>
{Prime areas of <glaucoma>research therefore include identification and optimization of risk factors for the <disease>}
{<glaucoma>,<research therefore include identification and optimization of risk factors for the >,<disease>
{measured and described <glaucoma>patient knowledge using questionnaires were identified from the literature including cross-sectional studies of <disease>}
{<glaucoma>,<patient knowledge using questionnaires were identified from the literature including cross-sectional studies of >,<disease>
{on understanding what <glaucoma>patients know about their <disease>}
{<glaucoma>,<patients know about their >,<disease>
{from exfoliation syndrome <glaucoma>patients at the time of surgery and discuss the potential implications of these findings for understanding the cellular sources of the <disease>}
{<glaucoma>,<patients at the time of surgery and discuss the potential implications of these findings for understanding the cellular sources of the >,<disease>
{the spectrum of <glaucoma>regardless of subtype or <disease>}
{<glaucoma>,<regardless of subtype or >,<disease>
{early onset Myocilin <glaucoma>can facilitate early detection of <disease>}
{<glaucoma>,<can facilitate early detection of >,<disease>
{significant numbers of <glaucoma>patients are undiagnosed and present late in the course of their <disease>}
{<glaucoma>,<patients are undiagnosed and present late in the course of their >,<disease>
{patients with advanced <glaucoma>fractal dimension D was significantly lower than in controls whereas in the early stage of <disease>}
{<glaucoma>,<fractal dimension D was significantly lower than in controls whereas in the early stage of >,<disease>
{SLT and eventually <glaucoma>surgery Trabectome in 2 eyes for <disease>}
{<glaucoma>,<surgery Trabectome in 2 eyes for >,<disease>
{half of the <glaucoma>population unaware of their <disease>}
{<glaucoma>,<population unaware of their >,<disease>
{A determination of <glaucoma>diagnosis as well as classification of <disease>}
{<glaucoma>,<diagnosis as well as classification of >,<disease>
{changes associated with <glaucoma>within the family has enabled unaffected members to stratify their risk of future <disease>}
{<glaucoma>,<within the family has enabled unaffected members to stratify their risk of future >,<disease>
{functioning associated with <glaucoma>progression but could not measure quality of life changes in the mildest <disease>}
{<glaucoma>,<progression but could not measure quality of life changes in the mildest >,<disease>
{risk factor for <glaucoma>that can be therapeutically manipulated to change the course of the <disease>}
{<glaucoma>,<that can be therapeutically manipulated to change the course of the >,<disease>
{CSFI for discriminating <glaucoma>from normal eyes and the different stages of <disease>}
{<glaucoma>,<from normal eyes and the different stages of >,<disease>
{ BACKGROUND Open-angle <glaucoma>OAG is a prevalent degenerate ocular <disease>}
{<glaucoma>,<OAG is a prevalent degenerate ocular >,<disease>
{stable course of <glaucoma>process in 1 patient 0 6% with initial stage in 51 3% of patients with advanced stage and in 50% of patients with the end stage of the <disease>}
{<glaucoma>,<process in 1 patient 0 6% with initial stage in 51 3% of patients with advanced stage and in 50% of patients with the end stage of the >,<disease>
{not follow recommendations <glaucoma>progression was found in 99 4% of patients with initial <disease>}
{<glaucoma>,<progression was found in 99 4% of patients with initial >,<disease>
{Patients with higher <glaucoma>stage worse <disease>}
{<glaucoma>,<stage worse >,<disease>
{to cause early-onset <glaucoma>was not identified however COL15A1 variants were found in the youngest affected members of 7 of 15 pedigrees with variable <disease>}
{<glaucoma>,<was not identified however COL15A1 variants were found in the youngest affected members of 7 of 15 pedigrees with variable >,<disease>
{main goal of <glaucoma>treatment is to slow the rate of <disease>}
{<glaucoma>,<treatment is to slow the rate of >,<disease>
{relationship between self-reported <glaucoma>diagnosis and consumption of the oxidants calcium and iron suggest a possible relationship indicating increased risk of the <disease>}
{<glaucoma>,<diagnosis and consumption of the oxidants calcium and iron suggest a possible relationship indicating increased risk of the >,<disease>
{the prevalence of <glaucoma>is higher in OSAHS patients especially in those with severe <disease>}
{<glaucoma>,<is higher in OSAHS patients especially in those with severe >,<disease>
{patients with uveitic <glaucoma>secondary to BehÃ§et <disease>}
{<glaucoma>,<secondary to BehÃ§et >,<disease>
{  However <glaucoma>is not solely a retinal <disease>}
{<glaucoma>,<is not solely a retinal >,<disease>
{many forms of <glaucoma>across the spectrum of <disease>}
{<glaucoma>,<across the spectrum of >,<disease>
{surgical treatment of <glaucoma>to offer patients an earlier and safer transition to surgical management of their <disease>}
{<glaucoma>,<to offer patients an earlier and safer transition to surgical management of their >,<disease>
{Compared to Caucasians <glaucoma>patients in North India seem to present nearly a decade earlier and the <disease>}
{<glaucoma>,<patients in North India seem to present nearly a decade earlier and the >,<disease>
{evidence of pigmentary <glaucoma>implying a pathogenic role of inflammation/immunity in this <disease>}
{<glaucoma>,<implying a pathogenic role of inflammation/immunity in this >,<disease>
{early diagnosis of <glaucoma>but the absence of dyschromatopsia does not exclude the <disease>}
{<glaucoma>,<but the absence of dyschromatopsia does not exclude the >,<disease>
{risk factors for <glaucoma>indicates that PERG has a predictive potential for the development or progression of the <disease>}
{<glaucoma>,<indicates that PERG has a predictive potential for the development or progression of the >,<disease>
{cause of the <glaucoma>decades before the first manifestation of the <disease>}
{<glaucoma>,<decades before the first manifestation of the >,<disease>
{sent to our <glaucoma>department we analyzed the structures behaviour and knowledge about the <disease>}
{<glaucoma>,<department we analyzed the structures behaviour and knowledge about the >,<disease>
{associated with normal-tension <glaucoma>but are not associated with <disease>}
{<glaucoma>,<but are not associated with >,<disease>
{dog with inherited <glaucoma>appeared identical to that of the normal dog prior to expression of the <disease>}
{<glaucoma>,<appeared identical to that of the normal dog prior to expression of the >,<disease>
{distinctive features of <glaucoma>disk morphology visual field patterns and <disease>}
{<glaucoma>,<disk morphology visual field patterns and >,<disease>
{medical treatment for <glaucoma>requires a complex decision-making process that involves the patient the severity of the <disease>}
{<glaucoma>,<requires a complex decision-making process that involves the patient the severity of the >,<disease>
{ AMD and <glaucoma>contain features of chronic retinal inflammation that may promote <disease>}
{<glaucoma>,<contain features of chronic retinal inflammation that may promote >,<disease>
{risk factor for <glaucoma>a neurodegenerative <disease>}
{<glaucoma>,<a neurodegenerative >,<disease>
{classifying eyes with <glaucoma>was able to overcome the difficulties caused by the diverse nature of the <disease>}
{<glaucoma>,<was able to overcome the difficulties caused by the diverse nature of the >,<disease>
{therapeutic management of <glaucoma>is lowering of intraocular pressure there is as of now no cure for the <disease>}
{<glaucoma>,<is lowering of intraocular pressure there is as of now no cure for the >,<disease>
{  Since <glaucoma>is a 24-h <disease>}
{<glaucoma>,<is a 24-h >,<disease>
{vision loss from <glaucoma>is irreversible it is important to detect and treat patients at early stages of the <disease>}
{<glaucoma>,<is irreversible it is important to detect and treat patients at early stages of the >,<disease>
{  Normal-tension <glaucoma>NTG is a multifactorial <disease>}
{<glaucoma>,<NTG is a multifactorial >,<disease>
{for treatment of <glaucoma>because the pathology of the <disease>}
{<glaucoma>,<because the pathology of the >,<disease>
{different definitions of <glaucoma>have led to a rather big range of reported incidences of this <disease>}
{<glaucoma>,<have led to a rather big range of reported incidences of this >,<disease>
{monitoring of advanced <glaucoma>often exceeds that with earlier <disease>}
{<glaucoma>,<often exceeds that with earlier >,<disease>
{the stage of <glaucoma>from pre-diagnosis to end-stage <disease>}
{<glaucoma>,<from pre-diagnosis to end-stage >,<disease>
{The incidence of <glaucoma>depends on the anatomic localisation of inflammation and the associated underlying <disease>}
{<glaucoma>,<depends on the anatomic localisation of inflammation and the associated underlying >,<disease>
{a panel of <glaucoma>specialists and additional modifications were made after pilot testing to cover the full range of <disease>}
{<glaucoma>,<specialists and additional modifications were made after pilot testing to cover the full range of >,<disease>
{advanced stages of <glaucoma>the progression of the <disease>}
{<glaucoma>,<the progression of the >,<disease>
{growing acceptance that <glaucoma>should be viewed as a slowly progressive neurodegenerative <disease>}
{<glaucoma>,<should be viewed as a slowly progressive neurodegenerative >,<disease>
{  Frequently <glaucoma>is associated with elevated intraocular pressure but this condition is neither necessary nor sufficient for onset and progression of the <disease>}
{<glaucoma>,<is associated with elevated intraocular pressure but this condition is neither necessary nor sufficient for onset and progression of the >,<disease>
{including ophthalmology visits <glaucoma>surgeries and medication use increased as <disease>}
{<glaucoma>,<surgeries and medication use increased as >,<disease>
{per year for <glaucoma>suspects or patients with early-stage <disease>}
{<glaucoma>,<suspects or patients with early-stage >,<disease>
{family history of <glaucoma>low ocular perfusion pressure systemic hypotension cardiovascular disease cerebrovascular <disease>}
{<glaucoma>,<low ocular perfusion pressure systemic hypotension cardiovascular disease cerebrovascular >,<disease>
{percentage of the <glaucoma>discs were labeled as normal and eyes in the earlier stage of the <disease>}
{<glaucoma>,<discs were labeled as normal and eyes in the earlier stage of the >,<disease>
{risk factor for <glaucoma>it is clear that other factors can also influence <disease>}
{<glaucoma>,<it is clear that other factors can also influence >,<disease>
{may improve longitudinal <glaucoma>follow-up and <disease>}
{<glaucoma>,<follow-up and >,<disease>
{the fact that <glaucoma>is a progressive neurodegenerative <disease>}
{<glaucoma>,<is a progressive neurodegenerative >,<disease>
{follow-up from the <glaucoma>clinic were age sex place of domicile diagnosis at referral severity of <disease>}
{<glaucoma>,<clinic were age sex place of domicile diagnosis at referral severity of >,<disease>
{those with mild/moderate <glaucoma>than those with severe <disease>}
{<glaucoma>,<than those with severe >,<disease>
{individuals with spontaneous <glaucoma>are associated with the rise of intraocular pressure and subsequent development of this <disease>}
{<glaucoma>,<are associated with the rise of intraocular pressure and subsequent development of this >,<disease>
{functional impairment of <glaucoma>patients using a modified Bahasa Malaysia version of VF-14 questionnaire and to correlate the score with the severity of the <disease>}
{<glaucoma>,<patients using a modified Bahasa Malaysia version of VF-14 questionnaire and to correlate the score with the severity of the >,<disease>
{ultimate goal in <glaucoma>research is to find new compounds that will not only normalize IOP but also arrest or even reverse apoptotic damage to the optic nerve and RGCs to slow the rate of progression of the <disease>}
{<glaucoma>,<research is to find new compounds that will not only normalize IOP but also arrest or even reverse apoptotic damage to the optic nerve and RGCs to slow the rate of progression of the >,<disease>
{economic burden of <glaucoma>is significant and increases as the <disease>}
{<glaucoma>,<is significant and increases as the >,<disease>
{edu Cats with <glaucoma>typically present late in the course of <disease>}
{<glaucoma>,<typically present late in the course of >,<disease>
{ Of the <glaucoma>patients 27 had early <disease>}
{<glaucoma>,<patients 27 had early >,<disease>
{  As <glaucoma>is a chronic potentially progressive <disease>}
{<glaucoma>,<is a chronic potentially progressive >,<disease>
{modifiable factor in <glaucoma>management proven to alter the natural course of the <disease>}
{<glaucoma>,<management proven to alter the natural course of the >,<disease>
{ Nanotechnology and <glaucoma>little particles for a big <disease>}
{<glaucoma>,<little particles for a big >,<disease>
{molecular mechanisms underlying <glaucoma>is required to obtain early diagnosis and avoid potential <disease>}
{<glaucoma>,<is required to obtain early diagnosis and avoid potential >,<disease>
{Vision loss from <glaucoma>has a significant impact on health-related quality of life even in the early stages of <disease>}
{<glaucoma>,<has a significant impact on health-related quality of life even in the early stages of >,<disease>
{the manifestation of <glaucoma>has helped us to understand its mechanism of origin and definitely confirmed the hereditary nature of this <disease>}
{<glaucoma>,<has helped us to understand its mechanism of origin and definitely confirmed the hereditary nature of this >,<disease>
{the stage of <glaucoma>from prediagnosis to end-stage <disease>}
{<glaucoma>,<from prediagnosis to end-stage >,<disease>
{in treatment of <glaucoma>includes lowering IOP to prevent further progression of the <disease>}
{<glaucoma>,<includes lowering IOP to prevent further progression of the >,<disease>
{the efficiency of <glaucoma>therapy it is necessary to detect progression of the <disease>}
{<glaucoma>,<therapy it is necessary to detect progression of the >,<disease>
{with untreated normal-tension <glaucoma>NTG as well as 56 control eyes without ophthalmological <disease>}
{<glaucoma>,<NTG as well as 56 control eyes without ophthalmological >,<disease>
{the severity of <glaucoma>to adjust therapy on the basis of disease severity to describe visual field conditions in a short and simple format to monitor the progression of the <disease>}
{<glaucoma>,<to adjust therapy on the basis of disease severity to describe visual field conditions in a short and simple format to monitor the progression of the >,<disease>
{of normal tension <glaucoma>NTG suggests that the <disease>}
{<glaucoma>,<NTG suggests that the >,<disease>
{significant proportion of <glaucoma>patients present late particularly in the developing world and unfortunately in an advanced stage of the <disease>}
{<glaucoma>,<patients present late particularly in the developing world and unfortunately in an advanced stage of the >,<disease>
{strategy to improve <glaucoma>case detection and to reduce the burden of this <disease>}
{<glaucoma>,<case detection and to reduce the burden of this >,<disease>
{Management of the <glaucoma>is difficult because of the often chronic course of the underlying <disease>}
{<glaucoma>,<is difficult because of the often chronic course of the underlying >,<disease>
{the management of <glaucoma>for several reasons a it is a precursor of <disease>}
{<glaucoma>,<for several reasons a it is a precursor of >,<disease>
{have treatment for <glaucoma>initiated than would be predicted based on the magnitude of <disease>}
{<glaucoma>,<initiated than would be predicted based on the magnitude of >,<disease>
{patients with normal-tension <glaucoma>NTG and those with Alzheimer <disease>}
{<glaucoma>,<NTG and those with Alzheimer >,<disease>
{progression complications of <glaucoma>therapy iatrogenic especially steroid induction of the <disease>}
{<glaucoma>,<therapy iatrogenic especially steroid induction of the >,<disease>
{risk factors in <glaucoma>the wide variety of presentations of the <disease>}
{<glaucoma>,<the wide variety of presentations of the >,<disease>
{the treatment of <glaucoma>allergic eye <disease>}
{<glaucoma>,<allergic eye >,<disease>
{  Although <glaucoma>is a blinding <disease>}
{<glaucoma>,<is a blinding >,<disease>
{patients with chronic <glaucoma>has a particular purpose to measure patients' perception of the <disease>}
{<glaucoma>,<has a particular purpose to measure patients' perception of the >,<disease>
{has suggested that <glaucoma>may be viewed as a neurodegenerative <disease>}
{<glaucoma>,<may be viewed as a neurodegenerative >,<disease>
{Perhaps in exfoliation <glaucoma>circullatory disturbances combined with high IOP lead to a particularly relentlessly progressing form of the <disease>}
{<glaucoma>,<circullatory disturbances combined with high IOP lead to a particularly relentlessly progressing form of the >,<disease>
{exfoliation syndrome exfoliative <glaucoma>normal-tension glaucoma and normal control subjects without vascular or inflammatory ocular <disease>}
{<glaucoma>,<normal-tension glaucoma and normal control subjects without vascular or inflammatory ocular >,<disease>
{the premise that <glaucoma>is a neurodegenerative <disease>}
{<glaucoma>,<is a neurodegenerative >,<disease>
{at diagnosis than <glaucoma>patients without a family history of the <disease>}
{<glaucoma>,<patients without a family history of the >,<disease>
{to determine whether <glaucoma>patients with a family history of the <disease>}
{<glaucoma>,<patients with a family history of the >,<disease>
{have suggested that <glaucoma>may be viewed as a neurodegenerative <disease>}
{<glaucoma>,<may be viewed as a neurodegenerative >,<disease>
{ post-retinal surgery <glaucoma>glaucoma associated with penetrating keratoplasties and glaucoma in eyes with scarred conjunctiva from surgery or <disease>}
{<glaucoma>,<glaucoma associated with penetrating keratoplasties and glaucoma in eyes with scarred conjunctiva from surgery or >,<disease>
{the development of <glaucoma>we studied its expression in response to factors known to be associated with the <disease>}
{<glaucoma>,<we studied its expression in response to factors known to be associated with the >,<disease>
{cause of open-angle <glaucoma>however very few investigators are engaged in basic research on this <disease>}
{<glaucoma>,<however very few investigators are engaged in basic research on this >,<disease>
{trabecular meshwork of <glaucoma>address the pathologic problem of the <disease>}
{<glaucoma>,<address the pathologic problem of the >,<disease>
{  of <glaucoma>the regulation of IOP and new therapeutic approaches to prevent the irreversible loss of vision from this <disease>}
{<glaucoma>,<the regulation of IOP and new therapeutic approaches to prevent the irreversible loss of vision from this >,<disease>
{fully simulate human <glaucoma>or any other neurodegenerative <disease>}
{<glaucoma>,<or any other neurodegenerative >,<disease>
{of vision in <glaucoma>the pathogenesis of the <disease>}
{<glaucoma>,<the pathogenesis of the >,<disease>
{of uveitic secondary <glaucoma>should only be performed if medical treatment of the underlying <disease>}
{<glaucoma>,<should only be performed if medical treatment of the underlying >,<disease>
{pathogenesis of normal-tension <glaucoma>by analyzing the effect of a 30% intraocular pressure reduction on the subsequent course of the <disease>}
{<glaucoma>,<by analyzing the effect of a 30% intraocular pressure reduction on the subsequent course of the >,<disease>
{Moreover in some <glaucoma>patients significant IOP reduction does not prevent progression of the <disease>}
{<glaucoma>,<patients significant IOP reduction does not prevent progression of the >,<disease>
{whether normal tension <glaucoma>NTG is associated with increased risk of developing dementia/Alzheimer <disease>}
{<glaucoma>,<NTG is associated with increased risk of developing dementia/Alzheimer >,<disease>
{CONCLUSION Normal tension <glaucoma>is from the etiopathogenetical view a different <disease>}
{<glaucoma>,<is from the etiopathogenetical view a different >,<disease>
{work-up can improve <glaucoma>management and potentially discover life-threatening <disease>}
{<glaucoma>,<management and potentially discover life-threatening >,<disease>
{ PURPOSE Normal-tension <glaucoma>NTG is a heterogenous <disease>}
{<glaucoma>,<NTG is a heterogenous >,<disease>
{patients with low-pressure <glaucoma>LPG and to assess the risk factors for <disease>}
{<glaucoma>,<LPG and to assess the risk factors for >,<disease>
{counterparts and that <glaucoma>patients retained more knowledge of their <disease>}
{<glaucoma>,<patients retained more knowledge of their >,<disease>
{in eyes with <glaucoma>suggest that the number of ganglion cells subserving macular function is decreased even in early stages of the <disease>}
{<glaucoma>,<suggest that the number of ganglion cells subserving macular function is decreased even in early stages of the >,<disease>
{those with secondary <glaucoma>particularly when it was associated with inflammatory <disease>}
{<glaucoma>,<particularly when it was associated with inflammatory >,<disease>
{  from <glaucoma>is irreversible early detection of the <disease>}
{<glaucoma>,<is irreversible early detection of the >,<disease>
{those with secondary <glaucoma>particularly where it was associated with inflammatory <disease>}
{<glaucoma>,<particularly where it was associated with inflammatory >,<disease>
{different types of <glaucoma>the constitution of this <disease>}
{<glaucoma>,<the constitution of this >,<disease>
{those with secondary <glaucoma>especially where it was associated with inflammatory <disease>}
{<glaucoma>,<especially where it was associated with inflammatory >,<disease>
{with manifest open-angle <glaucoma>the initial progression was detected much more often in the visual field series than in the optic disc photographs at all stages of <disease>}
{<glaucoma>,<the initial progression was detected much more often in the visual field series than in the optic disc photographs at all stages of >,<disease>
{population who have <glaucoma>but do not know it and those who are likely to develop the <disease>}
{<glaucoma>,<but do not know it and those who are likely to develop the >,<disease>
{blood flow in <glaucoma>diagnostics independently of the question whether perfusion abnormalities are a cause or a consequence of the <disease>}
{<glaucoma>,<diagnostics independently of the question whether perfusion abnormalities are a cause or a consequence of the >,<disease>
{vision loss from <glaucoma>early identification of nonadherent members is crucial to effective <disease>}
{<glaucoma>,<early identification of nonadherent members is crucial to effective >,<disease>
{  While <glaucoma>is a lifelong <disease>}
{<glaucoma>,<is a lifelong >,<disease>
{the eyes with <glaucoma>was within the normal range in the very early stage of the <disease>}
{<glaucoma>,<was within the normal range in the very early stage of the >,<disease>
{P1 reductions and <glaucoma>lend support to the ischaemic origins of the <disease>}
{<glaucoma>,<lend support to the ischaemic origins of the >,<disease>
{Poor retention of <glaucoma>knowledge may impact the likelihood of patient follow-up and reinforcement with repeated counseling may be beneficial with regard to both <disease>}
{<glaucoma>,<knowledge may impact the likelihood of patient follow-up and reinforcement with repeated counseling may be beneficial with regard to both >,<disease>
{not surprising since <glaucoma>is a multifactorial <disease>}
{<glaucoma>,<is a multifactorial >,<disease>
{level duration of <glaucoma>difficulty in instilling the drops medication regimens a family history of glaucoma knowledge of the <disease>}
{<glaucoma>,<difficulty in instilling the drops medication regimens a family history of glaucoma knowledge of the >,<disease>
{PURPOSE To evaluate <glaucoma>prevalence and <disease>}
{<glaucoma>,<prevalence and >,<disease>
{Fifty-four normal tension <glaucoma>cases were studied to determine the value of several clinical tests for predicting the progression of the <disease>}
{<glaucoma>,<cases were studied to determine the value of several clinical tests for predicting the progression of the >,<disease>
{patients with normal-tension <glaucoma>had one or more immune-related <disease>}
{<glaucoma>,<had one or more immune-related >,<disease>
{is that low-tension <glaucoma>is the result of decreased optic nerve perfusion on the basis of vascular <disease>}
{<glaucoma>,<is the result of decreased optic nerve perfusion on the basis of vascular >,<disease>
{The etiology of <glaucoma>is not known but numerous risk factors are associated with this <disease>}
{<glaucoma>,<is not known but numerous risk factors are associated with this >,<disease>
{the course of <glaucoma>progression in animal models of the <disease>}
{<glaucoma>,<progression in animal models of the >,<disease>
{patients with normal-tension <glaucoma>all of whom had an early stage of the <disease>}
{<glaucoma>,<all of whom had an early stage of the >,<disease>
{function in normal-tension <glaucoma>the surgery is worth further consideration as a potent treatment for the <disease>}
{<glaucoma>,<the surgery is worth further consideration as a potent treatment for the >,<disease>
{cause of open-angle <glaucoma>worldwide and is a potentially reversible or even curable <disease>}
{<glaucoma>,<worldwide and is a potentially reversible or even curable >,<disease>
{ or normal-tension <glaucoma>but it was present in only 11 of 206 eyes 5% that were normal had ocular hypertension or had retinal <disease>}
{<glaucoma>,<but it was present in only 11 of 206 eyes 5% that were normal had ocular hypertension or had retinal >,<disease>
{the etiology of <glaucoma>or whether it is the result of the loss of neural components caused by this <disease>}
{<glaucoma>,<or whether it is the result of the loss of neural components caused by this >,<disease>
{To determine whether <glaucoma>affects mobility performance and whether there is a relationship between mobility performance and stage of <disease>}
{<glaucoma>,<affects mobility performance and whether there is a relationship between mobility performance and stage of >,<disease>
{The search for <glaucoma>genes--implications for pathogenesis and <disease>}
{<glaucoma>,<genes--implications for pathogenesis and >,<disease>
{and far advanced <glaucoma>showed that the <disease>}
{<glaucoma>,<showed that the >,<disease>
{filters of the <glaucoma>subjects is correlated with stage of <disease>}
{<glaucoma>,<subjects is correlated with stage of >,<disease>
{energy thresholds of <glaucoma>patients at various stages of the <disease>}
{<glaucoma>,<patients at various stages of the >,<disease>
{familial chronic open-angle <glaucoma>COAG for the <disease>}
{<glaucoma>,<COAG for the >,<disease>
{regimen for open-angle <glaucoma>is very important to the eventual outcome of their <disease>}
{<glaucoma>,<is very important to the eventual outcome of their >,<disease>
{pseudoexfoliation syndrome with <glaucoma>suggesting an abnormal regulation of elastin synthesis and/or degradation in the optic nerve of patients with this <disease>}
{<glaucoma>,<suggesting an abnormal regulation of elastin synthesis and/or degradation in the optic nerve of patients with this >,<disease>
{  Although <glaucoma>is a chronic <disease>}
{<glaucoma>,<is a chronic >,<disease>
{common features of <glaucoma>we have analysed available data on the three main forms of the <disease>}
{<glaucoma>,<we have analysed available data on the three main forms of the >,<disease>
{the screening of <glaucoma>families and the identification of individuals at risk for the <disease>}
{<glaucoma>,<families and the identification of individuals at risk for the >,<disease>
{patients with open-angle <glaucoma>are statistically investigated to show the meteorotropism of this <disease>}
{<glaucoma>,<are statistically investigated to show the meteorotropism of this >,<disease>
{clinical forms of <glaucoma>present lesions corresponding to the evolution stage of the <disease>}
{<glaucoma>,<present lesions corresponding to the evolution stage of the >,<disease>
{advanced and quasi-absolute <glaucoma>stage and only 17% in the initial stage of the <disease>}
{<glaucoma>,<stage and only 17% in the initial stage of the >,<disease>
{families with GLC1A <glaucoma>now reported from only a few centers worldwide raise questions about whether this <disease>}
{<glaucoma>,<now reported from only a few centers worldwide raise questions about whether this >,<disease>
{relation of the <glaucoma>present in this family to the common later-age-onset form of the <disease>}
{<glaucoma>,<present in this family to the common later-age-onset form of the >,<disease>
glaucoma,glaucoma
{missed diagnoses of <glaucoma>and/or <glaucoma>}
{<glaucoma>,<and/or >,<glaucoma>
{Patients with pigmentary <glaucoma>may be distinguished from those with other <glaucoma>}
{<glaucoma>,<may be distinguished from those with other >,<glaucoma>
{uric acid and <glaucoma>severity in primary angle closure <glaucoma>}
{<glaucoma>,<severity in primary angle closure >,<glaucoma>
{need for clear <glaucoma>care pathways with early case finding in the community two-way referral/feedback systems well-equipped <glaucoma>}
{<glaucoma>,<care pathways with early case finding in the community two-way referral/feedback systems well-equipped >,<glaucoma>
{Increased risk of <glaucoma>may be limited to a few susceptible individuals such as individuals with a family history of <glaucoma>}
{<glaucoma>,<may be limited to a few susceptible individuals such as individuals with a family history of >,<glaucoma>
{ 5% of <glaucoma>suspects 14% of ocular hypertensives 32% of pseudoexfoliative glaucoma and 50% of normal tension <glaucoma>}
{<glaucoma>,<suspects 14% of ocular hypertensives 32% of pseudoexfoliative glaucoma and 50% of normal tension >,<glaucoma>
{ BACKGROUND Microinvasive <glaucoma>surgery MIGS is a relatively new addition to the <glaucoma>}
{<glaucoma>,<surgery MIGS is a relatively new addition to the >,<glaucoma>
{Costs from visits <glaucoma>follow-up studies laser and <glaucoma>}
{<glaucoma>,<follow-up studies laser and >,<glaucoma>
{areas of latest <glaucoma>research into risk factors of <glaucoma>}
{<glaucoma>,<research into risk factors of >,<glaucoma>
{for terms including <glaucoma>risk factors glaucoma diagnostics glaucoma treatment glaucoma drug delivery and <glaucoma>}
{<glaucoma>,<risk factors glaucoma diagnostics glaucoma treatment glaucoma drug delivery and >,<glaucoma>
{various subtypes of <glaucoma>was open-angle <glaucoma>}
{<glaucoma>,<was open-angle >,<glaucoma>
{cases of low-tension <glaucoma>the presence of other familial cases of high-tension <glaucoma>}
{<glaucoma>,<the presence of other familial cases of high-tension >,<glaucoma>
{Hg 124 high-tension <glaucoma>patients abnormal visual field and/or abnormal optic nerve and IOP 22 mm Hg and 47 low-tension <glaucoma>}
{<glaucoma>,<patients abnormal visual field and/or abnormal optic nerve and IOP 22 mm Hg and 47 low-tension >,<glaucoma>
{some forms of <glaucoma>such as normal tension <glaucoma>}
{<glaucoma>,<such as normal tension >,<glaucoma>
{patients with normal-tension <glaucoma>15 eyes with practically stable visual field defects in patients with normal-tension <glaucoma>}
{<glaucoma>,<15 eyes with practically stable visual field defects in patients with normal-tension >,<glaucoma>
{ 132 high-tension <glaucoma>HTG and 50 normal-tension <glaucoma>}
{<glaucoma>,<HTG and 50 normal-tension >,<glaucoma>
{patients with normal-tension <glaucoma>NTG and high-tension <glaucoma>}
{<glaucoma>,<NTG and high-tension >,<glaucoma>
{the majority of <glaucoma>HIOPG cases but some patients have low-tension <glaucoma>}
{<glaucoma>,<HIOPG cases but some patients have low-tension >,<glaucoma>
{01 in acute <glaucoma>patients after laser therapy than in acute <glaucoma>}
{<glaucoma>,<patients after laser therapy than in acute >,<glaucoma>
{patients with open-angle <glaucoma>POAG four patients with chronic angle closure <glaucoma>}
{<glaucoma>,<POAG four patients with chronic angle closure >,<glaucoma>
{development of normal-tension <glaucoma>or whether they are a result of normal-tension <glaucoma>}
{<glaucoma>,<or whether they are a result of normal-tension >,<glaucoma>
{patients with normal-tension <glaucoma>were compared with 14 age- and sex-matched <glaucoma>}
{<glaucoma>,<were compared with 14 age- and sex-matched >,<glaucoma>
{parameters in high-tension <glaucoma>HTG and normal-tension <glaucoma>}
{<glaucoma>,<HTG and normal-tension >,<glaucoma>
{no history of <glaucoma>or elevated IOP and normal visual field on automated perimetry and 50 control subjects untreated IOP less than 21 mm Hg with normal optic nerve head and no history of <glaucoma>}
{<glaucoma>,<or elevated IOP and normal visual field on automated perimetry and 50 control subjects untreated IOP less than 21 mm Hg with normal optic nerve head and no history of >,<glaucoma>
{eyes with pseudoexfoliative <glaucoma>PXE 42 eyes with chronic angle closure glaucoma CACG and 232 <glaucoma>}
{<glaucoma>,<PXE 42 eyes with chronic angle closure glaucoma CACG and 232 >,<glaucoma>
{quadrants in high-tension <glaucoma>whereas a more localized defect on the inferior RNFL occurs in normal-tension <glaucoma>}
{<glaucoma>,<whereas a more localized defect on the inferior RNFL occurs in normal-tension >,<glaucoma>
{patients with low-tension <glaucoma>untreated IOP less than 21 mm Hg with evidence of optic nerve head damage and corresponding visual field loss on automated perimetry 80 patients with COAG untreated IOP 21 mm Hg or greater with evidence of optic nerve head damage and corresponding visual field loss on automated perimetry 16 patients with ocular hypertension untreated IOP 21 mm Hg or greater with normal optic nerve head and no history of <glaucoma>}
{<glaucoma>,<untreated IOP less than 21 mm Hg with evidence of optic nerve head damage and corresponding visual field loss on automated perimetry 80 patients with COAG untreated IOP 21 mm Hg or greater with evidence of optic nerve head damage and corresponding visual field loss on automated perimetry 16 patients with ocular hypertension untreated IOP 21 mm Hg or greater with normal optic nerve head and no history of >,<glaucoma>
{defects 30 low-tension <glaucoma>LTG 61 high-tension <glaucoma>}
{<glaucoma>,<LTG 61 high-tension >,<glaucoma>
{of both PDS/pigmentary <glaucoma>PG and XFS/exfoliative <glaucoma>}
{<glaucoma>,<PG and XFS/exfoliative >,<glaucoma>
{patients with high-tension <glaucoma>without visual field defects preHTG and 91 patients with open-angle glaucoma with visual field defects 30 low-tension <glaucoma>}
{<glaucoma>,<without visual field defects preHTG and 91 patients with open-angle glaucoma with visual field defects 30 low-tension >,<glaucoma>
{primary angle closure <glaucoma>AC 24 had pseudoexfoliation <glaucoma>}
{<glaucoma>,<AC 24 had pseudoexfoliation >,<glaucoma>
{24 had pseudoexfoliation <glaucoma>PEX 13 had pigmentary <glaucoma>}
{<glaucoma>,<PEX 13 had pigmentary >,<glaucoma>
{2 with juvenile <glaucoma>53 eyes of patients suspected of <glaucoma>}
{<glaucoma>,<53 eyes of patients suspected of >,<glaucoma>
{RESULTS Both the <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{open-angle or high-tension <glaucoma>POAG and normal-tension <glaucoma>}
{<glaucoma>,<POAG and normal-tension >,<glaucoma>
{17 with pseudoexfoliative <glaucoma>3 with angle closure glaucoma and 2 with juvenile <glaucoma>}
{<glaucoma>,<3 with angle closure glaucoma and 2 with juvenile >,<glaucoma>
{the diagnosis of <glaucoma>especially normal tension <glaucoma>}
{<glaucoma>,<especially normal tension >,<glaucoma>
{eyes with low-tension <glaucoma>LTG and 25 patients 50 eyes with pseudoexfoliative <glaucoma>}
{<glaucoma>,<LTG and 25 patients 50 eyes with pseudoexfoliative >,<glaucoma>
{9% of the <glaucoma>patients identified through screening had normal tension <glaucoma>}
{<glaucoma>,<patients identified through screening had normal tension >,<glaucoma>
{26 normal tension <glaucoma>patients NTG and 27 high tension <glaucoma>}
{<glaucoma>,<patients NTG and 27 high tension >,<glaucoma>
{study differences between <glaucoma>patients identified through a population screening and <glaucoma>}
{<glaucoma>,<patients identified through a population screening and >,<glaucoma>
{a number of <glaucoma>patients Open angle glaucoma POAG angle closure <glaucoma>}
{<glaucoma>,<patients Open angle glaucoma POAG angle closure >,<glaucoma>
{POAG angle closure <glaucoma>ACG normal tension <glaucoma>}
{<glaucoma>,<ACG normal tension >,<glaucoma>
{glaucoma vs normal-tension <glaucoma>patients showed that an increased homocysteine concentration was a significant risk factor for exfoliation syndrome in the presence of <glaucoma>}
{<glaucoma>,<patients showed that an increased homocysteine concentration was a significant risk factor for exfoliation syndrome in the presence of >,<glaucoma>
{99 with high-tension <glaucoma>HTG and 31 with normal-tension <glaucoma>}
{<glaucoma>,<HTG and 31 with normal-tension >,<glaucoma>
{indicate that normal-tension <glaucoma>is not necessarily part of the phenotypic spectrum of adult open-angle <glaucoma>}
{<glaucoma>,<is not necessarily part of the phenotypic spectrum of adult open-angle >,<glaucoma>
{patients with normal-tension <glaucoma>NTG high-tension <glaucoma>}
{<glaucoma>,<NTG high-tension >,<glaucoma>
{normal-tension or pseudoexfoliative <glaucoma>evaluated at the <glaucoma>}
{<glaucoma>,<evaluated at the >,<glaucoma>
{impact of various <glaucoma>therapies on the diurnal IOP curve and the use of diurnal curves in <glaucoma>}
{<glaucoma>,<therapies on the diurnal IOP curve and the use of diurnal curves in >,<glaucoma>
{from groups of <glaucoma>suspects and subjects without <glaucoma>}
{<glaucoma>,<suspects and subjects without >,<glaucoma>
{22% had secondary <glaucoma>including neovascular congenital and chronic closed-angle glaucoma and 4% had suspected <glaucoma>}
{<glaucoma>,<including neovascular congenital and chronic closed-angle glaucoma and 4% had suspected >,<glaucoma>
{patients with normal-tension <glaucoma>NTG n = 38 and high-tension <glaucoma>}
{<glaucoma>,<NTG n = 38 and high-tension >,<glaucoma>
{for either high-tension <glaucoma>or normal-tension <glaucoma>}
{<glaucoma>,<or normal-tension >,<glaucoma>
{were assembled group <glaucoma>patients with normal or subnormal trabecular pigmentation group 2 <glaucoma>}
{<glaucoma>,<patients with normal or subnormal trabecular pigmentation group 2 >,<glaucoma>
{74% had open-angle <glaucoma>including normal tension exfoliative and pigment glaucoma 22% had secondary <glaucoma>}
{<glaucoma>,<including normal tension exfoliative and pigment glaucoma 22% had secondary >,<glaucoma>
{among healthy and <glaucoma>suspect and preperimetric <glaucoma>}
{<glaucoma>,<suspect and preperimetric >,<glaucoma>
{POAG normal tension <glaucoma>NTG and normal tension <glaucoma>}
{<glaucoma>,<NTG and normal tension >,<glaucoma>
{using the Ex-PRESS <glaucoma>shunt in black and white patients with open-angle <glaucoma>}
{<glaucoma>,<shunt in black and white patients with open-angle >,<glaucoma>
{5 patients juvenile <glaucoma>2 patients and PEX <glaucoma>}
{<glaucoma>,<2 patients and PEX >,<glaucoma>
{model of glucocorticoid-induced <glaucoma>that exhibits <glaucoma>}
{<glaucoma>,<that exhibits >,<glaucoma>
{294 high tension <glaucoma>HTG and 106 normal tension <glaucoma>}
{<glaucoma>,<HTG and 106 normal tension >,<glaucoma>
{common in the <glaucoma>patients and impaired effect of <glaucoma>}
{<glaucoma>,<patients and impaired effect of >,<glaucoma>
{patients with normal-tension <glaucoma>NTG 12 <glaucoma>}
{<glaucoma>,<NTG 12 >,<glaucoma>
{man with open-angle <glaucoma>patient 1 and a 37-year-old man with neovascular <glaucoma>}
{<glaucoma>,<patient 1 and a 37-year-old man with neovascular >,<glaucoma>
{and normal tension <glaucoma>NTG <glaucoma>}
{<glaucoma>,<NTG >,<glaucoma>
{87 healthy subjects <glaucoma>suspects GS and 81 <glaucoma>}
{<glaucoma>,<suspects GS and 81 >,<glaucoma>
{ Early manifest <glaucoma>trial EMGT the Collaborative normal-tension <glaucoma>}
{<glaucoma>,<trial EMGT the Collaborative normal-tension >,<glaucoma>
{now known that <glaucoma>can occur at statistically normal IOPs and prevalence studies have shown that normal tension <glaucoma>}
{<glaucoma>,<can occur at statistically normal IOPs and prevalence studies have shown that normal tension >,<glaucoma>
{effects of age <glaucoma>severity <glaucoma>}
{<glaucoma>,<severity >,<glaucoma>
{eyes initial preperimetric <glaucoma>developed perimetric glaucoma and terminal <glaucoma>}
{<glaucoma>,<developed perimetric glaucoma and terminal >,<glaucoma>
{  Normal-tension <glaucoma>was the most commonly encountered <glaucoma>}
{<glaucoma>,<was the most commonly encountered >,<glaucoma>
{as normal tension <glaucoma>NTG and 25 as high tension <glaucoma>}
{<glaucoma>,<NTG and 25 as high tension >,<glaucoma>
{some important factors <glaucoma>severity five stages 2 <glaucoma>}
{<glaucoma>,<severity five stages 2 >,<glaucoma>
{glaucoma primary open-angle <glaucoma>including normal tension <glaucoma>}
{<glaucoma>,<including normal tension >,<glaucoma>
{13 normal-tension NTGwm <glaucoma>patients under IOP-lowering treatment and in 28 normal-tension <glaucoma>}
{<glaucoma>,<patients under IOP-lowering treatment and in 28 normal-tension >,<glaucoma>
{primary angle closure <glaucoma>PACG and 135 patients with pseudoexfoliative <glaucoma>}
{<glaucoma>,<PACG and 135 patients with pseudoexfoliative >,<glaucoma>
{patients with normal-tension <glaucoma>NTG 15 patients with high-tension <glaucoma>}
{<glaucoma>,<NTG 15 patients with high-tension >,<glaucoma>
{surgery with microinvasive <glaucoma>surgery in phaco-plus procedures provides further options for lens-based <glaucoma>}
{<glaucoma>,<surgery in phaco-plus procedures provides further options for lens-based >,<glaucoma>
{classified into high-tension <glaucoma>HTG and normal-tension <glaucoma>}
{<glaucoma>,<HTG and normal-tension >,<glaucoma>
{ following Ahmed <glaucoma>valve implantation in pediatric eyes with <glaucoma>}
{<glaucoma>,<valve implantation in pediatric eyes with >,<glaucoma>
{optic disc high-tension <glaucoma>has elevated intraocular pressure whereas in normal-tension <glaucoma>}
{<glaucoma>,<has elevated intraocular pressure whereas in normal-tension >,<glaucoma>
{18Â years with open-angle <glaucoma>including primary exfoliative or pigment-dispersion <glaucoma>}
{<glaucoma>,<including primary exfoliative or pigment-dispersion >,<glaucoma>
{24 normal tension <glaucoma>n = 3 angle closure <glaucoma>}
{<glaucoma>,<n = 3 angle closure >,<glaucoma>
{chronic angle closure <glaucoma>46 13% cases with secondary <glaucoma>}
{<glaucoma>,<46 13% cases with secondary >,<glaucoma>
{referred to a <glaucoma>screening clinic were classified as <glaucoma>}
{<glaucoma>,<screening clinic were classified as >,<glaucoma>
{If only open-angle <glaucoma>was considered multivariate analysis revealed no significant association between SFCT and presence of open-angle <glaucoma>}
{<glaucoma>,<was considered multivariate analysis revealed no significant association between SFCT and presence of open-angle >,<glaucoma>
{OR for high-tension <glaucoma>HTG was higher than that for normal-tension <glaucoma>}
{<glaucoma>,<HTG was higher than that for normal-tension >,<glaucoma>
{two types of <glaucoma>there are indications that primary laser trabeculoplasty has a higher success rate in pseudoexfoliation <glaucoma>}
{<glaucoma>,<there are indications that primary laser trabeculoplasty has a higher success rate in pseudoexfoliation >,<glaucoma>
{from 89 healthy <glaucoma>suspects and 104 <glaucoma>}
{<glaucoma>,<suspects and 104 >,<glaucoma>
{ Following CRVO <glaucoma>surgery is necessary for pre-existing <glaucoma>}
{<glaucoma>,<surgery is necessary for pre-existing >,<glaucoma>
{A total of <glaucoma>patients were seen at the <glaucoma>}
{<glaucoma>,<patients were seen at the >,<glaucoma>
{intraocular pressure in <glaucoma>suspects and normal tension <glaucoma>}
{<glaucoma>,<suspects and normal tension >,<glaucoma>
{as having normal-tension <glaucoma>NTG and those with higher IOP were classified as having high-tension <glaucoma>}
{<glaucoma>,<NTG and those with higher IOP were classified as having high-tension >,<glaucoma>
{our Australian normal-tension <glaucoma>cohort including the first example of more than 1 extra copy of this gene in <glaucoma>}
{<glaucoma>,<cohort including the first example of more than 1 extra copy of this gene in >,<glaucoma>
{of suspected normal-tension <glaucoma>eyes and may differentiate between eyes with normal trabecular outflow capacity and eyes with increased resistance in the trabecular meshwork that are prone to pressure peaks and deterioration to <glaucoma>}
{<glaucoma>,<eyes and may differentiate between eyes with normal trabecular outflow capacity and eyes with increased resistance in the trabecular meshwork that are prone to pressure peaks and deterioration to >,<glaucoma>
{cause of normal-tension <glaucoma>but do not suggest common involvement in high-tension <glaucoma>}
{<glaucoma>,<but do not suggest common involvement in high-tension >,<glaucoma>
{70% of the <glaucoma>suspects still remained as <glaucoma>}
{<glaucoma>,<suspects still remained as >,<glaucoma>
{patients with early <glaucoma>from the Erlangen <glaucoma>}
{<glaucoma>,<from the Erlangen >,<glaucoma>
{pattern of the <glaucoma>group compared with the nonglaucoma group in aqueous humor confirm the results of previous studies using sera of <glaucoma>}
{<glaucoma>,<group compared with the nonglaucoma group in aqueous humor confirm the results of previous studies using sera of >,<glaucoma>
{in 3 normal-tension <glaucoma>patients while 2 extra doses of the gene triplication were detected in a fourth normal-tension <glaucoma>}
{<glaucoma>,<patients while 2 extra doses of the gene triplication were detected in a fourth normal-tension >,<glaucoma>
{POAG normal tension <glaucoma>OHT or <glaucoma>}
{<glaucoma>,<OHT or >,<glaucoma>
{to have either <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{with high tension <glaucoma>HTG and normal tension <glaucoma>}
{<glaucoma>,<HTG and normal tension >,<glaucoma>
{  POAG <glaucoma>suspects GS normal tension <glaucoma>}
{<glaucoma>,<suspects GS normal tension >,<glaucoma>
{participating in a <glaucoma>screening programme and those who were examined in the <glaucoma>}
{<glaucoma>,<screening programme and those who were examined in the >,<glaucoma>
{105 eyes of <glaucoma>suspects and 49 eyes of perimetric <glaucoma>}
{<glaucoma>,<suspects and 49 eyes of perimetric >,<glaucoma>
{admitted to the <glaucoma>clinic for a detailed <glaucoma>}
{<glaucoma>,<clinic for a detailed >,<glaucoma>
{FED diagnosis/severity and <glaucoma>diagnosis/type of <glaucoma>}
{<glaucoma>,<diagnosis/type of >,<glaucoma>
{POAG including normal-tension <glaucoma>NTG and high-tension <glaucoma>}
{<glaucoma>,<NTG and high-tension >,<glaucoma>
{from pure atopic <glaucoma>to a mixed type of atopic/steroid-induced <glaucoma>}
{<glaucoma>,<to a mixed type of atopic/steroid-induced >,<glaucoma>
{OF REVIEW Normal-tension <glaucoma>NTG is a common form of open-angle <glaucoma>}
{<glaucoma>,<NTG is a common form of open-angle >,<glaucoma>
{eyes with high-tension <glaucoma>HTG and 20 eyes with normal-tension <glaucoma>}
{<glaucoma>,<HTG and 20 eyes with normal-tension >,<glaucoma>
{findings suggestive of <glaucoma>were subjected to a comprehensive <glaucoma>}
{<glaucoma>,<were subjected to a comprehensive >,<glaucoma>
{Among these subjects <glaucoma>patients normal-tension <glaucoma>}
{<glaucoma>,<patients normal-tension >,<glaucoma>
{patients with high-tension <glaucoma>HTG 37 patients with normal-tension <glaucoma>}
{<glaucoma>,<HTG 37 patients with normal-tension >,<glaucoma>
{criteria were congenital <glaucoma>any type of angle closure <glaucoma>}
{<glaucoma>,<any type of angle closure >,<glaucoma>
{ocular hypertension open-angle <glaucoma>or normal tension <glaucoma>}
{<glaucoma>,<or normal tension >,<glaucoma>
{of angle closure <glaucoma>advanced-stage <glaucoma>}
{<glaucoma>,<advanced-stage >,<glaucoma>
{Significance of epidemiological <glaucoma>survey --awareness of normal-tension <glaucoma>}
{<glaucoma>,<survey --awareness of normal-tension >,<glaucoma>
{Neural losses from <glaucoma>are irreversible and so the aim of <glaucoma>}
{<glaucoma>,<are irreversible and so the aim of >,<glaucoma>
{to risk of <glaucoma>was investigated in a case-control genetic association study in 272 patients with high-tension <glaucoma>}
{<glaucoma>,<was investigated in a case-control genetic association study in 272 patients with high-tension >,<glaucoma>
{the uptake of <glaucoma>screening by first degree relatives of <glaucoma>}
{<glaucoma>,<screening by first degree relatives of >,<glaucoma>
{82 high tension <glaucoma>HTG 42 normal tension <glaucoma>}
{<glaucoma>,<HTG 42 normal tension >,<glaucoma>
{patients with childhood <glaucoma>who underwent wide-field fluorescein angiography after surgical or medical treatment of <glaucoma>}
{<glaucoma>,<who underwent wide-field fluorescein angiography after surgical or medical treatment of >,<glaucoma>
{17% had high-tension <glaucoma>HTG and 70% had normal-tension <glaucoma>}
{<glaucoma>,<HTG and 70% had normal-tension >,<glaucoma>
{IOP elevation or <glaucoma>n=14 and group 2 patients did have history of IOP elevation or <glaucoma>}
{<glaucoma>,<n=14 and group 2 patients did have history of IOP elevation or >,<glaucoma>
{combined cataract and <glaucoma>surgery in patients with early to moderate stages of <glaucoma>}
{<glaucoma>,<surgery in patients with early to moderate stages of >,<glaucoma>
{feasible in NHS <glaucoma>clinics for genetic counselling and cascade testing of relatives of patients affected by myocilin <glaucoma>}
{<glaucoma>,<clinics for genetic counselling and cascade testing of relatives of patients affected by myocilin >,<glaucoma>
{  Noninvasive <glaucoma>procedures NIGPs represent a new dawn in the management of <glaucoma>}
{<glaucoma>,<procedures NIGPs represent a new dawn in the management of >,<glaucoma>
{As minimally invasive <glaucoma>surgeries continue to improve in terms of efficacy there is an evolving role for combined cataract and <glaucoma>}
{<glaucoma>,<surgeries continue to improve in terms of efficacy there is an evolving role for combined cataract and >,<glaucoma>
{patients with high-tension <glaucoma>HTG 70 patients with normal-tension <glaucoma>}
{<glaucoma>,<HTG 70 patients with normal-tension >,<glaucoma>
{including normal tension <glaucoma>NTG n=213 and high tension <glaucoma>}
{<glaucoma>,<NTG n=213 and high tension >,<glaucoma>
{with unilateral normal-tension <glaucoma>intereye comparison of baseline spherical equivalent central corneal thickness untreated intraocular pressure disc area and zone beta variables was performed among the following 4 subgroups classified according to age and visual field pattern standard deviation of the eye with <glaucoma>}
{<glaucoma>,<intereye comparison of baseline spherical equivalent central corneal thickness untreated intraocular pressure disc area and zone beta variables was performed among the following 4 subgroups classified according to age and visual field pattern standard deviation of the eye with >,<glaucoma>
{including high tension <glaucoma>HTG and normal tension <glaucoma>}
{<glaucoma>,<HTG and normal tension >,<glaucoma>
{relationships with the <glaucoma>subtypes intraocular pressure and <glaucoma>}
{<glaucoma>,<subtypes intraocular pressure and >,<glaucoma>
{demographics type of <glaucoma>IOP over time best-corrected visual acuity number of <glaucoma>}
{<glaucoma>,<IOP over time best-corrected visual acuity number of >,<glaucoma>
{46 with high-tension <glaucoma>HTG 57 with normal-tension <glaucoma>}
{<glaucoma>,<HTG 57 with normal-tension >,<glaucoma>
{Patients with open-angle <glaucoma>Shaffer Grade 3 and 4 and uncontrolled medicated intraocular pressure IOP 21Â mm Hg at baseline and candidates for conventional <glaucoma>}
{<glaucoma>,<Shaffer Grade 3 and 4 and uncontrolled medicated intraocular pressure IOP 21Â mm Hg at baseline and candidates for conventional >,<glaucoma>
{57 with normal-tension <glaucoma>NTG and 15 with pseudoexfoliation <glaucoma>}
{<glaucoma>,<NTG and 15 with pseudoexfoliation >,<glaucoma>
{48 normal tension <glaucoma>two primary angle closure <glaucoma>}
{<glaucoma>,<two primary angle closure >,<glaucoma>
{layer in surgical <glaucoma>specimens and this was not observed in controls or incidental <glaucoma>}
{<glaucoma>,<specimens and this was not observed in controls or incidental >,<glaucoma>
{--209 patients pseudoexfoliation <glaucoma>PEG --50 patients normal-tension <glaucoma>}
{<glaucoma>,<PEG --50 patients normal-tension >,<glaucoma>
{barriers to optimal <glaucoma>medication adherence among <glaucoma>}
{<glaucoma>,<medication adherence among >,<glaucoma>
{--50 patients normal-tension <glaucoma>NTG --15 patients closed-angle <glaucoma>}
{<glaucoma>,<NTG --15 patients closed-angle >,<glaucoma>
{with high myopic <glaucoma>matched with 48 highly myopic eyes without <glaucoma>}
{<glaucoma>,<matched with 48 highly myopic eyes without >,<glaucoma>
{POAG including normal-tension <glaucoma>NTG n = 213 and high-tension <glaucoma>}
{<glaucoma>,<NTG n = 213 and high-tension >,<glaucoma>
{the diagnosis of <glaucoma>even though the information obtained is not specific for <glaucoma>}
{<glaucoma>,<even though the information obtained is not specific for >,<glaucoma>
{were stratified by <glaucoma>type the deletion genotype T0M0 was not particularly associated with any type of <glaucoma>}
{<glaucoma>,<type the deletion genotype T0M0 was not particularly associated with any type of >,<glaucoma>
{POAG 255 high-tension <glaucoma>HTG 100 normal-tension <glaucoma>}
{<glaucoma>,<HTG 100 normal-tension >,<glaucoma>
{and the GSS <glaucoma>staging system 2 was used to differentiate between early group 1 and more advanced group 2 stages of <glaucoma>}
{<glaucoma>,<staging system 2 was used to differentiate between early group 1 and more advanced group 2 stages of >,<glaucoma>
{Participants with undiagnosed <glaucoma>ie answering no to whether they previously had been told by a physician that they had glaucoma not using glaucoma medication or not having undergone <glaucoma>}
{<glaucoma>,<ie answering no to whether they previously had been told by a physician that they had glaucoma not using glaucoma medication or not having undergone >,<glaucoma>
{ METHODS Ahmed <glaucoma>valves were implanted in 30 eyes of 30 patients with refractory <glaucoma>}
{<glaucoma>,<valves were implanted in 30 eyes of 30 patients with refractory >,<glaucoma>
{IOP namely high-tension <glaucoma>HTG as well as with IOP elevation which is a strong risk factor for <glaucoma>}
{<glaucoma>,<HTG as well as with IOP elevation which is a strong risk factor for >,<glaucoma>
{efficacy of nonpenetrating <glaucoma>surgery for open angle glaucoma with respect to target intraocular pressure IOP and severity of <glaucoma>}
{<glaucoma>,<surgery for open angle glaucoma with respect to target intraocular pressure IOP and severity of >,<glaucoma>
{ Of the <glaucoma>cases only 12 8% had a previous known history of <glaucoma>}
{<glaucoma>,<cases only 12 8% had a previous known history of >,<glaucoma>
{appeared glaucomatous to <glaucoma>specialists half were confirmed to have StratusOCT findings consistent with damage from <glaucoma>}
{<glaucoma>,<specialists half were confirmed to have StratusOCT findings consistent with damage from >,<glaucoma>
{association of the <glaucoma>gene MYOC with open-angle <glaucoma>}
{<glaucoma>,<gene MYOC with open-angle >,<glaucoma>
{slopes in high-tension <glaucoma>were significantly lower than those in normal-tension <glaucoma>}
{<glaucoma>,<were significantly lower than those in normal-tension >,<glaucoma>
{41 with advanced <glaucoma>MD -12 to -18Â dB and 46 with severe <glaucoma>}
{<glaucoma>,<MD -12 to -18Â dB and 46 with severe >,<glaucoma>
{ in high-tension <glaucoma>might be faster than those in normal-tension <glaucoma>}
{<glaucoma>,<might be faster than those in normal-tension >,<glaucoma>
{compared in high-tension <glaucoma>21 mmHg and normal-tension <glaucoma>}
{<glaucoma>,<21 mmHg and normal-tension >,<glaucoma>
{188 with early <glaucoma>MD greater than -6Â dB 45 with moderate <glaucoma>}
{<glaucoma>,<MD greater than -6Â dB 45 with moderate >,<glaucoma>
{glaucoma and normal-tension <glaucoma>the upper TD slope was similar for both types of glaucoma but the MD and lower TD slopes in high-tension <glaucoma>}
{<glaucoma>,<the upper TD slope was similar for both types of glaucoma but the MD and lower TD slopes in high-tension >,<glaucoma>
{45 with moderate <glaucoma>MD -6 to -12Â dB 41 with advanced <glaucoma>}
{<glaucoma>,<MD -6 to -12Â dB 41 with advanced >,<glaucoma>
{  Normal-tension <glaucoma>Low-tension <glaucoma>}
{<glaucoma>,<Low-tension >,<glaucoma>
{patients with open-angle <glaucoma>than controls without <glaucoma>}
{<glaucoma>,<than controls without >,<glaucoma>
{with uncontrolled open-angle <glaucoma>OAG who underwent Ahmed <glaucoma>}
{<glaucoma>,<OAG who underwent Ahmed >,<glaucoma>
{Diagnosis of normal-tension <glaucoma>NTG defined as <glaucoma>}
{<glaucoma>,<NTG defined as >,<glaucoma>
{of treating open-angle <glaucoma>OAG we tried to find a screening method of differentiating OAG from <glaucoma>}
{<glaucoma>,<OAG we tried to find a screening method of differentiating OAG from >,<glaucoma>
{patients with open-angle <glaucoma>OAG 12 <glaucoma>}
{<glaucoma>,<OAG 12 >,<glaucoma>
{use disorder and <glaucoma>were nearly 18 years younger than <glaucoma>}
{<glaucoma>,<were nearly 18 years younger than >,<glaucoma>
{risk factor for <glaucoma>subtypes low and moderate myopia also have a significant effect on <glaucoma>}
{<glaucoma>,<subtypes low and moderate myopia also have a significant effect on >,<glaucoma>
{programme for open-angle <glaucoma>a population-based comparison of incident <glaucoma>}
{<glaucoma>,<a population-based comparison of incident >,<glaucoma>
{usually limited to <glaucoma>suspects based on optic disc changes or less commonly visual field changes to assess the risk for development of glaucoma or in patients with progressive <glaucoma>}
{<glaucoma>,<suspects based on optic disc changes or less commonly visual field changes to assess the risk for development of glaucoma or in patients with progressive >,<glaucoma>
{low tension open-angle <glaucoma>NTG pigmentary open-angle <glaucoma>}
{<glaucoma>,<NTG pigmentary open-angle >,<glaucoma>
{  Ahmed <glaucoma>valve implantation in uveitic <glaucoma>}
{<glaucoma>,<valve implantation in uveitic >,<glaucoma>
{POAG 123 pseudoexfoliative <glaucoma>XFG and 139 normal tension <glaucoma>}
{<glaucoma>,<XFG and 139 normal tension >,<glaucoma>
{ OAG narrow-angle <glaucoma>NAG and normal-tension <glaucoma>}
{<glaucoma>,<NAG and normal-tension >,<glaucoma>
{glaucoma primary open-angle <glaucoma>POAG normal-tension <glaucoma>}
{<glaucoma>,<POAG normal-tension >,<glaucoma>
{ Agreement among <glaucoma>specialists in assessing progressive disc changes from photographs in open-angle <glaucoma>}
{<glaucoma>,<specialists in assessing progressive disc changes from photographs in open-angle >,<glaucoma>
{genes associated with <glaucoma>we have examined normal twins in the Twins Eye Study to determine the heritability of parameters that are abnormal in glaucoma - intraocular pressure and cup-to-disc ratio and confounding factors for <glaucoma>}
{<glaucoma>,<we have examined normal twins in the Twins Eye Study to determine the heritability of parameters that are abnormal in glaucoma - intraocular pressure and cup-to-disc ratio and confounding factors for >,<glaucoma>
{dioptres D mild-to-moderate <glaucoma>MMG 0 to -6â€…D and highly myopic <glaucoma>}
{<glaucoma>,<MMG 0 to -6â€…D and highly myopic >,<glaucoma>
{comparison of the <glaucoma>probability score to earlier heidelberg retina tomograph data analysis tools in classifying normal and <glaucoma>}
{<glaucoma>,<probability score to earlier heidelberg retina tomograph data analysis tools in classifying normal and >,<glaucoma>
{the search for <glaucoma>genes requires us to break down <glaucoma>}
{<glaucoma>,<genes requires us to break down >,<glaucoma>
{338 patients into <glaucoma>suspect and preperimetric early and moderate/advanced <glaucoma>}
{<glaucoma>,<suspect and preperimetric early and moderate/advanced >,<glaucoma>
{subgroups namely non-myopic <glaucoma>NMG 0 dioptres D mild-to-moderate <glaucoma>}
{<glaucoma>,<NMG 0 dioptres D mild-to-moderate >,<glaucoma>
{other hand angle-closure <glaucoma>can produce a green or gray pupil and therefore was called variously <glaucoma>}
{<glaucoma>,<can produce a green or gray pupil and therefore was called variously >,<glaucoma>
{IOP required fewer <glaucoma>medications and had a lower requirement for further <glaucoma>}
{<glaucoma>,<medications and had a lower requirement for further >,<glaucoma>
{eyes with uveitic <glaucoma>UG Retisert were different when compared to an Ahmed valve alone in eyes with uveitic <glaucoma>}
{<glaucoma>,<UG Retisert were different when compared to an Ahmed valve alone in eyes with uveitic >,<glaucoma>
{into a normal-pressure <glaucoma>group and a high-pressure <glaucoma>}
{<glaucoma>,<group and a high-pressure >,<glaucoma>
{trabectomy in exfoliative <glaucoma>PEX cohort 3 = trabectomy + IOL in POAG cohort 4 = trabectomy + IOL in PEX <glaucoma>}
{<glaucoma>,<PEX cohort 3 = trabectomy + IOL in POAG cohort 4 = trabectomy + IOL in PEX >,<glaucoma>
{ Performance of <glaucoma>progression analysis software in a <glaucoma>}
{<glaucoma>,<progression analysis software in a >,<glaucoma>
{  The <glaucoma>group was divided into subgroups of normal tension <glaucoma>}
{<glaucoma>,<group was divided into subgroups of normal tension >,<glaucoma>
{family history of <glaucoma>were positively associated with <glaucoma>}
{<glaucoma>,<were positively associated with >,<glaucoma>
{selected charts of <glaucoma>patients seen by 5 <glaucoma>}
{<glaucoma>,<patients seen by 5 >,<glaucoma>
{28 eyes of <glaucoma>patients with various stages of <glaucoma>}
{<glaucoma>,<patients with various stages of >,<glaucoma>
{transmitted to a <glaucoma>reading center where ophthalmologists who completed fellowship training in <glaucoma>}
{<glaucoma>,<reading center where ophthalmologists who completed fellowship training in >,<glaucoma>
{increased risk of <glaucoma>but excessive BP lowering in <glaucoma>}
{<glaucoma>,<but excessive BP lowering in >,<glaucoma>
{tolerability of nonpenetrating <glaucoma>surgery NPGS augmented with mitomycin C MMC compared with trabeculectomy TE plus MMC in the treatment of patients with open-angle <glaucoma>}
{<glaucoma>,<surgery NPGS augmented with mitomycin C MMC compared with trabeculectomy TE plus MMC in the treatment of patients with open-angle >,<glaucoma>
{patients with open-angle <glaucoma>24 eyes of 24 <glaucoma>}
{<glaucoma>,<24 eyes of 24 >,<glaucoma>
{  Africa <glaucoma>screening Africa and <glaucoma>}
{<glaucoma>,<screening Africa and >,<glaucoma>
{VF loss in <glaucoma>suspects and preperimetric <glaucoma>}
{<glaucoma>,<suspects and preperimetric >,<glaucoma>
{the prevalence of <glaucoma>among patients referred to a <glaucoma>}
{<glaucoma>,<among patients referred to a >,<glaucoma>
{adjunctive therapy in <glaucoma>is an important driver of <glaucoma>}
{<glaucoma>,<is an important driver of >,<glaucoma>
{Conversion to perimetric <glaucoma>was defined by VF pattern standard deviation PSD or <glaucoma>}
{<glaucoma>,<was defined by VF pattern standard deviation PSD or >,<glaucoma>
{glaucoma and normal-tension <glaucoma>but it is unclear if this dysfunction is more common in normal-tension <glaucoma>}
{<glaucoma>,<but it is unclear if this dysfunction is more common in normal-tension >,<glaucoma>
{CONCLUSIONS In open-angle <glaucoma>the Ex-PRESS mini <glaucoma>}
{<glaucoma>,<the Ex-PRESS mini >,<glaucoma>
{common in normal-tension <glaucoma>compared with high-tension <glaucoma>}
{<glaucoma>,<compared with high-tension >,<glaucoma>
{ AD and <glaucoma>has emerged from studies showing that patients with AD may have a significantly increased rate of <glaucoma>}
{<glaucoma>,<has emerged from studies showing that patients with AD may have a significantly increased rate of >,<glaucoma>
{RESULTS One new <glaucoma>case in each group was diagnosed postoperatively yielding <glaucoma>}
{<glaucoma>,<case in each group was diagnosed postoperatively yielding >,<glaucoma>
{patients with low-risk <glaucoma>undergoing primary glaucoma surgery including 55 patients who received a 350-mm 2 Baerveldt <glaucoma>}
{<glaucoma>,<undergoing primary glaucoma surgery including 55 patients who received a 350-mm 2 Baerveldt >,<glaucoma>
{ The Ex-PRESS <glaucoma>shunt versus trabeculectomy in open-angle <glaucoma>}
{<glaucoma>,<shunt versus trabeculectomy in open-angle >,<glaucoma>
{between normal subjects <glaucoma>suspects and <glaucoma>}
{<glaucoma>,<suspects and >,<glaucoma>
{analysis MRA and <glaucoma>probability score GPS were analyzed sectorially by <glaucoma>}
{<glaucoma>,<probability score GPS were analyzed sectorially by >,<glaucoma>
{as patients developing <glaucoma>or needing increased <glaucoma>}
{<glaucoma>,<or needing increased >,<glaucoma>
{  Since <glaucoma>severity most often correlates with increased costs minimizing or halting visual field loss and increasing patient treatment compliance may all contribute to a reduction in the overall economic burden of <glaucoma>}
{<glaucoma>,<severity most often correlates with increased costs minimizing or halting visual field loss and increasing patient treatment compliance may all contribute to a reduction in the overall economic burden of >,<glaucoma>
{patients with high-tension <glaucoma>HTG 21 mmHg versus normal-tension <glaucoma>}
{<glaucoma>,<HTG 21 mmHg versus normal-tension >,<glaucoma>
{patients with suspected <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{Sixty healthy participants <glaucoma>suspects and 55 subjects with <glaucoma>}
{<glaucoma>,<suspects and 55 subjects with >,<glaucoma>
{network of the <glaucoma>at the global level the efficiency of functional communication is altered in some specialized regions of the <glaucoma>}
{<glaucoma>,<at the global level the efficiency of functional communication is altered in some specialized regions of the >,<glaucoma>
{conventional normal tension <glaucoma>cNTG â‰ 21 mmHg or conventional high-tension <glaucoma>}
{<glaucoma>,<cNTG â‰ 21 mmHg or conventional high-tension >,<glaucoma>
{vascular aspects of <glaucoma>into the clinical practice of <glaucoma>}
{<glaucoma>,<into the clinical practice of >,<glaucoma>
{race type of <glaucoma>baseline IOP and number of preoperative <glaucoma>}
{<glaucoma>,<baseline IOP and number of preoperative >,<glaucoma>
{POAG and pseudoexfoliative <glaucoma>PEXG identified in the Thessaloniki Eye Study and to evaluate the proportion of subjects with and without pseudoexfoliation PEX who have <glaucoma>}
{<glaucoma>,<PEXG identified in the Thessaloniki Eye Study and to evaluate the proportion of subjects with and without pseudoexfoliation PEX who have >,<glaucoma>
{CONCLUSION A simple <glaucoma>index GI was created to capture <glaucoma>}
{<glaucoma>,<index GI was created to capture >,<glaucoma>
{glaucoma-related variables in <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{early detection of <glaucoma>possible but also presents a new direction for investigating the pathogenesis of <glaucoma>}
{<glaucoma>,<possible but also presents a new direction for investigating the pathogenesis of >,<glaucoma>
{ 27 normotensive <glaucoma>6 or pseudoexfoliative <glaucoma>}
{<glaucoma>,<6 or pseudoexfoliative >,<glaucoma>
{case series of <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{the cornea with <glaucoma>severity in open-angle <glaucoma>}
{<glaucoma>,<severity in open-angle >,<glaucoma>
{rate and event-based <glaucoma>progression analysis comparison in a <glaucoma>}
{<glaucoma>,<progression analysis comparison in a >,<glaucoma>
{family history of <glaucoma>group I included patients with family members with glaucoma and group II--those without family members with <glaucoma>}
{<glaucoma>,<group I included patients with family members with glaucoma and group II--those without family members with >,<glaucoma>
{trabeculectomy AIT by <glaucoma>severity using a simple and clinically useful <glaucoma>}
{<glaucoma>,<severity using a simple and clinically useful >,<glaucoma>
{coherence tomography in <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{the assessment of <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{patients with open-angle <glaucoma>or secondary forms of <glaucoma>}
{<glaucoma>,<or secondary forms of >,<glaucoma>
{for the 'nurse-led <glaucoma>clinic were recruited from specific categories of <glaucoma>}
{<glaucoma>,<clinic were recruited from specific categories of >,<glaucoma>
{POAG focal normal-pressure <glaucoma>pseudoexfoliative glaucoma and pigmentary <glaucoma>}
{<glaucoma>,<pseudoexfoliative glaucoma and pigmentary >,<glaucoma>
{ TGF-Î² and <glaucoma>myocilin mutants have been transduced to elevate the intraocular pressure in <glaucoma>}
{<glaucoma>,<myocilin mutants have been transduced to elevate the intraocular pressure in >,<glaucoma>
{TNF-alpha in open-angle <glaucoma>the results of the present study showed that inheritance of the high producer TNFA -308 A allele might be a susceptibility factor for the development of open-angle <glaucoma>}
{<glaucoma>,<the results of the present study showed that inheritance of the high producer TNFA -308 A allele might be a susceptibility factor for the development of open-angle >,<glaucoma>
{surgery in adult <glaucoma>patients as well as in infantile <glaucoma>}
{<glaucoma>,<patients as well as in infantile >,<glaucoma>
{risk factors affecting <glaucoma>have also been found in patients with myopia family history of <glaucoma>}
{<glaucoma>,<have also been found in patients with myopia family history of >,<glaucoma>
{family history of <glaucoma>did not vary significantly between age-related atrophic POAG focal normal-pressure <glaucoma>}
{<glaucoma>,<did not vary significantly between age-related atrophic POAG focal normal-pressure >,<glaucoma>
{ Unilateral capsular <glaucoma>after long-standing bilateral pigmentary <glaucoma>}
{<glaucoma>,<after long-standing bilateral pigmentary >,<glaucoma>
{attending an informational <glaucoma>workshop participants underwent a targeted <glaucoma>}
{<glaucoma>,<workshop participants underwent a targeted >,<glaucoma>
{patients with open-angle <glaucoma>were prospectively enrolled between September 1 2013 and June 30 2014 after a complete ophthalmologic examination at a tertiary <glaucoma>}
{<glaucoma>,<were prospectively enrolled between September 1 2013 and June 30 2014 after a complete ophthalmologic examination at a tertiary >,<glaucoma>
{the diagnosis of <glaucoma>by making appropriate referrals for routine ophthalmic examinations especially in patients with risk factors for <glaucoma>}
{<glaucoma>,<by making appropriate referrals for routine ophthalmic examinations especially in patients with risk factors for >,<glaucoma>
{POAG 685 high-tension <glaucoma>HTG and 181 normal-tension <glaucoma>}
{<glaucoma>,<HTG and 181 normal-tension >,<glaucoma>
{LC morphology and <glaucoma>severity in patients with primary forms of open-angle <glaucoma>}
{<glaucoma>,<severity in patients with primary forms of open-angle >,<glaucoma>
{fellow eyes of <glaucoma>patients and between healthy and PU eyes of <glaucoma>}
{<glaucoma>,<patients and between healthy and PU eyes of >,<glaucoma>
{PARTICIPANTS Thirty-eight subjects <glaucoma>patients 5 <glaucoma>}
{<glaucoma>,<patients 5 >,<glaucoma>
{divided into normal-tension <glaucoma>NTG and high-tension <glaucoma>}
{<glaucoma>,<NTG and high-tension >,<glaucoma>
{incites angle closure <glaucoma>3 denaturation of silicone oil into microdroplets may sweep into the trabecular meshwork with the development of secondary open angle glaucoma or 4 finally inflammation or exacerbation of pre-existing <glaucoma>}
{<glaucoma>,<3 denaturation of silicone oil into microdroplets may sweep into the trabecular meshwork with the development of secondary open angle glaucoma or 4 finally inflammation or exacerbation of pre-existing >,<glaucoma>
{We retrospectively reviewed <glaucoma>patients who received ripasudil as an additive <glaucoma>}
{<glaucoma>,<patients who received ripasudil as an additive >,<glaucoma>
{POAG primary closed-angle <glaucoma>PCAG and pseudoexfoliative <glaucoma>}
{<glaucoma>,<PCAG and pseudoexfoliative >,<glaucoma>
{treated for open-angle <glaucoma>indicates that while most patients did not undergo filtration surgery in the course of <glaucoma>}
{<glaucoma>,<indicates that while most patients did not undergo filtration surgery in the course of >,<glaucoma>
{POAG 28 normal-tension <glaucoma>NTG ten secondary <glaucoma>}
{<glaucoma>,<NTG ten secondary >,<glaucoma>
{a tertiary care <glaucoma>service in Ottawa because of a family history of pseudoexfoliation or <glaucoma>}
{<glaucoma>,<service in Ottawa because of a family history of pseudoexfoliation or >,<glaucoma>
{performed in high-tension <glaucoma>HTG and normal-tension <glaucoma>}
{<glaucoma>,<HTG and normal-tension >,<glaucoma>
{various systemic and <glaucoma>medications is important for the safe management of <glaucoma>}
{<glaucoma>,<medications is important for the safe management of >,<glaucoma>
{summarizes developments in <glaucoma>genetics and addresses their potential relevance to the clinical management of <glaucoma>}
{<glaucoma>,<genetics and addresses their potential relevance to the clinical management of >,<glaucoma>
{ IOP and <glaucoma>medications following selective laser trabeculoplasty SLT versus stand-alone placement of the Hydrus microstent a microinvasive <glaucoma>}
{<glaucoma>,<medications following selective laser trabeculoplasty SLT versus stand-alone placement of the Hydrus microstent a microinvasive >,<glaucoma>
{patients with early <glaucoma>or at very high risk for <glaucoma>}
{<glaucoma>,<or at very high risk for >,<glaucoma>
{eyes with early-stage <glaucoma>EG 33 eyes with advanced-stage <glaucoma>}
{<glaucoma>,<EG 33 eyes with advanced-stage >,<glaucoma>
{chronic angle closure <glaucoma>ACG in six eyes and acute angle closure <glaucoma>}
{<glaucoma>,<ACG in six eyes and acute angle closure >,<glaucoma>
{persons with a <glaucoma>family history there was a strong association between inhaled corticosteroid use and presence of either <glaucoma>}
{<glaucoma>,<family history there was a strong association between inhaled corticosteroid use and presence of either >,<glaucoma>
{model displays the <glaucoma>risk factors of elevated IOP and decreased aqueous outflow facility and may potentially serve as a model for studying <glaucoma>}
{<glaucoma>,<risk factors of elevated IOP and decreased aqueous outflow facility and may potentially serve as a model for studying >,<glaucoma>
{patients with open-angle <glaucoma>14 with a normal IOP and 29 with an elevated IOP and 71 subjects without <glaucoma>}
{<glaucoma>,<14 with a normal IOP and 29 with an elevated IOP and 71 subjects without >,<glaucoma>
{CSF-P in normal-IOP <glaucoma>may be similar to a high IOP in high-IOP <glaucoma>}
{<glaucoma>,<may be similar to a high IOP in high-IOP >,<glaucoma>
{in separating perimetric <glaucoma>patients and preperimetric <glaucoma>}
{<glaucoma>,<patients and preperimetric >,<glaucoma>
{de Pseudoexfoliation PEX <glaucoma>is the most common identifiable cause of open-angle <glaucoma>}
{<glaucoma>,<is the most common identifiable cause of open-angle >,<glaucoma>
{categories normal possible <glaucoma>probable glaucoma and definitive <glaucoma>}
{<glaucoma>,<probable glaucoma and definitive >,<glaucoma>
{PURPOSE To assess <glaucoma>awareness and screening uptake in relatives of people with <glaucoma>}
{<glaucoma>,<awareness and screening uptake in relatives of people with >,<glaucoma>
{form of nonfiltering <glaucoma>surgery-trabecular aspiration-designed to increase trabecular outflow in pseudoexfoliation <glaucoma>}
{<glaucoma>,<surgery-trabecular aspiration-designed to increase trabecular outflow in pseudoexfoliation >,<glaucoma>
{risk factors for <glaucoma>worsening may help us to develop new strategies to improve <glaucoma>}
{<glaucoma>,<worsening may help us to develop new strategies to improve >,<glaucoma>
{a group of <glaucoma>patients experienced in visual field testing we identified one eye randomly chosen from each of 25 <glaucoma>}
{<glaucoma>,<patients experienced in visual field testing we identified one eye randomly chosen from each of 25 >,<glaucoma>
{of subjects without <glaucoma>who are heterozygous or homozygous for Arg46Stop suggests that reduction in the amount of TIGR protein does not cause <glaucoma>}
{<glaucoma>,<who are heterozygous or homozygous for Arg46Stop suggests that reduction in the amount of TIGR protein does not cause >,<glaucoma>
{notches in high-pressure <glaucoma>may be due to a smaller size of hemorrhages and localized retinal nerve fiber layer defects in high-pressure <glaucoma>}
{<glaucoma>,<may be due to a smaller size of hemorrhages and localized retinal nerve fiber layer defects in high-pressure >,<glaucoma>
{patients with open-angle <glaucoma>OAG 4 <glaucoma>}
{<glaucoma>,<OAG 4 >,<glaucoma>
{patients with early <glaucoma>IOP remained stable without treatment during a 6-year period regardless of baseline IOP except for patients with exfoliation <glaucoma>}
{<glaucoma>,<IOP remained stable without treatment during a 6-year period regardless of baseline IOP except for patients with exfoliation >,<glaucoma>
{and in clinical <glaucoma>patients at different stages of <glaucoma>}
{<glaucoma>,<patients at different stages of >,<glaucoma>
{identified studies of <glaucoma>screening and treatment from MEDLINE the Cochrane Library and <glaucoma>}
{<glaucoma>,<screening and treatment from MEDLINE the Cochrane Library and >,<glaucoma>
{in the preperimetric <glaucoma>group was 44% for SDOCT-score 25% for FDT-score and 44% for combined score in the early <glaucoma>}
{<glaucoma>,<group was 44% for SDOCT-score 25% for FDT-score and 44% for combined score in the early >,<glaucoma>
{chamber angle in <glaucoma>suspects and in patients who acquired <glaucoma>}
{<glaucoma>,<suspects and in patients who acquired >,<glaucoma>
{in the early <glaucoma>group 83 81 and 89% respectively and in the moderate <glaucoma>}
{<glaucoma>,<group 83 81 and 89% respectively and in the moderate >,<glaucoma>
{of a mobile <glaucoma>unit for screening and early diagnosis of <glaucoma>}
{<glaucoma>,<unit for screening and early diagnosis of >,<glaucoma>
{  1--pseudoexfoliative <glaucoma>1--juvenile <glaucoma>}
{<glaucoma>,<1--juvenile >,<glaucoma>
{appositional angle closure <glaucoma>CAACG and 186 eyes of 124 patients had chronic synechial angle closure <glaucoma>}
{<glaucoma>,<CAACG and 186 eyes of 124 patients had chronic synechial angle closure >,<glaucoma>
{and philosophy of <glaucoma>drug therapy summarises some of the basic facts and principles of modern <glaucoma>}
{<glaucoma>,<drug therapy summarises some of the basic facts and principles of modern >,<glaucoma>
{patients--POAG 3--NPG 1--pigmentary <glaucoma>1--pseudoexfoliative <glaucoma>}
{<glaucoma>,<1--pseudoexfoliative >,<glaucoma>
{diagnoses for phacolytic <glaucoma>are acute angle closure <glaucoma>}
{<glaucoma>,<are acute angle closure >,<glaucoma>
{Thirty-four healthy patients <glaucoma>suspects and 26 patients with open-angle <glaucoma>}
{<glaucoma>,<suspects and 26 patients with open-angle >,<glaucoma>
{patients with pseudoexfoliative <glaucoma>had lower values of central endothelial cell density comparing to patients with open angle or angle closure <glaucoma>}
{<glaucoma>,<had lower values of central endothelial cell density comparing to patients with open angle or angle closure >,<glaucoma>
{referred to our <glaucoma>clinic and already treated for chronic <glaucoma>}
{<glaucoma>,<clinic and already treated for chronic >,<glaucoma>
{ and pseudo-exfoliation <glaucoma>among several <glaucoma>}
{<glaucoma>,<among several >,<glaucoma>
{of NO in <glaucoma>we determined NO levels in aqueous humor and plasma in <glaucoma>}
{<glaucoma>,<we determined NO levels in aqueous humor and plasma in >,<glaucoma>
{350-mm 2 Baerveldt <glaucoma>implants are a safe and effective treatment for intermediate-term intraocular pressure control in patients with refractory <glaucoma>}
{<glaucoma>,<implants are a safe and effective treatment for intermediate-term intraocular pressure control in patients with refractory >,<glaucoma>
{developed open-angle pseudoexfoliation <glaucoma>allergic to all anti <glaucoma>}
{<glaucoma>,<allergic to all anti >,<glaucoma>
{RNFL typical of <glaucoma>open angle at gonioscopy and no clinically apparent secondary cause for their <glaucoma>}
{<glaucoma>,<open angle at gonioscopy and no clinically apparent secondary cause for their >,<glaucoma>
{trabeculotomy for steroid-induced <glaucoma>was comparable to trabeculectomy for steroid-induced <glaucoma>}
{<glaucoma>,<was comparable to trabeculectomy for steroid-induced >,<glaucoma>
{a standard preclinical <glaucoma>model which spontaneously developed mutations resulting in chronic age-related pigmentary <glaucoma>}
{<glaucoma>,<model which spontaneously developed mutations resulting in chronic age-related pigmentary >,<glaucoma>
{a group of <glaucoma>suspects and <glaucoma>}
{<glaucoma>,<suspects and >,<glaucoma>
{normal OHT and <glaucoma>patients the HRT and visual field tests have fair to poor agreement in detecting <glaucoma>}
{<glaucoma>,<patients the HRT and visual field tests have fair to poor agreement in detecting >,<glaucoma>
{Vision loss from <glaucoma>cannot be recovered and improved case-detection methods for <glaucoma>}
{<glaucoma>,<cannot be recovered and improved case-detection methods for >,<glaucoma>
{  The <glaucoma>severity index was abnormal in 93 <glaucoma>}
{<glaucoma>,<severity index was abnormal in 93 >,<glaucoma>
{risk factor for <glaucoma>was a positive family history of <glaucoma>}
{<glaucoma>,<was a positive family history of >,<glaucoma>
{ PARTICIPANTS Seventy-four <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{10 normal subjects <glaucoma>suspects and 18 <glaucoma>}
{<glaucoma>,<suspects and 18 >,<glaucoma>
{  Early-onset <glaucoma>refers to genetically heterogeneous conditions for which <glaucoma>}
{<glaucoma>,<refers to genetically heterogeneous conditions for which >,<glaucoma>
{Causes of secondary <glaucoma>were found in four with neovascular <glaucoma>}
{<glaucoma>,<were found in four with neovascular >,<glaucoma>
{of non-steroidal drug-induced <glaucoma>are closed-angle <glaucoma>}
{<glaucoma>,<are closed-angle >,<glaucoma>
{  and <glaucoma>underwent successful <glaucoma>}
{<glaucoma>,<underwent successful >,<glaucoma>
{of COAG normal-pressure <glaucoma>or suspected glaucoma receiving therapy seen in a university-based <glaucoma>}
{<glaucoma>,<or suspected glaucoma receiving therapy seen in a university-based >,<glaucoma>
{normal eyes ninety-one <glaucoma>suspects seventy-six normal tension <glaucoma>}
{<glaucoma>,<suspects seventy-six normal tension >,<glaucoma>
{80 consecutive open-angle <glaucoma>patients requiring <glaucoma>}
{<glaucoma>,<patients requiring >,<glaucoma>
{subdivided into high-tension <glaucoma>HTG and normal-tension <glaucoma>}
{<glaucoma>,<HTG and normal-tension >,<glaucoma>
{  Syndroma <glaucoma>pigmentatum primarium--pigmented <glaucoma>}
{<glaucoma>,<pigmentatum primarium--pigmented >,<glaucoma>
{associated with increasing <glaucoma>medication expenditure trends include the increasing use of prostaglandin analogs changes in insurance coverage and possibly more aggressive <glaucoma>}
{<glaucoma>,<medication expenditure trends include the increasing use of prostaglandin analogs changes in insurance coverage and possibly more aggressive >,<glaucoma>
{from two university-based <glaucoma>clinical practices and a university-based general ophthalmology clinic and consisted of 121 patients with open-angle <glaucoma>}
{<glaucoma>,<clinical practices and a university-based general ophthalmology clinic and consisted of 121 patients with open-angle >,<glaucoma>
{risk factor for <glaucoma>is raised intraocular pressure but 40% of people with <glaucoma>}
{<glaucoma>,<is raised intraocular pressure but 40% of people with >,<glaucoma>
{early to moderate <glaucoma>34 ocular hypertensives 22 <glaucoma>}
{<glaucoma>,<34 ocular hypertensives 22 >,<glaucoma>
{may positively influence <glaucoma>parameters suggesting a possible causal link between H pylori and <glaucoma>}
{<glaucoma>,<parameters suggesting a possible causal link between H pylori and >,<glaucoma>
{any myopia and <glaucoma>I 2 =53% and low myopia and <glaucoma>}
{<glaucoma>,<I 2 =53% and low myopia and >,<glaucoma>
{of different topical <glaucoma>medications on the diameter of the retinal arterioles of healthy volunteers and <glaucoma>}
{<glaucoma>,<medications on the diameter of the retinal arterioles of healthy volunteers and >,<glaucoma>
{progression in untreated <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{8 in whom <glaucoma>was suspected and 8 <glaucoma>}
{<glaucoma>,<was suspected and 8 >,<glaucoma>
{with bilateral open-angle <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{loss in untreated <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{patients with preexisting <glaucoma>were similar to those of postkeratoplasty <glaucoma>}
{<glaucoma>,<were similar to those of postkeratoplasty >,<glaucoma>
{and the perimetric <glaucoma>group and for the differentiation between the normal group and the preperimetric <glaucoma>}
{<glaucoma>,<group and for the differentiation between the normal group and the preperimetric >,<glaucoma>
{glaucoma primary open-angle <glaucoma>POAG chronic closed-angle <glaucoma>}
{<glaucoma>,<POAG chronic closed-angle >,<glaucoma>
{Graft clarity and <glaucoma>control in patients with preexisting <glaucoma>}
{<glaucoma>,<control in patients with preexisting >,<glaucoma>
{After washout of <glaucoma>medications ocular hypertension or <glaucoma>}
{<glaucoma>,<medications ocular hypertension or >,<glaucoma>
{significantly lower in <glaucoma>patients compared with controls velocities were significantly lower in <glaucoma>}
{<glaucoma>,<patients compared with controls velocities were significantly lower in >,<glaucoma>
{ Factors for <glaucoma>progression and the effect of treatment the early manifest <glaucoma>}
{<glaucoma>,<progression and the effect of treatment the early manifest >,<glaucoma>
{patients with normal-pressure <glaucoma>2 patients with chronic narrow-angle <glaucoma>}
{<glaucoma>,<2 patients with chronic narrow-angle >,<glaucoma>
{is elevated in <glaucoma>patients and in animal models of <glaucoma>}
{<glaucoma>,<patients and in animal models of >,<glaucoma>
{who received topical <glaucoma>medication experienced conversion to <glaucoma>}
{<glaucoma>,<medication experienced conversion to >,<glaucoma>
{the eyes of <glaucoma>patients with diabetes mellitus and 47 nondiabetic patients who had <glaucoma>}
{<glaucoma>,<patients with diabetes mellitus and 47 nondiabetic patients who had >,<glaucoma>
{in the exfoliative <glaucoma>patients indicating a fundamentally different genetic basis for that <glaucoma>}
{<glaucoma>,<patients indicating a fundamentally different genetic basis for that >,<glaucoma>
{7 had exfoliative <glaucoma>EG and 2 had other types of <glaucoma>}
{<glaucoma>,<EG and 2 had other types of >,<glaucoma>
{review of the <glaucoma>clinical trials literature the <glaucoma>}
{<glaucoma>,<clinical trials literature the >,<glaucoma>
{acuity BCVA and <glaucoma>medication requirements in patients having phacoemulsification after preexisting <glaucoma>}
{<glaucoma>,<medication requirements in patients having phacoemulsification after preexisting >,<glaucoma>
{of a preexisting <glaucoma>filter was associated with improved BCVA a small but statistically significant increase in IOP and stability in the number of <glaucoma>}
{<glaucoma>,<filter was associated with improved BCVA a small but statistically significant increase in IOP and stability in the number of >,<glaucoma>
{normal subjects and <glaucoma>patients and could affect the diagnosis and management of <glaucoma>}
{<glaucoma>,<patients and could affect the diagnosis and management of >,<glaucoma>
{in a university <glaucoma>service with questions about the visit at which their <glaucoma>}
{<glaucoma>,<service with questions about the visit at which their >,<glaucoma>
{trabeculectomy and Ahmed <glaucoma>valve implant in the initial surgical management of primary open- and closed-angle <glaucoma>}
{<glaucoma>,<valve implant in the initial surgical management of primary open- and closed-angle >,<glaucoma>
{stage diagnosis of <glaucoma>can be done by genetic examination before occurrence of <glaucoma>}
{<glaucoma>,<can be done by genetic examination before occurrence of >,<glaucoma>
{patients with advanced <glaucoma>will not directly benefit from the use of such molecular diagnostic tools their immediate family members could certainly benefit from the identification of the cause of the <glaucoma>}
{<glaucoma>,<will not directly benefit from the use of such molecular diagnostic tools their immediate family members could certainly benefit from the identification of the cause of the >,<glaucoma>
{have shown that <glaucoma>is more severe in black populations than in Caucasian populations which would lead to the assumption that the people of Martinique have a high <glaucoma>}
{<glaucoma>,<is more severe in black populations than in Caucasian populations which would lead to the assumption that the people of Martinique have a high >,<glaucoma>
{likely to have <glaucoma>are necessary if the number of blind from <glaucoma>}
{<glaucoma>,<are necessary if the number of blind from >,<glaucoma>
{the aqueous of <glaucoma>patients could play a role in the pathogenesis of <glaucoma>}
{<glaucoma>,<patients could play a role in the pathogenesis of >,<glaucoma>
{001 in progressive <glaucoma>than in nonprogressive <glaucoma>}
{<glaucoma>,<than in nonprogressive >,<glaucoma>
{number of annual <glaucoma>surgeries among unique patients with a diagnosis of <glaucoma>}
{<glaucoma>,<surgeries among unique patients with a diagnosis of >,<glaucoma>
{ METHODS All <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{3 of the <glaucoma>groups than in the control group there was no significant difference in ET-1 level among the 3 <glaucoma>}
{<glaucoma>,<groups than in the control group there was no significant difference in ET-1 level among the 3 >,<glaucoma>
{the charts of <glaucoma>suspects and <glaucoma>}
{<glaucoma>,<suspects and >,<glaucoma>
{37 eyes normal-tension <glaucoma>81 eyes pigmentary <glaucoma>}
{<glaucoma>,<81 eyes pigmentary >,<glaucoma>
{117 with high-tension <glaucoma>HTG and 25 with normal-tension <glaucoma>}
{<glaucoma>,<HTG and 25 with normal-tension >,<glaucoma>
{into high tension <glaucoma>HTG and normal tension <glaucoma>}
{<glaucoma>,<HTG and normal tension >,<glaucoma>
{patients with open-angle <glaucoma>comparison between high-tension and normal-tension <glaucoma>}
{<glaucoma>,<comparison between high-tension and normal-tension >,<glaucoma>
{71 eyes of <glaucoma>patients group 1 receiving one type of antiglaucoma eye drops 61 eyes of 61 <glaucoma>}
{<glaucoma>,<patients group 1 receiving one type of antiglaucoma eye drops 61 eyes of 61 >,<glaucoma>
{61 eyes of <glaucoma>patients group 2 receiving two types of antiglaucoma eye drops and 30 eyes of 30 <glaucoma>}
{<glaucoma>,<patients group 2 receiving two types of antiglaucoma eye drops and 30 eyes of 30 >,<glaucoma>
{prospective descriptive study <glaucoma>suspects ocular hypertensives and <glaucoma>}
{<glaucoma>,<suspects ocular hypertensives and >,<glaucoma>
{ocular hypertensives and <glaucoma>patients were referred for mfVEP testing by a single <glaucoma>}
{<glaucoma>,<patients were referred for mfVEP testing by a single >,<glaucoma>
{POAG including normal-tension <glaucoma>NTG and high-tension <glaucoma>}
{<glaucoma>,<NTG and high-tension >,<glaucoma>
{damage between high-tension <glaucoma>HTG and normal-tension <glaucoma>}
{<glaucoma>,<HTG and normal-tension >,<glaucoma>
{As pathogenesis of <glaucoma>still is unknown the aim of this study was to analyze if the serum and antibodies of <glaucoma>}
{<glaucoma>,<still is unknown the aim of this study was to analyze if the serum and antibodies of >,<glaucoma>
{and normal tension <glaucoma>NTG and evaluated its association with vascular dysregulation in a subset of <glaucoma>}
{<glaucoma>,<NTG and evaluated its association with vascular dysregulation in a subset of >,<glaucoma>
{OHT normal tension <glaucoma>NTG pseudoexfoliative <glaucoma>}
{<glaucoma>,<NTG pseudoexfoliative >,<glaucoma>
{16 normal tension <glaucoma>NTG 6 high tension <glaucoma>}
{<glaucoma>,<NTG 6 high tension >,<glaucoma>
{the normal and <glaucoma>groups whereas ODP RA correlated with RNFL only in the <glaucoma>}
{<glaucoma>,<groups whereas ODP RA correlated with RNFL only in the >,<glaucoma>
{not completely established <glaucoma>treatment strategies so far are based upon the identification of <glaucoma>}
{<glaucoma>,<treatment strategies so far are based upon the identification of >,<glaucoma>
{edu Normal tension <glaucoma>NTG is a common form of open-angle <glaucoma>}
{<glaucoma>,<NTG is a common form of open-angle >,<glaucoma>
{familial primary open-angle <glaucoma>POAG the onset of which is not associated with intraocular pressure IOP elevation and is classified as normal-tension <glaucoma>}
{<glaucoma>,<POAG the onset of which is not associated with intraocular pressure IOP elevation and is classified as normal-tension >,<glaucoma>
{risk factor for <glaucoma>the relationship between vascular regulatory mechanisms and <glaucoma>}
{<glaucoma>,<the relationship between vascular regulatory mechanisms and >,<glaucoma>
{methods for diagnosing <glaucoma>analyze the eye with a main focus on the retina despite the transsynaptic nature of the fiber degeneration caused by <glaucoma>}
{<glaucoma>,<analyze the eye with a main focus on the retina despite the transsynaptic nature of the fiber degeneration caused by >,<glaucoma>
{with bilateral normal-tension <glaucoma>NTG or high-tension <glaucoma>}
{<glaucoma>,<NTG or high-tension >,<glaucoma>
{that is exfoliation <glaucoma>ExG and normal-tension <glaucoma>}
{<glaucoma>,<ExG and normal-tension >,<glaucoma>
{population-based survey of <glaucoma>were analyzed and compared with those of eight patients with previously diagnosed <glaucoma>}
{<glaucoma>,<were analyzed and compared with those of eight patients with previously diagnosed >,<glaucoma>
{eyes with high-pressure <glaucoma>HPG and normal-pressure <glaucoma>}
{<glaucoma>,<HPG and normal-pressure >,<glaucoma>
{thickness CCT among <glaucoma>patients particularly for pseudoexfoliative <glaucoma>}
{<glaucoma>,<patients particularly for pseudoexfoliative >,<glaucoma>
{patients with open-angle <glaucoma>OAG treated with topical Î²-blockers one in 24 patients with narrow-angle <glaucoma>}
{<glaucoma>,<OAG treated with topical Î²-blockers one in 24 patients with narrow-angle >,<glaucoma>
{and with normal-tension <glaucoma>NTG and high-tension <glaucoma>}
{<glaucoma>,<NTG and high-tension >,<glaucoma>
{31 healthy participants <glaucoma>suspects and 74 <glaucoma>}
{<glaucoma>,<suspects and 74 >,<glaucoma>
{eyes followed by <glaucoma>suspects mild glaucoma and moderate to severe <glaucoma>}
{<glaucoma>,<suspects mild glaucoma and moderate to severe >,<glaucoma>
{  and <glaucoma>clinical indices except that the mutant homozygous genotype G/G was associated with the family history of <glaucoma>}
{<glaucoma>,<clinical indices except that the mutant homozygous genotype G/G was associated with the family history of >,<glaucoma>
{a history of <glaucoma>surgery and group 2 included POAG patients with failed <glaucoma>}
{<glaucoma>,<surgery and group 2 included POAG patients with failed >,<glaucoma>
{erythrocyte suspensions between <glaucoma>patients and healthy subjects those from <glaucoma>}
{<glaucoma>,<patients and healthy subjects those from >,<glaucoma>
{predominantly demonstrated normal-tension <glaucoma>whereas the American cohort predominantly demonstrated high-tension <glaucoma>}
{<glaucoma>,<whereas the American cohort predominantly demonstrated high-tension >,<glaucoma>
{  high-tension <glaucoma>HTG and normal-tension <glaucoma>}
{<glaucoma>,<HTG and normal-tension >,<glaucoma>
{MICS and micro-invasive <glaucoma>surgery MIGS with the ab interno trabeculectomy TrabectomeÂ® in one eye versus two iStentÂ® inject devices in the contralateral eye in patients with open-angle <glaucoma>}
{<glaucoma>,<surgery MIGS with the ab interno trabeculectomy TrabectomeÂ® in one eye versus two iStentÂ® inject devices in the contralateral eye in patients with open-angle >,<glaucoma>
{  normal-tension <glaucoma>clinical diagnosis <glaucoma>}
{<glaucoma>,<clinical diagnosis >,<glaucoma>
{diagnosis of either <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{patients with moderate <glaucoma>compared to those with early-stage <glaucoma>}
{<glaucoma>,<compared to those with early-stage >,<glaucoma>
{seen in normal-tension <glaucoma>patients with hearing loss in comparison with normal-tension <glaucoma>}
{<glaucoma>,<patients with hearing loss in comparison with normal-tension >,<glaucoma>
{patient with exfoliation <glaucoma>which is the first example of a TBK1 mutation in a <glaucoma>}
{<glaucoma>,<which is the first example of a TBK1 mutation in a >,<glaucoma>
{mutation in a <glaucoma>patient with a diagnosis other than normal-tension <glaucoma>}
{<glaucoma>,<patient with a diagnosis other than normal-tension >,<glaucoma>
{period and the <glaucoma>suspect group who did not to analyse the risk factors for <glaucoma>}
{<glaucoma>,<suspect group who did not to analyse the risk factors for >,<glaucoma>
{eyes with preperimetric <glaucoma>PPG and eyes with mild normal-tension <glaucoma>}
{<glaucoma>,<PPG and eyes with mild normal-tension >,<glaucoma>
{The incidence of <glaucoma>was investigated using a comprehensive <glaucoma>}
{<glaucoma>,<was investigated using a comprehensive >,<glaucoma>
{This light-induced avian <glaucoma>LIAG is presented as an animal model system for human open-angle <glaucoma>}
{<glaucoma>,<LIAG is presented as an animal model system for human open-angle >,<glaucoma>
{classified into the <glaucoma>group who developed glaucoma during the study period and the <glaucoma>}
{<glaucoma>,<group who developed glaucoma during the study period and the >,<glaucoma>
{in this low-tension <glaucoma>population suggest that the natural history of low-tension <glaucoma>}
{<glaucoma>,<population suggest that the natural history of low-tension >,<glaucoma>
{ALT for open-angle <glaucoma>performed after failure of medical management particularly in blacks cautions that ALT may not be a good substitute for medications or filtering surgery in newly diagnosed <glaucoma>}
{<glaucoma>,<performed after failure of medical management particularly in blacks cautions that ALT may not be a good substitute for medications or filtering surgery in newly diagnosed >,<glaucoma>
{  Various <glaucoma>operations have however retained their value in the treatment of severe <glaucoma>}
{<glaucoma>,<operations have however retained their value in the treatment of severe >,<glaucoma>
{One subset of <glaucoma>normal tension <glaucoma>}
{<glaucoma>,<normal tension >,<glaucoma>
{patients with advanced <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{ophthalmology eye and <glaucoma>was conducted and the results reviewed by a panel of 15 experts in the field of <glaucoma>}
{<glaucoma>,<was conducted and the results reviewed by a panel of 15 experts in the field of >,<glaucoma>
{term low IOP <glaucoma>has been replaced by the term normal IOP <glaucoma>}
{<glaucoma>,<has been replaced by the term normal IOP >,<glaucoma>
{for normal tension <glaucoma>NTG and high tension <glaucoma>}
{<glaucoma>,<NTG and high tension >,<glaucoma>
{thickness in high-tension <glaucoma>HTG and low-tension <glaucoma>}
{<glaucoma>,<HTG and low-tension >,<glaucoma>
{ Primary infantile <glaucoma>commonly termed congenital <glaucoma>}
{<glaucoma>,<commonly termed congenital >,<glaucoma>
{in chronic open-angle <glaucoma>COAG ocular hypertension and pseudoexfoliative PXF <glaucoma>}
{<glaucoma>,<COAG ocular hypertension and pseudoexfoliative PXF >,<glaucoma>
{ lens-induced glaucoma <glaucoma>accompanied by ocular inflammation and trauma-induced <glaucoma>}
{<glaucoma>,<accompanied by ocular inflammation and trauma-induced >,<glaucoma>
{shunt implant for <glaucoma>filtration surgery has increased our ability to manage more successfully <glaucoma>}
{<glaucoma>,<filtration surgery has increased our ability to manage more successfully >,<glaucoma>
{ A novel <glaucoma>risk factor reference guide was constructed according to evidence strength and level of concern regarding risk of developing <glaucoma>}
{<glaucoma>,<risk factor reference guide was constructed according to evidence strength and level of concern regarding risk of developing >,<glaucoma>
{  Although <glaucoma>remains a disorder without a cure the advent of aqueous shunt implants for <glaucoma>}
{<glaucoma>,<remains a disorder without a cure the advent of aqueous shunt implants for >,<glaucoma>
{patients with juvenile <glaucoma>was significantly lower than it was for those with congenital <glaucoma>}
{<glaucoma>,<was significantly lower than it was for those with congenital >,<glaucoma>
{the literacy of <glaucoma>patients as well as <glaucoma>}
{<glaucoma>,<patients as well as >,<glaucoma>
{A panel of <glaucoma>experts diagnosed subjects with <glaucoma>}
{<glaucoma>,<experts diagnosed subjects with >,<glaucoma>
{recent studies of <glaucoma>surgery and makes recommendations about the most appropriate outcome measures for surgical studies of <glaucoma>}
{<glaucoma>,<surgery and makes recommendations about the most appropriate outcome measures for surgical studies of >,<glaucoma>
{to ably provide <glaucoma>care given the increase in the number of glaucoma patients and the shortage of <glaucoma>}
{<glaucoma>,<care given the increase in the number of glaucoma patients and the shortage of >,<glaucoma>
{need for further <glaucoma>medication or <glaucoma>}
{<glaucoma>,<medication or >,<glaucoma>
{to refine the <glaucoma>risk prediction model determine the optimum type and frequency of serial <glaucoma>}
{<glaucoma>,<risk prediction model determine the optimum type and frequency of serial >,<glaucoma>
{categories normal possible <glaucoma>probable glaucoma and definite <glaucoma>}
{<glaucoma>,<probable glaucoma and definite >,<glaucoma>
{the diagnosis of <glaucoma>or its progression complications of <glaucoma>}
{<glaucoma>,<or its progression complications of >,<glaucoma>
{support system for <glaucoma>care in an effort to promote participation of <glaucoma>}
{<glaucoma>,<care in an effort to promote participation of >,<glaucoma>
{the importance of <glaucoma>testing and treatment can be significant agents in the fight against <glaucoma>}
{<glaucoma>,<testing and treatment can be significant agents in the fight against >,<glaucoma>
{  Since <glaucoma>progression can often be effectively diminished when treated identifying individuals at risk for <glaucoma>}
{<glaucoma>,<progression can often be effectively diminished when treated identifying individuals at risk for >,<glaucoma>
{  The <glaucoma>group was divided into two subgroups ie patients on medical treatment for at least two years before inclusion with beta-blockers or prostaglandin analogs and nontreated <glaucoma>}
{<glaucoma>,<group was divided into two subgroups ie patients on medical treatment for at least two years before inclusion with beta-blockers or prostaglandin analogs and nontreated >,<glaucoma>
{and severity of <glaucoma>at presentation METHODS A hospital based prospective review of 602 <glaucoma>}
{<glaucoma>,<at presentation METHODS A hospital based prospective review of 602 >,<glaucoma>
{corneal parameters between <glaucoma>patients and controls may be due to the medical treatments used for <glaucoma>}
{<glaucoma>,<patients and controls may be due to the medical treatments used for >,<glaucoma>
{Three types of <glaucoma>primary-open-angle <glaucoma>}
{<glaucoma>,<primary-open-angle >,<glaucoma>
{primary angle closue <glaucoma>5 eyes and secondary <glaucoma>}
{<glaucoma>,<5 eyes and secondary >,<glaucoma>
{patients with uveitic <glaucoma>METHODS A retrospective chart review of 44 eyes of 44 patients with uveitic <glaucoma>}
{<glaucoma>,<METHODS A retrospective chart review of 44 eyes of 44 patients with uveitic >,<glaucoma>
{parameters in treated <glaucoma>patients nontreated <glaucoma>}
{<glaucoma>,<patients nontreated >,<glaucoma>
{GQL-15 summary score <glaucoma>severity multiple topical <glaucoma>}
{<glaucoma>,<severity multiple topical >,<glaucoma>
{severity multiple topical <glaucoma>medications worse eye mean deviation and pattern standard deviation use of topical beta blockers topical carbonic anhydrase inhibitors daily dose of BAK and <glaucoma>}
{<glaucoma>,<medications worse eye mean deviation and pattern standard deviation use of topical beta blockers topical carbonic anhydrase inhibitors daily dose of BAK and >,<glaucoma>
{of life QoL <glaucoma>severity and treatment in patients with open-angle <glaucoma>}
{<glaucoma>,<severity and treatment in patients with open-angle >,<glaucoma>
{Graft survival and <glaucoma>outcome after simultaneous penetrating keratoplasty and ahmed <glaucoma>}
{<glaucoma>,<outcome after simultaneous penetrating keratoplasty and ahmed >,<glaucoma>
{aphakia severe congenital/developmental <glaucoma>post-retinal surgery <glaucoma>}
{<glaucoma>,<post-retinal surgery >,<glaucoma>
{Patients with preexisting <glaucoma>have even higher risk for developing <glaucoma>}
{<glaucoma>,<have even higher risk for developing >,<glaucoma>
{  Whenever <glaucoma>was suspected patients were referred to fellowship-trained <glaucoma>}
{<glaucoma>,<was suspected patients were referred to fellowship-trained >,<glaucoma>
{received a comprehensive <glaucoma>workup including applanation tonometry stereoscopic examination of the optic nerve head performed by the <glaucoma>}
{<glaucoma>,<workup including applanation tonometry stereoscopic examination of the optic nerve head performed by the >,<glaucoma>
{ The Baerveldt <glaucoma>implant and Ahmed <glaucoma>}
{<glaucoma>,<implant and Ahmed >,<glaucoma>
{ IOP and <glaucoma>medication requirements in eyes with pseudoexfoliation <glaucoma>}
{<glaucoma>,<medication requirements in eyes with pseudoexfoliation >,<glaucoma>
{Mass screening of <glaucoma>patients for Myocilin mutations may be worthwhile if 3% to 5% of <glaucoma>}
{<glaucoma>,<patients for Myocilin mutations may be worthwhile if 3% to 5% of >,<glaucoma>
{185 mm2 Ahmed <glaucoma>valve and the 350 mm2 Baerveldt <glaucoma>}
{<glaucoma>,<valve and the 350 mm2 Baerveldt >,<glaucoma>
{patients with low-tension <glaucoma>intraocular pressure less than 21 mm Hg to the visual fields of 106 eyes 74 patients with high-tension <glaucoma>}
{<glaucoma>,<intraocular pressure less than 21 mm Hg to the visual fields of 106 eyes 74 patients with high-tension >,<glaucoma>
{patient with pigmentary <glaucoma>yet in none of them had a diagnosis of <glaucoma>}
{<glaucoma>,<yet in none of them had a diagnosis of >,<glaucoma>
{common types of <glaucoma>open angle glaucoma and angle closure <glaucoma>}
{<glaucoma>,<open angle glaucoma and angle closure >,<glaucoma>
{21 mm Hg <glaucoma>simplex 22-29 mm Hg 3 <glaucoma>}
{<glaucoma>,<simplex 22-29 mm Hg 3 >,<glaucoma>
{patients with low-tension <glaucoma>were compared with those of 41 eyes of 41 patients with high-tension <glaucoma>}
{<glaucoma>,<were compared with those of 41 eyes of 41 patients with high-tension >,<glaucoma>
{47 eyes of <glaucoma>suspects and <glaucoma>}
{<glaucoma>,<suspects and >,<glaucoma>
{pressures 1 low-tension <glaucoma>21 mm Hg 2 <glaucoma>}
{<glaucoma>,<21 mm Hg 2 >,<glaucoma>
{uncontrolled chronic open-angle <glaucoma>37 patients or low-tension <glaucoma>}
{<glaucoma>,<37 patients or low-tension >,<glaucoma>
{POAG and pseudoexfoliative <glaucoma>PXG are the most common primary and secondary forms of <glaucoma>}
{<glaucoma>,<PXG are the most common primary and secondary forms of >,<glaucoma>
{patients with low-tension <glaucoma>LTG <glaucoma>}
{<glaucoma>,<LTG >,<glaucoma>
{that 74% of <glaucoma>patients were willing to accept an alternative form of <glaucoma>}
{<glaucoma>,<patients were willing to accept an alternative form of >,<glaucoma>
{mixed cases of <glaucoma>was assessed to determine whether there were any genetic differences between different types of <glaucoma>}
{<glaucoma>,<was assessed to determine whether there were any genetic differences between different types of >,<glaucoma>
{patients with open-angle <glaucoma>OAG and <glaucoma>}
{<glaucoma>,<OAG and >,<glaucoma>
{451 eyes of <glaucoma>patients were examined with the Octopus 201 perimeter 83 patients with low-tension <glaucoma>}
{<glaucoma>,<patients were examined with the Octopus 201 perimeter 83 patients with low-tension >,<glaucoma>
{healthy subjects and <glaucoma>patients we conclude that the ratio of the OPA and blood pressure variances is a strong <glaucoma>}
{<glaucoma>,<patients we conclude that the ratio of the OPA and blood pressure variances is a strong >,<glaucoma>
{role within our <glaucoma>treatment algorithm continues to be clarified and differs from the role of more invasive <glaucoma>}
{<glaucoma>,<treatment algorithm continues to be clarified and differs from the role of more invasive >,<glaucoma>
{pressure in normal-tension <glaucoma>low-tension <glaucoma>}
{<glaucoma>,<low-tension >,<glaucoma>
{disease other than <glaucoma>or OHT that was diagnosed previously and six were newly diagnosed with an eye disease other than <glaucoma>}
{<glaucoma>,<or OHT that was diagnosed previously and six were newly diagnosed with an eye disease other than >,<glaucoma>
{Patients with high-tension <glaucoma>showed significant losses in both chromatic and achromatic sensitivities when compared with low-tension <glaucoma>}
{<glaucoma>,<showed significant losses in both chromatic and achromatic sensitivities when compared with low-tension >,<glaucoma>
{history of surgical <glaucoma>treatment and concentrate on the current surgical strategies for managing <glaucoma>}
{<glaucoma>,<treatment and concentrate on the current surgical strategies for managing >,<glaucoma>
{ In normal-tension <glaucoma>low-tension <glaucoma>}
{<glaucoma>,<low-tension >,<glaucoma>
{of 25 high-tension <glaucoma>patients and 25 eyes of 25 low-tension <glaucoma>}
{<glaucoma>,<patients and 25 eyes of 25 low-tension >,<glaucoma>
{pressure in normal-tension <glaucoma>low-tension <glaucoma>}
{<glaucoma>,<low-tension >,<glaucoma>
{20 diabetic open-angle <glaucoma>patients and 64 non-diabetic open-angle <glaucoma>}
{<glaucoma>,<patients and 64 non-diabetic open-angle >,<glaucoma>
{of 20 normal-tension <glaucoma>NTG patients and 20 eyes of high-tension <glaucoma>}
{<glaucoma>,<NTG patients and 20 eyes of high-tension >,<glaucoma>
{etiology of low-tension <glaucoma>then it must be localized or vasospastic since this study does not support the concept of a generalized vascular etiology either of an atheromatous or hyperviscous nature for the genesis of low-tension <glaucoma>}
{<glaucoma>,<then it must be localized or vasospastic since this study does not support the concept of a generalized vascular etiology either of an atheromatous or hyperviscous nature for the genesis of low-tension >,<glaucoma>
{PRFS result from <glaucoma>or share etiologies with low-tension <glaucoma>}
{<glaucoma>,<or share etiologies with low-tension >,<glaucoma>
{glaucoma diagnosis suspected <glaucoma>/other <glaucoma>}
{<glaucoma>,</other >,<glaucoma>
{patients with normal-tension <glaucoma>had a blood standstill of 12 seconds or more whereas only three of 30 control subjects and four of 30 patients with high-tension <glaucoma>}
{<glaucoma>,<had a blood standstill of 12 seconds or more whereas only three of 30 control subjects and four of 30 patients with high-tension >,<glaucoma>
{the practice of <glaucoma>diagnosis and indicate the lack of a widely accepted <glaucoma>}
{<glaucoma>,<diagnosis and indicate the lack of a widely accepted >,<glaucoma>
{discs 34 high-pressure <glaucoma>discs 13 normal-tension <glaucoma>}
{<glaucoma>,<discs 13 normal-tension >,<glaucoma>
{patients with angle-closure <glaucoma>ACG and 12 eyes of 12 patients with open-angle <glaucoma>}
{<glaucoma>,<ACG and 12 eyes of 12 patients with open-angle >,<glaucoma>
{important factor in <glaucoma>but did not support the traditional distinction between normal and elevated pressure nor its corollaries low-tension glaucoma and high-tension <glaucoma>}
{<glaucoma>,<but did not support the traditional distinction between normal and elevated pressure nor its corollaries low-tension glaucoma and high-tension >,<glaucoma>
{50% of the <glaucoma>cases unspecific types of glaucoma diagnosis suspected <glaucoma>}
{<glaucoma>,<cases unspecific types of glaucoma diagnosis suspected >,<glaucoma>
{15 ocular hypertensive <glaucoma>suspects 47 discs 34 high-pressure <glaucoma>}
{<glaucoma>,<suspects 47 discs 34 high-pressure >,<glaucoma>
{15 selected low-tension <glaucoma>LTG patients were compared with those in 15 eyes from 15 selected high-tension <glaucoma>}
{<glaucoma>,<LTG patients were compared with those in 15 eyes from 15 selected high-tension >,<glaucoma>
{hypertensives 28 normotensive <glaucoma>suspects and 15 ocular hypertensive <glaucoma>}
{<glaucoma>,<suspects and 15 ocular hypertensive >,<glaucoma>
{with chronic narrow-angle <glaucoma>1 eye with normal-tension <glaucoma>}
{<glaucoma>,<1 eye with normal-tension >,<glaucoma>
{patients with exfoliative <glaucoma>61 patients with primary open angle glaucoma and 50 patients with low-tension <glaucoma>}
{<glaucoma>,<61 patients with primary open angle glaucoma and 50 patients with low-tension >,<glaucoma>
{second form of <glaucoma>exfoliation-syndrome <glaucoma>}
{<glaucoma>,<exfoliation-syndrome >,<glaucoma>
{patients with normal-tension <glaucoma>had a significantly greater amount of localized visual field loss in the inferior hemifield than the patients with high-tension <glaucoma>}
{<glaucoma>,<had a significantly greater amount of localized visual field loss in the inferior hemifield than the patients with high-tension >,<glaucoma>
{and LGB of <glaucoma>patients supports the theory of apoptosis in the etiopathogenesis of <glaucoma>}
{<glaucoma>,<patients supports the theory of apoptosis in the etiopathogenesis of >,<glaucoma>
{present with advanced <glaucoma>than younger ones CONCLUSIONS Subjects with initial IOP 31 mmHg were nearly three times more likely to present with advanced <glaucoma>}
{<glaucoma>,<than younger ones CONCLUSIONS Subjects with initial IOP 31 mmHg were nearly three times more likely to present with advanced >,<glaucoma>
{patients with normal-tension <glaucoma>than in patients with high-tension <glaucoma>}
{<glaucoma>,<than in patients with high-tension >,<glaucoma>
{To compare the <glaucoma>diagnostic power of Stratus and Cirrus optical coherence tomographies OCTs in a Taiwan Chinese population with different <glaucoma>}
{<glaucoma>,<diagnostic power of Stratus and Cirrus optical coherence tomographies OCTs in a Taiwan Chinese population with different >,<glaucoma>
{ All suspected <glaucoma>cases were submitted to a panel of 6 ophthalmologists to determine <glaucoma>}
{<glaucoma>,<cases were submitted to a panel of 6 ophthalmologists to determine >,<glaucoma>
{patients with open-angle <glaucoma>taking calcium channel blockers showed no marked difference in the progression of <glaucoma>}
{<glaucoma>,<taking calcium channel blockers showed no marked difference in the progression of >,<glaucoma>
{ICD-9 diagnosis of <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{  from <glaucoma>a simple random sample of the population of County Roscommon was taken for a community based <glaucoma>}
{<glaucoma>,<a simple random sample of the population of County Roscommon was taken for a community based >,<glaucoma>
{those with preexisting <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{loss in low-tension <glaucoma>LTG is more focal than in ordinary or high-tension <glaucoma>}
{<glaucoma>,<LTG is more focal than in ordinary or high-tension >,<glaucoma>
{ICD-9 diagnoses of <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{independently associated with <glaucoma>or any signs of <glaucoma>}
{<glaucoma>,<or any signs of >,<glaucoma>
{the incidence of <glaucoma>progression using optical coherence tomography OCT and automated perimetry and to assess agreement between structural and functional tests for detecting <glaucoma>}
{<glaucoma>,<progression using optical coherence tomography OCT and automated perimetry and to assess agreement between structural and functional tests for detecting >,<glaucoma>
{patients with progressive <glaucoma>who had one eye fitted with a <glaucoma>}
{<glaucoma>,<who had one eye fitted with a >,<glaucoma>
{intraocular pressure IOP <glaucoma>medication requirements and visual acuity after <glaucoma>}
{<glaucoma>,<medication requirements and visual acuity after >,<glaucoma>
{characteristics between normal-tension <glaucoma>NTG and high-tension <glaucoma>}
{<glaucoma>,<NTG and high-tension >,<glaucoma>
{effect of topical <glaucoma>medication has been studied mainly in eyes with ocular hypertension or high tension <glaucoma>}
{<glaucoma>,<medication has been studied mainly in eyes with ocular hypertension or high tension >,<glaucoma>
{42% with classic <glaucoma>or normal-tension <glaucoma>}
{<glaucoma>,<or normal-tension >,<glaucoma>
{patients with open-angle <glaucoma>referred because of progressive damage despite controlled IOP and 39 normal-tension <glaucoma>}
{<glaucoma>,<referred because of progressive damage despite controlled IOP and 39 normal-tension >,<glaucoma>
{method to determine <glaucoma>status and has a potential for tracking <glaucoma>}
{<glaucoma>,<status and has a potential for tracking >,<glaucoma>
{of 12 normal-tension <glaucoma>NTG patients 16 eyes of 11 high-tension <glaucoma>}
{<glaucoma>,<NTG patients 16 eyes of 11 high-tension >,<glaucoma>
{de Pseudoexfoliation PEX <glaucoma>is the most frequent and most important type of secondary <glaucoma>}
{<glaucoma>,<is the most frequent and most important type of secondary >,<glaucoma>
{contraindicated in open-angle <glaucoma>or in angle-closure <glaucoma>}
{<glaucoma>,<or in angle-closure >,<glaucoma>
{visual field in <glaucoma>we applied the VARCLUS procedure a new clustering algorithm provided by SAS Institute to 379 <glaucoma>}
{<glaucoma>,<we applied the VARCLUS procedure a new clustering algorithm provided by SAS Institute to 379 >,<glaucoma>
{field loss PEX <glaucoma>represents a relatively severe and progressive type of <glaucoma>}
{<glaucoma>,<represents a relatively severe and progressive type of >,<glaucoma>
{primary angle closure <glaucoma>from POAG at screening sites so the part POAG patients may be included in primary angle closure <glaucoma>}
{<glaucoma>,<from POAG at screening sites so the part POAG patients may be included in primary angle closure >,<glaucoma>
{damage in normal-tension <glaucoma>NTG and high-tension <glaucoma>}
{<glaucoma>,<NTG and high-tension >,<glaucoma>
{The study included <glaucoma>patients with a remaining central visual field island and 22 <glaucoma>}
{<glaucoma>,<patients with a remaining central visual field island and 22 >,<glaucoma>
{for detection of <glaucoma>suspects or <glaucoma>}
{<glaucoma>,<suspects or >,<glaucoma>
{made between high-tension <glaucoma>defined as POAG with an IOP of more than 21 mmHg and normal-tension <glaucoma>}
{<glaucoma>,<defined as POAG with an IOP of more than 21 mmHg and normal-tension >,<glaucoma>
{patients with early <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{choice for normal-tension <glaucoma>because a large majority of the patients in the present study achieved an intraocular pressure allegedly beneficial in managing normal-tension <glaucoma>}
{<glaucoma>,<because a large majority of the patients in the present study achieved an intraocular pressure allegedly beneficial in managing normal-tension >,<glaucoma>
{Nine were high-tension <glaucoma>patients but progressing despite medically well-controlled intraocular pressure and 11 had normal-tension <glaucoma>}
{<glaucoma>,<patients but progressing despite medically well-controlled intraocular pressure and 11 had normal-tension >,<glaucoma>
{RESULTS There were <glaucoma>patients who did not receive timolol controls 1 406 beneficiaries who were prescribed timolol in addition to other <glaucoma>}
{<glaucoma>,<patients who did not receive timolol controls 1 406 beneficiaries who were prescribed timolol in addition to other >,<glaucoma>
{for detection of <glaucoma>suspects and <glaucoma>}
{<glaucoma>,<suspects and >,<glaucoma>
{or angle closure <glaucoma>currently on topical antiglaucoma medication for a minimum of six months from specialist <glaucoma>}
{<glaucoma>,<currently on topical antiglaucoma medication for a minimum of six months from specialist >,<glaucoma>
{subjects with asymmetric <glaucoma>damage between eyes Flow 3 and Vel 3 were significantly lower in the eyes with worse <glaucoma>}
{<glaucoma>,<damage between eyes Flow 3 and Vel 3 were significantly lower in the eyes with worse >,<glaucoma>
{a secondary aphakic <glaucoma>component that may explain the need for alternative <glaucoma>}
{<glaucoma>,<component that may explain the need for alternative >,<glaucoma>
{who were experienced <glaucoma>subspecialists optometrists ophthalmic nurses and patients to develop a reduced set of potential screening tests and testing arrangements that could then be explored in depth in a further study of their feasibility for evaluation in a <glaucoma>}
{<glaucoma>,<subspecialists optometrists ophthalmic nurses and patients to develop a reduced set of potential screening tests and testing arrangements that could then be explored in depth in a further study of their feasibility for evaluation in a >,<glaucoma>
{association with self-reported <glaucoma>may suggest a need for greater <glaucoma>}
{<glaucoma>,<may suggest a need for greater >,<glaucoma>
{The occurrence of <glaucoma>corneal changes secondary to <glaucoma>}
{<glaucoma>,<corneal changes secondary to >,<glaucoma>
{patients had open-angle <glaucoma>OAG and 61 patients were suspect for <glaucoma>}
{<glaucoma>,<OAG and 61 patients were suspect for >,<glaucoma>
{with an established <glaucoma>diagnosis as well as <glaucoma>}
{<glaucoma>,<diagnosis as well as >,<glaucoma>
{increased risk of <glaucoma>among myopes and the lack of association with self-reported <glaucoma>}
{<glaucoma>,<among myopes and the lack of association with self-reported >,<glaucoma>
{hemodynamic alterations and <glaucoma>progression will provide a unique and useful method for studying the pathophysiology of <glaucoma>}
{<glaucoma>,<progression will provide a unique and useful method for studying the pathophysiology of >,<glaucoma>
{eyes suspected of <glaucoma>group I and 84 eyes with chronic open-angle <glaucoma>}
{<glaucoma>,<group I and 84 eyes with chronic open-angle >,<glaucoma>
{142 eyes with <glaucoma>from our hospital-based <glaucoma>}
{<glaucoma>,<from our hospital-based >,<glaucoma>
{of 547 Caucasian <glaucoma>patients or <glaucoma>}
{<glaucoma>,<patients or >,<glaucoma>
{well as neovacular <glaucoma>is divided into four grades that is prerubeotic preglaucomatous open-angle and angle closure <glaucoma>}
{<glaucoma>,<is divided into four grades that is prerubeotic preglaucomatous open-angle and angle closure >,<glaucoma>
{100 subjects from <glaucoma>clinics were examined by a single <glaucoma>}
{<glaucoma>,<clinics were examined by a single >,<glaucoma>
{ocular hypertensive and <glaucoma>subgroup suggested that HRT parameters and FDT indices could detect <glaucoma>}
{<glaucoma>,<subgroup suggested that HRT parameters and FDT indices could detect >,<glaucoma>
{AND METHODS Consecutive <glaucoma>patients who underwent Ahmed <glaucoma>}
{<glaucoma>,<patients who underwent Ahmed >,<glaucoma>
{ to pigment <glaucoma>or the inclusion criteria in the studies treating patients older than 40 years or genetic dispositions in pigment <glaucoma>}
{<glaucoma>,<or the inclusion criteria in the studies treating patients older than 40 years or genetic dispositions in pigment >,<glaucoma>
{ METHODS Two <glaucoma>fellowship-trained ophthalmologists masked to temporal sequence independently graded serial flicker chronoscopy images from 1 eye of a cohort of <glaucoma>}
{<glaucoma>,<fellowship-trained ophthalmologists masked to temporal sequence independently graded serial flicker chronoscopy images from 1 eye of a cohort of >,<glaucoma>
{angle or pseudoexfoliative <glaucoma>who required <glaucoma>}
{<glaucoma>,<who required >,<glaucoma>
{12 with suspected <glaucoma>by field 61 with suspected <glaucoma>}
{<glaucoma>,<by field 61 with suspected >,<glaucoma>
{or early pigment <glaucoma>there is a lack of clinical evidence that this procedure has a long-term effect in preventing <glaucoma>}
{<glaucoma>,<there is a lack of clinical evidence that this procedure has a long-term effect in preventing >,<glaucoma>
{the contribution of <glaucoma>to ocular morbidity and the different types of <glaucoma>}
{<glaucoma>,<to ocular morbidity and the different types of >,<glaucoma>
{156 healthy eyes <glaucoma>suspects and 127 eyes with <glaucoma>}
{<glaucoma>,<suspects and 127 eyes with >,<glaucoma>
{patients with diagnosed <glaucoma>were more likely to adhere to therapy than patients with suspect <glaucoma>}
{<glaucoma>,<were more likely to adhere to therapy than patients with suspect >,<glaucoma>
{risk factor for <glaucoma>it may also result in structural and functional defects that cannot be distinguished from those caused by <glaucoma>}
{<glaucoma>,<it may also result in structural and functional defects that cannot be distinguished from those caused by >,<glaucoma>
{eyes with open-angle <glaucoma>or in eyes with ocular hypertension conversion to open-angle <glaucoma>}
{<glaucoma>,<or in eyes with ocular hypertension conversion to open-angle >,<glaucoma>
{  Early-onset <glaucoma>occurred at a mean age of 6 months in 15 eyes and delayed-onset <glaucoma>}
{<glaucoma>,<occurred at a mean age of 6 months in 15 eyes and delayed-onset >,<glaucoma>
{newly diagnosed open-angle <glaucoma>underwent a comprehensive ocular examination and were classified as mild moderate or advanced according to the Canadian Ophthalmological Society <glaucoma>}
{<glaucoma>,<underwent a comprehensive ocular examination and were classified as mild moderate or advanced according to the Canadian Ophthalmological Society >,<glaucoma>
{results irrespective of <glaucoma>diagnosis or <glaucoma>}
{<glaucoma>,<diagnosis or >,<glaucoma>
{system to assess <glaucoma>stage in the absence of an universally accepted <glaucoma>}
{<glaucoma>,<stage in the absence of an universally accepted >,<glaucoma>
{of 100% of <glaucoma>on the basis of visual fields and other data enabling evaluation of disease progression and resource utilization at various <glaucoma>}
{<glaucoma>,<on the basis of visual fields and other data enabling evaluation of disease progression and resource utilization at various >,<glaucoma>
{cyclodestructive procedures and <glaucoma>implant are effective surgical options for chronic angle closure <glaucoma>}
{<glaucoma>,<implant are effective surgical options for chronic angle closure >,<glaucoma>
{the Ex-PRESS miniature <glaucoma>implant in technically challenging advanced <glaucoma>}
{<glaucoma>,<implant in technically challenging advanced >,<glaucoma>
{ophthalmic examinations for <glaucoma>prevalence rates of <glaucoma>}
{<glaucoma>,<prevalence rates of >,<glaucoma>
{ocular hypertension and <glaucoma>were reviewed by a panel of <glaucoma>}
{<glaucoma>,<were reviewed by a panel of >,<glaucoma>
{to distinguish this <glaucoma>from other types of childhood <glaucoma>}
{<glaucoma>,<from other types of childhood >,<glaucoma>
{with a defined <glaucoma>diagnostic code linked to a <glaucoma>}
{<glaucoma>,<diagnostic code linked to a >,<glaucoma>
{findings suggest that <glaucoma>patients with thinner corneas are just as likely to have advanced levels of field loss as <glaucoma>}
{<glaucoma>,<patients with thinner corneas are just as likely to have advanced levels of field loss as >,<glaucoma>
{ 5% of <glaucoma>costs whereas cost per person was highest in other <glaucoma>}
{<glaucoma>,<costs whereas cost per person was highest in other >,<glaucoma>
{ POAG pseudoexfoliative <glaucoma>PEXG normotensive <glaucoma>}
{<glaucoma>,<PEXG normotensive >,<glaucoma>
{patients with open-angle <glaucoma>narrow-angle <glaucoma>}
{<glaucoma>,<narrow-angle >,<glaucoma>
{of agreement among <glaucoma>experts in Latin America on key practices related to treatment and diagnosis of <glaucoma>}
{<glaucoma>,<experts in Latin America on key practices related to treatment and diagnosis of >,<glaucoma>
{used to differentiate <glaucoma>suspects from <glaucoma>}
{<glaucoma>,<suspects from >,<glaucoma>
{in process of <glaucoma>treatment and lower achieved IOP after new <glaucoma>}
{<glaucoma>,<treatment and lower achieved IOP after new >,<glaucoma>
{the treatment of <glaucoma>and/or in the monitoring of <glaucoma>}
{<glaucoma>,<and/or in the monitoring of >,<glaucoma>
{risk factor for <glaucoma>damage and corneal hysteresis a proposed measure of corneal resistance to deformation on various indicators of <glaucoma>}
{<glaucoma>,<damage and corneal hysteresis a proposed measure of corneal resistance to deformation on various indicators of >,<glaucoma>
{ METHODS Two <glaucoma>fellowship-trained ophthalmologists masked to temporal sequence independently graded serial flicker chronoscopy images from one eye of a cohort of <glaucoma>}
{<glaucoma>,<fellowship-trained ophthalmologists masked to temporal sequence independently graded serial flicker chronoscopy images from one eye of a cohort of >,<glaucoma>
{ Even though <glaucoma>surgery was necessary in two cases both ocular inflammation and <glaucoma>}
{<glaucoma>,<surgery was necessary in two cases both ocular inflammation and >,<glaucoma>
{patients with open-angle <glaucoma>or with suspected <glaucoma>}
{<glaucoma>,<or with suspected >,<glaucoma>
{52 eyes of <glaucoma>patients 26 eyes of 26 <glaucoma>}
{<glaucoma>,<patients 26 eyes of 26 >,<glaucoma>
{  The <glaucoma>suspect differentiation of the future <glaucoma>}
{<glaucoma>,<suspect differentiation of the future >,<glaucoma>
{method we selected <glaucoma>patients from among those visiting <glaucoma>}
{<glaucoma>,<patients from among those visiting >,<glaucoma>
{no previous incisional <glaucoma>surgery from 9 <glaucoma>}
{<glaucoma>,<surgery from 9 >,<glaucoma>
{In the high-pressure <glaucoma>group n=681 eyes rate of <glaucoma>}
{<glaucoma>,<group n=681 eyes rate of >,<glaucoma>
{  pigmentdispersion <glaucoma>glaucoma in aphakia and <glaucoma>}
{<glaucoma>,<glaucoma in aphakia and >,<glaucoma>
{ongoing management of <glaucoma>patients is pragmatically considered in the light of the availability of potentially more sensitive means of <glaucoma>}
{<glaucoma>,<patients is pragmatically considered in the light of the availability of potentially more sensitive means of >,<glaucoma>
{patients in whom <glaucoma>developed after the operation and patients with pre-existing <glaucoma>}
{<glaucoma>,<developed after the operation and patients with pre-existing >,<glaucoma>
{patients with open-angle <glaucoma>but the control was insufficient in patients with angle-closure <glaucoma>}
{<glaucoma>,<but the control was insufficient in patients with angle-closure >,<glaucoma>
{direct costs of <glaucoma>generally not covered by health insurance as well as indirect costs of <glaucoma>}
{<glaucoma>,<generally not covered by health insurance as well as indirect costs of >,<glaucoma>
{outcomes of Ahmed <glaucoma>valve implantation for uveitic <glaucoma>}
{<glaucoma>,<valve implantation for uveitic >,<glaucoma>
{results of Ahmed <glaucoma>valve implantation for uveitic <glaucoma>}
{<glaucoma>,<valve implantation for uveitic >,<glaucoma>
{history of open-angle <glaucoma>OAG previous intraocular surgery prior steroid exposure type of retinal pathology treated pre- and post-injection IOP and post-injection <glaucoma>}
{<glaucoma>,<OAG previous intraocular surgery prior steroid exposure type of retinal pathology treated pre- and post-injection IOP and post-injection >,<glaucoma>
{direct cost of <glaucoma>treatment particularly the precise quantification of <glaucoma>}
{<glaucoma>,<treatment particularly the precise quantification of >,<glaucoma>
{patients with open-angle <glaucoma>who underwent combined phacoemulsification and canaloplasty phacocanaloplasty and 41 eyes of 41 patients with open-angle <glaucoma>}
{<glaucoma>,<who underwent combined phacoemulsification and canaloplasty phacocanaloplasty and 41 eyes of 41 patients with open-angle >,<glaucoma>
{performance for diagnosing <glaucoma>when <glaucoma>}
{<glaucoma>,<when >,<glaucoma>
{patients with suspected <glaucoma>were referred to the <glaucoma>}
{<glaucoma>,<were referred to the >,<glaucoma>
{closed-angle variants of <glaucoma>but also in individuals with open-angle <glaucoma>}
{<glaucoma>,<but also in individuals with open-angle >,<glaucoma>
{patients with suspected <glaucoma>patients in whom <glaucoma>}
{<glaucoma>,<patients in whom >,<glaucoma>
{that the pseudoexfoliative <glaucoma>represents 53% of all glaucoma that it is a particular form of primitive <glaucoma>}
{<glaucoma>,<represents 53% of all glaucoma that it is a particular form of primitive >,<glaucoma>
{pronounced for open-angle <glaucoma>OAG than for angle-closure <glaucoma>}
{<glaucoma>,<OAG than for angle-closure >,<glaucoma>
{criteria for open-angle <glaucoma>normal and abnormal optic disc anatomy and funduscopic signs of open-angle <glaucoma>}
{<glaucoma>,<normal and abnormal optic disc anatomy and funduscopic signs of open-angle >,<glaucoma>
{no history of <glaucoma>diagnosis antiglaucoma medication use or <glaucoma>}
{<glaucoma>,<diagnosis antiglaucoma medication use or >,<glaucoma>
{Two hundred forty <glaucoma>patients who attended 2 <glaucoma>}
{<glaucoma>,<patients who attended 2 >,<glaucoma>
{5 eyes neovascular <glaucoma>4 eyes traumatic <glaucoma>}
{<glaucoma>,<4 eyes traumatic >,<glaucoma>
{patients with advanced <glaucoma>the forth group 18 patients 28 eyes comprised patients with terminal <glaucoma>}
{<glaucoma>,<the forth group 18 patients 28 eyes comprised patients with terminal >,<glaucoma>
{4 eyes traumatic <glaucoma>4 eyes secondary <glaucoma>}
{<glaucoma>,<4 eyes secondary >,<glaucoma>
{patients with open-angle <glaucoma>20 normotensive NTG and 14 high tension <glaucoma>}
{<glaucoma>,<20 normotensive NTG and 14 high tension >,<glaucoma>
{IOP a major <glaucoma>risk factor underscore the public health importance of controlling these systemic conditions in black populations where <glaucoma>}
{<glaucoma>,<risk factor underscore the public health importance of controlling these systemic conditions in black populations where >,<glaucoma>
{  and <glaucoma>progression in the early manifest <glaucoma>}
{<glaucoma>,<progression in the early manifest >,<glaucoma>
{8 eyes aphakic <glaucoma>5 eyes after silicone surgery 5 eyes neovascular <glaucoma>}
{<glaucoma>,<5 eyes after silicone surgery 5 eyes neovascular >,<glaucoma>
{polypropylene plate Ahmed <glaucoma>valve AGV S-2 and the newer silicone plate AGV FP-7 with minimum 12 months follow-up in patients with intractable <glaucoma>}
{<glaucoma>,<valve AGV S-2 and the newer silicone plate AGV FP-7 with minimum 12 months follow-up in patients with intractable >,<glaucoma>
{were categorized into <glaucoma>likely suspects and confirmed <glaucoma>}
{<glaucoma>,<likely suspects and confirmed >,<glaucoma>
{significantly with increasing <glaucoma>damage indicated by smaller neuroretinal rim area higher visual field loss decreased retinal nerve fiber layer index and more advanced morphological <glaucoma>}
{<glaucoma>,<damage indicated by smaller neuroretinal rim area higher visual field loss decreased retinal nerve fiber layer index and more advanced morphological >,<glaucoma>
{polypropylene plate Ahmed <glaucoma>valve to the silicone plate Ahmed <glaucoma>}
{<glaucoma>,<valve to the silicone plate Ahmed >,<glaucoma>
{were classified as <glaucoma>likely in the final exam were also classified as <glaucoma>}
{<glaucoma>,<likely in the final exam were also classified as >,<glaucoma>
{mixed forms of <glaucoma>starting from the <glaucoma>}
{<glaucoma>,<starting from the >,<glaucoma>
{eyes with open-angle <glaucoma>PSX <glaucoma>}
{<glaucoma>,<PSX >,<glaucoma>
{patients with chronic <glaucoma>8 with open-angle <glaucoma>}
{<glaucoma>,<8 with open-angle >,<glaucoma>
{used for childhood <glaucoma>although little is known concerning the use of the newer <glaucoma>}
{<glaucoma>,<although little is known concerning the use of the newer >,<glaucoma>
{exists about which <glaucoma>suspects should be treated this study sought to identify the <glaucoma>}
{<glaucoma>,<suspects should be treated this study sought to identify the >,<glaucoma>
{in the congenital <glaucoma>group and 36 mmHg in the aphakic <glaucoma>}
{<glaucoma>,<group and 36 mmHg in the aphakic >,<glaucoma>
{of topically applied <glaucoma>medications and emphasize the need for the universal application of these techniques during patient treatment and in clinical studies of topically applied <glaucoma>}
{<glaucoma>,<medications and emphasize the need for the universal application of these techniques during patient treatment and in clinical studies of topically applied >,<glaucoma>
{enrolled 124 black <glaucoma>72 normal and 96 white 32 <glaucoma>}
{<glaucoma>,<72 normal and 96 white 32 >,<glaucoma>
{CONCLUSIONS High myopic <glaucoma>eyes demonstrated significantly lower MD and visual acuity compared to those of moderate myopic <glaucoma>}
{<glaucoma>,<eyes demonstrated significantly lower MD and visual acuity compared to those of moderate myopic >,<glaucoma>
{early stages of <glaucoma>the disc changes prior to visual field loss so assessment of the optic disc is very important for the evaluation of the <glaucoma>}
{<glaucoma>,<the disc changes prior to visual field loss so assessment of the optic disc is very important for the evaluation of the >,<glaucoma>
{ Ex-PRESS miniature <glaucoma>implant inserted under a scleral flap in open-angle <glaucoma>}
{<glaucoma>,<implant inserted under a scleral flap in open-angle >,<glaucoma>
{for management of <glaucoma>or those at risk for developing <glaucoma>}
{<glaucoma>,<or those at risk for developing >,<glaucoma>
{Eighty-one high myopic <glaucoma>eyes or = -8 diopter D and eighty moderate myopic <glaucoma>}
{<glaucoma>,<eyes or = -8 diopter D and eighty moderate myopic >,<glaucoma>
{dispersion in pigmentary <glaucoma>pseudo-exfoliation material deposition in capsular <glaucoma>}
{<glaucoma>,<pseudo-exfoliation material deposition in capsular >,<glaucoma>
{ Chronic open-angle <glaucoma>10 cases was the commonest <glaucoma>}
{<glaucoma>,<10 cases was the commonest >,<glaucoma>
{in ocular hypertensives <glaucoma>suspects and <glaucoma>}
{<glaucoma>,<suspects and >,<glaucoma>
{of ocular hypertensives <glaucoma>suspects and <glaucoma>}
{<glaucoma>,<suspects and >,<glaucoma>
{patients with various <glaucoma>stages has brought the authors to a conclusion on the diagnostic value of the symptom of the optic disk 'outlining' vessels phenomenon of the optic disk 'sinking' phenomenon of retinal nerve fiber 'loss' and reduced number and diameter of the retinal vessels in the patients with initial stages of <glaucoma>}
{<glaucoma>,<stages has brought the authors to a conclusion on the diagnostic value of the symptom of the optic disk 'outlining' vessels phenomenon of the optic disk 'sinking' phenomenon of retinal nerve fiber 'loss' and reduced number and diameter of the retinal vessels in the patients with initial stages of >,<glaucoma>
{frequency testing on <glaucoma>suspects without visual field loss in either eye 52 <glaucoma>}
{<glaucoma>,<suspects without visual field loss in either eye 52 >,<glaucoma>
{seen in most <glaucoma>patients but only in a minority of <glaucoma>}
{<glaucoma>,<patients but only in a minority of >,<glaucoma>
{patients with aphakic/pseudophakic <glaucoma>three 75% of the four patients with congenital glaucoma and four 80% of the five patients with uveitic <glaucoma>}
{<glaucoma>,<three 75% of the four patients with congenital glaucoma and four 80% of the five patients with uveitic >,<glaucoma>
{ METHODS Three <glaucoma>cohorts were identified based on hierarchical inclusion of patients with /=2 <glaucoma>}
{<glaucoma>,<cohorts were identified based on hierarchical inclusion of patients with /=2 >,<glaucoma>
{safety of non-penetrating <glaucoma>surgery NPGS augmented with mitomycin C MMC or 5-fluorouracil 5FU in eyes at high risk of failure of <glaucoma>}
{<glaucoma>,<surgery NPGS augmented with mitomycin C MMC or 5-fluorouracil 5FU in eyes at high risk of failure of >,<glaucoma>
{patients with neovascular <glaucoma>four 80% of the five patients with uveitic glaucoma and two 50% of the four patients with congenital <glaucoma>}
{<glaucoma>,<four 80% of the five patients with uveitic glaucoma and two 50% of the four patients with congenital >,<glaucoma>
{moderate stages of <glaucoma>before angle closure and lens dislocation is an animal model for studies in open-angle <glaucoma>}
{<glaucoma>,<before angle closure and lens dislocation is an animal model for studies in open-angle >,<glaucoma>
{18 with neovascular <glaucoma>19 79% of the 24 patients with aphakic/pseudophakic <glaucoma>}
{<glaucoma>,<19 79% of the 24 patients with aphakic/pseudophakic >,<glaucoma>
{severe cases of <glaucoma>than in groups of patients with more easily treatable <glaucoma>}
{<glaucoma>,<than in groups of patients with more easily treatable >,<glaucoma>
{fistulation in open-angle <glaucoma>on the one hand and close-angle <glaucoma>}
{<glaucoma>,<on the one hand and close-angle >,<glaucoma>
{the most practical <glaucoma>screening program is that which is directed at those individuals who are first degree relatives of patients known to have <glaucoma>}
{<glaucoma>,<screening program is that which is directed at those individuals who are first degree relatives of patients known to have >,<glaucoma>
{To examine whether <glaucoma>status or measures of visual function affected by <glaucoma>}
{<glaucoma>,<status or measures of visual function affected by >,<glaucoma>
{cases chronic open-angle <glaucoma>was associated with varying degrees of expression of the full pigmentary <glaucoma>}
{<glaucoma>,<was associated with varying degrees of expression of the full pigmentary >,<glaucoma>
{patients with bilateral <glaucoma>points to the fact that <glaucoma>}
{<glaucoma>,<points to the fact that >,<glaucoma>
{ in open-angle <glaucoma>but is a good operation against early closed-angle <glaucoma>}
{<glaucoma>,<but is a good operation against early closed-angle >,<glaucoma>
{diagnosed to have <glaucoma>1 of whom had undergone <glaucoma>}
{<glaucoma>,<1 of whom had undergone >,<glaucoma>
{patients with pigmentary <glaucoma>were asked to report possible side effects of topical <glaucoma>}
{<glaucoma>,<were asked to report possible side effects of topical >,<glaucoma>
{who had open-angle <glaucoma>or phacotopic <glaucoma>}
{<glaucoma>,<or phacotopic >,<glaucoma>
{Studies on detecting <glaucoma>progression showed that although there was often agreement on progression between the structural and functional VF tests a significant proportion of <glaucoma>}
{<glaucoma>,<progression showed that although there was often agreement on progression between the structural and functional VF tests a significant proportion of >,<glaucoma>
{patients with refractory <glaucoma>treated with the Ahmed <glaucoma>}
{<glaucoma>,<treated with the Ahmed >,<glaucoma>
{ BACKGROUND Juvenile <glaucoma>is an uncommon form of open-angle <glaucoma>}
{<glaucoma>,<is an uncommon form of open-angle >,<glaucoma>
{24 consecutive white <glaucoma>patients matched to 24 African-American <glaucoma>}
{<glaucoma>,<patients matched to 24 African-American >,<glaucoma>
{of the Ahmed <glaucoma>valve implant in eyes with refractory <glaucoma>}
{<glaucoma>,<valve implant in eyes with refractory >,<glaucoma>
{POAG eyes congenital <glaucoma>eyes and juvenile <glaucoma>}
{<glaucoma>,<eyes and juvenile >,<glaucoma>
{normal N perimetric <glaucoma>PG and <glaucoma>}
{<glaucoma>,<PG and >,<glaucoma>
{trial use on <glaucoma>patients 80 cases 143 eyes demonstrated good IOP depressive effect on primary open--or closed-angle glaucoma and secondary <glaucoma>}
{<glaucoma>,<patients 80 cases 143 eyes demonstrated good IOP depressive effect on primary open--or closed-angle glaucoma and secondary >,<glaucoma>
{ PG and <glaucoma>suspect and preperimetric <glaucoma>}
{<glaucoma>,<suspect and preperimetric >,<glaucoma>
{a group of <glaucoma>patients and 8 normal subjects were tested with nicotine and another group of 11 <glaucoma>}
{<glaucoma>,<patients and 8 normal subjects were tested with nicotine and another group of 11 >,<glaucoma>
{the definition of <glaucoma>intraocular pressure measurements central corneal thickness gonioscopy optic disc assessment preferred first-line <glaucoma>}
{<glaucoma>,<intraocular pressure measurements central corneal thickness gonioscopy optic disc assessment preferred first-line >,<glaucoma>
{that had undergone <glaucoma>filtering surgery Group A and in 47 <glaucoma>}
{<glaucoma>,<filtering surgery Group A and in 47 >,<glaucoma>
{patients with capsular <glaucoma>than in patients with simple <glaucoma>}
{<glaucoma>,<than in patients with simple >,<glaucoma>
{their relationship with <glaucoma>are desirable patients with evidence of pseudo-exfoliation should be treated as <glaucoma>}
{<glaucoma>,<are desirable patients with evidence of pseudo-exfoliation should be treated as >,<glaucoma>
{70% in open-angle <glaucoma>was 25% higher in pseudocapsular <glaucoma>}
{<glaucoma>,<was 25% higher in pseudocapsular >,<glaucoma>
{  --pseudoexfoliative <glaucoma>PXFG and chronic open-angle <glaucoma>}
{<glaucoma>,<PXFG and chronic open-angle >,<glaucoma>
{diagnosis type of <glaucoma>--pseudoexfoliative <glaucoma>}
{<glaucoma>,<--pseudoexfoliative >,<glaucoma>
{prior diagnosis of <glaucoma>or ocular hypertension or prior medical treatment for glaucoma or prior <glaucoma>}
{<glaucoma>,<or ocular hypertension or prior medical treatment for glaucoma or prior >,<glaucoma>
{paper looked at <glaucoma>practice patterns and consisted of questions on demographic data the definition of <glaucoma>}
{<glaucoma>,<practice patterns and consisted of questions on demographic data the definition of >,<glaucoma>
{III HRT III <glaucoma>probability score in differentiating normal from pathologic eyes and to compare the <glaucoma>}
{<glaucoma>,<probability score in differentiating normal from pathologic eyes and to compare the >,<glaucoma>
{origin of the <glaucoma>was neovascular 26 patients open angle glaucoma 9 patients secondary <glaucoma>}
{<glaucoma>,<was neovascular 26 patients open angle glaucoma 9 patients secondary >,<glaucoma>
{ A displaced <glaucoma>probability score was found in 35 eyes but with unchanged <glaucoma>}
{<glaucoma>,<probability score was found in 35 eyes but with unchanged >,<glaucoma>
{carried out in <glaucoma>eyes that had undergone <glaucoma>}
{<glaucoma>,<eyes that had undergone >,<glaucoma>
{the early primary <glaucoma>patients and suspects via the way of the public health survey more patients with primary <glaucoma>}
{<glaucoma>,<patients and suspects via the way of the public health survey more patients with primary >,<glaucoma>
{patients with normal-pressure <glaucoma>29% of those with POAG and 54% of <glaucoma>}
{<glaucoma>,<29% of those with POAG and 54% of >,<glaucoma>
{intervention for primary <glaucoma>to ophthalmologists and ophthalmic residents popularizing the knowledge of <glaucoma>}
{<glaucoma>,<to ophthalmologists and ophthalmic residents popularizing the knowledge of >,<glaucoma>
{of each of <glaucoma>suspects and 16 <glaucoma>}
{<glaucoma>,<suspects and 16 >,<glaucoma>
{to treat neovascular <glaucoma>or <glaucoma>}
{<glaucoma>,<or >,<glaucoma>
{the knowledge of <glaucoma>to public and screening the early primary <glaucoma>}
{<glaucoma>,<to public and screening the early primary >,<glaucoma>
{patients with primary <glaucoma>who attended the <glaucoma>}
{<glaucoma>,<who attended the >,<glaucoma>
{history for open-angle <glaucoma>101 patients showed that 3% developed confirmed <glaucoma>}
{<glaucoma>,<101 patients showed that 3% developed confirmed >,<glaucoma>
{patients with early <glaucoma>130 eyes 70 patients with advanced <glaucoma>}
{<glaucoma>,<130 eyes 70 patients with advanced >,<glaucoma>
{patients with advanced <glaucoma>than those in patients with early <glaucoma>}
{<glaucoma>,<than those in patients with early >,<glaucoma>
{of aphakic open-angle <glaucoma>AO aphakic angle-closure <glaucoma>}
{<glaucoma>,<AO aphakic angle-closure >,<glaucoma>
{pronounced in capsular <glaucoma>but not significant for simple <glaucoma>}
{<glaucoma>,<but not significant for simple >,<glaucoma>
{IOP in open-angle <glaucoma>was investigated in patients with aphakic glaucoma and with simultaneous administration of a miotic in patients with narrow-angle <glaucoma>}
{<glaucoma>,<was investigated in patients with aphakic glaucoma and with simultaneous administration of a miotic in patients with narrow-angle >,<glaucoma>
{patients with open-angle <glaucoma>needing cataract extraction not simply those with inadequate <glaucoma>}
{<glaucoma>,<needing cataract extraction not simply those with inadequate >,<glaucoma>
{patients had campimetric <glaucoma>at the beginning of the study whereas 76 patients had satisfactory intraocular pressure control and in the majority stabilization of <glaucoma>}
{<glaucoma>,<at the beginning of the study whereas 76 patients had satisfactory intraocular pressure control and in the majority stabilization of >,<glaucoma>
{successful in open-angle <glaucoma>or more especially in closed-angle <glaucoma>}
{<glaucoma>,<or more especially in closed-angle >,<glaucoma>
{often misinterpreted as <glaucoma>simplex and in families with pigmentary glaucoma and exfoliation <glaucoma>}
{<glaucoma>,<simplex and in families with pigmentary glaucoma and exfoliation >,<glaucoma>
{monitoring of stable <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{eyes with normal-pressure <glaucoma>it did not vary significantly between the various <glaucoma>}
{<glaucoma>,<it did not vary significantly between the various >,<glaucoma>
{sciences in clinical <glaucoma>steroids ocular hypertension and <glaucoma>}
{<glaucoma>,<steroids ocular hypertension and >,<glaucoma>
{underwent more additional <glaucoma>surgeries were treated with more <glaucoma>}
{<glaucoma>,<surgeries were treated with more >,<glaucoma>
{cost-effectiveness of various <glaucoma>screening options our analysis indicates that <glaucoma>}
{<glaucoma>,<screening options our analysis indicates that >,<glaucoma>
{= 114 pseudoexfoliative <glaucoma>n = 41 normal-pressure <glaucoma>}
{<glaucoma>,<n = 41 normal-pressure >,<glaucoma>
{patients with open-angle <glaucoma>OAG and in 13 <glaucoma>}
{<glaucoma>,<OAG and in 13 >,<glaucoma>
{130 eyes had <glaucoma>simplex and 50 eyes had <glaucoma>}
{<glaucoma>,<simplex and 50 eyes had >,<glaucoma>
{and stability of <glaucoma>between treated and nontreated eyes 2 surgery had altered the clinical course of the patients and 3 there was any relation between level of IOP and <glaucoma>}
{<glaucoma>,<between treated and nontreated eyes 2 surgery had altered the clinical course of the patients and 3 there was any relation between level of IOP and >,<glaucoma>
{the treatment of <glaucoma>simplex and <glaucoma>}
{<glaucoma>,<simplex and >,<glaucoma>
{overall detection rates <glaucoma>+ <glaucoma>}
{<glaucoma>,<+ >,<glaucoma>
{timolol in aphakic <glaucoma>cases is almost identical with the effect of the drug in cases of chronic open-angle <glaucoma>}
{<glaucoma>,<cases is almost identical with the effect of the drug in cases of chronic open-angle >,<glaucoma>
{  and <glaucoma>was observed in this family but the <glaucoma>}
{<glaucoma>,<was observed in this family but the >,<glaucoma>
{33% of the <glaucoma>simplex group and in 8% of the <glaucoma>}
{<glaucoma>,<simplex group and in 8% of the >,<glaucoma>
{ Minimally invasive <glaucoma>surgery MIGS that targets the outflow pathway with minimal to no scleral dissection has resulted in the need to reconsider the <glaucoma>}
{<glaucoma>,<surgery MIGS that targets the outflow pathway with minimal to no scleral dissection has resulted in the need to reconsider the >,<glaucoma>
{30 2014 English-language <glaucoma>literature search on PubMed of articles containing <glaucoma>}
{<glaucoma>,<literature search on PubMed of articles containing >,<glaucoma>
{no patient developed <glaucoma>lifelong follow-up is mandatory to detect chronic open-angle and traumatic angle-recession <glaucoma>}
{<glaucoma>,<lifelong follow-up is mandatory to detect chronic open-angle and traumatic angle-recession >,<glaucoma>
{in eyes with <glaucoma>which confirmed that vascular factor is one of the pathogenesis of <glaucoma>}
{<glaucoma>,<which confirmed that vascular factor is one of the pathogenesis of >,<glaucoma>
{the management of <glaucoma>through the use of novel microinvasive <glaucoma>}
{<glaucoma>,<through the use of novel microinvasive >,<glaucoma>
{outcomes of Ahmed <glaucoma>valve AGV implantation in patients with neovascular <glaucoma>}
{<glaucoma>,<valve AGV implantation in patients with neovascular >,<glaucoma>
{outcomes of Ahmed <glaucoma>valve implantation in patients with neovascular <glaucoma>}
{<glaucoma>,<valve implantation in patients with neovascular >,<glaucoma>
{future development for <glaucoma>treatment will include a combination of these treatments to prevent the pathophysiology of <glaucoma>}
{<glaucoma>,<treatment will include a combination of these treatments to prevent the pathophysiology of >,<glaucoma>
{the spotlight of <glaucoma>research and may form the impending and promising target for <glaucoma>}
{<glaucoma>,<research and may form the impending and promising target for >,<glaucoma>
{classified as definite <glaucoma>cases are less prone to false labeling than normal fields whereas field defects identified as probable/possible <glaucoma>}
{<glaucoma>,<cases are less prone to false labeling than normal fields whereas field defects identified as probable/possible >,<glaucoma>
{noted for the <glaucoma>suspect group though not as strongly as for the definite <glaucoma>}
{<glaucoma>,<suspect group though not as strongly as for the definite >,<glaucoma>
{eyes with rubeotic <glaucoma>demonstrated pressures of less than 20 mmHg without therapy four eyes with traumatic <glaucoma>}
{<glaucoma>,<demonstrated pressures of less than 20 mmHg without therapy four eyes with traumatic >,<glaucoma>
{ 65% of <glaucoma>were found including ten cases of angle closure <glaucoma>}
{<glaucoma>,<were found including ten cases of angle closure >,<glaucoma>
{corticosteroid response in <glaucoma>suspects and family members of established <glaucoma>}
{<glaucoma>,<suspects and family members of established >,<glaucoma>
{or in aphakic <glaucoma>12 cases not included in this study and 'escape' in pseudo-capsular <glaucoma>}
{<glaucoma>,<12 cases not included in this study and 'escape' in pseudo-capsular >,<glaucoma>
{primary angle closure <glaucoma>exhibited RVO showing the highest incidence among <glaucoma>}
{<glaucoma>,<exhibited RVO showing the highest incidence among >,<glaucoma>
{and in pigmentary <glaucoma>bad results in myopic or in aphakic <glaucoma>}
{<glaucoma>,<bad results in myopic or in aphakic >,<glaucoma>
{open-angle and normal-pressure <glaucoma>which may be important in the management of <glaucoma>}
{<glaucoma>,<which may be important in the management of >,<glaucoma>
{technique in normals <glaucoma>suspects and <glaucoma>}
{<glaucoma>,<suspects and >,<glaucoma>
{to corticosteroids prior <glaucoma>treatment and family history of <glaucoma>}
{<glaucoma>,<treatment and family history of >,<glaucoma>
{any type of <glaucoma>suspected glaucoma or a history of <glaucoma>}
{<glaucoma>,<suspected glaucoma or a history of >,<glaucoma>
{patients with early <glaucoma>22 with capsular glaucoma and ten with simple <glaucoma>}
{<glaucoma>,<22 with capsular glaucoma and ten with simple >,<glaucoma>
{3 patients pigmentary <glaucoma>2 patients juvenile <glaucoma>}
{<glaucoma>,<2 patients juvenile >,<glaucoma>
{patients with narrow-angle <glaucoma>but not in patients with open-angle <glaucoma>}
{<glaucoma>,<but not in patients with open-angle >,<glaucoma>
{ SUMMARY Newer <glaucoma>procedures targeting different aqueous outflow pathways have improved the safety profile of <glaucoma>}
{<glaucoma>,<procedures targeting different aqueous outflow pathways have improved the safety profile of >,<glaucoma>
{medical treatment of <glaucoma>exist particularly in patient adherence medical therapy remains the first line treatment for almost all <glaucoma>}
{<glaucoma>,<exist particularly in patient adherence medical therapy remains the first line treatment for almost all >,<glaucoma>
{identified as possible <glaucoma>12 as probable glaucoma and 8 as definite <glaucoma>}
{<glaucoma>,<12 as probable glaucoma and 8 as definite >,<glaucoma>
{hypertension or suspect <glaucoma>and/or prescribed topical <glaucoma>}
{<glaucoma>,<and/or prescribed topical >,<glaucoma>
{treatment for complex <glaucoma>but a new wave of <glaucoma>}
{<glaucoma>,<but a new wave of >,<glaucoma>
{5 required Ahmed <glaucoma>valve surgery for the management of steroid-responsive <glaucoma>}
{<glaucoma>,<valve surgery for the management of steroid-responsive >,<glaucoma>
{Simple and capsular <glaucoma>respond well to repeated ALT but in secondary <glaucoma>}
{<glaucoma>,<respond well to repeated ALT but in secondary >,<glaucoma>
{SD with primary <glaucoma>subdivided by irido-corneal angle configuration into closed-angle <glaucoma>}
{<glaucoma>,<subdivided by irido-corneal angle configuration into closed-angle >,<glaucoma>
{four groups of <glaucoma>patients 1 chronic open-angle <glaucoma>}
{<glaucoma>,<patients 1 chronic open-angle >,<glaucoma>
{individuals in whom <glaucoma>was suspected <glaucoma>}
{<glaucoma>,<was suspected >,<glaucoma>
{history of primary <glaucoma>emphasized 13 cases of glaucoma and 5 cases suspicious of <glaucoma>}
{<glaucoma>,<emphasized 13 cases of glaucoma and 5 cases suspicious of >,<glaucoma>
{in 1 case <glaucoma>was suspected in 4 cases and <glaucoma>}
{<glaucoma>,<was suspected in 4 cases and >,<glaucoma>
{CONCLUSIONS In early <glaucoma>changes are more marked in optic disk appearance than in the visual field suggesting that at least for some patients for early <glaucoma>}
{<glaucoma>,<changes are more marked in optic disk appearance than in the visual field suggesting that at least for some patients for early >,<glaucoma>
{history of primary <glaucoma>revealed that the reaction is similar to the one presented by the patients with simple <glaucoma>}
{<glaucoma>,<revealed that the reaction is similar to the one presented by the patients with simple >,<glaucoma>
{resulted in excellent <glaucoma>control good visual recovery and a need for fewer <glaucoma>}
{<glaucoma>,<control good visual recovery and a need for fewer >,<glaucoma>
{clinically diagnosed as <glaucoma>but also most of their siblings in whom <glaucoma>}
{<glaucoma>,<but also most of their siblings in whom >,<glaucoma>
{hemorrhage with open-angle <glaucoma>was confirmed particularly low-pressure <glaucoma>}
{<glaucoma>,<was confirmed particularly low-pressure >,<glaucoma>
{clinical follow-up of <glaucoma>patients and <glaucoma>}
{<glaucoma>,<patients and >,<glaucoma>
{observations suggest that <glaucoma>surgery must give a sufficient drop of ocular pressure in all cases with pressure between 15 and 20 adjuvant medical therapy is useful old patients are a poor material for <glaucoma>}
{<glaucoma>,<surgery must give a sufficient drop of ocular pressure in all cases with pressure between 15 and 20 adjuvant medical therapy is useful old patients are a poor material for >,<glaucoma>
{ patients and <glaucoma>suspects should primarily take place at an ophthalmologist's office and the new effective <glaucoma>}
{<glaucoma>,<suspects should primarily take place at an ophthalmologist's office and the new effective >,<glaucoma>
{The diagnosis of <glaucoma>could not however be confirmed in 54 31% <glaucoma>}
{<glaucoma>,<could not however be confirmed in 54 31% >,<glaucoma>
{years but later <glaucoma>surgery is often required in eyes with far advanced <glaucoma>}
{<glaucoma>,<surgery is often required in eyes with far advanced >,<glaucoma>
{The author analysed <glaucoma>screenings of white populations published in the past 30 years and compared these with the <glaucoma>}
{<glaucoma>,<screenings of white populations published in the past 30 years and compared these with the >,<glaucoma>
{course of untreated <glaucoma>such uncertainty is in tolerable and the author suggests that <glaucoma>}
{<glaucoma>,<such uncertainty is in tolerable and the author suggests that >,<glaucoma>
{in the secondary <glaucoma>triple procedure SGTP as compared to primary <glaucoma>}
{<glaucoma>,<triple procedure SGTP as compared to primary >,<glaucoma>
{RET proto-oncogene and <glaucoma>remains unclear since <glaucoma>}
{<glaucoma>,<remains unclear since >,<glaucoma>
{C in secondary <glaucoma>triple procedure as compared to primary <glaucoma>}
{<glaucoma>,<triple procedure as compared to primary >,<glaucoma>
{patients with open-angle <glaucoma>42 with diagnosis of <glaucoma>}
{<glaucoma>,<42 with diagnosis of >,<glaucoma>
{visual field or <glaucoma>suspects 52 moderately advanced <glaucoma>}
{<glaucoma>,<suspects 52 moderately advanced >,<glaucoma>
{be greater in <glaucoma>eyes than in controls <glaucoma>}
{<glaucoma>,<eyes than in controls >,<glaucoma>
{from 2 university-based <glaucoma>clinical practices and a university-based general ophthalmology clinic and consisted of 121 patients with open-angle <glaucoma>}
{<glaucoma>,<clinical practices and a university-based general ophthalmology clinic and consisted of 121 patients with open-angle >,<glaucoma>
{II brought together <glaucoma>clinicians and researchers from all over the world to discuss current practices in glaucoma diagnosis and management and the neurobiology of <glaucoma>}
{<glaucoma>,<clinicians and researchers from all over the world to discuss current practices in glaucoma diagnosis and management and the neurobiology of >,<glaucoma>
{  As <glaucoma>is a potentially progressive disease surgeons who treat patients with coexistent glaucoma and cataracts must consider that future <glaucoma>}
{<glaucoma>,<is a potentially progressive disease surgeons who treat patients with coexistent glaucoma and cataracts must consider that future >,<glaucoma>
{presenting with advanced <glaucoma>presents a challenge to <glaucoma>}
{<glaucoma>,<presents a challenge to >,<glaucoma>
{glaucoma status one <glaucoma>medication related to health status five <glaucoma>}
{<glaucoma>,<medication related to health status five >,<glaucoma>
{the etiology of <glaucoma>is multi-factorial intraocular pressure IOP is the only modifiable factor in <glaucoma>}
{<glaucoma>,<is multi-factorial intraocular pressure IOP is the only modifiable factor in >,<glaucoma>
{topical medication use <glaucoma>type and <glaucoma>}
{<glaucoma>,<type and >,<glaucoma>
{ Early Ahmed <glaucoma>valve implantation after penetrating keratoplasty leads to better outcomes in an Asian population with preexisting <glaucoma>}
{<glaucoma>,<valve implantation after penetrating keratoplasty leads to better outcomes in an Asian population with preexisting >,<glaucoma>
{patients with refractory <glaucoma>who underwent Ahmed <glaucoma>}
{<glaucoma>,<who underwent Ahmed >,<glaucoma>
{goals of the <glaucoma>research and is increasingly being applied to identify molecular mechanisms and biomarkers of <glaucoma>}
{<glaucoma>,<research and is increasingly being applied to identify molecular mechanisms and biomarkers of >,<glaucoma>
{  Because <glaucoma>is associated with increased IOP level the primary goal in treatment of <glaucoma>}
{<glaucoma>,<is associated with increased IOP level the primary goal in treatment of >,<glaucoma>
{eyes number of <glaucoma>surgeries in the treatment history and the presence of depression were independent predictors for VRQoL of <glaucoma>}
{<glaucoma>,<surgeries in the treatment history and the presence of depression were independent predictors for VRQoL of >,<glaucoma>
{age sex race <glaucoma>type previous antiglaucoma medications previous <glaucoma>}
{<glaucoma>,<type previous antiglaucoma medications previous >,<glaucoma>
{OF REVIEW As <glaucoma>surgeons continue to search for an improvement over trabeculectomy the ExPRESS miniature <glaucoma>}
{<glaucoma>,<surgeons continue to search for an improvement over trabeculectomy the ExPRESS miniature >,<glaucoma>
{risk factor for <glaucoma>is increased intraocular pressure IOP this is currently the only target for treatment of <glaucoma>}
{<glaucoma>,<is increased intraocular pressure IOP this is currently the only target for treatment of >,<glaucoma>
{pharmaceutical therapy of <glaucoma>dates back to 1875 when Weber introduced pilocarpine into the medicinal treatment of <glaucoma>}
{<glaucoma>,<dates back to 1875 when Weber introduced pilocarpine into the medicinal treatment of >,<glaucoma>
{effective types of <glaucoma>surgery in advanced <glaucoma>}
{<glaucoma>,<surgery in advanced >,<glaucoma>
{eyes were identified <glaucoma>before Moroz keratoprosthesis surgery and 3 eyes developed <glaucoma>}
{<glaucoma>,<before Moroz keratoprosthesis surgery and 3 eyes developed >,<glaucoma>
{able to detect <glaucoma>than isolated measures of structure and function and that it performs well even in preperimetric <glaucoma>}
{<glaucoma>,<than isolated measures of structure and function and that it performs well even in preperimetric >,<glaucoma>
{central corneal thickness <glaucoma>medical therapy neuroprotection <glaucoma>}
{<glaucoma>,<medical therapy neuroprotection >,<glaucoma>
{30 2013 English-language <glaucoma>literature search on PubMed using the following terms <glaucoma>}
{<glaucoma>,<literature search on PubMed using the following terms >,<glaucoma>
{risk factor in <glaucoma>development and progression remains nascent multiple observations have shown gender differences in the incidence and prevalence of <glaucoma>}
{<glaucoma>,<development and progression remains nascent multiple observations have shown gender differences in the incidence and prevalence of >,<glaucoma>
{seen in the <glaucoma>clinic were <glaucoma>}
{<glaucoma>,<clinic were >,<glaucoma>
{use in refractory <glaucoma>the indications for ECP have expanded broadly to include many forms of <glaucoma>}
{<glaucoma>,<the indications for ECP have expanded broadly to include many forms of >,<glaucoma>
Aging,chronic kidney disease
{   <Aging>and <chronic kidney disease>}
{<Aging>,<and >,<chronic kidney disease>
{   <Aging>and <chronic kidney disease>}
{<Aging>,<and >,<chronic kidney disease>
raised intraocular pressure,ocular hypertension
{the management of <raised intraocular pressure>and <ocular hypertension>}
{<raised intraocular pressure>,<and >,<ocular hypertension>
{the management of <raised intraocular pressure>and is a suitable alternative to ocular timolol in patients with chronic open angle glaucoma or <ocular hypertension>}
{<raised intraocular pressure>,<and is a suitable alternative to ocular timolol in patients with chronic open angle glaucoma or >,<ocular hypertension>
Acute appendicitis,dietary fibre intake
{   <Acute appendicitis>and <dietary fibre intake>}
{<Acute appendicitis>,<and >,<dietary fibre intake>
meningitis endocarditis,eye infections
{   <meningitis endocarditis>and <eye infections>}
{<meningitis endocarditis>,<and >,<eye infections>
open-angle glaucoma,proliferative diabetic retinopathy
{patients with primary <open-angle glaucoma>and <proliferative diabetic retinopathy>}
{<open-angle glaucoma>,<and >,<proliferative diabetic retinopathy>
{patients with primary <open-angle glaucoma>if eyes with <proliferative diabetic retinopathy>}
{<open-angle glaucoma>,<if eyes with >,<proliferative diabetic retinopathy>
coronary artery disease,chronic kidney disease
{the management of <coronary artery disease>and <chronic kidney disease>}
{<coronary artery disease>,<and >,<chronic kidney disease>
{   <coronary artery disease>or <chronic kidney disease>}
{<coronary artery disease>,<or >,<chronic kidney disease>
chronic heart failure arrhythmias,glaucoma
{   <chronic heart failure arrhythmias>and <glaucoma>}
{<chronic heart failure arrhythmias>,<and >,<glaucoma>
pressure,open-angle glaucoma
{Blood pressure perfusion <pressure>and <open-angle glaucoma>}
{<pressure>,<and >,<open-angle glaucoma>
{ Postoperative intraocular <pressure>rise in <open-angle glaucoma>}
{<pressure>,<rise in >,<open-angle glaucoma>
{LTP on intraocular <pressure>IOP outflow facility the morphology of the trabecular meshwork TM and the pattern of extracellular glycoprotein fibronectin in trabeculum were studied in 46 eyes of patients with primary <open-angle glaucoma>}
{<pressure>,<IOP outflow facility the morphology of the trabecular meshwork TM and the pattern of extracellular glycoprotein fibronectin in trabeculum were studied in 46 eyes of patients with primary >,<open-angle glaucoma>
{in reducing intraocular <pressure>in patients with chronic <open-angle glaucoma>}
{<pressure>,<in patients with chronic >,<open-angle glaucoma>
{manoeuvre on intraocular <pressure>IOP in four groups of volunteer subjects 37 healthy young control subjects 10 patients with chronic <open-angle glaucoma>}
{<pressure>,<IOP in four groups of volunteer subjects 37 healthy young control subjects 10 patients with chronic >,<open-angle glaucoma>
{rate systemic blood <pressure>and vital capacity of the lungs in ten patients with primary <open-angle glaucoma>}
{<pressure>,<and vital capacity of the lungs in ten patients with primary >,<open-angle glaucoma>
{chronically elevated intraocular <pressure>would produce similar effects we measured electro-oculograms in two groups of patients ocular hypertensive patients and patients with primary <open-angle glaucoma>}
{<pressure>,<would produce similar effects we measured electro-oculograms in two groups of patients ocular hypertensive patients and patients with primary >,<open-angle glaucoma>
{on both intraocular <pressure>and retinal sensitivity as determined from visual fields in a randomized two-year parallel study in 20 patients with primary <open-angle glaucoma>}
{<pressure>,<and retinal sensitivity as determined from visual fields in a randomized two-year parallel study in 20 patients with primary >,<open-angle glaucoma>
{antagonists on intraocular <pressure>and retinal sensitivity in primary <open-angle glaucoma>}
{<pressure>,<and retinal sensitivity in primary >,<open-angle glaucoma>
{of increased intraocular <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{increases in intraocular <pressure>after cycloplegia in eyes of <open-angle glaucoma>}
{<pressure>,<after cycloplegia in eyes of >,<open-angle glaucoma>
{Twenty-four-hour ambulatory blood <pressure>recording was performed on 38 patients with normal-tension glaucoma and on 46 with primary <open-angle glaucoma>}
{<pressure>,<recording was performed on 38 patients with normal-tension glaucoma and on 46 with primary >,<open-angle glaucoma>
{ high intraocular <pressure>and family history of <open-angle glaucoma>}
{<pressure>,<and family history of >,<open-angle glaucoma>
{field of postlaser <pressure>elevations the first 24 h following primary laser trabeculoplasty were investigated in 61 patients with exfoliative or <open-angle glaucoma>}
{<pressure>,<elevations the first 24 h following primary laser trabeculoplasty were investigated in 61 patients with exfoliative or >,<open-angle glaucoma>
{on the intra-ocular <pressure>IOP of patients with primary <open-angle glaucoma>}
{<pressure>,<IOP of patients with primary >,<open-angle glaucoma>
{24-hour ambulatory blood <pressure>monitoring in 169 adult patients with either ocular hypertension or primary <open-angle glaucoma>}
{<pressure>,<monitoring in 169 adult patients with either ocular hypertension or primary >,<open-angle glaucoma>
{distribution of intraocular <pressure>IOP in a predominantly black population which has a high prevalence of <open-angle glaucoma>}
{<pressure>,<IOP in a predominantly black population which has a high prevalence of >,<open-angle glaucoma>
{and arterial blood <pressure>in patients with progressive and non-progressive primary <open-angle glaucoma>}
{<pressure>,<in patients with progressive and non-progressive primary >,<open-angle glaucoma>
{for increased intraocular <pressure>in patients with chronic <open-angle glaucoma>}
{<pressure>,<in patients with chronic >,<open-angle glaucoma>
{the final intraocular <pressure>outcome of the primary trabeculectomy combined with phacoemulsification and intraocular lens implantation in patients with primary <open-angle glaucoma>}
{<pressure>,<outcome of the primary trabeculectomy combined with phacoemulsification and intraocular lens implantation in patients with primary >,<open-angle glaucoma>
{Trusopt on intraocular <pressure>and some ocular functions have been studied in patients with primary <open-angle glaucoma>}
{<pressure>,<and some ocular functions have been studied in patients with primary >,<open-angle glaucoma>
{of reducing intraocular <pressure>in patients with chronic <open-angle glaucoma>}
{<pressure>,<in patients with chronic >,<open-angle glaucoma>
{ Diurnal intraocular <pressure>in juvenile <open-angle glaucoma>}
{<pressure>,<in juvenile >,<open-angle glaucoma>
{variation of intraocular <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{solution on intraocular <pressure>and blood pressure in <open-angle glaucoma>}
{<pressure>,<and blood pressure in >,<open-angle glaucoma>
{alone controlled intraocular <pressure>in 87% of ocular hypertensives in 68% of patients with chronic <open-angle glaucoma>}
{<pressure>,<in 87% of ocular hypertensives in 68% of patients with chronic >,<open-angle glaucoma>
{bupranolol on intraocular <pressure>were investigated in 21 and respectively 20 eyes with chronic uncomplicated <open-angle glaucoma>}
{<pressure>,<were investigated in 21 and respectively 20 eyes with chronic uncomplicated >,<open-angle glaucoma>
{Fluctuations of intraocular <pressure>during the day in <open-angle glaucoma>}
{<pressure>,<during the day in >,<open-angle glaucoma>
{change in intraocular <pressure>achieved after 98 trabeculectomy operations performed on 70 patients with primary <open-angle glaucoma>}
{<pressure>,<achieved after 98 trabeculectomy operations performed on 70 patients with primary >,<open-angle glaucoma>
{monotherapy on intraocular <pressure>and visual field for normal-tension glaucoma and primary <open-angle glaucoma>}
{<pressure>,<and visual field for normal-tension glaucoma and primary >,<open-angle glaucoma>
{on the nycthemeral <pressure>curve in an eye with chronic primary <open-angle glaucoma>}
{<pressure>,<curve in an eye with chronic primary >,<open-angle glaucoma>
{greater lowering of <pressure>than that achieved by treatment with timolol alone in cases of <open-angle glaucoma>}
{<pressure>,<than that achieved by treatment with timolol alone in cases of >,<open-angle glaucoma>
{ with normal <pressure>normal-tension glaucoma in Japan implies that treatment of pressure-independent damaging factors in Japanese <open-angle glaucoma>}
{<pressure>,<normal-tension glaucoma in Japan implies that treatment of pressure-independent damaging factors in Japanese >,<open-angle glaucoma>
{changes in intraocular <pressure>in eyes with primary <open-angle glaucoma>}
{<pressure>,<in eyes with primary >,<open-angle glaucoma>
{trough times of <pressure>readings in the suspected <open-angle glaucoma>}
{<pressure>,<readings in the suspected >,<open-angle glaucoma>
{levels of intraocular <pressure>were analysed for 120 patients with primary <open-angle glaucoma>}
{<pressure>,<were analysed for 120 patients with primary >,<open-angle glaucoma>
{ Lowering intraocular <pressure>IOP delays or prevents the loss of vision in primary <open-angle glaucoma>}
{<pressure>,<IOP delays or prevents the loss of vision in primary >,<open-angle glaucoma>
{therapy to reduce <pressure>in incipient <open-angle glaucoma>}
{<pressure>,<in incipient >,<open-angle glaucoma>
{IOP ocular perfusion <pressure>OPP and ocular pulse amplitude OPA in those with or at risk for primary <open-angle glaucoma>}
{<pressure>,<OPP and ocular pulse amplitude OPA in those with or at risk for primary >,<open-angle glaucoma>
{controlling increased intraocular <pressure>in two different age groups treated for medically uncontrolled primary <open-angle glaucoma>}
{<pressure>,<in two different age groups treated for medically uncontrolled primary >,<open-angle glaucoma>
{pattern of intra-ocular <pressure>in untreated patients with primary <open-angle glaucoma>}
{<pressure>,<in untreated patients with primary >,<open-angle glaucoma>
{guanethidine lower intraocular <pressure>efficiently in cases of <open-angle glaucoma>}
{<pressure>,<efficiently in cases of >,<open-angle glaucoma>
{during ambulatory blood <pressure>monitoring are associated with progressive visual field loss we performed a systematic review and meta-analysis of studies in patients with primary <open-angle glaucoma>}
{<pressure>,<monitoring are associated with progressive visual field loss we performed a systematic review and meta-analysis of studies in patients with primary >,<open-angle glaucoma>
{of increased intraocular <pressure>in the pathogenesis of <open-angle glaucoma>}
{<pressure>,<in the pathogenesis of >,<open-angle glaucoma>
{between nocturnal blood <pressure>reduction and progression of visual field defect in patients with primary <open-angle glaucoma>}
{<pressure>,<reduction and progression of visual field defect in patients with primary >,<open-angle glaucoma>
{closure on intraocular <pressure>IOP measurements in normal-tension NTG and high-tension HTG <open-angle glaucoma>}
{<pressure>,<IOP measurements in normal-tension NTG and high-tension HTG >,<open-angle glaucoma>
{and lower intraocular <pressure>IOP in primary <open-angle glaucoma>}
{<pressure>,<IOP in primary >,<open-angle glaucoma>
{a given intraocular <pressure>in chronic <open-angle glaucoma>}
{<pressure>,<in chronic >,<open-angle glaucoma>
{ Elevated intraocular <pressure>is a strong modifiable risk factor for <open-angle glaucoma>}
{<pressure>,<is a strong modifiable risk factor for >,<open-angle glaucoma>
{relation to intraocular <pressure>in highly myopic eyes with chronic <open-angle glaucoma>}
{<pressure>,<in highly myopic eyes with chronic >,<open-angle glaucoma>
{latanoprost on intraocular <pressure>IOP and pulsatile ocular blood flow POBF in primary <open-angle glaucoma>}
{<pressure>,<IOP and pulsatile ocular blood flow POBF in primary >,<open-angle glaucoma>
{latanoprost on intraocular <pressure>and pulsatile ocular blood flow in primary <open-angle glaucoma>}
{<pressure>,<and pulsatile ocular blood flow in primary >,<open-angle glaucoma>
{and systemic blood <pressure>in patients with primary <open-angle glaucoma>}
{<pressure>,<in patients with primary >,<open-angle glaucoma>
{of asymmetric intraocular <pressure>IOP and assess associations with undiagnosed <open-angle glaucoma>}
{<pressure>,<IOP and assess associations with undiagnosed >,<open-angle glaucoma>
{that lowering intraocular <pressure>IOP in patients with ocular hypertension OHT or <open-angle glaucoma>}
{<pressure>,<IOP in patients with ocular hypertension OHT or >,<open-angle glaucoma>
{cerebrospinal fluid CSF <pressure>in patients with primary <open-angle glaucoma>}
{<pressure>,<in patients with primary >,<open-angle glaucoma>
{monotherapies for intraocular <pressure>IOP lowering in adult patients with primary <open-angle glaucoma>}
{<pressure>,<IOP lowering in adult patients with primary >,<open-angle glaucoma>
{optic nerve tissue <pressure>may be of importance for the pathogenesis of the highly myopic type of chronic <open-angle glaucoma>}
{<pressure>,<may be of importance for the pathogenesis of the highly myopic type of chronic >,<open-angle glaucoma>
{reduction of intraocular <pressure>IOP in patients with ocular hypertension or <open-angle glaucoma>}
{<pressure>,<IOP in patients with ocular hypertension or >,<open-angle glaucoma>
{changes in intraocular <pressure>on ocular hemodynamics in patients with primary <open-angle glaucoma>}
{<pressure>,<on ocular hemodynamics in patients with primary >,<open-angle glaucoma>
{variations in intraocular <pressure>IOP during the day in normals in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP during the day in normals in patients with primary >,<open-angle glaucoma>
{provides improved intraocular <pressure>reduction over the 24-hour diurnal curve and for each individual time point in patients with primary <open-angle glaucoma>}
{<pressure>,<reduction over the 24-hour diurnal curve and for each individual time point in patients with primary >,<open-angle glaucoma>
{increases in intraocular <pressure>IOP in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP in patients with primary >,<open-angle glaucoma>
{transiently increases intraocular <pressure>IOP is associated with the risk of primary <open-angle glaucoma>}
{<pressure>,<IOP is associated with the risk of primary >,<open-angle glaucoma>
{trabeculoplasty on intraocular <pressure>control in <open-angle glaucoma>}
{<pressure>,<control in >,<open-angle glaucoma>
{ Diurnal intraocular <pressure>profiles and progression of chronic <open-angle glaucoma>}
{<pressure>,<profiles and progression of chronic >,<open-angle glaucoma>
{PURPOSE Elevated intraocular <pressure>IOP in primary <open-angle glaucoma>}
{<pressure>,<IOP in primary >,<open-angle glaucoma>
{reduction of intraocular <pressure>helps to prevent progression in patients with primary <open-angle glaucoma>}
{<pressure>,<helps to prevent progression in patients with primary >,<open-angle glaucoma>
{ Mean intraocular <pressure>and progression based on corneal thickness in primary <open-angle glaucoma>}
{<pressure>,<and progression based on corneal thickness in primary >,<open-angle glaucoma>
{between elevated intraocular <pressure>IOP <open-angle glaucoma>}
{<pressure>,<IOP >,<open-angle glaucoma>
{characterize diurnal intraocular <pressure>IOP changes in primary <open-angle glaucoma>}
{<pressure>,<IOP changes in primary >,<open-angle glaucoma>
{PGAs on intraocular <pressure>IOP reduction in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP reduction in patients with primary >,<open-angle glaucoma>
{also lowers intraocular <pressure>and preserves vision in patients with primary <open-angle glaucoma>}
{<pressure>,<and preserves vision in patients with primary >,<open-angle glaucoma>
{reduction of intraocular <pressure>IOP in patients with ocular hypertension OHT and <open-angle glaucoma>}
{<pressure>,<IOP in patients with ocular hypertension OHT and >,<open-angle glaucoma>
{the baseline intraocular <pressure>IOP in eyes with primary <open-angle glaucoma>}
{<pressure>,<IOP in eyes with primary >,<open-angle glaucoma>
{polymorphisms with intra-ocular <pressure>response to latanoprost in patients with primary <open-angle glaucoma>}
{<pressure>,<response to latanoprost in patients with primary >,<open-angle glaucoma>
{changes in intraocular <pressure>IOP axial length AL and choroidal thickness ChT in primary <open-angle glaucoma>}
{<pressure>,<IOP axial length AL and choroidal thickness ChT in primary >,<open-angle glaucoma>
{reduction of intraocular <pressure>IOP in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP in patients with primary >,<open-angle glaucoma>
{flow after intraocular <pressure>reduction in <open-angle glaucoma>}
{<pressure>,<reduction in >,<open-angle glaucoma>
{maleate reduces intraocular <pressure>in Japanese patients with primary <open-angle glaucoma>}
{<pressure>,<in Japanese patients with primary >,<open-angle glaucoma>
{pattern of intraocular <pressure>in normal person and patient with primary <open-angle glaucoma>}
{<pressure>,<in normal person and patient with primary >,<open-angle glaucoma>
{alone on intraocular <pressure>IOP control medication use and quality of life in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP control medication use and quality of life in patients with primary >,<open-angle glaucoma>
{any diurnal intraocular <pressure>IOP variation in healthy Cayo Santiago macaques as well as Cayo Santiago macaques with normotensive and hypertensive primary <open-angle glaucoma>}
{<pressure>,<IOP variation in healthy Cayo Santiago macaques as well as Cayo Santiago macaques with normotensive and hypertensive primary >,<open-angle glaucoma>
{ Diurnal intraocular <pressure>curves in healthy rhesus macaques Macaca mulatta and rhesus macaques with normotensive and hypertensive primary <open-angle glaucoma>}
{<pressure>,<curves in healthy rhesus macaques Macaca mulatta and rhesus macaques with normotensive and hypertensive primary >,<open-angle glaucoma>
{investigate the intra-ocular <pressure>IOP -lowering effects of a selective Rho kinase inhibitor ripasudil K-115 over 24 hr in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP -lowering effects of a selective Rho kinase inhibitor ripasudil K-115 over 24 hr in patients with primary >,<open-angle glaucoma>
{extract on intraocular <pressure>IOP in eyes with primary <open-angle glaucoma>}
{<pressure>,<IOP in eyes with primary >,<open-angle glaucoma>
{burns and intraocular <pressure>for patients with primary <open-angle glaucoma>}
{<pressure>,<for patients with primary >,<open-angle glaucoma>
{nepafenac on intraocular <pressure>IOP in primary <open-angle glaucoma>}
{<pressure>,<IOP in primary >,<open-angle glaucoma>
{in lowering intraocular <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{that control intraocular <pressure>IOP after trabeculotomy combined with phacoemulsification and intraocular lens implantation as an initial procedure in adults with primary <open-angle glaucoma>}
{<pressure>,<IOP after trabeculotomy combined with phacoemulsification and intraocular lens implantation as an initial procedure in adults with primary >,<open-angle glaucoma>
{decrease in intraocular <pressure>averaging over 20% lasting at least a year in 74% of the eyes with non-normotensive <open-angle glaucoma>}
{<pressure>,<averaging over 20% lasting at least a year in 74% of the eyes with non-normotensive >,<open-angle glaucoma>
{ Nocturnal blood <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{2% on intraocular <pressure>IOP and pulsatile ocular blood flow pOBF in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP and pulsatile ocular blood flow pOBF in patients with primary >,<open-angle glaucoma>
{2% on intraocular <pressure>and pulsatile ocular blood flow in patients with primary <open-angle glaucoma>}
{<pressure>,<and pulsatile ocular blood flow in patients with primary >,<open-angle glaucoma>
{of elevated intraocular <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{of elevated intraocular <pressure>IOP and to report the incidence of <open-angle glaucoma>}
{<pressure>,<IOP and to report the incidence of >,<open-angle glaucoma>
{of reducing intraocular <pressure>IOP in early previously untreated <open-angle glaucoma>}
{<pressure>,<IOP in early previously untreated >,<open-angle glaucoma>
{with elevated intraocular <pressure>due to impaired outflow of aqueous humor resulting from abnormalities within the drainage system of the anterior chamber angle <open-angle glaucoma>}
{<pressure>,<due to impaired outflow of aqueous humor resulting from abnormalities within the drainage system of the anterior chamber angle >,<open-angle glaucoma>
{perimetry elevated intraocular <pressure>21 mm Hg 59 patients with preperimetric <open-angle glaucoma>}
{<pressure>,<21 mm Hg 59 patients with preperimetric >,<open-angle glaucoma>
{the circadian intraocular <pressure>IOP reductions induced by latanoprost brimonidine tartrate and a fixed combination of timolol maleate and dorzolamide hydrochloride in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP reductions induced by latanoprost brimonidine tartrate and a fixed combination of timolol maleate and dorzolamide hydrochloride in patients with primary >,<open-angle glaucoma>
{prelamina after intraocular <pressure>reduction in patients with primary <open-angle glaucoma>}
{<pressure>,<reduction in patients with primary >,<open-angle glaucoma>
{atrophy elevated intraocular <pressure>no visual field defects in standard white-on-white perimetry 199 perimetric <open-angle glaucoma>}
{<pressure>,<no visual field defects in standard white-on-white perimetry 199 perimetric >,<open-angle glaucoma>
{extraction on intraocular <pressure>in patients with primary <open-angle glaucoma>}
{<pressure>,<in patients with primary >,<open-angle glaucoma>
{and ocular perfusion <pressure>in patients with primary <open-angle glaucoma>}
{<pressure>,<in patients with primary >,<open-angle glaucoma>
{ Trans-lamina cribrosa <pressure>difference and <open-angle glaucoma>}
{<pressure>,<difference and >,<open-angle glaucoma>
{elevation of intraocular <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{CSFP trans-lamina cribrosa <pressure>difference TLCPD and prevalence of <open-angle glaucoma>}
{<pressure>,<difference TLCPD and prevalence of >,<open-angle glaucoma>
{of diurnal intraocular <pressure>IOP patterns in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP patterns in patients with primary >,<open-angle glaucoma>
{24-hour diurnal intraocular <pressure>is lowered more by a small but statistically significant amount with TDFC compared with latanoprost in primary <open-angle glaucoma>}
{<pressure>,<is lowered more by a small but statistically significant amount with TDFC compared with latanoprost in primary >,<open-angle glaucoma>
{to reduce intraocular <pressure>in patients with primary <open-angle glaucoma>}
{<pressure>,<in patients with primary >,<open-angle glaucoma>
{difference in intraocular <pressure>between the sitting and supine positions was observed in the worse eye of patients with primary <open-angle glaucoma>}
{<pressure>,<between the sitting and supine positions was observed in the worse eye of patients with primary >,<open-angle glaucoma>
{the elevated intraocular <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{the elevated intraocular <pressure>IOP in primary <open-angle glaucoma>}
{<pressure>,<IOP in primary >,<open-angle glaucoma>
{drops on intraocular <pressure>IOP and pulsatile ocular blood flow pOBF in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP and pulsatile ocular blood flow pOBF in patients with primary >,<open-angle glaucoma>
{phacoemulsification on intraocular <pressure>IOP in patients with ocular hypertension and <open-angle glaucoma>}
{<pressure>,<IOP in patients with ocular hypertension and >,<open-angle glaucoma>
{the normal day-and-night <pressure>profile which was usually shown in normal eyes and eyes treated for other types of chronic <open-angle glaucoma>}
{<pressure>,<profile which was usually shown in normal eyes and eyes treated for other types of chronic >,<open-angle glaucoma>
{and systemic blood <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{combination on intraocular <pressure>and ocular blood flow in patients with primary <open-angle glaucoma>}
{<pressure>,<and ocular blood flow in patients with primary >,<open-angle glaucoma>
{travoprost-timolol on intraocular <pressure>IOP in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP in patients with primary >,<open-angle glaucoma>
{change in intraocular <pressure>IOP in Egyptian patients after selective laser trabeculoplasty SLT as a primary or adjunctive treatment for primary <open-angle glaucoma>}
{<pressure>,<IOP in Egyptian patients after selective laser trabeculoplasty SLT as a primary or adjunctive treatment for primary >,<open-angle glaucoma>
{position on intraocular <pressure>in patients with untreated <open-angle glaucoma>}
{<pressure>,<in patients with untreated >,<open-angle glaucoma>
{changes in intraocular <pressure>on the risk of primary <open-angle glaucoma>}
{<pressure>,<on the risk of primary >,<open-angle glaucoma>
{of systemic blood <pressure>with intraday variations in ocular perfusion pressure and intraocular pressure in patients with primary <open-angle glaucoma>}
{<pressure>,<with intraday variations in ocular perfusion pressure and intraocular pressure in patients with primary >,<open-angle glaucoma>
{that ocular perfusion <pressure>in patients with primary <open-angle glaucoma>}
{<pressure>,<in patients with primary >,<open-angle glaucoma>
{Lumigan on intraocular <pressure>and retrobulbar blood flow in patients with primary <open-angle glaucoma>}
{<pressure>,<and retrobulbar blood flow in patients with primary >,<open-angle glaucoma>
{the diurnal intraocular <pressure>IOP curve and retrobulbar haemodynamics in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP curve and retrobulbar haemodynamics in patients with primary >,<open-angle glaucoma>
{that lowering intraocular <pressure>IOP does reduce progression of primary <open-angle glaucoma>}
{<pressure>,<IOP does reduce progression of primary >,<open-angle glaucoma>
{changes in intraocular <pressure>are associated with asymmetrical retinal nerve fiber thinning in treated patients with primary <open-angle glaucoma>}
{<pressure>,<are associated with asymmetrical retinal nerve fiber thinning in treated patients with primary >,<open-angle glaucoma>
{variability of intraocular <pressure>is an independent risk of primary <open-angle glaucoma>}
{<pressure>,<is an independent risk of primary >,<open-angle glaucoma>
{the diurnal intraocular <pressure>IOP curve and retinal and retrobulbar hemodynamics in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP curve and retinal and retrobulbar hemodynamics in patients with primary >,<open-angle glaucoma>
{the diurnal intraocular <pressure>variability over 24 hours in primary <open-angle glaucoma>}
{<pressure>,<variability over 24 hours in primary >,<open-angle glaucoma>
{spray on intraocular <pressure>IOP in patients with ocular hypertension or controlled primary <open-angle glaucoma>}
{<pressure>,<IOP in patients with ocular hypertension or controlled primary >,<open-angle glaucoma>
{ Peak intraocular <pressure>and glaucomatous progression in primary <open-angle glaucoma>}
{<pressure>,<and glaucomatous progression in primary >,<open-angle glaucoma>
{24-h peak intraocular <pressure>IOP on the progression of primary <open-angle glaucoma>}
{<pressure>,<IOP on the progression of primary >,<open-angle glaucoma>
{increase in intraocular <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{increase in intraocular <pressure>and <open-angle glaucoma>}
{<pressure>,<and >,<open-angle glaucoma>
{between ocular perfusion <pressure>and <open-angle glaucoma>}
{<pressure>,<and >,<open-angle glaucoma>
{ Elevated intraocular <pressure>IOP causes glaucomatous optic nerve damage especially in the primary <open-angle glaucoma>}
{<pressure>,<IOP causes glaucomatous optic nerve damage especially in the primary >,<open-angle glaucoma>
{comparing ocular perfusion <pressure>OPP diastolic ocular perfusion pressure dOPP and retrobulbar haemodynamics in pseudoexfoliative glaucoma and primary <open-angle glaucoma>}
{<pressure>,<OPP diastolic ocular perfusion pressure dOPP and retrobulbar haemodynamics in pseudoexfoliative glaucoma and primary >,<open-angle glaucoma>
{variation in intraocular <pressure>IOP in primary <open-angle glaucoma>}
{<pressure>,<IOP in primary >,<open-angle glaucoma>
{combination on intraocular <pressure>IOP and retinal and optic nerve head haemodynamics in primary <open-angle glaucoma>}
{<pressure>,<IOP and retinal and optic nerve head haemodynamics in primary >,<open-angle glaucoma>
{favourable postoperative intraocular <pressure>IOP after cataract surgery in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP after cataract surgery in patients with primary >,<open-angle glaucoma>
{for elevated intraocular <pressure>IOP associated with <open-angle glaucoma>}
{<pressure>,<IOP associated with >,<open-angle glaucoma>
{of reduced intraocular <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{of systemic blood <pressure>and submacular choroidal blood flow in eyes of patients with primary <open-angle glaucoma>}
{<pressure>,<and submacular choroidal blood flow in eyes of patients with primary >,<open-angle glaucoma>
{difference in intraocular <pressure>measured by DCT and GAT was compared with the interocular CCT difference in 125 patients with primary <open-angle glaucoma>}
{<pressure>,<measured by DCT and GAT was compared with the interocular CCT difference in 125 patients with primary >,<open-angle glaucoma>
{Blood pressure perfusion <pressure>and <open-angle glaucoma>}
{<pressure>,<and >,<open-angle glaucoma>
{of baseline intraocular <pressure>b-IOP as a risk factor for incident <open-angle glaucoma>}
{<pressure>,<b-IOP as a risk factor for incident >,<open-angle glaucoma>
{evaluate circadian intraocular <pressure>IOP profiles in eyes with different types of chronic <open-angle glaucoma>}
{<pressure>,<IOP profiles in eyes with different types of chronic >,<open-angle glaucoma>
{Twenty-four-hour ocular perfusion <pressure>in primary <open-angle glaucoma>}
{<pressure>,<in primary >,<open-angle glaucoma>
{among systemic blood <pressure>intraocular pressure and <open-angle glaucoma>}
{<pressure>,<intraocular pressure and >,<open-angle glaucoma>
{and ocular perfusion <pressure>were significantly associated with the prevalence of <open-angle glaucoma>}
{<pressure>,<were significantly associated with the prevalence of >,<open-angle glaucoma>
{between ocular perfusion <pressure>and <open-angle glaucoma>}
{<pressure>,<and >,<open-angle glaucoma>
{change in intraocular <pressure>IOP levels in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP levels in patients with primary >,<open-angle glaucoma>
{Changes in intraocular <pressure>following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary <open-angle glaucoma>}
{<pressure>,<following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary >,<open-angle glaucoma>
{5% on intraocular <pressure>retrobulbar blood flow and the progression of visual field damage in patients with primary <open-angle glaucoma>}
{<pressure>,<retrobulbar blood flow and the progression of visual field damage in patients with primary >,<open-angle glaucoma>
{decrease in intraocular <pressure>IOP in primary <open-angle glaucoma>}
{<pressure>,<IOP in primary >,<open-angle glaucoma>
{elevated episcleral venous <pressure>and <open-angle glaucoma>}
{<pressure>,<and >,<open-angle glaucoma>
{BID on intraocular <pressure>IOP retrobulbar blood flow and the progression of visual field damage in patients with primary <open-angle glaucoma>}
{<pressure>,<IOP retrobulbar blood flow and the progression of visual field damage in patients with primary >,<open-angle glaucoma>
{pattern of intraocular <pressure>with optic disc appearance in primary <open-angle glaucoma>}
{<pressure>,<with optic disc appearance in primary >,<open-angle glaucoma>
{pattern of intraocular <pressure>IOP with optic disc appearance in primary <open-angle glaucoma>}
{<pressure>,<IOP with optic disc appearance in primary >,<open-angle glaucoma>
growth retardation pulmonary fibrosis,biliary cirrhosis
{   <growth retardation pulmonary fibrosis>and <biliary cirrhosis>}
{<growth retardation pulmonary fibrosis>,<and >,<biliary cirrhosis>
raised intraocular pressure,glaucoma
{the management of <raised intraocular pressure>and <glaucoma>}
{<raised intraocular pressure>,<and >,<glaucoma>
Crohn's disease,ulcerative colitis
{   <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{   <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{manifestations for both <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{gastrointestinal diseases including <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{immunological responses affecting <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{IBD which includes <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{two major entities <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{colonic lesions in <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{The prevalence of <Crohn's disease>79/10 5 <ulcerative colitis>}
{<Crohn's disease>,<79/10 5 >,<ulcerative colitis>
{   <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{reliable in differentiating <Crohn's disease>from <ulcerative colitis>}
{<Crohn's disease>,<from >,<ulcerative colitis>
{surgical treatment in <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{be observed between <Crohn's disease>and <ulcerative colitis>}
{<Crohn's disease>,<and >,<ulcerative colitis>
{The prevalence of <Crohn's disease>was comparable to that reported from various centres in Britain but <ulcerative colitis>}
{<Crohn's disease>,<was comparable to that reported from various centres in Britain but >,<ulcerative colitis>
pressure,secondary glaucoma
{to elevated intraocular <pressure>and <secondary glaucoma>}
{<pressure>,<and >,<secondary glaucoma>
{treatment of intraocular <pressure>elevation and <secondary glaucoma>}
{<pressure>,<elevation and >,<secondary glaucoma>
{surgery on intraocular <pressure>after filtering operation due to primary open angle glaucoma and <secondary glaucoma>}
{<pressure>,<after filtering operation due to primary open angle glaucoma and >,<secondary glaucoma>
diabetic retinopathy cataracts,glaucoma
{  AMD <diabetic retinopathy cataracts>and <glaucoma>}
{<diabetic retinopathy cataracts>,<and >,<glaucoma>
pressure,pressure
{IOP systemic blood <pressure>and heart rate were measured and ocular perfusion <pressure>}
{<pressure>,<and heart rate were measured and ocular perfusion >,<pressure>
{ Circadian intraocular <pressure>management with latanoprost diurnal and nocturnal intraocular <pressure>}
{<pressure>,<management with latanoprost diurnal and nocturnal intraocular >,<pressure>
{the postoperative intraocular <pressure>was the same or higher than the preoperative level or reductions of intraocular <pressure>}
{<pressure>,<was the same or higher than the preoperative level or reductions of intraocular >,<pressure>
{and diastolic blood <pressure>heart rate and ocular perfusion <pressure>}
{<pressure>,<heart rate and ocular perfusion >,<pressure>
{rate systolic blood <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{24-hour ambulatory blood <pressure>and diurnal curve of intra-ocular <pressure>}
{<pressure>,<and diurnal curve of intra-ocular >,<pressure>
{drop in blood <pressure>as well as heart rate during sleep and a significantly greater drop in mean diastolic blood <pressure>}
{<pressure>,<as well as heart rate during sleep and a significantly greater drop in mean diastolic blood >,<pressure>
{nighttime systolic blood <pressure>measurements as well as nighttime diastolic blood <pressure>}
{<pressure>,<measurements as well as nighttime diastolic blood >,<pressure>
{test systolic blood <pressure>disc hemorrhage corrected pattern standard deviation mean deviation and fluctuation of intraocular <pressure>}
{<pressure>,<disc hemorrhage corrected pattern standard deviation mean deviation and fluctuation of intraocular >,<pressure>
{Hourly average blood <pressure>data analyses showed overall a drop in blood <pressure>}
{<pressure>,<data analyses showed overall a drop in blood >,<pressure>
{ A piezoresistive <pressure>sensor was used to measure the <pressure>}
{<pressure>,<sensor was used to measure the >,<pressure>
{Changes in intraocular <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{intraocular pressures the <pressure>is involved in its pathogenesis and that <pressure>}
{<pressure>,<is involved in its pathogenesis and that >,<pressure>
{that govern the <pressure>and circumferential flow in Schlemm's canal are established based on the linear relationships between <pressure>}
{<pressure>,<and circumferential flow in Schlemm's canal are established based on the linear relationships between >,<pressure>
{ in intraocular <pressure>were recently identified as a risk factor for visual field loss in addition to intraocular <pressure>}
{<pressure>,<were recently identified as a risk factor for visual field loss in addition to intraocular >,<pressure>
{increased in the <pressure>range of 5 to 20 mm Hg for the three HA preparations and the flow rates declined in the <pressure>}
{<pressure>,<range of 5 to 20 mm Hg for the three HA preparations and the flow rates declined in the >,<pressure>
{the desired intraocular <pressure>in glaucoma patients in the future CCT measurements should be considered along with intraocular <pressure>}
{<pressure>,<in glaucoma patients in the future CCT measurements should be considered along with intraocular >,<pressure>
{and ocular perfusion <pressure>OPP as well as the 24-hour ambulatory blood <pressure>}
{<pressure>,<OPP as well as the 24-hour ambulatory blood >,<pressure>
{included preoperative intraocular <pressure>early at 2 months and late at 18 months postoperative intraocular <pressure>}
{<pressure>,<early at 2 months and late at 18 months postoperative intraocular >,<pressure>
{the daily intraocular <pressure>curve the ambulatory intraocular <pressure>}
{<pressure>,<curve the ambulatory intraocular >,<pressure>
{fluctuation of the <pressure>seen in the daily intraocular <pressure>}
{<pressure>,<seen in the daily intraocular >,<pressure>
{of target intraocular <pressure>depends on the pretreatment level of intraocular <pressure>}
{<pressure>,<depends on the pretreatment level of intraocular >,<pressure>
{ Target intraocular <pressure>is the level of intraocular <pressure>}
{<pressure>,<is the level of intraocular >,<pressure>
{ Single intraocular <pressure>measurements and diurnal intraocular <pressure>}
{<pressure>,<measurements and diurnal intraocular >,<pressure>
{005% on intraocular <pressure>IOP blood pressure BP and diastolic ocular perfusion pressure DOPP calculated as the difference between the diastolic blood <pressure>}
{<pressure>,<IOP blood pressure BP and diastolic ocular perfusion pressure DOPP calculated as the difference between the diastolic blood >,<pressure>
{the ambulatory intraocular <pressure>curve with the water-drinking test and the fluctuation of the <pressure>}
{<pressure>,<curve with the water-drinking test and the fluctuation of the >,<pressure>
{IOP systemic blood <pressure>BP mean ocular perfusion <pressure>}
{<pressure>,<BP mean ocular perfusion >,<pressure>
{ITA on intraocular <pressure>IOP following intravitreal injection and in those patients who experience post-injection elevation of IOP to determine the time course effect of multiple injections and risk factors for the <pressure>}
{<pressure>,<IOP following intravitreal injection and in those patients who experience post-injection elevation of IOP to determine the time course effect of multiple injections and risk factors for the >,<pressure>
{lower postoperative intraocular <pressure>although results showed no statistically significant difference between groups regarding postoperative intraocular <pressure>}
{<pressure>,<although results showed no statistically significant difference between groups regarding postoperative intraocular >,<pressure>
{and diastolic blood <pressure>at baseline as well as with increases in blood <pressure>}
{<pressure>,<at baseline as well as with increases in blood >,<pressure>
{fluctuation of intraocular <pressure>obtained in the association of the ambulatory intraocular <pressure>}
{<pressure>,<obtained in the association of the ambulatory intraocular >,<pressure>
{the daily intraocular <pressure>curve was the ambulatory intraocular <pressure>}
{<pressure>,<curve was the ambulatory intraocular >,<pressure>
{the daily intraocular <pressure>curve and the <pressure>}
{<pressure>,<curve and the >,<pressure>
{observed between the <pressure>peaks collected from the daily intraocular <pressure>}
{<pressure>,<peaks collected from the daily intraocular >,<pressure>
{correlation between the <pressure>peaks and the peaks of the daily intraocular <pressure>}
{<pressure>,<peaks and the peaks of the daily intraocular >,<pressure>
{PPP performing intraocular <pressure>measurements disc evaluations and imaging and visual field tests on 90% of OAG patients but carrying out gonioscopy central corneal thickness measurement and setting of target intraocular <pressure>}
{<pressure>,<measurements disc evaluations and imaging and visual field tests on 90% of OAG patients but carrying out gonioscopy central corneal thickness measurement and setting of target intraocular >,<pressure>
{curve and the <pressure>peaks seen in the ambulatory intraocular pressure curve on the water-drinking test as well as in the association of the ambulatory intraocular <pressure>}
{<pressure>,<peaks seen in the ambulatory intraocular pressure curve on the water-drinking test as well as in the association of the ambulatory intraocular >,<pressure>
{weight diastolic blood <pressure>systolic blood <pressure>}
{<pressure>,<systolic blood >,<pressure>
{effects on intraocular <pressure>IOP and ocular perfusion <pressure>}
{<pressure>,<IOP and ocular perfusion >,<pressure>
{mean arterial blood <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{fluctuation of intraocular <pressure>seen in the association of the ambulatory intraocular <pressure>}
{<pressure>,<seen in the association of the ambulatory intraocular >,<pressure>
{between diurnal intraocular <pressure>curve and the association of ambulatory intraocular <pressure>}
{<pressure>,<curve and the association of ambulatory intraocular >,<pressure>
{mean arterial blood <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{HR systolic blood <pressure>SBP and diastolic blood <pressure>}
{<pressure>,<SBP and diastolic blood >,<pressure>
{differences in intraocular <pressure>mean arterial <pressure>}
{<pressure>,<mean arterial >,<pressure>
{elevated retro-lamina cribrosa <pressure>compensated for an increased intraocular <pressure>}
{<pressure>,<compensated for an increased intraocular >,<pressure>
{is that the <pressure>transmitted via the vitreous is higher at the periphery because it is transmitted across a shorter distance since the vitreous acts as a buffer that absorbs part of the <pressure>}
{<pressure>,<transmitted via the vitreous is higher at the periphery because it is transmitted across a shorter distance since the vitreous acts as a buffer that absorbs part of the >,<pressure>
{the diurnal intraocular <pressure>profile pre and post trabeculectomy using 24-hour monitoring of intraocular <pressure>}
{<pressure>,<profile pre and post trabeculectomy using 24-hour monitoring of intraocular >,<pressure>
{elevated retro-lamina cribrosa <pressure>may have led to a normal trans-laminar <pressure>}
{<pressure>,<may have led to a normal trans-laminar >,<pressure>
{ Systemic blood <pressure>BP and ocular perfusion <pressure>}
{<pressure>,<BP and ocular perfusion >,<pressure>
{consumption on intraocular <pressure>IOP ocular perfusion <pressure>}
{<pressure>,<IOP ocular perfusion >,<pressure>
{consumption on intraocular <pressure>ocular perfusion <pressure>}
{<pressure>,<ocular perfusion >,<pressure>
{required to document <pressure>exposure in these eyes and understand the <pressure>}
{<pressure>,<exposure in these eyes and understand the >,<pressure>
{in preoperative intraocular <pressure>without antiglaucoma medications and failed blebs group 2 32 patients 33 eyes as a less than one-third reduction in preoperative intraocular <pressure>}
{<pressure>,<without antiglaucoma medications and failed blebs group 2 32 patients 33 eyes as a less than one-third reduction in preoperative intraocular >,<pressure>
{fluctuations of intraocular <pressure>IOP and systemic blood <pressure>}
{<pressure>,<IOP and systemic blood >,<pressure>
{optic nerve tissue <pressure>and not the atmospheric <pressure>}
{<pressure>,<and not the atmospheric >,<pressure>
{baseline/mean treated intraocular <pressure>and systemic factors including systolic or diastolic blood pressure/perfusion <pressure>}
{<pressure>,<and systemic factors including systolic or diastolic blood pressure/perfusion >,<pressure>
{elevated trans-lamina cribrosa <pressure>difference and a steeper trans-lamina cribrosa <pressure>}
{<pressure>,<difference and a steeper trans-lamina cribrosa >,<pressure>
{ mean blood <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{not the atmospheric <pressure>form the retro-laminar counter-pressure against the IOP and are thus part of the trans-lamina cribrosa <pressure>}
{<pressure>,<form the retro-laminar counter-pressure against the IOP and are thus part of the trans-lamina cribrosa >,<pressure>
{ diastolic blood <pressure>mean blood <pressure>}
{<pressure>,<mean blood >,<pressure>
{whether nocturnal blood <pressure>or blood pressure dip during ambulatory blood <pressure>}
{<pressure>,<or blood pressure dip during ambulatory blood >,<pressure>
{daytime mean arterial <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{blood pressure blood <pressure>amplitude mean ocular perfusion <pressure>}
{<pressure>,<amplitude mean ocular perfusion >,<pressure>
{TZ on intraocular <pressure>IOP and ocular perfusion <pressure>}
{<pressure>,<IOP and ocular perfusion >,<pressure>
{blood pressure intraocular <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{age sex intraocular <pressure>and systemic blood <pressure>}
{<pressure>,<and systemic blood >,<pressure>
{nighttime mean arterial <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{daytime mean arterial <pressure>or ocular perfusion <pressure>}
{<pressure>,<or ocular perfusion >,<pressure>
{nighttime mean arterial <pressure>or ocular perfusion <pressure>}
{<pressure>,<or ocular perfusion >,<pressure>
{short-term mean arterial <pressure>and/or ocular perfusion <pressure>}
{<pressure>,<and/or ocular perfusion >,<pressure>
{nocturnal diastolic blood <pressure>values a low mean ocular perfusion <pressure>}
{<pressure>,<values a low mean ocular perfusion >,<pressure>
{nighttime mean arterial <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{short-term mean arterial <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{DTFC on intraocular <pressure>IOP heart rate HR blood pressure BP ocular perfusion <pressure>}
{<pressure>,<IOP heart rate HR blood pressure BP ocular perfusion >,<pressure>
{of diurnal intraocular <pressure>IOP and ocular perfusion <pressure>}
{<pressure>,<IOP and ocular perfusion >,<pressure>
{alterations in intraocular <pressure>IOP blood pressure BP and ocular perfusion <pressure>}
{<pressure>,<IOP blood pressure BP and ocular perfusion >,<pressure>
{influence on intraocular <pressure>as well as arterial blood <pressure>}
{<pressure>,<as well as arterial blood >,<pressure>
{that lowering intracranial <pressure>is more important than decreasing blood pressure for those patients with a high intracranial <pressure>}
{<pressure>,<is more important than decreasing blood pressure for those patients with a high intracranial >,<pressure>
{Gastric intramucosal CO <pressure>pCO 2 i was measured under standardized flow and intraperitoneal pressure using continuous air tonometry TONOCAP Â® Datex Ohmeda and Î”pCO 2 pCO 2 i - end-expiratory CO 2 <pressure>}
{<pressure>,<pCO 2 i was measured under standardized flow and intraperitoneal pressure using continuous air tonometry TONOCAP Â® Datex Ohmeda and Î”pCO 2 pCO 2 i - end-expiratory CO 2 >,<pressure>
{ INTERPRETATION Blood <pressure>lowering significantly reduces vascular risk across various baseline blood <pressure>}
{<pressure>,<lowering significantly reduces vascular risk across various baseline blood >,<pressure>
{and diastolic arterial <pressure>mean arterial <pressure>}
{<pressure>,<mean arterial >,<pressure>
{with different blood <pressure>targets or different blood <pressure>}
{<pressure>,<targets or different blood >,<pressure>
{ In blood <pressure>research American Heart Association AHA /American College of Cardiology ACC 2015 guidelines recommended a target for blood <pressure>}
{<pressure>,<research American Heart Association AHA /American College of Cardiology ACC 2015 guidelines recommended a target for blood >,<pressure>
{Increased systolic blood <pressure>and decreased diastolic blood <pressure>}
{<pressure>,<and decreased diastolic blood >,<pressure>
{ Systolic blood <pressure>between 130 and 139 mmHg and diastolic blood <pressure>}
{<pressure>,<between 130 and 139 mmHg and diastolic blood >,<pressure>
{level of blood <pressure>control proved to protect kidney function against the potential effects that aggressive blood <pressure>}
{<pressure>,<control proved to protect kidney function against the potential effects that aggressive blood >,<pressure>
{of systemic blood <pressure>they maintain a constant perfusion <pressure>}
{<pressure>,<they maintain a constant perfusion >,<pressure>
{reductions in intraglomerular <pressure>systemic blood <pressure>}
{<pressure>,<systemic blood >,<pressure>
{Although elevated intraocular <pressure>may also result from systemic therapy the relationship between the <pressure>}
{<pressure>,<may also result from systemic therapy the relationship between the >,<pressure>
{to reduce intraglomerular <pressure>systemic blood <pressure>}
{<pressure>,<systemic blood >,<pressure>
{ Episcleral venous <pressure>was elevated on the affected side and histopathologic analysis of the conjunctival tissue confirmed perivascular amyloid deposits further suggesting raised episcleral venous <pressure>}
{<pressure>,<was elevated on the affected side and histopathologic analysis of the conjunctival tissue confirmed perivascular amyloid deposits further suggesting raised episcleral venous >,<pressure>
{effectively reduce intraocular <pressure>and number of glaucoma medications needed to achieve target intraocular <pressure>}
{<pressure>,<and number of glaucoma medications needed to achieve target intraocular >,<pressure>
{chronically elevated intraocular <pressure>IOP and the prophylactic treatment of acute <pressure>}
{<pressure>,<IOP and the prophylactic treatment of acute >,<pressure>
{Although monitoring intraocular <pressure>values should not be the only consideration in glaucoma management undetected rises in <pressure>}
{<pressure>,<values should not be the only consideration in glaucoma management undetected rises in >,<pressure>
{of elevated intraocular <pressure>and conversely elevated intraocular <pressure>}
{<pressure>,<and conversely elevated intraocular >,<pressure>
{The high postoperative <pressure>outcomes suggest that single plate Molteno implantation is not an ideal way of achieving low target <pressure>}
{<pressure>,<outcomes suggest that single plate Molteno implantation is not an ideal way of achieving low target >,<pressure>
{ Elevated intraocular <pressure>is believed to play a role yet some people with normal <pressure>}
{<pressure>,<is believed to play a role yet some people with normal >,<pressure>
{compared with high <pressure>suggests a lower orbital CSF-P in patients with POAG with normal <pressure>}
{<pressure>,<suggests a lower orbital CSF-P in patients with POAG with normal >,<pressure>
{had an intraocular <pressure>less than or equal to 19 mm Hg and 19 of these 20 successfully treated eyes 95% had an intraocular <pressure>}
{<pressure>,<less than or equal to 19 mm Hg and 19 of these 20 successfully treated eyes 95% had an intraocular >,<pressure>
{establish a target <pressure>based on extent of visual damage threat to visual performance risk profile for further damage pre-treatment <pressure>}
{<pressure>,<based on extent of visual damage threat to visual performance risk profile for further damage pre-treatment >,<pressure>
{ The 'carry-over <pressure>reduction of an ordinary four times a day drop medication was significantly less effective in controlling the morning intraocular <pressure>}
{<pressure>,<reduction of an ordinary four times a day drop medication was significantly less effective in controlling the morning intraocular >,<pressure>
{Measurements of intra-ocular <pressure>and visual acuity provide insufficient guidance whereas periodic photography of the nerve fibre layer yields early diagnostic information and an indication of the appropriate individual level of intra-ocular <pressure>}
{<pressure>,<and visual acuity provide insufficient guidance whereas periodic photography of the nerve fibre layer yields early diagnostic information and an indication of the appropriate individual level of intra-ocular >,<pressure>
{changes in intraocular <pressure>have little effect on the <pressure>}
{<pressure>,<have little effect on the >,<pressure>
{baseline low intraocular <pressure>during therapy after elevation of intraocular <pressure>}
{<pressure>,<during therapy after elevation of intraocular >,<pressure>
{ In high <pressure>advanced glaucoma a low target intraocular <pressure>}
{<pressure>,<advanced glaucoma a low target intraocular >,<pressure>
{higher preoperative intraocular <pressure>had a greater <pressure>}
{<pressure>,<had a greater >,<pressure>
{construct diurnal intraocular <pressure>curves to evaluate the type of pressure and to determine the diurnal fluctuations or respectively the time of the <pressure>}
{<pressure>,<curves to evaluate the type of pressure and to determine the diurnal fluctuations or respectively the time of the >,<pressure>
{anti-VEGF chronic intraocular <pressure>elevation in anti-VEGF high IOP with anti-VEGF acute elevation in intraocular <pressure>}
{<pressure>,<elevation in anti-VEGF high IOP with anti-VEGF acute elevation in intraocular >,<pressure>
{evidence on blood <pressure>targets for patients with hypertension and diabetes and continue to recommend a blood <pressure>}
{<pressure>,<targets for patients with hypertension and diabetes and continue to recommend a blood >,<pressure>
{intraocular pressure blood <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{the mean intraocular <pressure>measured 54% of the pre-laser <pressure>}
{<pressure>,<measured 54% of the pre-laser >,<pressure>
{ Systemic blood <pressure>pulse rates intraocular <pressure>}
{<pressure>,<pulse rates intraocular >,<pressure>
{magnitude of postlaser <pressure>increase were the same in both groups when taking into consideration the <pressure>}
{<pressure>,<increase were the same in both groups when taking into consideration the >,<pressure>
{The inner eye <pressure>also called intraocular <pressure>}
{<pressure>,<also called intraocular >,<pressure>
{intraocular pressure blood <pressure>ocular perfusion <pressure>}
{<pressure>,<ocular perfusion >,<pressure>
{the mean arterial <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{at high intraocular <pressure>and above the center at low intraocular <pressure>}
{<pressure>,<and above the center at low intraocular >,<pressure>
{ Systemic blood <pressure>and intraocular pressure were measured to determine the mean arterial <pressure>}
{<pressure>,<and intraocular pressure were measured to determine the mean arterial >,<pressure>
{significantly with intraocular <pressure>the deepest point tended to be located below the center of the optic disc at high intraocular <pressure>}
{<pressure>,<the deepest point tended to be located below the center of the optic disc at high intraocular >,<pressure>
{The monocular trial <pressure>change was defined as the IOP change in the treated eye between the visit immediately before and immediately after the medication addition corrected by subtracting the <pressure>}
{<pressure>,<change was defined as the IOP change in the treated eye between the visit immediately before and immediately after the medication addition corrected by subtracting the >,<pressure>
{with mean intraocular <pressure>less than 17 mm Hg remained stable and approximately half of the eyes with mean intraocular <pressure>}
{<pressure>,<less than 17 mm Hg remained stable and approximately half of the eyes with mean intraocular >,<pressure>
{for mean arterial <pressure>or ocular perfusion <pressure>}
{<pressure>,<or ocular perfusion >,<pressure>
{facility at normal <pressure>but decreases it at elevated <pressure>}
{<pressure>,<but decreases it at elevated >,<pressure>
{adequacy of blood <pressure>control need to be reassessed because clinic blood <pressure>}
{<pressure>,<control need to be reassessed because clinic blood >,<pressure>
{and high intraocular <pressure>may undergo combined trabeculectomy and phacoemulsification and achieve long-term postoperative intraocular control similar to those patients who have trabeculectomy only or a combined procedure and controlled preoperative <pressure>}
{<pressure>,<may undergo combined trabeculectomy and phacoemulsification and achieve long-term postoperative intraocular control similar to those patients who have trabeculectomy only or a combined procedure and controlled preoperative >,<pressure>
{ Elevated blood <pressure>during sleep is the major criterion for the diagnoses of hypertension and inadequate therapeutic ambulatory blood <pressure>}
{<pressure>,<during sleep is the major criterion for the diagnoses of hypertension and inadequate therapeutic ambulatory blood >,<pressure>
{and nocturnal blood <pressure>elevations and maximum systolic blood <pressure>}
{<pressure>,<elevations and maximum systolic blood >,<pressure>
{ Lower perfusion <pressure>blood pressure-intraocular <pressure>}
{<pressure>,<blood pressure-intraocular >,<pressure>
{is total blood <pressure>burden and reliance on isolated clinic blood <pressure>}
{<pressure>,<burden and reliance on isolated clinic blood >,<pressure>
{visual fields intraocular <pressure>ocular perfusion <pressure>}
{<pressure>,<ocular perfusion >,<pressure>
{by increased intraocular <pressure>from those that may be <pressure>}
{<pressure>,<from those that may be >,<pressure>
{pressure is the <pressure>at which <pressure>}
{<pressure>,<at which >,<pressure>
{control of blood <pressure>inhibition of the renin-angiotensin system to reduce blood <pressure>}
{<pressure>,<inhibition of the renin-angiotensin system to reduce blood >,<pressure>
{as systolic blood <pressure>from 120 to 139 mmHg or diastolic blood <pressure>}
{<pressure>,<from 120 to 139 mmHg or diastolic blood >,<pressure>
{or mean arterial <pressure>130 mm Hg and lower blood <pressure>}
{<pressure>,<130 mm Hg and lower blood >,<pressure>
{monotherapy on intraocular <pressure>IOP and ocular perfusion <pressure>}
{<pressure>,<IOP and ocular perfusion >,<pressure>
{the preoperative intraocular <pressure>levels are the less likely that the postoperative intraocular <pressure>}
{<pressure>,<levels are the less likely that the postoperative intraocular >,<pressure>
{monotherapy on intraocular <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{Program G1 intraocular <pressure>measurement funduscopy as well as pulse and arterial blood <pressure>}
{<pressure>,<measurement funduscopy as well as pulse and arterial blood >,<pressure>
{which casual blood <pressure>is normal but ambulatory blood <pressure>}
{<pressure>,<is normal but ambulatory blood >,<pressure>
{POAG with normal <pressure>compared with high <pressure>}
{<pressure>,<compared with high >,<pressure>
{measuring central blood <pressure>in patients with CKD and whether it could provide incremental prognostic value beyond that of peripheral blood <pressure>}
{<pressure>,<in patients with CKD and whether it could provide incremental prognostic value beyond that of peripheral blood >,<pressure>
{patients had normal <pressure>intraocular pressure IOP 21 mmHg and 18 patients had high <pressure>}
{<pressure>,<intraocular pressure IOP 21 mmHg and 18 patients had high >,<pressure>
{easier postoperative intraocular <pressure>control intraocular <pressure>}
{<pressure>,<control intraocular >,<pressure>
{of low intraocular <pressure>with no infusion foot pedal position 0 to maximum irrigation foot pedal position 2 creating a maximal <pressure>}
{<pressure>,<with no infusion foot pedal position 0 to maximum irrigation foot pedal position 2 creating a maximal >,<pressure>
{1 month and <pressure>increase peak pressure prelaser <pressure>}
{<pressure>,<increase peak pressure prelaser >,<pressure>
{of ocular perfusion <pressure>status may be more relevant to glaucoma pathogenesis than ocular perfusion <pressure>}
{<pressure>,<status may be more relevant to glaucoma pathogenesis than ocular perfusion >,<pressure>
{ All nocturnal <pressure>parameters except pulse pressure were lower in the 37 patients with progressive field defects compared with the 15 patients whose <pressure>}
{<pressure>,<parameters except pulse pressure were lower in the 37 patients with progressive field defects compared with the 15 patients whose >,<pressure>
{12am ocular perfusion <pressure>and simultaneously systolic and diastolic blood <pressure>}
{<pressure>,<and simultaneously systolic and diastolic blood >,<pressure>
{postlaser or the <pressure>decrease or <pressure>}
{<pressure>,<decrease or >,<pressure>
{ Ocular perfusion <pressure>OPP was automatically calculated from self-measurements of intraocular pressure IOP systolic SBP and diastolic blood <pressure>}
{<pressure>,<OPP was automatically calculated from self-measurements of intraocular pressure IOP systolic SBP and diastolic blood >,<pressure>
{peak pressure prelaser <pressure>prelaser visual field indices the use of timolol postlaser or the <pressure>}
{<pressure>,<prelaser visual field indices the use of timolol postlaser or the >,<pressure>
{manoeuver influences intra-ocular <pressure>IOP cerebrospinal fluid pressure CSF-P and by a change in the trans-laminar cribrosa <pressure>}
{<pressure>,<IOP cerebrospinal fluid pressure CSF-P and by a change in the trans-laminar cribrosa >,<pressure>
{tracer after intraocular <pressure>reduced to 7 mmHg while in the two-color control group n = 6 eyes were perfused with green tracer with intraocular <pressure>}
{<pressure>,<reduced to 7 mmHg while in the two-color control group n = 6 eyes were perfused with green tracer with intraocular >,<pressure>
{  applanation <pressure>cup-disc ratio and <pressure>}
{<pressure>,<cup-disc ratio and >,<pressure>
{low systemic blood <pressure>particularly at night could physiologically be associated with a low cerebrospinal fluid pressure which leads to an abnormally high trans-lamina cribrosa <pressure>}
{<pressure>,<particularly at night could physiologically be associated with a low cerebrospinal fluid pressure which leads to an abnormally high trans-lamina cribrosa >,<pressure>
{the mean intraocular <pressure>and the maximum <pressure>}
{<pressure>,<and the maximum >,<pressure>
{where mean arterial <pressure>MAP = DBP + 1/3 SBP - DBP systolic perfusion <pressure>}
{<pressure>,<MAP = DBP + 1/3 SBP - DBP systolic perfusion >,<pressure>
{indicate about equal <pressure>reducing properties in both high and low pre-treatment <pressure>}
{<pressure>,<reducing properties in both high and low pre-treatment >,<pressure>
{2/3 mean arterial <pressure>- IOP where mean arterial <pressure>}
{<pressure>,<- IOP where mean arterial >,<pressure>
{The relative intraocular <pressure>decrease at the beginning of the study was 47% of the untreated <pressure>}
{<pressure>,<decrease at the beginning of the study was 47% of the untreated >,<pressure>
{the trans-lamina cribrosa <pressure>difference and not the trans-corneal <pressure>}
{<pressure>,<difference and not the trans-corneal >,<pressure>
{ Episcleral venous <pressure>measured on six unilateral cases showed increased <pressure>}
{<pressure>,<measured on six unilateral cases showed increased >,<pressure>
{elevation in intraocular <pressure>with subsequent worsening of the field and/or disc the immediate rise in intraocular <pressure>}
{<pressure>,<with subsequent worsening of the field and/or disc the immediate rise in intraocular >,<pressure>
{analysis systolic blood <pressure>diastolic blood <pressure>}
{<pressure>,<diastolic blood >,<pressure>
{history of blood <pressure>and treatment of blood <pressure>}
{<pressure>,<and treatment of blood >,<pressure>
{ratios systolic blood <pressure>and diastolic blood <pressure>}
{<pressure>,<and diastolic blood >,<pressure>
{DBP systolic perfusion <pressure>SPP = SBP - IOP and diastolic perfusion <pressure>}
{<pressure>,<SPP = SBP - IOP and diastolic perfusion >,<pressure>
{statistically significant lower <pressure>in the morning after the Ocusert unit especially in glaucomatous eyes with high pre-treatment <pressure>}
{<pressure>,<in the morning after the Ocusert unit especially in glaucomatous eyes with high pre-treatment >,<pressure>
{high trans-lamina cribrosa <pressure>difference whether the result of elevated intraocular <pressure>}
{<pressure>,<difference whether the result of elevated intraocular >,<pressure>
{001 and the <pressure>decrease induced by propranolol treatment tended to be proportional to the <pressure>}
{<pressure>,<decrease induced by propranolol treatment tended to be proportional to the >,<pressure>
{and diastolic blood <pressure>to intraocular <pressure>}
{<pressure>,<to intraocular >,<pressure>
{CONCLUSION Diurnal intraocular <pressure>data collected on a single day characterize the diurnal intraocular <pressure>}
{<pressure>,<data collected on a single day characterize the diurnal intraocular >,<pressure>
{which a considerable <pressure>reduction is called for because of extensive field loss or high intraocular <pressure>}
{<pressure>,<reduction is called for because of extensive field loss or high intraocular >,<pressure>
{ Systemic blood <pressure>and intraocular pressure were measured and ocular perfusion <pressure>}
{<pressure>,<and intraocular pressure were measured and ocular perfusion >,<pressure>
{ Average preoperative <pressure>values of over 22 mm Hg and a postoperative <pressure>}
{<pressure>,<values of over 22 mm Hg and a postoperative >,<pressure>
{The trans-lamina cribrosa <pressure>difference was calculated as difference of intraocular pressure minus lumbar CSF <pressure>}
{<pressure>,<difference was calculated as difference of intraocular pressure minus lumbar CSF >,<pressure>
{lesser degree of <pressure>reduction but these patients were more frequently subject to high <pressure>}
{<pressure>,<reduction but these patients were more frequently subject to high >,<pressure>
{change of intraocular <pressure>one hour after dilation was compared with the one-hour postoperative change in intraocular <pressure>}
{<pressure>,<one hour after dilation was compared with the one-hour postoperative change in intraocular >,<pressure>
{patients with intraocular <pressure>less than 31 mmHg and mild relative field loss 17% at three years than in those with intraocular <pressure>}
{<pressure>,<less than 31 mmHg and mild relative field loss 17% at three years than in those with intraocular >,<pressure>
{and ocular perfusion <pressure>OPP were defined as the difference between systolic and diastolic BP and the difference between mean arterial <pressure>}
{<pressure>,<OPP were defined as the difference between systolic and diastolic BP and the difference between mean arterial >,<pressure>
{as an intra-ocular <pressure>IOP 21 mm Hg and 20% <pressure>}
{<pressure>,<IOP 21 mm Hg and 20% >,<pressure>
{correlation between pre-laser <pressure>level and <pressure>}
{<pressure>,<level and >,<pressure>
{The trans-lamina cribrosa <pressure>difference as the difference of intraocular pressure minus the lumbar CSF <pressure>}
{<pressure>,<difference as the difference of intraocular pressure minus the lumbar CSF >,<pressure>
{on mean blood <pressure>has been less pronounced overall decreases have been less than 4 mm Hg for both systolic and diastolic blood <pressure>}
{<pressure>,<has been less pronounced overall decreases have been less than 4 mm Hg for both systolic and diastolic blood >,<pressure>
{with trans-lamina cribrosa <pressure>difference than for the associations between rim area/visual field defect and intraocular pressure or lumbar CSF <pressure>}
{<pressure>,<difference than for the associations between rim area/visual field defect and intraocular pressure or lumbar CSF >,<pressure>
{The five-year percentage <pressure>reduction and the minimum percentage <pressure>}
{<pressure>,<reduction and the minimum percentage >,<pressure>
{that pulsations in <pressure>due to small variations in volume are directly proportional to the average intraocular <pressure>}
{<pressure>,<due to small variations in volume are directly proportional to the average intraocular >,<pressure>
{ Systolic blood <pressure>decreased significantly in both groups however diastolic blood <pressure>}
{<pressure>,<decreased significantly in both groups however diastolic blood >,<pressure>
{reductions in intraocular <pressure>percent of patients with adequately controlled intraocular <pressure>}
{<pressure>,<percent of patients with adequately controlled intraocular >,<pressure>
{successful in intraocular <pressure>control in 17 of 25 eyes 21 mmHg and additional surgical procedures resulted in intraocular <pressure>}
{<pressure>,<control in 17 of 25 eyes 21 mmHg and additional surgical procedures resulted in intraocular >,<pressure>
{S-timolol on intraocular <pressure>and systemic arterial blood <pressure>}
{<pressure>,<and systemic arterial blood >,<pressure>
{solution on intraocular <pressure>IOP and ocular perfusion <pressure>}
{<pressure>,<IOP and ocular perfusion >,<pressure>
{flow resistance blood <pressure>in the orbital artery-central retinal artery system perfusion ocular <pressure>}
{<pressure>,<in the orbital artery-central retinal artery system perfusion ocular >,<pressure>
{potassium reduces intraocular <pressure>is not mediated by a decrease in blood <pressure>}
{<pressure>,<is not mediated by a decrease in blood >,<pressure>
{Measurements of opthalmodynamometric <pressure>can be used for evaluation of perfusion <pressure>}
{<pressure>,<can be used for evaluation of perfusion >,<pressure>
{factors were blood <pressure>in the orbital artery-central retinal artery system and perfusion ocular <pressure>}
{<pressure>,<in the orbital artery-central retinal artery system and perfusion ocular >,<pressure>
{as having intraocular <pressure>21 mm Hg on no treatment normal visual field normal ONH and RNFL elevated intraocular <pressure>}
{<pressure>,<21 mm Hg on no treatment normal visual field normal ONH and RNFL elevated intraocular >,<pressure>
{The mean intraocular <pressure>at 8 AM 10 AM and 4 PM in the patient's eye with the higher intraocular <pressure>}
{<pressure>,<at 8 AM 10 AM and 4 PM in the patient's eye with the higher intraocular >,<pressure>
{substitute for arterial <pressure>in ocular vessels while intraocular pressure gives an estimate for ocular venous <pressure>}
{<pressure>,<in ocular vessels while intraocular pressure gives an estimate for ocular venous >,<pressure>
{practice mean arterial <pressure>is used to substitute for arterial <pressure>}
{<pressure>,<is used to substitute for arterial >,<pressure>
{analyses low intraocular <pressure>is associated with reduced progression of visual field defect supporting evidence from earlier studies of a protective role for low intraocular <pressure>}
{<pressure>,<is associated with reduced progression of visual field defect supporting evidence from earlier studies of a protective role for low intraocular >,<pressure>
{therapeutic lowering of <pressure>in this condition the degree of benefit as well as the side effects from treatment required for successful lowering of <pressure>}
{<pressure>,<in this condition the degree of benefit as well as the side effects from treatment required for successful lowering of >,<pressure>
{ METHODS Intraocular <pressure>IOP ocular pulse amplitude OPA ocular pulse volume OPV systemic blood <pressure>}
{<pressure>,<IOP ocular pulse amplitude OPA ocular pulse volume OPV systemic blood >,<pressure>
{decrease of intra-ocular <pressure>is comparable in classical trabeculectomy and with punch the decrease of intra-ocular <pressure>}
{<pressure>,<is comparable in classical trabeculectomy and with punch the decrease of intra-ocular >,<pressure>
{reduction of intraocular <pressure>from baseline intraocular <pressure>}
{<pressure>,<from baseline intraocular >,<pressure>
{or without intraocular <pressure>elevation diffuse hypoperfusion suggested that prolonged intraocular <pressure>}
{<pressure>,<elevation diffuse hypoperfusion suggested that prolonged intraocular >,<pressure>
{ Systolic blood <pressure>SBP diastolic blood <pressure>}
{<pressure>,<SBP diastolic blood >,<pressure>
{retinal vessel collapse <pressure>was measured by a Goldmann contact lens fitted with a <pressure>}
{<pressure>,<was measured by a Goldmann contact lens fitted with a >,<pressure>
{variation of intraocular <pressure>diurnal IOP blood flow velocity of the ophthalmic artery by color Doppler imaging blood flow volume of digital tissue by laser flowmetry and systemic blood <pressure>}
{<pressure>,<diurnal IOP blood flow velocity of the ophthalmic artery by color Doppler imaging blood flow volume of digital tissue by laser flowmetry and systemic blood >,<pressure>
{initial systolic blood <pressure>to be significantly contributory to a favorable outcome in the brovincamine-treated group and the use of brovincamine better cold recovery rate and higher initial systolic blood <pressure>}
{<pressure>,<to be significantly contributory to a favorable outcome in the brovincamine-treated group and the use of brovincamine better cold recovery rate and higher initial systolic blood >,<pressure>
{included brachial arterial <pressure>heart rate intraocular <pressure>}
{<pressure>,<heart rate intraocular >,<pressure>
{reduction in intraocular <pressure>in clinical trials can be determined through the mean intraocular <pressure>}
{<pressure>,<in clinical trials can be determined through the mean intraocular >,<pressure>
{baseline examination blood <pressure>heart rate intraocular <pressure>}
{<pressure>,<heart rate intraocular >,<pressure>
{have the intraocular <pressure>reduced to a specific target intraocular <pressure>}
{<pressure>,<reduced to a specific target intraocular >,<pressure>
{the mean intraocular <pressure>through the proportion of patients who have the intraocular <pressure>}
{<pressure>,<through the proportion of patients who have the intraocular >,<pressure>
{ Systemic pulse <pressure>and systolic blood <pressure>}
{<pressure>,<and systolic blood >,<pressure>
{increase in intraocular <pressure>seen in this population of patients with ocular hypertension during infusions of fenoldopam is consistent with fenoldopam-associated increases in intraocular <pressure>}
{<pressure>,<seen in this population of patients with ocular hypertension during infusions of fenoldopam is consistent with fenoldopam-associated increases in intraocular >,<pressure>
{sofZia on intraocular <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{elevation of hydraulic <pressure>to 20-30 mm Hg indicating that a part of the human trabecular cells could sense the change in hydraulic <pressure>}
{<pressure>,<to 20-30 mm Hg indicating that a part of the human trabecular cells could sense the change in hydraulic >,<pressure>
{hemodialysis on intraocular <pressure>and ocular perfusion <pressure>}
{<pressure>,<and ocular perfusion >,<pressure>
{monitoring of intraocular <pressure>and arterial blood <pressure>}
{<pressure>,<and arterial blood >,<pressure>
{Valsalva manoeuver intra-ocular <pressure>cerebrospinal fluid pressure optic disc topography Beijing intracranial and intra-ocular <pressure>}
{<pressure>,<cerebrospinal fluid pressure optic disc topography Beijing intracranial and intra-ocular >,<pressure>
{diastolic blood pressure-intraocular <pressure>differences and low systolic and diastolic blood pressure/intraocular <pressure>}
{<pressure>,<differences and low systolic and diastolic blood pressure/intraocular >,<pressure>
{sofZia on intraocular <pressure>IOP and ocular perfusion <pressure>}
{<pressure>,<IOP and ocular perfusion >,<pressure>
{acuity presenting intra-ocular <pressure>current intra-ocular <pressure>}
{<pressure>,<current intra-ocular >,<pressure>
{low systolic blood <pressure>and some described no difference in blood <pressure>}
{<pressure>,<and some described no difference in blood >,<pressure>
{reduction of intraocular <pressure>and it is the consequence of altered relationship between capillary pressure and interstitial fluid <pressure>}
{<pressure>,<and it is the consequence of altered relationship between capillary pressure and interstitial fluid >,<pressure>
{changes of atmospheric <pressure>and temperature whereas patients with no recovery of hearing had the highest values for atmospheric <pressure>}
{<pressure>,<and temperature whereas patients with no recovery of hearing had the highest values for atmospheric >,<pressure>
{ophthalmologic examination intraocular <pressure>IOP measurements evaluation of ocular surface Schirmer's test blood <pressure>}
{<pressure>,<IOP measurements evaluation of ocular surface Schirmer's test blood >,<pressure>
{Alterations of intraocular <pressure>in comparison of self- and external-administered topical antiglaucomatosa during diurnal intraocular <pressure>}
{<pressure>,<in comparison of self- and external-administered topical antiglaucomatosa during diurnal intraocular >,<pressure>
{changes in arterial <pressure>IOP or calculated ocular perfusion <pressure>}
{<pressure>,<IOP or calculated ocular perfusion >,<pressure>
{solutions on intraocular <pressure>ocular hemodynamics pupil size depth of the anterior chamber ocular functions arterial <pressure>}
{<pressure>,<ocular hemodynamics pupil size depth of the anterior chamber ocular functions arterial >,<pressure>
{determined as pretreatment <pressure>- posttreatment pressure / pretreatment <pressure>}
{<pressure>,<- posttreatment pressure / pretreatment >,<pressure>
{variation of intraocular <pressure>IOP and ocular perfusion <pressure>}
{<pressure>,<IOP and ocular perfusion >,<pressure>
{significantly higher intraocular <pressure>peaks and a larger <pressure>}
{<pressure>,<peaks and a larger >,<pressure>
{and diastolic blood <pressure>and diastolic blood <pressure>}
{<pressure>,<and diastolic blood >,<pressure>
{relatively high intraocular <pressure>have more pronounced optic nerve damage than do eyes with relatively low intraocular <pressure>}
{<pressure>,<have more pronounced optic nerve damage than do eyes with relatively low intraocular >,<pressure>
{ diastolic blood <pressure>+ â… Ã— systolic blood <pressure>}
{<pressure>,<+ â… Ã— systolic blood >,<pressure>
{tested for intraocular <pressure>IOP heart rate blood <pressure>}
{<pressure>,<IOP heart rate blood >,<pressure>
{ Ocular perfusion <pressure>was calculated as follows â… diastolic blood <pressure>}
{<pressure>,<was calculated as follows â… diastolic blood >,<pressure>
{Ã— systolic blood <pressure>- diastolic blood <pressure>}
{<pressure>,<- diastolic blood >,<pressure>
{POAG with elevated <pressure>or not POAG with normal <pressure>}
{<pressure>,<or not POAG with normal >,<pressure>
{in mean intraocular <pressure>was observed but in fourteen patients intraocular <pressure>}
{<pressure>,<was observed but in fourteen patients intraocular >,<pressure>
{24-hour ambulatory blood <pressure>monitoring is becoming popular among ophthalmic researchers multiple confounding factors in ambulatory blood <pressure>}
{<pressure>,<monitoring is becoming popular among ophthalmic researchers multiple confounding factors in ambulatory blood >,<pressure>
{that taking translamina <pressure>difference into consideration changes associations between ocular perfusion <pressure>}
{<pressure>,<difference into consideration changes associations between ocular perfusion >,<pressure>
Postoperative intra-abdominal abscess,wound
{   <Postoperative intra-abdominal abscess>and <wound>}
{<Postoperative intra-abdominal abscess>,<and >,<wound>
failure,complications
{risk factors for <failure>and <complications>}
{<failure>,<and >,<complications>
{consequence to this <failure>in asymmetry development serious <complications>}
{<failure>,<in asymmetry development serious >,<complications>
{risk of filtration <failure>and a higher risk of postoperative <complications>}
{<failure>,<and a higher risk of postoperative >,<complications>
{increased likelihood of <failure>and <complications>}
{<failure>,<and >,<complications>
{risk of treatment <failure>but entails a risk of <complications>}
{<failure>,<but entails a risk of >,<complications>
metabolic syndrome,atherosclerosis
{risk factors of <metabolic syndrome>and <atherosclerosis>}
{<metabolic syndrome>,<and >,<atherosclerosis>
Non-alcoholic fatty liver disease,steatohepatitis
{   <Non-alcoholic fatty liver disease>and <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<and >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>- the most common chronic liver disease - encompasses a histological spectrum ranging from simple steatosis to non-alcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<- the most common chronic liver disease - encompasses a histological spectrum ranging from simple steatosis to non-alcoholic >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>NAFLD /non-alcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD /non-alcoholic >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>NAFLD encompasses a spectrum of fatty simple steatosis and <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD encompasses a spectrum of fatty simple steatosis and >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>NAFLD is a multifactorial condition that encompasses a wide spectrum of liver abnormalities ranging from simple liver steatosis to <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD is a multifactorial condition that encompasses a wide spectrum of liver abnormalities ranging from simple liver steatosis to >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>NAFLD and its progression to <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD and its progression to >,<steatohepatitis>
{  it <Non-alcoholic fatty liver disease>NAFLD is a multi-faceted disorder which ranges from simple steatosis to non-alcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD is a multi-faceted disorder which ranges from simple steatosis to non-alcoholic >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>is a multifactorial condition ranging from simple steatosis to non-alcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<is a multifactorial condition ranging from simple steatosis to non-alcoholic >,<steatohepatitis>
{ it AIMS/HYPOTHESIS <Non-alcoholic fatty liver disease>NAFLD encompasses a spectrum ranging from simple steatosis to non-alcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD encompasses a spectrum ranging from simple steatosis to non-alcoholic >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>NAFLD includes a variety of histological conditions ranging from liver steatosis and <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD includes a variety of histological conditions ranging from liver steatosis and >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>NAFLD ranges from simple steatosis to nonalcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD ranges from simple steatosis to nonalcoholic >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>NAFLD which includes steatosis and <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD which includes steatosis and >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>covers a wide spectrum of liver pathologies which range from simple steatosis to non-alcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<covers a wide spectrum of liver pathologies which range from simple steatosis to non-alcoholic >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>NAFLD is a multi-faceted condition including simple steatosis alone or associated with inflammation and ballooning non-alcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<NAFLD is a multi-faceted condition including simple steatosis alone or associated with inflammation and ballooning non-alcoholic >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>encompasses a spectrum of liver diseases including simple steatosis <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<encompasses a spectrum of liver diseases including simple steatosis >,<steatohepatitis>
{   <Non-alcoholic fatty liver disease>encompasses a spectrum of pathologies ranging from simple steatosis to non-alcoholic <steatohepatitis>}
{<Non-alcoholic fatty liver disease>,<encompasses a spectrum of pathologies ranging from simple steatosis to non-alcoholic >,<steatohepatitis>
headache thyrotoxicosis,glaucoma
{   <headache thyrotoxicosis>and <glaucoma>}
{<headache thyrotoxicosis>,<and >,<glaucoma>
Open-angle glaucoma,blood groups
{   <Open-angle glaucoma>and <blood groups>}
{<Open-angle glaucoma>,<and >,<blood groups>
diabetic retinopathy macular degeneration,glaucoma
{   <diabetic retinopathy macular degeneration>and <glaucoma>}
{<diabetic retinopathy macular degeneration>,<and >,<glaucoma>
glaucoma osteoporosis,fractures
{   <glaucoma osteoporosis>and <fractures>}
{<glaucoma osteoporosis>,<and >,<fractures>
Nonalcoholic fatty liver disease,atherosclerosis
{   <Nonalcoholic fatty liver disease>and <atherosclerosis>}
{<Nonalcoholic fatty liver disease>,<and >,<atherosclerosis>
intestinal obstruction cholecystitis,appendicitis
{   <intestinal obstruction cholecystitis>and <appendicitis>}
{<intestinal obstruction cholecystitis>,<and >,<appendicitis>
inflammatory bowel disease nephritic syndrome,metabolic diseases
{   <inflammatory bowel disease nephritic syndrome>and <metabolic diseases>}
{<inflammatory bowel disease nephritic syndrome>,<and >,<metabolic diseases>
open-angle glaucoma,glaucoma
{ocular hypertension primary <open-angle glaucoma>and low-tension <glaucoma>}
{<open-angle glaucoma>,<and low-tension >,<glaucoma>
{71 with secondary <open-angle glaucoma>30 with normal-tension glaucoma and 10 with angle-closure <glaucoma>}
{<open-angle glaucoma>,<30 with normal-tension glaucoma and 10 with angle-closure >,<glaucoma>
{37 with chronic <open-angle glaucoma>and 1 with low-tension <glaucoma>}
{<open-angle glaucoma>,<and 1 with low-tension >,<glaucoma>
{patients had primary <open-angle glaucoma>and two had normal-tension <glaucoma>}
{<open-angle glaucoma>,<and two had normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and 52 patients with pigmentary <glaucoma>}
{<open-angle glaucoma>,<POAG and 52 patients with pigmentary >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and controls without <glaucoma>}
{<open-angle glaucoma>,<POAG and controls without >,<glaucoma>
{ocular hypertension primary <open-angle glaucoma>and normal tension <glaucoma>}
{<open-angle glaucoma>,<and normal tension >,<glaucoma>
{ Eyes with <open-angle glaucoma>showed twice as much loss of sensitivity in the spared hemifield as compared to eyes with low-tension <glaucoma>}
{<open-angle glaucoma>,<showed twice as much loss of sensitivity in the spared hemifield as compared to eyes with low-tension >,<glaucoma>
{eyes with primary <open-angle glaucoma>POAG and eyes with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and eyes with normal-tension >,<glaucoma>
{48 ones with <open-angle glaucoma>and 14 with suspected <glaucoma>}
{<open-angle glaucoma>,<and 14 with suspected >,<glaucoma>
{as having primary <open-angle glaucoma>POAG normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal tension >,<glaucoma>
{betaxolol on primary <open-angle glaucoma>and normal-tension <glaucoma>}
{<open-angle glaucoma>,<and normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>or normal-tension <glaucoma>}
{<open-angle glaucoma>,<or normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>and in 23 eyes of 23 patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<and in 23 eyes of 23 patients with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>and low-tension <glaucoma>}
{<open-angle glaucoma>,<and low-tension >,<glaucoma>
{readings in suspected <open-angle glaucoma>patients which helps in better management of <glaucoma>}
{<open-angle glaucoma>,<patients which helps in better management of >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and 11 eyes of 11 patients with special forms of high-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and 11 eyes of 11 patients with special forms of high-tension >,<glaucoma>
{ However the <open-angle glaucoma>patients with progression despite well-controlled IOP and also the patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<patients with progression despite well-controlled IOP and also the patients with normal-tension >,<glaucoma>
{patient with primary <open-angle glaucoma>POAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal tension >,<glaucoma>
{patients with bilateral <open-angle glaucoma>and bilateral angle-closure <glaucoma>}
{<open-angle glaucoma>,<and bilateral angle-closure >,<glaucoma>
{32 control patients <open-angle glaucoma>patients referred because of decompensated IOP despite maximum treatment 40 patients with open-angle <glaucoma>}
{<open-angle glaucoma>,<patients referred because of decompensated IOP despite maximum treatment 40 patients with open-angle >,<glaucoma>
{patients with primary <open-angle glaucoma>and normal tension <glaucoma>}
{<open-angle glaucoma>,<and normal tension >,<glaucoma>
{ three primary <open-angle glaucoma>and two secondary <glaucoma>}
{<open-angle glaucoma>,<and two secondary >,<glaucoma>
{211 with primary <open-angle glaucoma>POAG and 290 with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and 290 with normal-tension >,<glaucoma>
{surgery in primary <open-angle glaucoma>in 24 consecutive white <glaucoma>}
{<open-angle glaucoma>,<in 24 consecutive white >,<glaucoma>
{patients with chronic <open-angle glaucoma>and 24 eyes of 24 patients with low-tension <glaucoma>}
{<open-angle glaucoma>,<and 24 eyes of 24 patients with low-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>and normal-tension <glaucoma>}
{<open-angle glaucoma>,<and normal-tension >,<glaucoma>
{103 with primary <open-angle glaucoma>by means of ophthalmologic and dopplerographic techniques have revealed no relationship between occlusion abnormalities of the carotid arteries and <glaucoma>}
{<open-angle glaucoma>,<by means of ophthalmologic and dopplerographic techniques have revealed no relationship between occlusion abnormalities of the carotid arteries and >,<glaucoma>
{49 with primary <open-angle glaucoma>and 5 with pigmentary <glaucoma>}
{<open-angle glaucoma>,<and 5 with pigmentary >,<glaucoma>
{tonometer in primary <open-angle glaucoma>and normal tension <glaucoma>}
{<open-angle glaucoma>,<and normal tension >,<glaucoma>
{patients with chronic <open-angle glaucoma>or suspected low-tension <glaucoma>}
{<open-angle glaucoma>,<or suspected low-tension >,<glaucoma>
{55 subjects with <open-angle glaucoma>who had had IOP measured before and after pharmacological pupillary dilatation was performed to establish the rate of progression of glaucoma based on serial evaluation of the visual fields using the <glaucoma>}
{<open-angle glaucoma>,<who had had IOP measured before and after pharmacological pupillary dilatation was performed to establish the rate of progression of glaucoma based on serial evaluation of the visual fields using the >,<glaucoma>
{15 with primary <open-angle glaucoma>1 with pigmentary glaucoma and 1 <glaucoma>}
{<open-angle glaucoma>,<1 with pigmentary glaucoma and 1 >,<glaucoma>
{the prevalence of <open-angle glaucoma>OAG <glaucoma>}
{<open-angle glaucoma>,<OAG >,<glaucoma>
{field in primary <open-angle glaucoma>and normal-tension <glaucoma>}
{<open-angle glaucoma>,<and normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG or normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG or normal-tension >,<glaucoma>
{ in primary <open-angle glaucoma>and normal-tension <glaucoma>}
{<open-angle glaucoma>,<and normal-tension >,<glaucoma>
{6 with primary <open-angle glaucoma>4 with normal-tension <glaucoma>}
{<open-angle glaucoma>,<4 with normal-tension >,<glaucoma>
{beneficiaries with primary <open-angle glaucoma>POAG treated medically or surgically utilization rates for each major class of <glaucoma>}
{<open-angle glaucoma>,<POAG treated medically or surgically utilization rates for each major class of >,<glaucoma>
{patients with primary <open-angle glaucoma>and 15 patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<and 15 patients with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG 23 eyes 22 patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG 23 eyes 22 patients with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>normal-tension <glaucoma>}
{<open-angle glaucoma>,<normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG 45 age-matched <glaucoma>}
{<open-angle glaucoma>,<POAG 45 age-matched >,<glaucoma>
{individuals with primary <open-angle glaucoma>POAG normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal-tension >,<glaucoma>
{patients with chronic <open-angle glaucoma>and those with normal-tension <glaucoma>}
{<open-angle glaucoma>,<and those with normal-tension >,<glaucoma>
{24 with primary <open-angle glaucoma>POAG and 30 with pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG and 30 with pseudoexfoliative >,<glaucoma>
{patients with primary <open-angle glaucoma>23 low-risk patients in whom <glaucoma>}
{<open-angle glaucoma>,<23 low-risk patients in whom >,<glaucoma>
{technology in primary <open-angle glaucoma>and normal-tension <glaucoma>}
{<open-angle glaucoma>,<and normal-tension >,<glaucoma>
{ are primary <open-angle glaucoma>POAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal tension >,<glaucoma>
{angiograms in primary <open-angle glaucoma>POAG normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal-tension >,<glaucoma>
{74 with primary <open-angle glaucoma>POAG and 76 with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and 76 with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and in patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and in patients with normal-tension >,<glaucoma>
{hemorrhage in primary <open-angle glaucoma>POAG normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG 34 with normal-pressure glaucoma and 125 with suspected <glaucoma>}
{<open-angle glaucoma>,<POAG 34 with normal-pressure glaucoma and 125 with suspected >,<glaucoma>
{patients with primary <open-angle glaucoma>vs those with normal-tension <glaucoma>}
{<open-angle glaucoma>,<vs those with normal-tension >,<glaucoma>
{as follows primary <open-angle glaucoma>POAG --209 patients pseudoexfoliation <glaucoma>}
{<open-angle glaucoma>,<POAG --209 patients pseudoexfoliation >,<glaucoma>
{children with juvenile <open-angle glaucoma>and in some children with aphakic <glaucoma>}
{<open-angle glaucoma>,<and in some children with aphakic >,<glaucoma>
{49 with primary <open-angle glaucoma>POAG 26 with low-tension <glaucoma>}
{<open-angle glaucoma>,<POAG 26 with low-tension >,<glaucoma>
{subjects with primary <open-angle glaucoma>POAG normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and 27 <glaucoma>}
{<open-angle glaucoma>,<POAG and 27 >,<glaucoma>
{ hypertensive primary <open-angle glaucoma>and normal tension <glaucoma>}
{<open-angle glaucoma>,<and normal tension >,<glaucoma>
{patients with primary <open-angle glaucoma>or normal-tension <glaucoma>}
{<open-angle glaucoma>,<or normal-tension >,<glaucoma>
{asymptomatic early chronic <open-angle glaucoma>in the community is likely to be best achieved by a combination of public awareness of <glaucoma>}
{<open-angle glaucoma>,<in the community is likely to be best achieved by a combination of public awareness of >,<glaucoma>
{patients with primary <open-angle glaucoma>132 high-tension <glaucoma>}
{<open-angle glaucoma>,<132 high-tension >,<glaucoma>
{ninety-five subjects with <open-angle glaucoma>seen by multiple <glaucoma>}
{<open-angle glaucoma>,<seen by multiple >,<glaucoma>
{patients with chronic <open-angle glaucoma>11 age-matched control subjects and 8 <glaucoma>}
{<open-angle glaucoma>,<11 age-matched control subjects and 8 >,<glaucoma>
{including both primary <open-angle glaucoma>POAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal tension >,<glaucoma>
{Patients with primary <open-angle glaucoma>who underwent <glaucoma>}
{<open-angle glaucoma>,<who underwent >,<glaucoma>
{ocular hypertension primary <open-angle glaucoma>or normal tension <glaucoma>}
{<open-angle glaucoma>,<or normal tension >,<glaucoma>
{unoprostone in primary <open-angle glaucoma>and normal-tension <glaucoma>}
{<open-angle glaucoma>,<and normal-tension >,<glaucoma>
{that causes primary <open-angle glaucoma>POAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal tension >,<glaucoma>
{patients had preexisting <open-angle glaucoma>whereas 1 patient developed postoperative steroid-response <glaucoma>}
{<open-angle glaucoma>,<whereas 1 patient developed postoperative steroid-response >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal-tension >,<glaucoma>
{ophthalmologist to be <open-angle glaucoma>suspects or to have definite early open-angle <glaucoma>}
{<open-angle glaucoma>,<suspects or to have definite early open-angle >,<glaucoma>
{between Japanese primary <open-angle glaucoma>and normal tension <glaucoma>}
{<open-angle glaucoma>,<and normal tension >,<glaucoma>
{patients with primary <open-angle glaucoma>ocular hypertension or normal-tension <glaucoma>}
{<open-angle glaucoma>,<ocular hypertension or normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal tension >,<glaucoma>
{cases with primary <open-angle glaucoma>58 17% cases with chronic angle closure <glaucoma>}
{<open-angle glaucoma>,<58 17% cases with chronic angle closure >,<glaucoma>
{Patients with primary <open-angle glaucoma>POAG the most frequent form of <glaucoma>}
{<open-angle glaucoma>,<POAG the most frequent form of >,<glaucoma>
{the treatment of <open-angle glaucoma>ocular hypertension or normal-tension <glaucoma>}
{<open-angle glaucoma>,<ocular hypertension or normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG n = 20 and one group of patients with normal-pressure <glaucoma>}
{<open-angle glaucoma>,<POAG n = 20 and one group of patients with normal-pressure >,<glaucoma>
{  from <open-angle glaucoma>75% worst with juvenile <glaucoma>}
{<open-angle glaucoma>,<75% worst with juvenile >,<glaucoma>
{  or <open-angle glaucoma>treated with two or more drugs and coexisting cataract with no known risk factors for <glaucoma>}
{<open-angle glaucoma>,<treated with two or more drugs and coexisting cataract with no known risk factors for >,<glaucoma>
{who had chronic <open-angle glaucoma>were suspected to have <glaucoma>}
{<open-angle glaucoma>,<were suspected to have >,<glaucoma>
{patients with primary <open-angle glaucoma>and 63 patients with secondary <glaucoma>}
{<open-angle glaucoma>,<and 63 patients with secondary >,<glaucoma>
{11 eyes with <open-angle glaucoma>and functioning avascular blebs six of which were treated with topical anti-glaucomatous medications and had no history of surgery 15 with open-angle glaucoma and untreated eyes suspected of having open-angle <glaucoma>}
{<open-angle glaucoma>,<and functioning avascular blebs six of which were treated with topical anti-glaucomatous medications and had no history of surgery 15 with open-angle glaucoma and untreated eyes suspected of having open-angle >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal tension >,<glaucoma>
{20 with primary <open-angle glaucoma>and 13 with suspected <glaucoma>}
{<open-angle glaucoma>,<and 13 with suspected >,<glaucoma>
{development of primary <open-angle glaucoma>has become increasingly well recognized the ability of CCT to predict severity of <glaucoma>}
{<open-angle glaucoma>,<has become increasingly well recognized the ability of CCT to predict severity of >,<glaucoma>
{  from <open-angle glaucoma>with narrow angles aiding in repositioning and maintaining the position of intraocular lenses treatment of pigmentary <glaucoma>}
{<open-angle glaucoma>,<with narrow angles aiding in repositioning and maintaining the position of intraocular lenses treatment of pigmentary >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG pseudoexfoliative >,<glaucoma>
{efficacy for primary <open-angle glaucoma>POAG patients with disruption of Schlemm canal SC wall resulting from prior <glaucoma>}
{<open-angle glaucoma>,<POAG patients with disruption of Schlemm canal SC wall resulting from prior >,<glaucoma>
{types of chronic <open-angle glaucoma>for the separation of glaucomatous eyes from nonglaucomatous eyes and for the detection of progression of <glaucoma>}
{<open-angle glaucoma>,<for the separation of glaucomatous eyes from nonglaucomatous eyes and for the detection of progression of >,<glaucoma>
{high-pressure or normal-pressure <open-angle glaucoma>number and type of pressure-lowering medications lens status pre-SLT IOP IOP at the time of diagnosis duration of <glaucoma>}
{<open-angle glaucoma>,<number and type of pressure-lowering medications lens status pre-SLT IOP IOP at the time of diagnosis duration of >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG n=19 and patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG n=19 and patients with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG 268 patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG 268 patients with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal tension >,<glaucoma>
{woman with primary <open-angle glaucoma>n=66 and pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<n=66 and pseudoexfoliative >,<glaucoma>
{medically controlled primary <open-angle glaucoma>OAG or exfoliation glaucoma and no history of <glaucoma>}
{<open-angle glaucoma>,<OAG or exfoliation glaucoma and no history of >,<glaucoma>
{manifestations of primary <open-angle glaucoma>POAG the most common subtype of <glaucoma>}
{<open-angle glaucoma>,<POAG the most common subtype of >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and patients with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG or pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG or pseudoexfoliative >,<glaucoma>
{211 with primary <open-angle glaucoma>POAG and 294 with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and 294 with normal-tension >,<glaucoma>
{eyes with primary <open-angle glaucoma>POAG and normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG 310 were patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG 310 were patients with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG 217 with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG 217 with normal-tension >,<glaucoma>
{and in primary <open-angle glaucoma>POAG and in exfoliation <glaucoma>}
{<open-angle glaucoma>,<POAG and in exfoliation >,<glaucoma>
{237 eyes chronic <open-angle glaucoma>82% pigment-dispersion <glaucoma>}
{<open-angle glaucoma>,<82% pigment-dispersion >,<glaucoma>
{881 eyes chronic <open-angle glaucoma>94% pigment-dispersion <glaucoma>}
{<open-angle glaucoma>,<94% pigment-dispersion >,<glaucoma>
{glaucoma and primary <open-angle glaucoma>POAG making animals models of GC-induced OHT and <glaucoma>}
{<open-angle glaucoma>,<POAG making animals models of GC-induced OHT and >,<glaucoma>
{ In primary <open-angle glaucoma>the most frequent form of <glaucoma>}
{<open-angle glaucoma>,<the most frequent form of >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG chronic primary angle closure <glaucoma>}
{<open-angle glaucoma>,<POAG chronic primary angle closure >,<glaucoma>
{patients with primary <open-angle glaucoma>and <glaucoma>}
{<open-angle glaucoma>,<and >,<glaucoma>
{76 eyes chronic <open-angle glaucoma>72% pigment-dispersion <glaucoma>}
{<open-angle glaucoma>,<72% pigment-dispersion >,<glaucoma>
{86% for aphakic <open-angle glaucoma>32 of 37 eyes to 53% for neovascular <glaucoma>}
{<open-angle glaucoma>,<32 of 37 eyes to 53% for neovascular >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG lost vision due to cataract and <glaucoma>}
{<open-angle glaucoma>,<POAG lost vision due to cataract and >,<glaucoma>
{57% in primary <open-angle glaucoma>and 94% in capsular <glaucoma>}
{<open-angle glaucoma>,<and 94% in capsular >,<glaucoma>
{by uncontrolled primary <open-angle glaucoma>POAG exfoliation syndrome <glaucoma>}
{<open-angle glaucoma>,<POAG exfoliation syndrome >,<glaucoma>
{patients with primary <open-angle glaucoma>and normal tension <glaucoma>}
{<open-angle glaucoma>,<and normal tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and 29 patients with exfoliation XFS <glaucoma>}
{<open-angle glaucoma>,<POAG and 29 patients with exfoliation XFS >,<glaucoma>
{patients with primary <open-angle glaucoma>or pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<or pseudoexfoliative >,<glaucoma>
{patients with primary <open-angle glaucoma>normal tension <glaucoma>}
{<open-angle glaucoma>,<normal tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and patients with exfoliation <glaucoma>}
{<open-angle glaucoma>,<POAG and patients with exfoliation >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG as well as in animal models of <glaucoma>}
{<open-angle glaucoma>,<POAG as well as in animal models of >,<glaucoma>
{patients with primary <open-angle glaucoma>or normal tension <glaucoma>}
{<open-angle glaucoma>,<or normal tension >,<glaucoma>
{patients with primary <open-angle glaucoma>10 patients with normal-pressure <glaucoma>}
{<open-angle glaucoma>,<10 patients with normal-pressure >,<glaucoma>
{as having primary <open-angle glaucoma>POAG low tension open-angle <glaucoma>}
{<open-angle glaucoma>,<POAG low tension open-angle >,<glaucoma>
{associated with primary <open-angle glaucoma>in pathogenic mechanisms and family history of <glaucoma>}
{<open-angle glaucoma>,<in pathogenic mechanisms and family history of >,<glaucoma>
{  and <open-angle glaucoma>normal-tension <glaucoma>}
{<open-angle glaucoma>,<normal-tension >,<glaucoma>
{ Incidence of <open-angle glaucoma>normal-tension <glaucoma>}
{<open-angle glaucoma>,<normal-tension >,<glaucoma>
{8% had primary <open-angle glaucoma>3 with low-pressure and 2 with high-pressure <glaucoma>}
{<open-angle glaucoma>,<3 with low-pressure and 2 with high-pressure >,<glaucoma>
{prevalence rates of <open-angle glaucoma>OAG narrow-angle <glaucoma>}
{<open-angle glaucoma>,<OAG narrow-angle >,<glaucoma>
{including both primary <open-angle glaucoma>POAG and normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal-tension >,<glaucoma>
{eyes with primary <open-angle glaucoma>but not in eyes with normal-tension <glaucoma>}
{<open-angle glaucoma>,<but not in eyes with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>and 3 eyes of 3 patients with normal-tension <glaucoma>}
{<open-angle glaucoma>,<and 3 eyes of 3 patients with normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG or pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG or pseudoexfoliative >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG including normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG including normal-tension >,<glaucoma>
{history of primary <open-angle glaucoma>27 normotensive <glaucoma>}
{<open-angle glaucoma>,<27 normotensive >,<glaucoma>
{43 with primary <open-angle glaucoma>POAG and 33 with preperimetric <glaucoma>}
{<open-angle glaucoma>,<POAG and 33 with preperimetric >,<glaucoma>
{canaloplasty for primary <open-angle glaucoma>POAG with failed <glaucoma>}
{<open-angle glaucoma>,<POAG with failed >,<glaucoma>
{42 ACG patients <open-angle glaucoma>OAG patients and 35 controls without <glaucoma>}
{<open-angle glaucoma>,<OAG patients and 35 controls without >,<glaucoma>
{VF progression in <open-angle glaucoma>OAG including primary OAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<OAG including primary OAG and normal tension >,<glaucoma>
{1244 had primary <open-angle glaucoma>POAG 140 normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG 140 normal tension >,<glaucoma>
{Patients with primary <open-angle glaucoma>POAG normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG normal-tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG patients with pseudoexfoliation <glaucoma>}
{<open-angle glaucoma>,<POAG patients with pseudoexfoliation >,<glaucoma>
{association with primary <open-angle glaucoma>POAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal tension >,<glaucoma>
{68 with primary <open-angle glaucoma>POAG 76 with normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG 76 with normal-tension >,<glaucoma>
{thickness in primary <open-angle glaucoma>POAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal tension >,<glaucoma>
{applicable on primary <open-angle glaucoma>and especially effective for normal tension <glaucoma>}
{<open-angle glaucoma>,<and especially effective for normal tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG including normal-tension <glaucoma>}
{<open-angle glaucoma>,<POAG including normal-tension >,<glaucoma>
{ONSD in primary <open-angle glaucoma>POAG and normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG and normal tension >,<glaucoma>
{34 eyes primary <open-angle glaucoma>275 eyes and exfoliative <glaucoma>}
{<open-angle glaucoma>,<275 eyes and exfoliative >,<glaucoma>
{ in primary <open-angle glaucoma>and normal tension <glaucoma>}
{<open-angle glaucoma>,<and normal tension >,<glaucoma>
{different stages ofprimary <open-angle glaucoma>complicated by pseudoexfoliation syndrome PES and/or patients with pseudoexfoliation <glaucoma>}
{<open-angle glaucoma>,<complicated by pseudoexfoliation syndrome PES and/or patients with pseudoexfoliation >,<glaucoma>
{patients with chronic <open-angle glaucoma>COAG 9 patients with pseudoexfoliation <glaucoma>}
{<open-angle glaucoma>,<COAG 9 patients with pseudoexfoliation >,<glaucoma>
{iris neovascularisation silicomacrophagocytic <open-angle glaucoma>secondary to silicone oil emulsification and preoperative history of <glaucoma>}
{<open-angle glaucoma>,<secondary to silicone oil emulsification and preoperative history of >,<glaucoma>
{cases with primary <open-angle glaucoma>and pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<and pseudoexfoliative >,<glaucoma>
{to moderate primary <open-angle glaucoma>and <glaucoma>}
{<open-angle glaucoma>,<and >,<glaucoma>
{The ratio of <open-angle glaucoma>to angle-closure <glaucoma>}
{<open-angle glaucoma>,<to angle-closure >,<glaucoma>
{patients with primary <open-angle glaucoma>pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<pseudoexfoliative >,<glaucoma>
{ Ratio of <open-angle glaucoma>to angle-closure <glaucoma>}
{<open-angle glaucoma>,<to angle-closure >,<glaucoma>
{patients with primary <open-angle glaucoma>n=14 and pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<n=14 and pseudoexfoliative >,<glaucoma>
{5 had primary <open-angle glaucoma>and one patient had previously diagnosed <glaucoma>}
{<open-angle glaucoma>,<and one patient had previously diagnosed >,<glaucoma>
{likely to have <open-angle glaucoma>or to have <glaucoma>}
{<open-angle glaucoma>,<or to have >,<glaucoma>
{patient had primary <open-angle glaucoma>and 3 had previously diagnosed <glaucoma>}
{<open-angle glaucoma>,<and 3 had previously diagnosed >,<glaucoma>
{1 with bilateral <open-angle glaucoma>1 with unilateral <glaucoma>}
{<open-angle glaucoma>,<1 with unilateral >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG and pseudoexfoliative >,<glaucoma>
{the treatment of <open-angle glaucoma>OAG METHODS A prospective study of uncontrolled open-angle <glaucoma>}
{<open-angle glaucoma>,<OAG METHODS A prospective study of uncontrolled open-angle >,<glaucoma>
{analog for primary <open-angle glaucoma>POAG n=5 or normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG n=5 or normal tension >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and 155 with exfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG and 155 with exfoliative >,<glaucoma>
{or bilateral primary <open-angle glaucoma>POAG or normal tension <glaucoma>}
{<open-angle glaucoma>,<POAG or normal tension >,<glaucoma>
{patients with either <open-angle glaucoma>or normal-pressure <glaucoma>}
{<open-angle glaucoma>,<or normal-pressure >,<glaucoma>
{patients with primary <open-angle glaucoma>group I 25 patients with exfoliative <glaucoma>}
{<open-angle glaucoma>,<group I 25 patients with exfoliative >,<glaucoma>
{patients with primary <open-angle glaucoma>or pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<or pseudoexfoliative >,<glaucoma>
{66 with primary <open-angle glaucoma>using the Laguna ONhE HRT-III Heidelberg Engineering and OCT Spectralis Heidelberg Engineering instruments and photographs of the optic disc were examined by a blinded observer experienced <glaucoma>}
{<open-angle glaucoma>,<using the Laguna ONhE HRT-III Heidelberg Engineering and OCT Spectralis Heidelberg Engineering instruments and photographs of the optic disc were examined by a blinded observer experienced >,<glaucoma>
{paired eyes of <open-angle glaucoma>patients and <glaucoma>}
{<open-angle glaucoma>,<patients and >,<glaucoma>
{metabolism in primary <open-angle glaucoma>and normal-pressure <glaucoma>}
{<open-angle glaucoma>,<and normal-pressure >,<glaucoma>
{patients with primary <open-angle glaucoma>and in 138 eyes of 69 patients with normal-pressure <glaucoma>}
{<open-angle glaucoma>,<and in 138 eyes of 69 patients with normal-pressure >,<glaucoma>
{study for primary <open-angle glaucoma>POAG in 1 007 cases with high-pressure <glaucoma>}
{<open-angle glaucoma>,<POAG in 1 007 cases with high-pressure >,<glaucoma>
{eyes with primary <open-angle glaucoma>POAG and to correlate their concentrations with the severity of <glaucoma>}
{<open-angle glaucoma>,<POAG and to correlate their concentrations with the severity of >,<glaucoma>
{patients with primary <open-angle glaucoma>using tract-based spatial statistical analysis of diffusion tensor imaging and correlate these measures with the clinical severity of <glaucoma>}
{<open-angle glaucoma>,<using tract-based spatial statistical analysis of diffusion tensor imaging and correlate these measures with the clinical severity of >,<glaucoma>
{RESULTS Out of <open-angle glaucoma>patients examined in 2001 77 69% subjects participated in the follow-up examination and 16 21% eyes showed <glaucoma>}
{<open-angle glaucoma>,<patients examined in 2001 77 69% subjects participated in the follow-up examination and 16 21% eyes showed >,<glaucoma>
{ for primary <open-angle glaucoma>POAG the major type of <glaucoma>}
{<open-angle glaucoma>,<POAG the major type of >,<glaucoma>
{ â€ Eighty-four <open-angle glaucoma>patients 20 diabetic open-angle <glaucoma>}
{<open-angle glaucoma>,<patients 20 diabetic open-angle >,<glaucoma>
{The diagnosis was <open-angle glaucoma>in 15 eyes pseudoexfoliative glaucoma in 12 eyes secondary rubeotic glaucoma in 7 eyes and secondary <glaucoma>}
{<open-angle glaucoma>,<in 15 eyes pseudoexfoliative glaucoma in 12 eyes secondary rubeotic glaucoma in 7 eyes and secondary >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG with spectral-domain optical coherence tomography SD-OCT and to investigate the relationship of SC size with intraocular pressure IOP and <glaucoma>}
{<open-angle glaucoma>,<POAG with spectral-domain optical coherence tomography SD-OCT and to investigate the relationship of SC size with intraocular pressure IOP and >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG 82 patients with primary angle closure <glaucoma>}
{<open-angle glaucoma>,<POAG 82 patients with primary angle closure >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and 30 patients with pseudoexfoliation <glaucoma>}
{<open-angle glaucoma>,<POAG and 30 patients with pseudoexfoliation >,<glaucoma>
{Among persons with <open-angle glaucoma>or <glaucoma>}
{<open-angle glaucoma>,<or >,<glaucoma>
{patients with primary <open-angle glaucoma>with and without one or more of the prognostic factors for filtration failure of primary <glaucoma>}
{<open-angle glaucoma>,<with and without one or more of the prognostic factors for filtration failure of primary >,<glaucoma>
{medically uncontrolled chronic <open-angle glaucoma>and without previous <glaucoma>}
{<open-angle glaucoma>,<and without previous >,<glaucoma>
{highly myopic primary <open-angle glaucoma>pseudoexfoliative glaucoma and focal normal-pressure <glaucoma>}
{<open-angle glaucoma>,<pseudoexfoliative glaucoma and focal normal-pressure >,<glaucoma>
{patients with secondary <open-angle glaucoma>including 85 patients with pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<including 85 patients with pseudoexfoliative >,<glaucoma>
{eyes with primary <open-angle glaucoma>POAG and in eyes with pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG and in eyes with pseudoexfoliative >,<glaucoma>
{hypertension or primary <open-angle glaucoma>who were prescribed latanoprost for the purpose of simplifying their <glaucoma>}
{<open-angle glaucoma>,<who were prescribed latanoprost for the purpose of simplifying their >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and in those with pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG and in those with pseudoexfoliative >,<glaucoma>
{patients with primary <open-angle glaucoma>who underwent a primary <glaucoma>}
{<open-angle glaucoma>,<who underwent a primary >,<glaucoma>
{patients with secondary <open-angle glaucoma>pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<pseudoexfoliative >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG 67 eyes with <glaucoma>}
{<open-angle glaucoma>,<POAG 67 eyes with >,<glaucoma>
{com BACKGROUND Primary <open-angle glaucoma>POAG is the most common form of <glaucoma>}
{<open-angle glaucoma>,<POAG is the most common form of >,<glaucoma>
{with early primary <open-angle glaucoma>or ocular hypertensive <glaucoma>}
{<open-angle glaucoma>,<or ocular hypertensive >,<glaucoma>
{patients with primary <open-angle glaucoma>compared with pseudoexfoliation <glaucoma>}
{<open-angle glaucoma>,<compared with pseudoexfoliation >,<glaucoma>
{as with primary <open-angle glaucoma>though more frequently with primary closed-angle glaucoma in the absence of prophylaxis and with exfoliative <glaucoma>}
{<open-angle glaucoma>,<though more frequently with primary closed-angle glaucoma in the absence of prophylaxis and with exfoliative >,<glaucoma>
{ PARTICIPANTS Twenty-four <open-angle glaucoma>17 primary open-angle and 7 pseudo-exfoliation <glaucoma>}
{<open-angle glaucoma>,<17 primary open-angle and 7 pseudo-exfoliation >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and control subjects and to identify patients with ocular hypertension OHT at risk for developing <glaucoma>}
{<open-angle glaucoma>,<POAG and control subjects and to identify patients with ocular hypertension OHT at risk for developing >,<glaucoma>
{   <open-angle glaucoma>but not significantly different among eyes with various stages of <glaucoma>}
{<open-angle glaucoma>,<but not significantly different among eyes with various stages of >,<glaucoma>
{eyes with primary <open-angle glaucoma>POAG and to correlate their concentration with severity of <glaucoma>}
{<open-angle glaucoma>,<POAG and to correlate their concentration with severity of >,<glaucoma>
{likely to have <open-angle glaucoma>were older men and had a family history of open-angle <glaucoma>}
{<open-angle glaucoma>,<were older men and had a family history of open-angle >,<glaucoma>
{CS in primary <open-angle glaucoma>and that increased amounts of CS could play a key role in the IOP dysregulation characteristic of <glaucoma>}
{<open-angle glaucoma>,<and that increased amounts of CS could play a key role in the IOP dysregulation characteristic of >,<glaucoma>
{patients with primary <open-angle glaucoma>n = 114 pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<n = 114 pseudoexfoliative >,<glaucoma>
{ability to distinguish <open-angle glaucoma>OAG patients from <glaucoma>}
{<open-angle glaucoma>,<OAG patients from >,<glaucoma>
{patients with primary <open-angle glaucoma>and in one patient with juvenile <glaucoma>}
{<open-angle glaucoma>,<and in one patient with juvenile >,<glaucoma>
{patients with primary <open-angle glaucoma>the EX-PRESS <glaucoma>}
{<open-angle glaucoma>,<the EX-PRESS >,<glaucoma>
{indices in primary <open-angle glaucoma>patients and <glaucoma>}
{<open-angle glaucoma>,<patients and >,<glaucoma>
{rs13181 with primary <open-angle glaucoma>POAG and primary closed-angle <glaucoma>}
{<open-angle glaucoma>,<POAG and primary closed-angle >,<glaucoma>
{patients with primary <open-angle glaucoma>and 24 patients without <glaucoma>}
{<open-angle glaucoma>,<and 24 patients without >,<glaucoma>
{patients with primary <open-angle glaucoma>POAG and pseudoexfoliative <glaucoma>}
{<open-angle glaucoma>,<POAG and pseudoexfoliative >,<glaucoma>
{ocular hypertension primary <open-angle glaucoma>and normal-pressure <glaucoma>}
{<open-angle glaucoma>,<and normal-pressure >,<glaucoma>
{a form of <open-angle glaucoma>in which developmental anomalies of the iris and irido-corneal angle are associated with a juvenile-onset <glaucoma>}
{<open-angle glaucoma>,<in which developmental anomalies of the iris and irido-corneal angle are associated with a juvenile-onset >,<glaucoma>
{patients with primary <open-angle glaucoma>53 patients with pseudoexfoliative glaucoma and 55 patients with normal-pressure <glaucoma>}
{<open-angle glaucoma>,<53 patients with pseudoexfoliative glaucoma and 55 patients with normal-pressure >,<glaucoma>
{patients with primary <open-angle glaucoma>compared with normal subjects and patients with normal-pressure <glaucoma>}
{<open-angle glaucoma>,<compared with normal subjects and patients with normal-pressure >,<glaucoma>
{patients with primary <open-angle glaucoma>and 43 patients with normal-pressure <glaucoma>}
{<open-angle glaucoma>,<and 43 patients with normal-pressure >,<glaucoma>
{ocular hypertension primary <open-angle glaucoma>and normal-pressure <glaucoma>}
{<open-angle glaucoma>,<and normal-pressure >,<glaucoma>
{patients with primary <open-angle glaucoma>and normal-pressure <glaucoma>}
{<open-angle glaucoma>,<and normal-pressure >,<glaucoma>
schizophrenia amyotrophic lateral sclerosis,glaucoma
{   <schizophrenia amyotrophic lateral sclerosis>or <glaucoma>}
{<schizophrenia amyotrophic lateral sclerosis>,<or >,<glaucoma>
age related macular degeneration primary open angle glaucoma,diabetic retinopathy
{   <age related macular degeneration primary open angle glaucoma>and <diabetic retinopathy>}
{<age related macular degeneration primary open angle glaucoma>,<and >,<diabetic retinopathy>
age-related macular degeneration optic neuritis,retinal detachment
{   <age-related macular degeneration optic neuritis>and <retinal detachment>}
{<age-related macular degeneration optic neuritis>,<and >,<retinal detachment>
anemia,wound
{   <anemia>and <wound>}
{<anemia>,<and >,<wound>
sepsis,acute appendicitis
{   <sepsis>and <acute appendicitis>}
{<sepsis>,<and >,<acute appendicitis>
{patients with HSP <sepsis>patients with rash patients with urticaria simple hematuria or <acute appendicitis>}
{<sepsis>,<patients with rash patients with urticaria simple hematuria or >,<acute appendicitis>
{4 manifested with <sepsis>and concurrent <acute appendicitis>}
{<sepsis>,<and concurrent >,<acute appendicitis>
age-related macular degeneration,glaucoma
{   <age-related macular degeneration>and <glaucoma>}
{<age-related macular degeneration>,<and >,<glaucoma>
{   <age-related macular degeneration>and <glaucoma>}
{<age-related macular degeneration>,<and >,<glaucoma>
{ such as <age-related macular degeneration>AMD and <glaucoma>}
{<age-related macular degeneration>,<AMD and >,<glaucoma>
{and frequencies of <age-related macular degeneration>retinal vein occlusions and chronic open-angle <glaucoma>}
{<age-related macular degeneration>,<retinal vein occlusions and chronic open-angle >,<glaucoma>
{patients with exudative <age-related macular degeneration>AMD and <glaucoma>}
{<age-related macular degeneration>,<AMD and >,<glaucoma>
{irreversible blindness include <age-related macular degeneration>retinal vascular diseases and <glaucoma>}
{<age-related macular degeneration>,<retinal vascular diseases and >,<glaucoma>
{patients with exudative <age-related macular degeneration>and concomitant <glaucoma>}
{<age-related macular degeneration>,<and concomitant >,<glaucoma>
{eyes with exudative <age-related macular degeneration>and <glaucoma>}
{<age-related macular degeneration>,<and >,<glaucoma>
{risk of cataract <age-related macular degeneration>and <glaucoma>}
{<age-related macular degeneration>,<and >,<glaucoma>
{potential role in <age-related macular degeneration>and some types of <glaucoma>}
{<age-related macular degeneration>,<and some types of >,<glaucoma>
{ two eyes <age-related macular degeneration>two eyes <glaucoma>}
{<age-related macular degeneration>,<two eyes >,<glaucoma>
Measles,acute appendicitis
{   <Measles>and <acute appendicitis>}
{<Measles>,<and >,<acute appendicitis>
{   <Measles>and <acute appendicitis>}
{<Measles>,<and >,<acute appendicitis>
Sarcoidosis,uveitis
{   <Sarcoidosis>and <uveitis>}
{<Sarcoidosis>,<and >,<uveitis>
{   <Sarcoidosis>is an uncommon cause of childhood <uveitis>}
{<Sarcoidosis>,<is an uncommon cause of childhood >,<uveitis>
choroidal degeneration cataracts,glaucoma
{   <choroidal degeneration cataracts>and <glaucoma>}
{<choroidal degeneration cataracts>,<and >,<glaucoma>
hyperuricemia,gout
{risk factors for <hyperuricemia>and <gout>}
{<hyperuricemia>,<and >,<gout>
{The kidney in <hyperuricemia>and <gout>}
{<hyperuricemia>,<and >,<gout>
{frequently associated with <hyperuricemia>and <gout>}
{<hyperuricemia>,<and >,<gout>
{of management of <hyperuricemia>and <gout>}
{<hyperuricemia>,<and >,<gout>
{approaches to chronic <hyperuricemia>and <gout>}
{<hyperuricemia>,<and >,<gout>
{  and <hyperuricemia>contribute to the pathogenesis of their comorbidities creates greater urgency for appropriate <gout>}
{<hyperuricemia>,<contribute to the pathogenesis of their comorbidities creates greater urgency for appropriate >,<gout>
{  and <hyperuricemia>has increased dramatically during the last several decades to the point that <gout>}
{<hyperuricemia>,<has increased dramatically during the last several decades to the point that >,<gout>
Diabetic maculopathy,glaucoma
{   <Diabetic maculopathy>and <glaucoma>}
{<Diabetic maculopathy>,<and >,<glaucoma>
Intussusception,acute appendicitis
{   <Intussusception>and <acute appendicitis>}
{<Intussusception>,<and >,<acute appendicitis>
ocular hypertension,primary open-angle glaucoma
{in eyes with <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{diagnosis of either <ocular hypertension>OHT or <primary open-angle glaucoma>}
{<ocular hypertension>,<OHT or >,<primary open-angle glaucoma>
{risk factor for <ocular hypertension>OH vs glaucomatous optic nerve damage we reviewed the clinical records of 361 <primary open-angle glaucoma>}
{<ocular hypertension>,<OH vs glaucomatous optic nerve damage we reviewed the clinical records of 361 >,<primary open-angle glaucoma>
{The pathophysiology of <ocular hypertension>OH leading to <primary open-angle glaucoma>}
{<ocular hypertension>,<OH leading to >,<primary open-angle glaucoma>
{58 eyes with <ocular hypertension>OHT or <primary open-angle glaucoma>}
{<ocular hypertension>,<OHT or >,<primary open-angle glaucoma>
{ BACKGROUND Steroid-induced <ocular hypertension>is currently treated in the same way as <primary open-angle glaucoma>}
{<ocular hypertension>,<is currently treated in the same way as >,<primary open-angle glaucoma>
{between different groups <ocular hypertension>n=16 eyes glaucoma suspects n=15 and <primary open-angle glaucoma>}
{<ocular hypertension>,<n=16 eyes glaucoma suspects n=15 and >,<primary open-angle glaucoma>
{for glaucoma and <ocular hypertension>OHT in England and 2 any geographical variation in glaucoma/OHT prescribing trends and its association with established risk factors for <primary open-angle glaucoma>}
{<ocular hypertension>,<OHT in England and 2 any geographical variation in glaucoma/OHT prescribing trends and its association with established risk factors for >,<primary open-angle glaucoma>
{the treatment of <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{the definitions of <ocular hypertension>OH and <primary open-angle glaucoma>}
{<ocular hypertension>,<OH and >,<primary open-angle glaucoma>
{patients with treated <ocular hypertension>OHT and <primary open-angle glaucoma>}
{<ocular hypertension>,<OHT and >,<primary open-angle glaucoma>
{16 subjects with <ocular hypertension>OHT in 16 subjects with <primary open-angle glaucoma>}
{<ocular hypertension>,<OHT in 16 subjects with >,<primary open-angle glaucoma>
{and previously treated <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{the majority of <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{Initial management of <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{ suspect GS <ocular hypertension>OHT 59 primary angle-closure disease PACD 36 <primary open-angle glaucoma>}
{<ocular hypertension>,<OHT 59 primary angle-closure disease PACD 36 >,<primary open-angle glaucoma>
{following clinical diagnoses <ocular hypertension>OHT <primary open-angle glaucoma>}
{<ocular hypertension>,<OHT >,<primary open-angle glaucoma>
{introduced to treat <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{influence conversion of <ocular hypertension>into <primary open-angle glaucoma>}
{<ocular hypertension>,<into >,<primary open-angle glaucoma>
{clinical differentiation of <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{to that of <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{in diagnostics of <ocular hypertension>and its conversion into <primary open-angle glaucoma>}
{<ocular hypertension>,<and its conversion into >,<primary open-angle glaucoma>
{endothelial dysfunction in <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{with normal findings <ocular hypertension>OHT and <primary open-angle glaucoma>}
{<ocular hypertension>,<OHT and >,<primary open-angle glaucoma>
{the diagnosis of <ocular hypertension>and its conversion to <primary open-angle glaucoma>}
{<ocular hypertension>,<and its conversion to >,<primary open-angle glaucoma>
{74 eyes with <ocular hypertension>suspected glaucoma or <primary open-angle glaucoma>}
{<ocular hypertension>,<suspected glaucoma or >,<primary open-angle glaucoma>
{  So-called <ocular hypertension>and new signs of <primary open-angle glaucoma>}
{<ocular hypertension>,<and new signs of >,<primary open-angle glaucoma>
{in cases of <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{  of <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{similarities between DEX-induced <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{enzyme inhibitor in <ocular hypertension>and <primary open-angle glaucoma>}
{<ocular hypertension>,<and >,<primary open-angle glaucoma>
{was chosen from <ocular hypertension>OH patients 27 glaucoma-suspect GS patients 35 <primary open-angle glaucoma>}
{<ocular hypertension>,<OH patients 27 glaucoma-suspect GS patients 35 >,<primary open-angle glaucoma>
chronic kidney disease,chronic lung disease
{   <chronic kidney disease>and <chronic lung disease>}
{<chronic kidney disease>,<and >,<chronic lung disease>
Pseudophakia,glaucoma
{   <Pseudophakia>and <glaucoma>}
{<Pseudophakia>,<and >,<glaucoma>
glaucoma cataract,diabetic retinopathy
{  AMD <glaucoma cataract>and <diabetic retinopathy>}
{<glaucoma cataract>,<and >,<diabetic retinopathy>
{macular degeneration open-angle <glaucoma cataract>and <diabetic retinopathy>}
{<glaucoma cataract>,<and >,<diabetic retinopathy>
{   <glaucoma cataract>and <diabetic retinopathy>}
{<glaucoma cataract>,<and >,<diabetic retinopathy>
metabolic syndrome,fatty liver
{features of the <metabolic syndrome>and <fatty liver>}
{<metabolic syndrome>,<and >,<fatty liver>
{insulin resistance and <metabolic syndrome>predisposing individuals to a greater risk for the development of non-alcoholic <fatty liver>}
{<metabolic syndrome>,<predisposing individuals to a greater risk for the development of non-alcoholic >,<fatty liver>
{profile of the <metabolic syndrome>a condition frequently associated with <fatty liver>}
{<metabolic syndrome>,<a condition frequently associated with >,<fatty liver>
{role in obesity <metabolic syndrome>and <fatty liver>}
{<metabolic syndrome>,<and >,<fatty liver>
{key components of <metabolic syndrome>glucose and triglycerides are overproduced by the <fatty liver>}
{<metabolic syndrome>,<glucose and triglycerides are overproduced by the >,<fatty liver>
syncope allergic reactions,anaphylaxis
{   <syncope allergic reactions>and <anaphylaxis>}
{<syncope allergic reactions>,<and >,<anaphylaxis>
age-related macular degeneration retinitis pigmentosa,choroideremia
{   <age-related macular degeneration retinitis pigmentosa>or <choroideremia>}
{<age-related macular degeneration retinitis pigmentosa>,<or >,<choroideremia>
myopia cataracts,uveitis
{  AMD <myopia cataracts>and <uveitis>}
{<myopia cataracts>,<and >,<uveitis>
signs,symptoms
{the relationship between <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{causes of clinical <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{children with equivocal <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{no specific clinical <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{children with equivocal <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{patients with equivocal <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{recognition of characteristic <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{patients who had <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{present with equivocal <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{duration of symptoms <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{basis of clinical <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{lifestyle comorbidities uraemic <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{overlap in presenting <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{Diagnostic validity of <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{differences in clinical <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{with age or <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{patient demographics presenting <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{the four following <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{by nonspecific clinical <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{days until their <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{ four with <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{function and uraemic <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{complete resolution of <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{surface might reduce <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{embodied by various <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{not have localizing <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{causes common presenting <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{early detection of <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{not associated with <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{large variety of <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{discontinued D-penicillamine her <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{ monitoring for <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{Due to vague <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{in the clinical <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{  The <signs><symptoms>}
{<signs>,<>,<symptoms>
{present with various <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{abdomen with accompanying <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{present with various <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{ Demographic factors <signs><symptoms>}
{<signs>,<>,<symptoms>
{pupil size ocular <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{by other non-specific <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{necessary only if <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{disease hyperemia ocular <signs><symptoms>}
{<signs>,<>,<symptoms>
{ Profile of <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{girl presented with <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{the known classical <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{may have dramatic <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{present with various <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{about glaucoma its <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{and after appendectomy <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{without masking physical <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{on admission with <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{in patients whose <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{and presented with <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{18 years had <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{utility for presenting <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
{166 children presenting <signs>and <symptoms>}
{<signs>,<and >,<symptoms>
open-angle glaucoma,pseudoexfoliation glaucoma
{patients with primary <open-angle glaucoma>and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<and >,<pseudoexfoliation glaucoma>
{patients had primary <open-angle glaucoma>or <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<or >,<pseudoexfoliation glaucoma>
{eyes with primary <open-angle glaucoma>POAG <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG >,<pseudoexfoliation glaucoma>
{patients with primary <open-angle glaucoma>POAG and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG and >,<pseudoexfoliation glaucoma>
{biometry in primary <open-angle glaucoma>POAG and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG and >,<pseudoexfoliation glaucoma>
{analogues for primary <open-angle glaucoma>n = 25 or <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<n = 25 or >,<pseudoexfoliation glaucoma>
{128 eyes chronic <open-angle glaucoma>82% <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<82% >,<pseudoexfoliation glaucoma>
{surgery for primary <open-angle glaucoma>or <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<or >,<pseudoexfoliation glaucoma>
{goniotrephination in primary <open-angle glaucoma>and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<and >,<pseudoexfoliation glaucoma>
{surgery for primary <open-angle glaucoma>POAG and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG and >,<pseudoexfoliation glaucoma>
{-13 with primary <open-angle glaucoma>POAG and four with <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG and four with >,<pseudoexfoliation glaucoma>
{patients with primary <open-angle glaucoma>including <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<including >,<pseudoexfoliation glaucoma>
{myocilin in primary <open-angle glaucoma>POAG and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG and >,<pseudoexfoliation glaucoma>
{medically uncontrolled primary <open-angle glaucoma>or <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<or >,<pseudoexfoliation glaucoma>
{patients with primary <open-angle glaucoma>POAG and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG and >,<pseudoexfoliation glaucoma>
{Greece with primary <open-angle glaucoma>and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<and >,<pseudoexfoliation glaucoma>
{association with primary <open-angle glaucoma>POAG and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG and >,<pseudoexfoliation glaucoma>
{positions in primary <open-angle glaucoma>POAG and <pseudoexfoliation glaucoma>}
{<open-angle glaucoma>,<POAG and >,<pseudoexfoliation glaucoma>
portal vein obstruction,portal hypertension
{risk of developing <portal vein obstruction>and <portal hypertension>}
{<portal vein obstruction>,<and >,<portal hypertension>
vomiting constipation,fever
{   <vomiting constipation>and <fever>}
{<vomiting constipation>,<and >,<fever>
nonalcoholic fatty liver disease,atherosclerosis
{   <nonalcoholic fatty liver disease>and <atherosclerosis>}
{<nonalcoholic fatty liver disease>,<and >,<atherosclerosis>
{the severity of <nonalcoholic fatty liver disease>bear a positive consequence on evolution of <atherosclerosis>}
{<nonalcoholic fatty liver disease>,<bear a positive consequence on evolution of >,<atherosclerosis>
{the relationship between <nonalcoholic fatty liver disease>and <atherosclerosis>}
{<nonalcoholic fatty liver disease>,<and >,<atherosclerosis>
Non-Alcoholic Fatty Liver Disease,Atherosclerosis
{   <Non-Alcoholic Fatty Liver Disease>and <Atherosclerosis>}
{<Non-Alcoholic Fatty Liver Disease>,<and >,<Atherosclerosis>
diarrhea abdominal pain,weight loss
{   <diarrhea abdominal pain>and <weight loss>}
{<diarrhea abdominal pain>,<and >,<weight loss>
Sudden cardiac death,diabetes mellitus
{   <Sudden cardiac death>and <diabetes mellitus>}
{<Sudden cardiac death>,<and >,<diabetes mellitus>
Glaucomatocyclitic crisis,primary open-angle glaucoma
{   <Glaucomatocyclitic crisis>and <primary open-angle glaucoma>}
{<Glaucomatocyclitic crisis>,<and >,<primary open-angle glaucoma>
{   <Glaucomatocyclitic crisis>showed a more significant hypotensive response to 1% apraclonidine than <primary open-angle glaucoma>}
{<Glaucomatocyclitic crisis>,<showed a more significant hypotensive response to 1% apraclonidine than >,<primary open-angle glaucoma>
ocular ischemic syndrome,glaucoma
{   <ocular ischemic syndrome>or <glaucoma>}
{<ocular ischemic syndrome>,<or >,<glaucoma>
Hypothyroidism,open-angle glaucoma
{   <Hypothyroidism>and <open-angle glaucoma>}
{<Hypothyroidism>,<and >,<open-angle glaucoma>
{   <Hypothyroidism>and the risk of developing <open-angle glaucoma>}
{<Hypothyroidism>,<and the risk of developing >,<open-angle glaucoma>
{   <Hypothyroidism>and <open-angle glaucoma>}
{<Hypothyroidism>,<and >,<open-angle glaucoma>
{   <Hypothyroidism>was diagnosed in a 62-year-old woman with poorly controlled primary <open-angle glaucoma>}
{<Hypothyroidism>,<was diagnosed in a 62-year-old woman with poorly controlled primary >,<open-angle glaucoma>
angle-closure glaucoma,pseudophakia
{patients with primary <angle-closure glaucoma>and <pseudophakia>}
{<angle-closure glaucoma>,<and >,<pseudophakia>
Headache,abdominal pain
{   <Headache>and <abdominal pain>}
{<Headache>,<and >,<abdominal pain>
psoriasis inflammatory bowel disease,ankylosing spondylitis
{   <psoriasis inflammatory bowel disease>and <ankylosing spondylitis>}
{<psoriasis inflammatory bowel disease>,<and >,<ankylosing spondylitis>
Iridoschisis,glaucoma
{   <Iridoschisis>and <glaucoma>}
{<Iridoschisis>,<and >,<glaucoma>
Ileocolic intussusceptions,intussusceptions
{   <Ileocolic intussusceptions>and <intussusceptions>}
{<Ileocolic intussusceptions>,<and >,<intussusceptions>
open-angle glaucoma,cataract
{patients with primary <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{  patients <open-angle glaucoma>patients 25 <cataract>}
{<open-angle glaucoma>,<patients 25 >,<cataract>
{reported case of <open-angle glaucoma>after primary intraocular lens IOL implantation for congenital or developmental <cataract>}
{<open-angle glaucoma>,<after primary intraocular lens IOL implantation for congenital or developmental >,<cataract>
{patients with chronic <open-angle glaucoma>undergoing trabeculectomy primary or surgical revision of failed trabeculectomy trabeculectomy combined with <cataract>}
{<open-angle glaucoma>,<undergoing trabeculectomy primary or surgical revision of failed trabeculectomy trabeculectomy combined with >,<cataract>
{  METHODS <open-angle glaucoma>OAG eyes with <cataract>}
{<open-angle glaucoma>,<OAG eyes with >,<cataract>
{patients with primary <open-angle glaucoma>and concurrent <cataract>}
{<open-angle glaucoma>,<and concurrent >,<cataract>
{patients with primary <open-angle glaucoma>with coexisting <cataract>}
{<open-angle glaucoma>,<with coexisting >,<cataract>
{  IOP <open-angle glaucoma>OAG and use of glaucoma medications with 5-year incident <cataract>}
{<open-angle glaucoma>,<OAG and use of glaucoma medications with 5-year incident >,<cataract>
{was caused by <open-angle glaucoma>OAG alone or combined with <cataract>}
{<open-angle glaucoma>,<OAG alone or combined with >,<cataract>
{patients with uncontrolled <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{antifibrotics in primary <open-angle glaucoma>with coexisting <cataract>}
{<open-angle glaucoma>,<with coexisting >,<cataract>
{with uncontrolled primary <open-angle glaucoma>including pseudoexfoliation and pigmentary and a cataract underwent clear cornea phacoemulsification <cataract>}
{<open-angle glaucoma>,<including pseudoexfoliation and pigmentary and a cataract underwent clear cornea phacoemulsification >,<cataract>
{patients with primary <open-angle glaucoma>and coexisting <cataract>}
{<open-angle glaucoma>,<and coexisting >,<cataract>
{treatment of primary <open-angle glaucoma>and coexisting <cataract>}
{<open-angle glaucoma>,<and coexisting >,<cataract>
{population with primary <open-angle glaucoma>each implanted with one trabecular micro-bypass stent during <cataract>}
{<open-angle glaucoma>,<each implanted with one trabecular micro-bypass stent during >,<cataract>
{humour in primary <open-angle glaucoma>POAG exfoliative glaucoma EXFG or <cataract>}
{<open-angle glaucoma>,<POAG exfoliative glaucoma EXFG or >,<cataract>
{mild or moderate <open-angle glaucoma>or OHT and <cataract>}
{<open-angle glaucoma>,<or OHT and >,<cataract>
{patients with primary <open-angle glaucoma>with a history of glaucoma filtration surgery requiring glaucoma medical therapy and in need of <cataract>}
{<open-angle glaucoma>,<with a history of glaucoma filtration surgery requiring glaucoma medical therapy and in need of >,<cataract>
{patients with primary <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{  and <open-angle glaucoma>following congenital <cataract>}
{<open-angle glaucoma>,<following congenital >,<cataract>
{the prevalence of <open-angle glaucoma>and of different types of <cataract>}
{<open-angle glaucoma>,<and of different types of >,<cataract>
{patients with primary <open-angle glaucoma>POAG with cataract and in patients with only <cataract>}
{<open-angle glaucoma>,<POAG with cataract and in patients with only >,<cataract>
{trabeculotomy for primary <open-angle glaucoma>and the normal aqueous from normal bovine eyes and patients undergoing <cataract>}
{<open-angle glaucoma>,<and the normal aqueous from normal bovine eyes and patients undergoing >,<cataract>
{patients with primary <open-angle glaucoma>POAG and <cataract>}
{<open-angle glaucoma>,<POAG and >,<cataract>
{phacoemulsification for coexistent <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{patients with mild-to-moderate <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{patients with primary <open-angle glaucoma>POAG were collected during phacoemulsification <cataract>}
{<open-angle glaucoma>,<POAG were collected during phacoemulsification >,<cataract>
{canaloplasty to treat <open-angle glaucoma>when combined with <cataract>}
{<open-angle glaucoma>,<when combined with >,<cataract>
{ rise in <open-angle glaucoma>patients after <cataract>}
{<open-angle glaucoma>,<patients after >,<cataract>
{anterior chamber in <open-angle glaucoma>in one patient who developed this phenomenon several years after an intracapsular <cataract>}
{<open-angle glaucoma>,<in one patient who developed this phenomenon several years after an intracapsular >,<cataract>
{patients with primary <open-angle glaucoma>POAG after previous glaucomatous and/or <cataract>}
{<open-angle glaucoma>,<POAG after previous glaucomatous and/or >,<cataract>
{out-patients with primary <open-angle glaucoma>and 18 <cataract>}
{<open-angle glaucoma>,<and 18 >,<cataract>
{and effective for <open-angle glaucoma>OAG subjects during <cataract>}
{<open-angle glaucoma>,<OAG subjects during >,<cataract>
{ in primary <open-angle glaucoma>POAG the protein profiles of aqueous humor obtained from POAG patients were compared with those of <cataract>}
{<open-angle glaucoma>,<POAG the protein profiles of aqueous humor obtained from POAG patients were compared with those of >,<cataract>
{193 eyes with <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{patients with uncontrolled <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{a new primary <open-angle glaucoma>POAG diagnosis within 365 days after <cataract>}
{<open-angle glaucoma>,<POAG diagnosis within 365 days after >,<cataract>
{of advanced primary <open-angle glaucoma>POAG as well as from ten age-matched normal human subjects undergoing <cataract>}
{<open-angle glaucoma>,<POAG as well as from ten age-matched normal human subjects undergoing >,<cataract>
{patients affected by <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{surgical treatment for <open-angle glaucoma>in glaucoma patients with coexisting <cataract>}
{<open-angle glaucoma>,<in glaucoma patients with coexisting >,<cataract>
{patients with concurrent <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{Seventeen cases of <open-angle glaucoma>requiring cataract extraction underwent intracapsular <cataract>}
{<open-angle glaucoma>,<requiring cataract extraction underwent intracapsular >,<cataract>
{it to primary <open-angle glaucoma>POAG and <cataract>}
{<open-angle glaucoma>,<POAG and >,<cataract>
{surgical treatment for <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{ Uncontrolled primary <open-angle glaucoma>and coexisting <cataract>}
{<open-angle glaucoma>,<and coexisting >,<cataract>
{for rates of <open-angle glaucoma>increased IOP of 4 mmHg from baseline change in IOP from baseline and <cataract>}
{<open-angle glaucoma>,<increased IOP of 4 mmHg from baseline change in IOP from baseline and >,<cataract>
{patients with primary <open-angle glaucoma>POAG as well as those with senile <cataract>}
{<open-angle glaucoma>,<POAG as well as those with senile >,<cataract>
{patients with primary <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{to treat coexistent <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{patients with primary <open-angle glaucoma>POAG and group III comprised 25 patients with senile <cataract>}
{<open-angle glaucoma>,<POAG and group III comprised 25 patients with senile >,<cataract>
{glaucoma developed secondary <open-angle glaucoma>after an intracapsular <cataract>}
{<open-angle glaucoma>,<after an intracapsular >,<cataract>
{implantation for coexistent <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{patients with chronic <open-angle glaucoma>and <cataract>}
{<open-angle glaucoma>,<and >,<cataract>
{patients with chronic <open-angle glaucoma>who underwent combined trabeculectomy and <cataract>}
{<open-angle glaucoma>,<who underwent combined trabeculectomy and >,<cataract>
disease celiac disease,irritable bowel syndrome
{   <disease celiac disease>and <irritable bowel syndrome>}
{<disease celiac disease>,<and >,<irritable bowel syndrome>
ocular hypertension,open-angle glaucoma
{the management of <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{of progression from <ocular hypertension>to primary <open-angle glaucoma>}
{<ocular hypertension>,<to primary >,<open-angle glaucoma>
{the conversion from <ocular hypertension>OHT to primary <open-angle glaucoma>}
{<ocular hypertension>,<OHT to primary >,<open-angle glaucoma>
{patients with either <ocular hypertension>OHT or <open-angle glaucoma>}
{<ocular hypertension>,<OHT or >,<open-angle glaucoma>
{the fundus in <ocular hypertension>OHT and <open-angle glaucoma>}
{<ocular hypertension>,<OHT and >,<open-angle glaucoma>
{the cornea in <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{development of glaucomatous <ocular hypertension>and a secondary <open-angle glaucoma>}
{<ocular hypertension>,<and a secondary >,<open-angle glaucoma>
{the progression from <ocular hypertension>to primary <open-angle glaucoma>}
{<ocular hypertension>,<to primary >,<open-angle glaucoma>
{of conversion of <ocular hypertension>into a primary <open-angle glaucoma>}
{<ocular hypertension>,<into a primary >,<open-angle glaucoma>
{retinal function in <ocular hypertension>OHT and <open-angle glaucoma>}
{<ocular hypertension>,<OHT and >,<open-angle glaucoma>
{Glucocorticoid GC -induced <ocular hypertension>and secondary iatrogenic <open-angle glaucoma>}
{<ocular hypertension>,<and secondary iatrogenic >,<open-angle glaucoma>
{characteristics in untreated <ocular hypertension>OH and in topically treated primary <open-angle glaucoma>}
{<ocular hypertension>,<OH and in topically treated primary >,<open-angle glaucoma>
{patients with long-standing <ocular hypertension>and patients with primary <open-angle glaucoma>}
{<ocular hypertension>,<and patients with primary >,<open-angle glaucoma>
{maleate to treat <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{  or <ocular hypertension>show such a decrease in aqueous humor flow with age or whether there is an autoregulation mechanism in eyes with primary <open-angle glaucoma>}
{<ocular hypertension>,<show such a decrease in aqueous humor flow with age or whether there is an autoregulation mechanism in eyes with primary >,<open-angle glaucoma>
{and retina in <ocular hypertension>and high pressure <open-angle glaucoma>}
{<ocular hypertension>,<and high pressure >,<open-angle glaucoma>
{overall prevalence of <ocular hypertension>hypertensive primary <open-angle glaucoma>}
{<ocular hypertension>,<hypertensive primary >,<open-angle glaucoma>
{pulse amplitude in <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{ Correlation between <ocular hypertension>induced by ibopamine and perimetric defect in primary <open-angle glaucoma>}
{<ocular hypertension>,<induced by ibopamine and perimetric defect in primary >,<open-angle glaucoma>
{monkey with angle-laser-induced <ocular hypertension>and of a human with primary <open-angle glaucoma>}
{<ocular hypertension>,<and of a human with primary >,<open-angle glaucoma>
{gender-specific prevalences of <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{Doppler imaging in <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{care for both <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{patients affected by <ocular hypertension>from developing primary <open-angle glaucoma>}
{<ocular hypertension>,<from developing primary >,<open-angle glaucoma>
{a change from <ocular hypertension>to primary <open-angle glaucoma>}
{<ocular hypertension>,<to primary >,<open-angle glaucoma>
{ 123 cases <ocular hypertension>186 cases and <open-angle glaucoma>}
{<ocular hypertension>,<186 cases and >,<open-angle glaucoma>
{and hemodynamics in <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{first-line treatment for <ocular hypertension>and <open-angle glaucoma>}
{<ocular hypertension>,<and >,<open-angle glaucoma>
{who transition from <ocular hypertension>to primary <open-angle glaucoma>}
{<ocular hypertension>,<to primary >,<open-angle glaucoma>
{of transition from <ocular hypertension>OHT to primary <open-angle glaucoma>}
{<ocular hypertension>,<OHT to primary >,<open-angle glaucoma>
{in newly diagnosed <ocular hypertension>OH or <open-angle glaucoma>}
{<ocular hypertension>,<OH or >,<open-angle glaucoma>
{The prevalence of <ocular hypertension>but not primary <open-angle glaucoma>}
{<ocular hypertension>,<but not primary >,<open-angle glaucoma>
{development of GC-induced <ocular hypertension>causing secondary <open-angle glaucoma>}
{<ocular hypertension>,<causing secondary >,<open-angle glaucoma>
{of conversion from <ocular hypertension>to primary <open-angle glaucoma>}
{<ocular hypertension>,<to primary >,<open-angle glaucoma>
{ PARTICIPANTS Twenty-four <ocular hypertension>and 64 <open-angle glaucoma>}
{<ocular hypertension>,<and 64 >,<open-angle glaucoma>
{Eighty-eight eyes from <ocular hypertension>and 64 <open-angle glaucoma>}
{<ocular hypertension>,<and 64 >,<open-angle glaucoma>
cataract,glaucoma
{the management of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{and triple procedure <cataract>extraction by phacoemulsification intraocular lens implantation and trabeculectomy 1 542 eyes of 900 patients with primary open angle glaucoma POAG or chronic primary angle closure <glaucoma>}
{<cataract>,<extraction by phacoemulsification intraocular lens implantation and trabeculectomy 1 542 eyes of 900 patients with primary open angle glaucoma POAG or chronic primary angle closure >,<glaucoma>
{the influence of <cataract>surgery on the quantitative and qualitative parameters of visual field in patients previously operated for <glaucoma>}
{<cataract>,<surgery on the quantitative and qualitative parameters of visual field in patients previously operated for >,<glaucoma>
{one-stage operation for <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{ Phacoviscocanalostomy versus <cataract>surgery only in patients with coexisting normal-tension <glaucoma>}
{<cataract>,<surgery only in patients with coexisting normal-tension >,<glaucoma>
{IOL implantation and <cataract>surgery phacoemulsification and IOL implantation in patients with normal-tension <glaucoma>}
{<cataract>,<surgery phacoemulsification and IOL implantation in patients with normal-tension >,<glaucoma>
{patients with coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{were 8 RD <cataract>2 <glaucoma>}
{<cataract>,<2 >,<glaucoma>
{manual small incision <cataract>surgery for phacolytic <glaucoma>}
{<cataract>,<surgery for phacolytic >,<glaucoma>
{manual small incision <cataract>surgery MSICS in the treatment of patients with phacolytic <glaucoma>}
{<cataract>,<surgery MSICS in the treatment of patients with phacolytic >,<glaucoma>
{ surgery concomitant <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{effective method of <cataract>extraction for patients with phacolytic <glaucoma>}
{<cataract>,<extraction for patients with phacolytic >,<glaucoma>
{patients with co-existing <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{   <cataract>extraction followed by <glaucoma>}
{<cataract>,<extraction followed by >,<glaucoma>
{Combined surgery versus <cataract>surgery alone for eyes with cataract and <glaucoma>}
{<cataract>,<surgery alone for eyes with cataract and >,<glaucoma>
{and management of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{treatment of comorbid <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{ surgery alone <cataract>surgery with non-concomitant <glaucoma>}
{<cataract>,<surgery with non-concomitant >,<glaucoma>
{common complications included <cataract>36-73% <glaucoma>}
{<cataract>,<36-73% >,<glaucoma>
{combined surgery of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{procedure without concurrent <cataract>extraction does lower IOP and reduces the dependency on <glaucoma>}
{<cataract>,<extraction does lower IOP and reduces the dependency on >,<glaucoma>
{side effects including <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{ was combined <cataract>surgery phacoemulsification and any type of <glaucoma>}
{<cataract>,<surgery phacoemulsification and any type of >,<glaucoma>
{patients having both <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{techniques for co-existing <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{Management of concomitant <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{alone for co-existing <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{effects such as <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{patients with combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{evidence suggests that <cataract>surgery may be useful in the clinical management of eyes with angle closure <glaucoma>}
{<cataract>,<surgery may be useful in the clinical management of eyes with angle closure >,<glaucoma>
{patients undergoing concurrent <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{patients undergoing concurrent <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{two-site bimanual microincisional <cataract>surgery combined with viscocanalostomy plus deeper sclerectomy two-site bimanual MICS-VC-DS in patients with cataract and <glaucoma>}
{<cataract>,<surgery combined with viscocanalostomy plus deeper sclerectomy two-site bimanual MICS-VC-DS in patients with cataract and >,<glaucoma>
{Arab origin with <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{26 females with <cataract>and 48 <glaucoma>}
{<cataract>,<and 48 >,<glaucoma>
{scheduled to undergo <cataract>surgery alone or combined with <glaucoma>}
{<cataract>,<surgery alone or combined with >,<glaucoma>
{presence of uveitic <cataract>and/or <glaucoma>}
{<cataract>,<and/or >,<glaucoma>
{exfoliative glaucoma and <cataract>who had phacoemulsification with endocapsular implantation of a foldable intraocular lens and intracanalicular implantation of an Eyepass <glaucoma>}
{<cataract>,<who had phacoemulsification with endocapsular implantation of a foldable intraocular lens and intracanalicular implantation of an Eyepass >,<glaucoma>
{of eye development <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{side effects including <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{   <cataract>surgery with non-concomitant <glaucoma>}
{<cataract>,<surgery with non-concomitant >,<glaucoma>
{   <cataract>formation and <glaucoma>}
{<cataract>,<formation and >,<glaucoma>
{risk of developing <cataract>or <glaucoma>}
{<cataract>,<or >,<glaucoma>
{increased incidence of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{of development of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{in IOP from <cataract>extraction - greater in the presence of pseudoexfoliation - which is likely to be of marginal benefit and only in milder forms of open-angle <glaucoma>}
{<cataract>,<extraction - greater in the presence of pseudoexfoliation - which is likely to be of marginal benefit and only in milder forms of open-angle >,<glaucoma>
{INTRODUCTION Manual small-incision <cataract>surgery with trabeculectomy is now an acceptable option in the surgical management of combined cataract and <glaucoma>}
{<cataract>,<surgery with trabeculectomy is now an acceptable option in the surgical management of combined cataract and >,<glaucoma>
{combined procedure of <cataract>extraction plus excimer laser trabeculotomy phaco-ELT for a selected group of <glaucoma>}
{<cataract>,<extraction plus excimer laser trabeculotomy phaco-ELT for a selected group of >,<glaucoma>
{procedure in coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{regarding awareness for <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{ and undergoing <cataract>or <glaucoma>}
{<cataract>,<or >,<glaucoma>
{Young patients undergoing <cataract>surgery should be monitored routinely for <glaucoma>}
{<cataract>,<surgery should be monitored routinely for >,<glaucoma>
{when followed by <cataract>surgery increases the risk of open-angle <glaucoma>}
{<cataract>,<surgery increases the risk of open-angle >,<glaucoma>
{need for combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{intraocular pressure after <cataract>surgery in primary <glaucoma>}
{<cataract>,<surgery in primary >,<glaucoma>
{cataract progression and <cataract>extraction on measured perimetric progression in <glaucoma>}
{<cataract>,<extraction on measured perimetric progression in >,<glaucoma>
{intraocular pressure after <cataract>surgery in primary angle closure <glaucoma>}
{<cataract>,<surgery in primary angle closure >,<glaucoma>
{RATIONALE HYPOTHESIS Although <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{patients who received <cataract>surgery during this study or had a history of any previous <glaucoma>}
{<cataract>,<surgery during this study or had a history of any previous >,<glaucoma>
{patients with coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{IOP reduction after <cataract>extraction particularly in closed-angle variants of <glaucoma>}
{<cataract>,<extraction particularly in closed-angle variants of >,<glaucoma>
{for dates of <cataract>surgery and <glaucoma>}
{<cataract>,<surgery and >,<glaucoma>
{type of congenital <cataract>primary intraocular lens IOL insertion duration of follow-up postoperative best corrected visual acuity development of aphakic glaucoma and development of <glaucoma>}
{<cataract>,<primary intraocular lens IOL insertion duration of follow-up postoperative best corrected visual acuity development of aphakic glaucoma and development of >,<glaucoma>
{a history of <cataract>removal with lens implantation argon laser trabeculoplasty and trabeculectomy 2 years previously for open-angle <glaucoma>}
{<cataract>,<removal with lens implantation argon laser trabeculoplasty and trabeculectomy 2 years previously for open-angle >,<glaucoma>
{aqueous humor of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{options for combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{phosphatase activity in <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{  Because <cataract>surgery alone is associated with IOP reduction the relative contribution of the <glaucoma>}
{<cataract>,<surgery alone is associated with IOP reduction the relative contribution of the >,<glaucoma>
{1 citation although <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{ filtration surgery <cataract>extraction minimally invasive <glaucoma>}
{<cataract>,<extraction minimally invasive >,<glaucoma>
{side effects are <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{aberrations including ametropia <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{average time between <cataract>surgery and the diagnosis of <glaucoma>}
{<cataract>,<surgery and the diagnosis of >,<glaucoma>
{CONCLUSION Patients undergoing <cataract>surgery early in life should be routinely examined for possible postoperative <glaucoma>}
{<cataract>,<surgery early in life should be routinely examined for possible postoperative >,<glaucoma>
{eyes with coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{inflammation after combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{combined procedure for <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{reduction following phacoemulsification <cataract>extraction with posterior chamber lens implantation in <glaucoma>}
{<cataract>,<extraction with posterior chamber lens implantation in >,<glaucoma>
{trabeculectomy combined with <cataract>surgery and to determine the role of adjunctive mitomycin C MMC in the secondary <glaucoma>}
{<cataract>,<surgery and to determine the role of adjunctive mitomycin C MMC in the secondary >,<glaucoma>
{and after combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{are discussed particularly <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{pertains to combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{patient with both <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{glaucoma after congenital <cataract>surgery and to identify factors that might lead to better diagnosis and treatment of such <glaucoma>}
{<cataract>,<surgery and to identify factors that might lead to better diagnosis and treatment of such >,<glaucoma>
{management of coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{methods of combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{of viscocanalostomy and <cataract>extraction by phacoemulsification combined with viscocanalostomy phacoviscocanalostomy in the management of medically uncontrolled <glaucoma>}
{<cataract>,<extraction by phacoemulsification combined with viscocanalostomy phacoviscocanalostomy in the management of medically uncontrolled >,<glaucoma>
{was sampled during <cataract>or <glaucoma>}
{<cataract>,<or >,<glaucoma>
{treatment of age-related <cataract>and enhancing strategies for early detection and treatment of open-angle <glaucoma>}
{<cataract>,<and enhancing strategies for early detection and treatment of open-angle >,<glaucoma>
{few years combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{ Eyes with <cataract>and without a <glaucoma>}
{<cataract>,<and without a >,<glaucoma>
{flare in combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{those receiving combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{tonometric curves after <cataract>surgery in patients with cataract only and in patients with cataract and <glaucoma>}
{<cataract>,<surgery in patients with cataract only and in patients with cataract and >,<glaucoma>
{volunteers without medication <cataract>patients treated with pyrenoxine eyedrops and 7 <glaucoma>}
{<cataract>,<patients treated with pyrenoxine eyedrops and 7 >,<glaucoma>
{138 eyes with <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{P-50 for combined <cataract>surgery and <glaucoma>}
{<cataract>,<surgery and >,<glaucoma>
{flap in combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{stent implantation during <cataract>surgery in patients with primary open-angle pseudo-exfoliation <glaucoma>}
{<cataract>,<surgery in patients with primary open-angle pseudo-exfoliation >,<glaucoma>
{implantation during small-incision <cataract>surgery for open-angle <glaucoma>}
{<cataract>,<surgery for open-angle >,<glaucoma>
{space allowed concomitant <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{after combined micro-incision <cataract>surgery MICS and micro-invasive <glaucoma>}
{<cataract>,<surgery MICS and micro-invasive >,<glaucoma>
{apt to exacerbate <cataract>formation unless normal-tension <glaucoma>}
{<cataract>,<formation unless normal-tension >,<glaucoma>
{early period after <cataract>surgery in eyes with open-angle <glaucoma>}
{<cataract>,<surgery in eyes with open-angle >,<glaucoma>
{ Age-related maculopathy <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{ Development/progression of <cataract>especially in eyes with chronic angle closure <glaucoma>}
{<cataract>,<especially in eyes with chronic angle closure >,<glaucoma>
{term results of <cataract>extraction combined with Molteno implant insertion or trabeculectomy in primary <glaucoma>}
{<cataract>,<extraction combined with Molteno implant insertion or trabeculectomy in primary >,<glaucoma>
{goniopuncture combined with <cataract>surgery to treat <glaucoma>}
{<cataract>,<surgery to treat >,<glaucoma>
{decision in both <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{who have both <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{when to do <cataract>surgery when to do <glaucoma>}
{<cataract>,<surgery when to do >,<glaucoma>
{138 eyes with <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{in eyes with <cataract>only without <glaucoma>}
{<cataract>,<only without >,<glaucoma>
{phacotrabeculectomy for concomitant <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{In this series <cataract>extraction was beneficial in improving visual acuity immediately postoperatively but posterior segment changes and <glaucoma>}
{<cataract>,<extraction was beneficial in improving visual acuity immediately postoperatively but posterior segment changes and >,<glaucoma>
{often combined with <cataract>extraction which appears to offer additional pressure-control benefits to patients with chronic angle closure <glaucoma>}
{<cataract>,<extraction which appears to offer additional pressure-control benefits to patients with chronic angle closure >,<glaucoma>
{   <cataract>growth problems in children and teenagers <glaucoma>}
{<cataract>,<growth problems in children and teenagers >,<glaucoma>
{the management of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{known reports of <cataract>or <glaucoma>}
{<cataract>,<or >,<glaucoma>
{conditions such as <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{  concomitant <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{The treatment includes <cataract>extraction <glaucoma>}
{<cataract>,<extraction >,<glaucoma>
{groups respectively and <cataract>occurred in 20% of phakic eyes in the congenital <glaucoma>}
{<cataract>,<occurred in 20% of phakic eyes in the congenital >,<glaucoma>
{technique in combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{morbid association of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{which require combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{patients with co-existing <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{sparing technique of <cataract>removal in patients with open-angle <glaucoma>}
{<cataract>,<removal in patients with open-angle >,<glaucoma>
{who had undergone <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{55 eyes with <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{The influence of <cataract>surgery on the efficacy of trabeculectomy in patients with open-angle <glaucoma>}
{<cataract>,<surgery on the efficacy of trabeculectomy in patients with open-angle >,<glaucoma>
{surgery for congenital <cataract>a risk factor for <glaucoma>}
{<cataract>,<a risk factor for >,<glaucoma>
{patients who require <cataract>or <glaucoma>}
{<cataract>,<or >,<glaucoma>
{treatment of coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{generally better in <cataract>surgery <glaucoma>}
{<cataract>,<surgery >,<glaucoma>
{ Combined interventions <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{for performing concomitant <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{strategies for coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{had recently undergone <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{or followed by <cataract>extraction with or without intraocular lens implantation underwent trabeculectomy with 5-fluorouracil 5-FU for intractable <glaucoma>}
{<cataract>,<extraction with or without intraocular lens implantation underwent trabeculectomy with 5-fluorouracil 5-FU for intractable >,<glaucoma>
{patients with coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{patients with coexistent <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{eyes that underwent <cataract>extraction and in two eyes at the time of <glaucoma>}
{<cataract>,<extraction and in two eyes at the time of >,<glaucoma>
{approaches for coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{patients with coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{of patients undergoing <cataract>or <glaucoma>}
{<cataract>,<or >,<glaucoma>
{Nineteen years after <cataract>surgery when the IOL-CB complex became dislocated they were sutured transclerally to the sulcus without Ahmed <glaucoma>}
{<cataract>,<surgery when the IOL-CB complex became dislocated they were sutured transclerally to the sulcus without Ahmed >,<glaucoma>
{laser endocyclophotocoagulation and <cataract>for treatment of <glaucoma>}
{<cataract>,<for treatment of >,<glaucoma>
{benefit particularly from <cataract>surgery in terms of IOP and <glaucoma>}
{<cataract>,<surgery in terms of IOP and >,<glaucoma>
{outcomes of combined <cataract>surgery with trabecular microbypass stents and ab interno trabeculotomy in patients with open-angle <glaucoma>}
{<cataract>,<surgery with trabecular microbypass stents and ab interno trabeculotomy in patients with open-angle >,<glaucoma>
{the subjects with <cataract>or <glaucoma>}
{<cataract>,<or >,<glaucoma>
{patients with traumatic <cataract>developed postoperative <glaucoma>}
{<cataract>,<developed postoperative >,<glaucoma>
{cases of coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{effect of extracapsular <cataract>extraction ECCE with posterior chamber intraocular lens PC IOL implantation via the inferotemporal limbal approach on the function of an established <glaucoma>}
{<cataract>,<extraction ECCE with posterior chamber intraocular lens PC IOL implantation via the inferotemporal limbal approach on the function of an established >,<glaucoma>
{patients of coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{eyes of coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{management of coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{efficacy of combined <cataract>extraction and intraocular lens IOL implantation with endoscopic ciliary process photocoagulation in <glaucoma>}
{<cataract>,<extraction and intraocular lens IOL implantation with endoscopic ciliary process photocoagulation in >,<glaucoma>
{body mass and <cataract>history were the only other factors related to open-angle <glaucoma>}
{<cataract>,<history were the only other factors related to open-angle >,<glaucoma>
{  or <cataract>removal and in eyes with secondary <glaucoma>}
{<cataract>,<removal and in eyes with secondary >,<glaucoma>
{The case favoring <cataract>surgery in open-angle <glaucoma>}
{<cataract>,<surgery in open-angle >,<glaucoma>
{Combined ECP and <cataract>extraction resulted in lower IOP and a greater reduction in <glaucoma>}
{<cataract>,<extraction resulted in lower IOP and a greater reduction in >,<glaucoma>
{124 patients undergoing <cataract>and/or <glaucoma>}
{<cataract>,<and/or >,<glaucoma>
{refractive error astigmatism <cataract>status glaucoma staging visual field reliability and <glaucoma>}
{<cataract>,<status glaucoma staging visual field reliability and >,<glaucoma>
{ extraction versus <cataract>extraction alone in eyes with medically controlled open-angle <glaucoma>}
{<cataract>,<extraction alone in eyes with medically controlled open-angle >,<glaucoma>
{CA with concurrent <cataract>surgery CS for reducing intraocular pressure IOP in open-angle <glaucoma>}
{<cataract>,<surgery CS for reducing intraocular pressure IOP in open-angle >,<glaucoma>
{endoscopic cyclophotocoagulation and <cataract>surgery phaco-ECP in patients with open-angle <glaucoma>}
{<cataract>,<surgery phaco-ECP in patients with open-angle >,<glaucoma>
{The sequence of <cataract>surgery relative to <glaucoma>}
{<cataract>,<surgery relative to >,<glaucoma>
{efficacy of combined <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{been obtained during <cataract>or filtering <glaucoma>}
{<cataract>,<or filtering >,<glaucoma>
{Eyes suffering from <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{one-time treatment for <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{eyes with coexisting <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{indication for combined <cataract>extraction with a <glaucoma>}
{<cataract>,<extraction with a >,<glaucoma>
{ Simultaneous extracapsular <cataract>extraction intraocular lens implantation and posterior lip sclerectomy filtering procedure in <glaucoma>}
{<cataract>,<extraction intraocular lens implantation and posterior lip sclerectomy filtering procedure in >,<glaucoma>
{better to perform <cataract>extraction alone and continue with drug therapy for the <glaucoma>}
{<cataract>,<extraction alone and continue with drug therapy for the >,<glaucoma>
{Surgical management of <cataract>and <glaucoma>}
{<cataract>,<and >,<glaucoma>
{the time of <cataract>surgery from six patients with phacolytic <glaucoma>}
{<cataract>,<surgery from six patients with phacolytic >,<glaucoma>
{whether to do <cataract>extraction alone <glaucoma>}
{<cataract>,<extraction alone >,<glaucoma>
{operation fistulation and <cataract>extraction in open- and closed-angle <glaucoma>}
{<cataract>,<extraction in open- and closed-angle >,<glaucoma>
keratoconus,glaucoma
{   <keratoconus>and <glaucoma>}
{<keratoconus>,<and >,<glaucoma>
{the hypothesis that <keratoconus>and pellucid patients who have <glaucoma>}
{<keratoconus>,<and pellucid patients who have >,<glaucoma>
{eye conditions including <keratoconus>and <glaucoma>}
{<keratoconus>,<and >,<glaucoma>
myocardial infarction cerebrovascular disease,death
{   <myocardial infarction cerebrovascular disease>and <death>}
{<myocardial infarction cerebrovascular disease>,<and >,<death>
diabetic retinopathy,neovascular glaucoma
{   <diabetic retinopathy>and <neovascular glaucoma>}
{<diabetic retinopathy>,<and >,<neovascular glaucoma>
{Patients with proliferative <diabetic retinopathy>or <neovascular glaucoma>}
{<diabetic retinopathy>,<or >,<neovascular glaucoma>
{ For proliferative <diabetic retinopathy>and <neovascular glaucoma>}
{<diabetic retinopathy>,<and >,<neovascular glaucoma>
age-related macular degeneration diabetic retinopathy,aging
{   <age-related macular degeneration diabetic retinopathy>and <aging>}
{<age-related macular degeneration diabetic retinopathy>,<and >,<aging>
Hypothyroidism,primary open-angle glaucoma
{   <Hypothyroidism>and <primary open-angle glaucoma>}
{<Hypothyroidism>,<and >,<primary open-angle glaucoma>
meningitis arthritis,sepsis
{   <meningitis arthritis>and <sepsis>}
{<meningitis arthritis>,<and >,<sepsis>
vernal keratoconjunctivitis atopic keratoconjunctivitis,giant papillary conjunctivitis
{   <vernal keratoconjunctivitis atopic keratoconjunctivitis>and <giant papillary conjunctivitis>}
{<vernal keratoconjunctivitis atopic keratoconjunctivitis>,<and >,<giant papillary conjunctivitis>
Nonalcoholic fatty liver disease,polycystic ovary syndrome
{   <Nonalcoholic fatty liver disease>and <polycystic ovary syndrome>}
{<Nonalcoholic fatty liver disease>,<and >,<polycystic ovary syndrome>
metabolic syndrome,nonalcoholic fatty liver disease
{   <metabolic syndrome>and <nonalcoholic fatty liver disease>}
{<metabolic syndrome>,<and >,<nonalcoholic fatty liver disease>
{manifestation of the <metabolic syndrome><nonalcoholic fatty liver disease>}
{<metabolic syndrome>,<>,<nonalcoholic fatty liver disease>
{  including <metabolic syndrome>diabetes and <nonalcoholic fatty liver disease>}
{<metabolic syndrome>,<diabetes and >,<nonalcoholic fatty liver disease>
{features of the <metabolic syndrome>and <nonalcoholic fatty liver disease>}
{<metabolic syndrome>,<and >,<nonalcoholic fatty liver disease>
{components of the <metabolic syndrome>we focused on 28 longitudinal studies which provided evidence for <nonalcoholic fatty liver disease>}
{<metabolic syndrome>,<we focused on 28 longitudinal studies which provided evidence for >,<nonalcoholic fatty liver disease>
{  or <metabolic syndrome>suggest that <nonalcoholic fatty liver disease>}
{<metabolic syndrome>,<suggest that >,<nonalcoholic fatty liver disease>
{prediabetes mellitus the <metabolic syndrome>and <nonalcoholic fatty liver disease>}
{<metabolic syndrome>,<and >,<nonalcoholic fatty liver disease>
central retinal vein occlusion central retinal artery occlusion,neovascular glaucoma
{   <central retinal vein occlusion central retinal artery occlusion>and <neovascular glaucoma>}
{<central retinal vein occlusion central retinal artery occlusion>,<and >,<neovascular glaucoma>
glaucoma cataract,infections
{   <glaucoma cataract>and <infections>}
{<glaucoma cataract>,<and >,<infections>
short stature,degenerative joint disease
{   <short stature>and <degenerative joint disease>}
{<short stature>,<and >,<degenerative joint disease>
open-angle glaucoma,ocular hypertension
{the treatment of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{its use in <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{of treating primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{angles NOA N <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the management of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{topical management of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the management of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{controlled trials of <open-angle glaucoma>OAG or <ocular hypertension>}
{<open-angle glaucoma>,<OAG or >,<ocular hypertension>
{observed in primary <open-angle glaucoma>POAG <ocular hypertension>}
{<open-angle glaucoma>,<POAG >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG <ocular hypertension>}
{<open-angle glaucoma>,<POAG >,<ocular hypertension>
{In the primary <open-angle glaucoma>POAG and <ocular hypertension>}
{<open-angle glaucoma>,<POAG and >,<ocular hypertension>
{with diagnoses of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{duration cross-over design <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG <ocular hypertension>}
{<open-angle glaucoma>,<POAG >,<ocular hypertension>
{with previously untreated <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{three patients of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{comparators for primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{visual field in <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{a diagnosis of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{diagnosed with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{beneficial in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{presenting with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the treatment of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{treatment of chronic <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{flow in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{for use in <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{newly diagnosed primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{ For primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{  although <open-angle glaucoma>was more frequent in men <ocular hypertension>}
{<open-angle glaucoma>,<was more frequent in men >,<ocular hypertension>
{patients with chronic <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the prevalence of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{no history of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{with early primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{  Neither <open-angle glaucoma>nor <ocular hypertension>}
{<open-angle glaucoma>,<nor >,<ocular hypertension>
{The pathogenesis of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{as having either <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{subjects with primary <open-angle glaucoma>POAG <ocular hypertension>}
{<open-angle glaucoma>,<POAG >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{ Prevalence of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{   <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{  CONCLUSIONS <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{SLT on primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{trabeculoplasty for primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{MEASURES Prevalence of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{or delaying primary <open-angle glaucoma>POAG in patients affected by <ocular hypertension>}
{<open-angle glaucoma>,<POAG in patients affected by >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{333 adults with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>n = 8 <ocular hypertension>}
{<open-angle glaucoma>,<n = 8 >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{DLT for primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{2% in primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{applicable to primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{placebo in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG and <ocular hypertension>}
{<open-angle glaucoma>,<POAG and >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{IOP associated with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{of bilateral primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the management of <open-angle glaucoma>OAG and <ocular hypertension>}
{<open-angle glaucoma>,<OAG and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the diagnosis of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{eyes with primary <open-angle glaucoma>suspect glaucoma <ocular hypertension>}
{<open-angle glaucoma>,<suspect glaucoma >,<ocular hypertension>
{patients with chronic <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>exfoliation glaucoma or <ocular hypertension>}
{<open-angle glaucoma>,<exfoliation glaucoma or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{commonly appear in <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{788 subjects with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{components for primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{relatively symmetric primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{abnormal in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{1862 with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG n = 19 <ocular hypertension>}
{<open-angle glaucoma>,<POAG n = 19 >,<ocular hypertension>
{29 eyes had <open-angle glaucoma>OAG and 10 <ocular hypertension>}
{<open-angle glaucoma>,<OAG and 10 >,<ocular hypertension>
{Falcon in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{relatively advanced chronic <open-angle glaucoma>and 21 with ocular hypertension 21 seven glucoma and 14 <ocular hypertension>}
{<open-angle glaucoma>,<and 21 with ocular hypertension 21 seven glucoma and 14 >,<ocular hypertension>
{diagnosed with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Thirteen subjects with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{under treatment for <open-angle glaucoma>23 subjects with <ocular hypertension>}
{<open-angle glaucoma>,<23 subjects with >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{and carteolol on <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{qualified charts of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the classification of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{vs timolol for <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{ METHODS Primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with mild <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>to the effects of glucocorticoids in raising intraocular pressure this potentiation may be responsible for the steroid sensitivity and for the <ocular hypertension>}
{<open-angle glaucoma>,<to the effects of glucocorticoids in raising intraocular pressure this potentiation may be responsible for the steroid sensitivity and for the >,<ocular hypertension>
{patients with chronic <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with well-controlled <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{combination for primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{timolol in primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG and <ocular hypertension>}
{<open-angle glaucoma>,<POAG and >,<ocular hypertension>
{the treatment of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{newly diagnosed with <open-angle glaucoma>OAG and <ocular hypertension>}
{<open-angle glaucoma>,<OAG and >,<ocular hypertension>
{affected with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{005% in primary <open-angle glaucoma>POAG and <ocular hypertension>}
{<open-angle glaucoma>,<POAG and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>including pseudoexfoliation or <ocular hypertension>}
{<open-angle glaucoma>,<including pseudoexfoliation or >,<ocular hypertension>
{with bilateral primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{adults with well-controlled <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{clinical diagnosis of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{diagnosed with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{diagnosed with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{SNJ-1656 in primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{ with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{inadequately controlled primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{DS for primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the treatment of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{with newly diagnosed <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>n=75 or <ocular hypertension>}
{<open-angle glaucoma>,<n=75 or >,<ocular hypertension>
{diagnosed with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the treatment of <open-angle glaucoma>OAG or <ocular hypertension>}
{<open-angle glaucoma>,<OAG or >,<ocular hypertension>
{analogues for primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{subjects with primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{twice daily in <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{adolescents with juvenile <open-angle glaucoma>JOAG and <ocular hypertension>}
{<open-angle glaucoma>,<JOAG and >,<ocular hypertension>
{or older with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{study in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{efficacy in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{IOP-lowering in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>capsular glaucoma or <ocular hypertension>}
{<open-angle glaucoma>,<capsular glaucoma or >,<ocular hypertension>
{hours in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Forty subjects with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG exfoliative glaucoma or <ocular hypertension>}
{<open-angle glaucoma>,<POAG exfoliative glaucoma or >,<ocular hypertension>
{as well as <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{due to primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{risk factors for <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{74 eyes with <open-angle glaucoma>and 32 eyes with <ocular hypertension>}
{<open-angle glaucoma>,<and 32 eyes with >,<ocular hypertension>
{18 years with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>suspect or <ocular hypertension>}
{<open-angle glaucoma>,<suspect or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{IOP associated with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{risk factors and <open-angle glaucoma>OAG and <ocular hypertension>}
{<open-angle glaucoma>,<OAG and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG and <ocular hypertension>}
{<open-angle glaucoma>,<POAG and >,<ocular hypertension>
{in Chinese primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{a diagnosis of <open-angle glaucoma>OAG or <ocular hypertension>}
{<open-angle glaucoma>,<OAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{of treatment for <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{women with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{phacoemulsification in coexistent <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>exfoliation glaucoma or <ocular hypertension>}
{<open-angle glaucoma>,<exfoliation glaucoma or >,<ocular hypertension>
{K-115 in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>capsular glaucoma with IOP above 22 mmHg on treatment with one or two ocular hypotensive drugs or <ocular hypertension>}
{<open-angle glaucoma>,<capsular glaucoma with IOP above 22 mmHg on treatment with one or two ocular hypotensive drugs or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>and/or <ocular hypertension>}
{<open-angle glaucoma>,<and/or >,<ocular hypertension>
{those with chronic <open-angle glaucoma>COAG or <ocular hypertension>}
{<open-angle glaucoma>,<COAG or >,<ocular hypertension>
{hypercapnia in primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{women with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{population with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{clinical diagnosis of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{ reduction in <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{with cataract and <open-angle glaucoma>OAG or <ocular hypertension>}
{<open-angle glaucoma>,<OAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>and/or <ocular hypertension>}
{<open-angle glaucoma>,<and/or >,<ocular hypertension>
{to have primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{predictive factors of <open-angle glaucoma>OAG in patients affected by <ocular hypertension>}
{<open-angle glaucoma>,<OAG in patients affected by >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{diagnosed with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>OAG or <ocular hypertension>}
{<open-angle glaucoma>,<OAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{diagnosed with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{inhibitor for primary <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{analogue therapy for <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{subjects with chronic <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{adults with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{with newly diagnosed <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{conducted in primary <open-angle glaucoma>suspect and <ocular hypertension>}
{<open-angle glaucoma>,<suspect and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>exfoliation glaucoma or <ocular hypertension>}
{<open-angle glaucoma>,<exfoliation glaucoma or >,<ocular hypertension>
{who had primary <open-angle glaucoma>pigment dispersion glaucoma or <ocular hypertension>}
{<open-angle glaucoma>,<pigment dispersion glaucoma or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{progression of chronic <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{Four-year incidence of <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{once daily for <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{presenting with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{4-year incidence of <open-angle glaucoma>OAG and <ocular hypertension>}
{<open-angle glaucoma>,<OAG and >,<ocular hypertension>
{of subjects with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{diagnosed with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>pigment dispersion glaucoma or <ocular hypertension>}
{<open-angle glaucoma>,<pigment dispersion glaucoma or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{136 patients of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{IOP reduction in <open-angle glaucoma>OAG and <ocular hypertension>}
{<open-angle glaucoma>,<OAG and >,<ocular hypertension>
{or bilateral primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{results suggest that <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{ METHODS Seventeen <open-angle glaucoma>patients and nineteen <ocular hypertension>}
{<open-angle glaucoma>,<patients and nineteen >,<ocular hypertension>
{AND had any <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{ with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{databases revealed that <open-angle glaucoma>and <ocular hypertension>}
{<open-angle glaucoma>,<and >,<ocular hypertension>
{initial therapy in <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{127 eyes with <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG or <ocular hypertension>}
{<open-angle glaucoma>,<POAG or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{  from <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>POAG and to compare the NLR and PLR results of patients with POAG and <ocular hypertension>}
{<open-angle glaucoma>,<POAG and to compare the NLR and PLR results of patients with POAG and >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with coexistent <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{  and <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{the treatment of <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Patients with primary <open-angle glaucoma>or <ocular hypertension>}
{<open-angle glaucoma>,<or >,<ocular hypertension>
{Japanese subjects with <open-angle glaucoma>OAG or <ocular hypertension>}
{<open-angle glaucoma>,<OAG or >,<ocular hypertension>
Peptic ulcer,gastritis
{   <Peptic ulcer>or <gastritis>}
{<Peptic ulcer>,<or >,<gastritis>
optic neuritis keratitis,corneal abrasion
{   <optic neuritis keratitis>and <corneal abrasion>}
{<optic neuritis keratitis>,<and >,<corneal abrasion>
Chronic kidney disease,premature ageing
{   <Chronic kidney disease>and <premature ageing>}
{<Chronic kidney disease>,<and >,<premature ageing>
{   <Chronic kidney disease>and <premature ageing>}
{<Chronic kidney disease>,<and >,<premature ageing>
cataracts,primary open-angle glaucoma
{the management of <cataracts>and <primary open-angle glaucoma>}
{<cataracts>,<and >,<primary open-angle glaucoma>
{  and <cataracts>combined with <primary open-angle glaucoma>}
{<cataracts>,<combined with >,<primary open-angle glaucoma>
choroidal atrophy cataracts,glaucoma
{   <choroidal atrophy cataracts>and <glaucoma>}
{<choroidal atrophy cataracts>,<and >,<glaucoma>
cognitive disorders,dementia
{risk of developing <cognitive disorders>and <dementia>}
{<cognitive disorders>,<and >,<dementia>
primary biliary cirrhosis systemic lupus erythematosus,ulcerative colitis
{   <primary biliary cirrhosis systemic lupus erythematosus>and <ulcerative colitis>}
{<primary biliary cirrhosis systemic lupus erythematosus>,<and >,<ulcerative colitis>
perioral dermatitis acne,purpura
{   <perioral dermatitis acne>and <purpura>}
{<perioral dermatitis acne>,<and >,<purpura>
kidney disease,renal failure
{patients with chronic <kidney disease>or <renal failure>}
{<kidney disease>,<or >,<renal failure>
{patients with chronic <kidney disease>dialysis-dependent <renal failure>}
{<kidney disease>,<dialysis-dependent >,<renal failure>
{ BACKGROUND Chronic <kidney disease>CKD is a frequent under-recognized condition and a risk factor for <renal failure>}
{<kidney disease>,<CKD is a frequent under-recognized condition and a risk factor for >,<renal failure>
{could cause chronic <kidney disease>or <renal failure>}
{<kidney disease>,<or >,<renal failure>
{injury in diabetic <kidney disease>might allow for the development of targeted therapeutics to prevent or ameliorate progression to end-stage <renal failure>}
{<kidney disease>,<might allow for the development of targeted therapeutics to prevent or ameliorate progression to end-stage >,<renal failure>
{their equivalents diabetes <kidney disease>and <renal failure>}
{<kidney disease>,<and >,<renal failure>
{lead to chronic <kidney disease>including end-stage <renal failure>}
{<kidney disease>,<including end-stage >,<renal failure>
{development of chronic <kidney disease>which in turn is strongly linked to development of cardiovascular disease end-stage <renal failure>}
{<kidney disease>,<which in turn is strongly linked to development of cardiovascular disease end-stage >,<renal failure>
{cause of chronic <kidney disease>and <renal failure>}
{<kidney disease>,<and >,<renal failure>
{ in accelerating <kidney disease>progression to end-stage <renal failure>}
{<kidney disease>,<progression to end-stage >,<renal failure>
heart failure,myocardial infarction
{   <heart failure>and <myocardial infarction>}
{<heart failure>,<and >,<myocardial infarction>
preglaucoma prediabetes,prehypertension
{   <preglaucoma prediabetes>and <prehypertension>}
{<preglaucoma prediabetes>,<and >,<prehypertension>
glaucoma age-related macular degeneration,dry eye syndrome
{   <glaucoma age-related macular degeneration>and <dry eye syndrome>}
{<glaucoma age-related macular degeneration>,<and >,<dry eye syndrome>
Central retinal vein occlusion,malignant glaucoma
{   <Central retinal vein occlusion>and <malignant glaucoma>}
{<Central retinal vein occlusion>,<and >,<malignant glaucoma>
heart failure,coronary artery disease
{   <heart failure>and <coronary artery disease>}
{<heart failure>,<and >,<coronary artery disease>
{risk factors for <heart failure>HF including hypertension diabetes and <coronary artery disease>}
{<heart failure>,<HF including hypertension diabetes and >,<coronary artery disease>
Sleep apnoea,glaucoma
{   <Sleep apnoea>and <glaucoma>}
{<Sleep apnoea>,<and >,<glaucoma>
cataracts diabetic retinopathy,primary open-angle glaucoma
{   <cataracts diabetic retinopathy>and <primary open-angle glaucoma>}
{<cataracts diabetic retinopathy>,<and >,<primary open-angle glaucoma>
Kearns-Sayre syndrome,primary open-angle glaucoma
{   <Kearns-Sayre syndrome>and <primary open-angle glaucoma>}
{<Kearns-Sayre syndrome>,<and >,<primary open-angle glaucoma>
glaucoma,ocular hypertension
{patients with chronic <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{a diagnosis of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{adults with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{diagnosed with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{in treatment of <glaucoma>patients was convened to critically analyze published population-based studies of <ocular hypertension>}
{<glaucoma>,<patients was convened to critically analyze published population-based studies of >,<ocular hypertension>
{the Collaborative normal-tension <glaucoma>study CNTGS and <ocular hypertension>}
{<glaucoma>,<study CNTGS and >,<ocular hypertension>
{  xviii <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{the management of <glaucoma>including a review of latanoprost recently approved for first-line treatment of glaucoma and <ocular hypertension>}
{<glaucoma>,<including a review of latanoprost recently approved for first-line treatment of glaucoma and >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{040 members with <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{POAG normal tension <glaucoma>NTG or <ocular hypertension>}
{<glaucoma>,<NTG or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{with normal tension <glaucoma>NTG 27 eyes with <ocular hypertension>}
{<glaucoma>,<NTG 27 eyes with >,<ocular hypertension>
{ normal tension <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{ POAG normal-tension <glaucoma>NTG <ocular hypertension>}
{<glaucoma>,<NTG >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{patients with normal-tension <glaucoma>NTG defined as IOP â‰ 21 mm Hg or <ocular hypertension>}
{<glaucoma>,<NTG defined as IOP â‰ 21 mm Hg or >,<ocular hypertension>
{ POAG normal-tension <glaucoma>NTG and <ocular hypertension>}
{<glaucoma>,<NTG and >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{with normal tension <glaucoma>Group B and 12 patients 24 eyes with <ocular hypertension>}
{<glaucoma>,<Group B and 12 patients 24 eyes with >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{including normal tension <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{  of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{participants 71 normal <glaucoma>suspect GS 38 <ocular hypertension>}
{<glaucoma>,<suspect GS 38 >,<ocular hypertension>
{glaucoma normal tension <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{  normal-tension <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{POAG normal tension <glaucoma>NTG and <ocular hypertension>}
{<glaucoma>,<NTG and >,<ocular hypertension>
{  normal-tension <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{the normal tension <glaucoma>patients as compared to those in the controls and in the primary open angle glaucoma patients whereas the <ocular hypertension>}
{<glaucoma>,<patients as compared to those in the controls and in the primary open angle glaucoma patients whereas the >,<ocular hypertension>
{of 272 high-tension <glaucoma>HTG and 58 <ocular hypertension>}
{<glaucoma>,<HTG and 58 >,<ocular hypertension>
{whole spectrum of <glaucoma>from <ocular hypertension>}
{<glaucoma>,<from >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{study on open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>11 and <ocular hypertension>}
{<glaucoma>,<11 and >,<ocular hypertension>
{continuity clinic or <glaucoma>faculty patients with primary open angle glaucoma POAG <ocular hypertension>}
{<glaucoma>,<faculty patients with primary open angle glaucoma POAG >,<ocular hypertension>
{risk factors for <glaucoma>one can confirm the diagnosis of <ocular hypertension>}
{<glaucoma>,<one can confirm the diagnosis of >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{increased risk for <glaucoma>development in patients with PEX and <ocular hypertension>}
{<glaucoma>,<development in patients with PEX and >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{Patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG and <ocular hypertension>}
{<glaucoma>,<OAG and >,<ocular hypertension>
{a diagnosis of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{eyes with pre-existing <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with uncontrolled <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{rates in open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{treatment of open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{the treatment of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{history of open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{  and <glaucoma>is similar to that of <ocular hypertension>}
{<glaucoma>,<is similar to that of >,<ocular hypertension>
{ POAG normal-tension <glaucoma>NTG and <ocular hypertension>}
{<glaucoma>,<NTG and >,<ocular hypertension>
{Patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{being used as <glaucoma>models to study <ocular hypertension>}
{<glaucoma>,<models to study >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{history of previous <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with pre-existing <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{individuals with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{a diagnosis of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{recommendations made by <glaucoma>specialists in cases of <ocular hypertension>}
{<glaucoma>,<specialists in cases of >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{the incidence of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{brimonidine for open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{Patients had open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{the probability of <glaucoma>from <ocular hypertension>}
{<glaucoma>,<from >,<ocular hypertension>
{A diagnosis of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{The probability of <glaucoma>from <ocular hypertension>}
{<glaucoma>,<from >,<ocular hypertension>
{culture diagnosis of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{brimonidine in open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{previous diagnosis of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{exfoliative or pigment-dispersion <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{  NTG <glaucoma>suspects NTG suspects or <ocular hypertension>}
{<glaucoma>,<suspects NTG suspects or >,<ocular hypertension>
{POAG normal tension <glaucoma>NTG and <ocular hypertension>}
{<glaucoma>,<NTG and >,<ocular hypertension>
{POAG normal tension <glaucoma>NTG and <ocular hypertension>}
{<glaucoma>,<NTG and >,<ocular hypertension>
{54 with open-angle <glaucoma>eight with <ocular hypertension>}
{<glaucoma>,<eight with >,<ocular hypertension>
{POWG normal tension <glaucoma>NDG and <ocular hypertension>}
{<glaucoma>,<NDG and >,<ocular hypertension>
{3 angle closure <glaucoma>n = 2 <ocular hypertension>}
{<glaucoma>,<n = 2 >,<ocular hypertension>
{= 343 normal-tension <glaucoma>NTG n = 192 and <ocular hypertension>}
{<glaucoma>,<NTG n = 192 and >,<ocular hypertension>
{disc asymmetry early <glaucoma>glaucomatous progression <ocular hypertension>}
{<glaucoma>,<glaucomatous progression >,<ocular hypertension>
{POAG normal tension <glaucoma>NTG <ocular hypertension>}
{<glaucoma>,<NTG >,<ocular hypertension>
{POAG normal tension <glaucoma>NTG or <ocular hypertension>}
{<glaucoma>,<NTG or >,<ocular hypertension>
{Low or normal-tension <glaucoma>NTG is a rare clinical condition characterized by a glaucomatous cupping of the optic disk associated with the appearance of typical visual field defects without <ocular hypertension>}
{<glaucoma>,<NTG is a rare clinical condition characterized by a glaucomatous cupping of the optic disk associated with the appearance of typical visual field defects without >,<ocular hypertension>
{patients with open-angle <glaucoma>POAG and <ocular hypertension>}
{<glaucoma>,<POAG and >,<ocular hypertension>
{a history of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{POAG normal tension <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{IOP normal tension <glaucoma>NTG and <ocular hypertension>}
{<glaucoma>,<NTG and >,<ocular hypertension>
{ POAG normal-tension <glaucoma>NTG <ocular hypertension>}
{<glaucoma>,<NTG >,<ocular hypertension>
{ NTG high-tension <glaucoma>HTG and <ocular hypertension>}
{<glaucoma>,<HTG and >,<ocular hypertension>
{in newly diagnosed <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{a diagnosis of <glaucoma>suspected glaucoma or <ocular hypertension>}
{<glaucoma>,<suspected glaucoma or >,<ocular hypertension>
{SLDF in open-angle <glaucoma>OAG and <ocular hypertension>}
{<glaucoma>,<OAG and >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{adults with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{of uveitic secondary <glaucoma>USG and <ocular hypertension>}
{<glaucoma>,<USG and >,<ocular hypertension>
{adults with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{beta-blocker in open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{sex history of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{of human open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{  primary-angle-closure <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{fifty-four eyes with <glaucoma>41 and <ocular hypertension>}
{<glaucoma>,<41 and >,<ocular hypertension>
{subjects with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{ and pseudoexfoliative <glaucoma>pilocarpine and timolol were almost equally effective while dipivalyl epinephrine and adrenaline were also effective but more as additive therapy though dipivalyl epinephrine may be useful on its own in <ocular hypertension>}
{<glaucoma>,<pilocarpine and timolol were almost equally effective while dipivalyl epinephrine and adrenaline were also effective but more as additive therapy though dipivalyl epinephrine may be useful on its own in >,<ocular hypertension>
{above suggest that <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{secondary angle closure <glaucoma>population this immediate postoperative <ocular hypertension>}
{<glaucoma>,<population this immediate postoperative >,<ocular hypertension>
{subjects with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{adults with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{5% in open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{newly diagnosed open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{velocities in untreated <glaucoma>eyes but not in <ocular hypertension>}
{<glaucoma>,<eyes but not in >,<ocular hypertension>
{60 eyes without <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{latanoprost in open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{adults with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{for chronic open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{  Because <glaucoma>developed in one quarter of eyes with <ocular hypertension>}
{<glaucoma>,<developed in one quarter of eyes with >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{primary chronic open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{primary chronic open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{configuration into closed-angle <glaucoma>123 cases <ocular hypertension>}
{<glaucoma>,<123 cases >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{eyes with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{subjects with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{treatment of open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with bilateral <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{diagnosed with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with high-pressure <glaucoma>13 patients with normal-pressure glaucoma and 17 subjects with <ocular hypertension>}
{<glaucoma>,<13 patients with normal-pressure glaucoma and 17 subjects with >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{ with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{= 41 normal-pressure <glaucoma>n = 54 <ocular hypertension>}
{<glaucoma>,<n = 54 >,<ocular hypertension>
{presenting with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{subjects with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{risk of open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{adults with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{latanoprost for open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{In a 3-generation <glaucoma>family affected with JOAG or <ocular hypertension>}
{<glaucoma>,<family affected with JOAG or >,<ocular hypertension>
{as having open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{162 eyes with <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{10-year incidence of <glaucoma>among patients with treated and untreated <ocular hypertension>}
{<glaucoma>,<among patients with treated and untreated >,<ocular hypertension>
{implants in open-angle <glaucoma>OAG+ patients and <ocular hypertension>}
{<glaucoma>,<OAG+ patients and >,<ocular hypertension>
{Patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{458 with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{with chronic open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{of 20 volunteers <glaucoma>subjects 4 <ocular hypertension>}
{<glaucoma>,<subjects 4 >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{eyes with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{74 eyes had <glaucoma>28 patients 51 eyes had <ocular hypertension>}
{<glaucoma>,<28 patients 51 eyes had >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{ with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{subjects with open-angle <glaucoma>OAG <ocular hypertension>}
{<glaucoma>,<OAG >,<ocular hypertension>
{late onset open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{dorzolamide/timolol in open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{the treatment of <glaucoma>and/or <ocular hypertension>}
{<glaucoma>,<and/or >,<ocular hypertension>
{African Americans with <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{black Americans with <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{Patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{participants with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{Patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{males with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{with attitudes regarding <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{of controls glaucoma <glaucoma>suspects and <ocular hypertension>}
{<glaucoma>,<suspects and >,<ocular hypertension>
{family history of <glaucoma>FHG as a risk factor for <ocular hypertension>}
{<glaucoma>,<FHG as a risk factor for >,<ocular hypertension>
{in open anlgle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG 55 subjects with <ocular hypertension>}
{<glaucoma>,<OAG 55 subjects with >,<ocular hypertension>
{naive for open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{with primary openangle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{established chronic open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{surgery for open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{in case of <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{Patients had open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{therapy for open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{were recently diagnosed <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{risk of open-angle <glaucoma>OAG in four cohorts of adults with <ocular hypertension>}
{<glaucoma>,<OAG in four cohorts of adults with >,<ocular hypertension>
{patients with treated <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{the myocilin MYOC <glaucoma>gene in monkey and human steroid-induced <ocular hypertension>}
{<glaucoma>,<gene in monkey and human steroid-induced >,<ocular hypertension>
{suffering from either <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{7 cases of <glaucoma>five chronic open angle glaucomas one normotensive glaucoma and one pseudoexfoliative glaucoma and 29 cases of <ocular hypertension>}
{<glaucoma>,<five chronic open angle glaucomas one normotensive glaucoma and one pseudoexfoliative glaucoma and 29 cases of >,<ocular hypertension>
{ from either <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{  Thirty <glaucoma>suspects 10 patients monitored for possible normal-pressure glaucoma and 20 patients with intermittent <ocular hypertension>}
{<glaucoma>,<suspects 10 patients monitored for possible normal-pressure glaucoma and 20 patients with intermittent >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{  OAG <glaucoma>suspects GS and <ocular hypertension>}
{<glaucoma>,<suspects GS and >,<ocular hypertension>
{hypertension and either <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{adults with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{diagnosis of OAG <glaucoma>suspect or <ocular hypertension>}
{<glaucoma>,<suspect or >,<ocular hypertension>
{patients sustaining primary <glaucoma>open angle or <ocular hypertension>}
{<glaucoma>,<open angle or >,<ocular hypertension>
{increased in untreated <glaucoma>eyes as compared to a similar group of eyes with <ocular hypertension>}
{<glaucoma>,<eyes as compared to a similar group of eyes with >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>n = 128 or <ocular hypertension>}
{<glaucoma>,<n = 128 or >,<ocular hypertension>
{study adults with <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{eyes with low-tension <glaucoma>were compared with 53 subjects 106 eyes with <ocular hypertension>}
{<glaucoma>,<were compared with 53 subjects 106 eyes with >,<ocular hypertension>
{long term for <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{and follow-up of <glaucoma>patients and 169 cases of <ocular hypertension>}
{<glaucoma>,<patients and 169 cases of >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{treatment of open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{ diagnosis open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{suffering from open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG or <ocular hypertension>}
{<glaucoma>,<OAG or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{topically treated open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{with PXF and <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{Patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{influenced significantly by <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{40 eyes with <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{not yet treated <glaucoma>16 patients with untreated <ocular hypertension>}
{<glaucoma>,<16 patients with untreated >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{eyes with open-angle <glaucoma>OAG and in eyes with no evidence of glaucoma or <ocular hypertension>}
{<glaucoma>,<OAG and in eyes with no evidence of glaucoma or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{Patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{pyrenoxine eyedrops and <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>or <ocular hypertension>}
{<glaucoma>,<or >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG and moderate field loss Humphrey 30-2 Humphrey Instruments San Leandro CA mean deviation or = -6 dB eight with <ocular hypertension>}
{<glaucoma>,<OAG and moderate field loss Humphrey 30-2 Humphrey Instruments San Leandro CA mean deviation or = -6 dB eight with >,<ocular hypertension>
{patients with open-angle <glaucoma>OAG and <ocular hypertension>}
{<glaucoma>,<OAG and >,<ocular hypertension>
conjunctivitis otitis media,bronchitis
{   <conjunctivitis otitis media>and <bronchitis>}
{<conjunctivitis otitis media>,<and >,<bronchitis>
Inhaled steroid use,glaucoma
{   <Inhaled steroid use>and <glaucoma>}
{<Inhaled steroid use>,<and >,<glaucoma>
Lens-induced uveitis,glaucoma
{   <Lens-induced uveitis>and <glaucoma>}
{<Lens-induced uveitis>,<and >,<glaucoma>
typhlitis ileus,intussusception
{   <typhlitis ileus>and <intussusception>}
{<typhlitis ileus>,<and >,<intussusception>
glaucoma,pressure
{and co-existent normal-pressure <glaucoma>the Beijing intracranial and intraocular <pressure>}
{<glaucoma>,<the Beijing intracranial and intraocular >,<pressure>
{treatments for open-angle <glaucoma>lower intraocular <pressure>}
{<glaucoma>,<lower intraocular >,<pressure>
{treatments for open-angle <glaucoma>lower intraocular <pressure>}
{<glaucoma>,<lower intraocular >,<pressure>
{  and <glaucoma>including its definition factors that influence its calculation and epidemiological studies investigating the influence of ocular perfusion <pressure>}
{<glaucoma>,<including its definition factors that influence its calculation and epidemiological studies investigating the influence of ocular perfusion >,<pressure>
{of any additional <glaucoma>procedure with influence on intraocular <pressure>}
{<glaucoma>,<procedure with influence on intraocular >,<pressure>
{optic nerve in <glaucoma>is primarily caused by increased intraocular <pressure>}
{<glaucoma>,<is primarily caused by increased intraocular >,<pressure>
{proven therapy for <glaucoma>is intraocular <pressure>}
{<glaucoma>,<is intraocular >,<pressure>
{these patients required <glaucoma>shunting procedures postoperatively for intraocular <pressure>}
{<glaucoma>,<shunting procedures postoperatively for intraocular >,<pressure>
{subjects were on <glaucoma>medication with either uncontrolled intraocular <pressure>}
{<glaucoma>,<medication with either uncontrolled intraocular >,<pressure>
{is a common <glaucoma>therapy that is safe and effective for reducing intraocular <pressure>}
{<glaucoma>,<therapy that is safe and effective for reducing intraocular >,<pressure>
{demographics etiology of <glaucoma>preoperative clinical data visual acuity intraocular <pressure>}
{<glaucoma>,<preoperative clinical data visual acuity intraocular >,<pressure>
{treatment of open-angle <glaucoma>the most frequent cause of irreversible visual loss fixed combinations of different topical intraocular <pressure>}
{<glaucoma>,<the most frequent cause of irreversible visual loss fixed combinations of different topical intraocular >,<pressure>
{microfibril hypothesis of <glaucoma>implications for treatment of elevated intraocular <pressure>}
{<glaucoma>,<implications for treatment of elevated intraocular >,<pressure>
{with angle closure <glaucoma>recent studies show that the decrease in intraocular <pressure>}
{<glaucoma>,<recent studies show that the decrease in intraocular >,<pressure>
{diagnostic points of <glaucoma>assessment before and after excimer laser refractive surgery and discussed the postoperative intraocular <pressure>}
{<glaucoma>,<assessment before and after excimer laser refractive surgery and discussed the postoperative intraocular >,<pressure>
{referral to a <glaucoma>specialist if <pressure>}
{<glaucoma>,<specialist if >,<pressure>
{medical records of <glaucoma>patients to investigate how switching medications may affect intraocular <pressure>}
{<glaucoma>,<patients to investigate how switching medications may affect intraocular >,<pressure>
{can easily measure <glaucoma>patients' BP and IOP to calculate their ocular perfusion <pressure>}
{<glaucoma>,<patients' BP and IOP to calculate their ocular perfusion >,<pressure>
{risk factor for <glaucoma>at this time is elevated intraocular <pressure>}
{<glaucoma>,<at this time is elevated intraocular >,<pressure>
{the focus of <glaucoma>research has shifted toward neuroprotection as the traditional strategies of lowering intraocular <pressure>}
{<glaucoma>,<research has shifted toward neuroprotection as the traditional strategies of lowering intraocular >,<pressure>
{at onset of <glaucoma>symptoms and signs corneal integrity intraocular <pressure>}
{<glaucoma>,<symptoms and signs corneal integrity intraocular >,<pressure>
{medical device for <glaucoma>patients associated with intraocular <pressure>}
{<glaucoma>,<patients associated with intraocular >,<pressure>
{risk factor for <glaucoma>is an increase in intraocular <pressure>}
{<glaucoma>,<is an increase in intraocular >,<pressure>
{pathogenesis of the <glaucoma>especially in cases where the level of intraocular <pressure>}
{<glaucoma>,<especially in cases where the level of intraocular >,<pressure>
{  As <glaucoma>requires lifelong management the development of cataract is a significant concern because its treatment may lead to loss of intraocular <pressure>}
{<glaucoma>,<requires lifelong management the development of cataract is a significant concern because its treatment may lead to loss of intraocular >,<pressure>
{demographics duration of <glaucoma>preoperative intraocular <pressure>}
{<glaucoma>,<preoperative intraocular >,<pressure>
{risk factors for <glaucoma>include elevated intraocular <pressure>}
{<glaucoma>,<include elevated intraocular >,<pressure>
{ocular surface in <glaucoma>patients and to define patient populations that might benefit from preservative-free topical intraocular <pressure>}
{<glaucoma>,<patients and to define patient populations that might benefit from preservative-free topical intraocular >,<pressure>
{the mechanism of <glaucoma>level of intraocular <pressure>}
{<glaucoma>,<level of intraocular >,<pressure>
{advanced state of <glaucoma>more difficulty controlling intraocular <pressure>}
{<glaucoma>,<more difficulty controlling intraocular >,<pressure>
{2012 English language <glaucoma>literature search on Pubmed using the following terms automated perimetry optic nerve imaging optical coherence tomography glaucoma structure and function intraocular <pressure>}
{<glaucoma>,<literature search on Pubmed using the following terms automated perimetry optic nerve imaging optical coherence tomography glaucoma structure and function intraocular >,<pressure>
{126 eyes without <glaucoma>being found with intraocular <pressure>}
{<glaucoma>,<being found with intraocular >,<pressure>
{duration of the <glaucoma>mean intraocular <pressure>}
{<glaucoma>,<mean intraocular >,<pressure>
{26% understood that <glaucoma>was associated with a high intraocular <pressure>}
{<glaucoma>,<was associated with a high intraocular >,<pressure>
{family history of <glaucoma>visual acuity intraocular <pressure>}
{<glaucoma>,<visual acuity intraocular >,<pressure>
{'biomechanical theory' of <glaucoma>which posits that the behavior of optic nerve head connective tissues specifically within the peripapillary sclera and lamina cribrosa in response to intraocular <pressure>}
{<glaucoma>,<which posits that the behavior of optic nerve head connective tissues specifically within the peripapillary sclera and lamina cribrosa in response to intraocular >,<pressure>
{Risk factors for <glaucoma>include an increase in intraocular <pressure>}
{<glaucoma>,<include an increase in intraocular >,<pressure>
{retinal neurons from <glaucoma>lowering ocular <pressure>}
{<glaucoma>,<lowering ocular >,<pressure>
{  When <glaucoma>needs three or more types of medication to reduce intraocular <pressure>}
{<glaucoma>,<needs three or more types of medication to reduce intraocular >,<pressure>
{predisposing factor for <glaucoma>we examined the effects of long-term atropine treatment for myopia on intraocular <pressure>}
{<glaucoma>,<we examined the effects of long-term atropine treatment for myopia on intraocular >,<pressure>
{patients with open-angle <glaucoma>who had uncontrolled intraocular <pressure>}
{<glaucoma>,<who had uncontrolled intraocular >,<pressure>
{the pathogenesis of <glaucoma>besides an elevated intraocular <pressure>}
{<glaucoma>,<besides an elevated intraocular >,<pressure>
{percentage of treatment-naive <glaucoma>patients initially treated with latanoprost monotherapy who do not respond with a clinically meaningful reduction of intraocular <pressure>}
{<glaucoma>,<patients initially treated with latanoprost monotherapy who do not respond with a clinically meaningful reduction of intraocular >,<pressure>
{ Management of <glaucoma>is directed at the control of intraocular <pressure>}
{<glaucoma>,<is directed at the control of intraocular >,<pressure>
{hypertension or open-angle <glaucoma>patients a 3-month efficacy analysis stratified by initial intraocular <pressure>}
{<glaucoma>,<patients a 3-month efficacy analysis stratified by initial intraocular >,<pressure>
{the treatment of <glaucoma>by reducing intra-ocular <pressure>}
{<glaucoma>,<by reducing intra-ocular >,<pressure>
{Increased likelihood of <glaucoma>at the same intraocular <pressure>}
{<glaucoma>,<at the same intraocular >,<pressure>
{outcome measurements regarding <glaucoma>the inadequacy of using intraocular <pressure>}
{<glaucoma>,<the inadequacy of using intraocular >,<pressure>
{compliance profiles of <glaucoma>patients and evaluate the association with intraocular <pressure>}
{<glaucoma>,<patients and evaluate the association with intraocular >,<pressure>
{for idiopathic open-angle <glaucoma>include advancing age black race a family history of glaucoma and increased intraocular <pressure>}
{<glaucoma>,<include advancing age black race a family history of glaucoma and increased intraocular >,<pressure>
{path to open-angle <glaucoma>gene discovery endophenotypic status of intraocular <pressure>}
{<glaucoma>,<gene discovery endophenotypic status of intraocular >,<pressure>
{ normal tension <glaucoma>NTG occurs in the absence of high intraocular <pressure>}
{<glaucoma>,<NTG occurs in the absence of high intraocular >,<pressure>
{Historically treatment for <glaucoma>has been based on lowering intraocular <pressure>}
{<glaucoma>,<has been based on lowering intraocular >,<pressure>
{status type of <glaucoma>follow-up visits and baseline intraocular <pressure>}
{<glaucoma>,<follow-up visits and baseline intraocular >,<pressure>
{Current concepts of <glaucoma>pathogenesis suggest it to be a neurodegenerative disorder which is triggered by different factors including mechanical stress due to intra-ocular <pressure>}
{<glaucoma>,<pathogenesis suggest it to be a neurodegenerative disorder which is triggered by different factors including mechanical stress due to intra-ocular >,<pressure>
{the pathogenesis of <glaucoma>depends on several interacting pathogenetic mechanisms which include mechanical effects by an increased intraocular <pressure>}
{<glaucoma>,<depends on several interacting pathogenetic mechanisms which include mechanical effects by an increased intraocular >,<pressure>
{pressure history of <glaucoma>treatment including medications and surgery and history of blood <pressure>}
{<glaucoma>,<treatment including medications and surgery and history of blood >,<pressure>
{PEX who have <glaucoma>by screening intraocular <pressure>}
{<glaucoma>,<by screening intraocular >,<pressure>
{ocular hypertensive eyes <glaucoma>suspects and 71 glaucomatous eyes depending on intraocular <pressure>}
{<glaucoma>,<suspects and 71 glaucomatous eyes depending on intraocular >,<pressure>
{select a special <glaucoma>surgical procedure the individual target <pressure>}
{<glaucoma>,<surgical procedure the individual target >,<pressure>
{risk factor for <glaucoma>progression is not as strong intraocular <pressure>}
{<glaucoma>,<progression is not as strong intraocular >,<pressure>
{in management of <glaucoma>is to prevent the risk factor especially elevated intraocular <pressure>}
{<glaucoma>,<is to prevent the risk factor especially elevated intraocular >,<pressure>
{ Treatment for <glaucoma>consists of reducing intraocular <pressure>}
{<glaucoma>,<consists of reducing intraocular >,<pressure>
{the eyes with <glaucoma>had high <pressure>}
{<glaucoma>,<had high >,<pressure>
{atrophy in human <glaucoma>patients is six times higher at a perfusion pressure of 30 mmHg which corresponds to a level where the optic nerve is hypoxic in experimental animals as compared to perfusion <pressure>}
{<glaucoma>,<patients is six times higher at a perfusion pressure of 30 mmHg which corresponds to a level where the optic nerve is hypoxic in experimental animals as compared to perfusion >,<pressure>
{80% of the <glaucoma>subjects of the present investigation had an intraocular <pressure>}
{<glaucoma>,<subjects of the present investigation had an intraocular >,<pressure>
{it believed that <glaucoma>is caused by an increased intraocular <pressure>}
{<glaucoma>,<is caused by an increased intraocular >,<pressure>
{ it Non-penetrating <glaucoma>surgery represented by deep sclerectomy and viscocanalostomy is an effective method to lower intraocular <pressure>}
{<glaucoma>,<surgery represented by deep sclerectomy and viscocanalostomy is an effective method to lower intraocular >,<pressure>
{Most of the <glaucoma>patients need more than one medication for adequate intraocular <pressure>}
{<glaucoma>,<patients need more than one medication for adequate intraocular >,<pressure>
{risk of open-angle <glaucoma>OAG associated with exposure to pseudoexfoliation PEX and increased intraocular <pressure>}
{<glaucoma>,<OAG associated with exposure to pseudoexfoliation PEX and increased intraocular >,<pressure>
{common form of <glaucoma>is a chronic progressive disease often though not always accompanied by elevated intraocular <pressure>}
{<glaucoma>,<is a chronic progressive disease often though not always accompanied by elevated intraocular >,<pressure>
{  Pseudoexfoliative <glaucoma>is aggressive with great <pressure>}
{<glaucoma>,<is aggressive with great >,<pressure>
{  Normal-tension <glaucoma>was previously thought to be pressure insensitive as medical treatment hardly reduced intraocular <pressure>}
{<glaucoma>,<was previously thought to be pressure insensitive as medical treatment hardly reduced intraocular >,<pressure>
{  Among <glaucoma>suspects 18 cases were diagnosed based on disc appearance eight based on intraocular <pressure>}
{<glaucoma>,<suspects 18 cases were diagnosed based on disc appearance eight based on intraocular >,<pressure>
{The aim of <glaucoma>therapy is to preserve vision by reducing intraocular <pressure>}
{<glaucoma>,<therapy is to preserve vision by reducing intraocular >,<pressure>
{patient examined for <glaucoma>because of an increased intraocular <pressure>}
{<glaucoma>,<because of an increased intraocular >,<pressure>
{treatment of normal-tension <glaucoma>by lowering intraocular <pressure>}
{<glaucoma>,<by lowering intraocular >,<pressure>
{ Medically controlled <glaucoma>patients show greater increase in intraocular <pressure>}
{<glaucoma>,<patients show greater increase in intraocular >,<pressure>
{  Although <glaucoma>is often associated with elevated intraocular <pressure>}
{<glaucoma>,<is often associated with elevated intraocular >,<pressure>
{  Although <glaucoma>is often associated with elevated intraocular <pressure>}
{<glaucoma>,<is often associated with elevated intraocular >,<pressure>
{patients with normal-tension <glaucoma>both bimatoprost and latanoprost reduce the 24 h intraocular <pressure>}
{<glaucoma>,<both bimatoprost and latanoprost reduce the 24 h intraocular >,<pressure>
{ In advanced <glaucoma>the greatest possible reduction from the initial intraocular <pressure>}
{<glaucoma>,<the greatest possible reduction from the initial intraocular >,<pressure>
{  high-tension <glaucoma>HTG and those with normal <pressure>}
{<glaucoma>,<HTG and those with normal >,<pressure>
{patients with initial <glaucoma>25% reduction from the initial intraocular <pressure>}
{<glaucoma>,<25% reduction from the initial intraocular >,<pressure>
{mmHg in advanced <glaucoma>has been recognized as a favorable strategy to reach target intraocular <pressure>}
{<glaucoma>,<has been recognized as a favorable strategy to reach target intraocular >,<pressure>
{ In exfoliative <glaucoma>patients latanoprost and travoprost showed higher baseline and treatment pressures although the <pressure>}
{<glaucoma>,<patients latanoprost and travoprost showed higher baseline and treatment pressures although the >,<pressure>
{progression of open-angle <glaucoma>under a standardised interventional protocol for intraocular <pressure>}
{<glaucoma>,<under a standardised interventional protocol for intraocular >,<pressure>
{with previously failed <glaucoma>surgery is an effective method for controlling intraocular <pressure>}
{<glaucoma>,<surgery is an effective method for controlling intraocular >,<pressure>
{advanced stage of <glaucoma>at diagnosis fluctuation of intraocular <pressure>}
{<glaucoma>,<at diagnosis fluctuation of intraocular >,<pressure>
{presumed etiology of <glaucoma>has moved from a pure <pressure>}
{<glaucoma>,<has moved from a pure >,<pressure>
{  The <glaucoma>medication latanoprost and possibly other topical prostaglandin analogs increase uveoscleral outflow and lower intraocular <pressure>}
{<glaucoma>,<medication latanoprost and possibly other topical prostaglandin analogs increase uveoscleral outflow and lower intraocular >,<pressure>
{and chronic open-angle <glaucoma>by French ophthalmologists the role of target intraocular <pressure>}
{<glaucoma>,<by French ophthalmologists the role of target intraocular >,<pressure>
{in untreated normal-tension <glaucoma>NTG patients and determine whether increased short-term mean arterial <pressure>}
{<glaucoma>,<NTG patients and determine whether increased short-term mean arterial >,<pressure>
{to worsening normal-tension <glaucoma>probably by increasing translaminar <pressure>}
{<glaucoma>,<probably by increasing translaminar >,<pressure>
{of early normal-tension <glaucoma>NTG patients with high and low intraocular <pressure>}
{<glaucoma>,<NTG patients with high and low intraocular >,<pressure>
{  Although <glaucoma>is often associated with elevated intraocular <pressure>}
{<glaucoma>,<is often associated with elevated intraocular >,<pressure>
{drug trial in <glaucoma>management is that fellow-eye pairs exhibit symmetric intraocular <pressure>}
{<glaucoma>,<management is that fellow-eye pairs exhibit symmetric intraocular >,<pressure>
{fluid pressure and <glaucoma>regulation of trans-lamina cribrosa <pressure>}
{<glaucoma>,<regulation of trans-lamina cribrosa >,<pressure>
{stability in low-pressure <glaucoma>patients randomized to intraocular <pressure>}
{<glaucoma>,<patients randomized to intraocular >,<pressure>
{defects of normal-tension <glaucoma>NTG the correlation between the right-left differences of VF defects and those of diurnal variations of intraocular <pressure>}
{<glaucoma>,<NTG the correlation between the right-left differences of VF defects and those of diurnal variations of intraocular >,<pressure>
{different types of <glaucoma>iii the distributions of intraocular <pressure>}
{<glaucoma>,<iii the distributions of intraocular >,<pressure>
{patients with normal-tension <glaucoma>had significantly lower CSFP and a higher trans-lamina cribrosa <pressure>}
{<glaucoma>,<had significantly lower CSFP and a higher trans-lamina cribrosa >,<pressure>
{participants with open-angle <glaucoma>this study identified a positive cross-sectional association between coffee consumption/higher caffeine intakes and elevated intraocular <pressure>}
{<glaucoma>,<this study identified a positive cross-sectional association between coffee consumption/higher caffeine intakes and elevated intraocular >,<pressure>
{medically treated normal-tension <glaucoma>patients with unstable ocular perfusion <pressure>}
{<glaucoma>,<patients with unstable ocular perfusion >,<pressure>
{role in early-onset <glaucoma>characterized by elevated intraocular <pressure>}
{<glaucoma>,<characterized by elevated intraocular >,<pressure>
{medically treated normal-tension <glaucoma>NTG patients Koreans with unstable ocular perfusion <pressure>}
{<glaucoma>,<NTG patients Koreans with unstable ocular perfusion >,<pressure>
{for other common <glaucoma>therapies while providing similar <pressure>}
{<glaucoma>,<therapies while providing similar >,<pressure>
{history of normal-tension <glaucoma>must be considered before embarking on intraocular <pressure>}
{<glaucoma>,<must be considered before embarking on intraocular >,<pressure>
{for most normal-tension <glaucoma>patients corneal thickness is not a major factor in accounting for the lower intraocular <pressure>}
{<glaucoma>,<patients corneal thickness is not a major factor in accounting for the lower intraocular >,<pressure>
{family history of <glaucoma>refraction systolic and diastolic pressures cup disc ratio ratio of area of parapapillary atrophy to disc area the mean deviations of the studied and contralateral eyes and intraocular <pressure>}
{<glaucoma>,<refraction systolic and diastolic pressures cup disc ratio ratio of area of parapapillary atrophy to disc area the mean deviations of the studied and contralateral eyes and intraocular >,<pressure>
{patients with normal-tension <glaucoma>selective beta-adrenergic blockade betaxolol may have ocular vasorelaxant effects independent of any influence on intraocular <pressure>}
{<glaucoma>,<selective beta-adrenergic blockade betaxolol may have ocular vasorelaxant effects independent of any influence on intraocular >,<pressure>
{noted in one <glaucoma>patient with low systemic blood <pressure>}
{<glaucoma>,<patient with low systemic blood >,<pressure>
{in the low-tension <glaucoma>the visual function undergoes more frequently stabilization after a more radical glaucomatous procedure of filtration type when the postoperative fall in the intraocular <pressure>}
{<glaucoma>,<the visual function undergoes more frequently stabilization after a more radical glaucomatous procedure of filtration type when the postoperative fall in the intraocular >,<pressure>
{63 of the <glaucoma>patients white-noise-field campimetry was carried out during artificial IOP elevation achieved by suction-cup oculopression during steplike increases of the negative pressure in the suction-cup up to maximum of 375 mmHg the following stages could be seen the percentage of eyes that perceived each phenomena over the negative <pressure>}
{<glaucoma>,<patients white-noise-field campimetry was carried out during artificial IOP elevation achieved by suction-cup oculopression during steplike increases of the negative pressure in the suction-cup up to maximum of 375 mmHg the following stages could be seen the percentage of eyes that perceived each phenomena over the negative >,<pressure>
{of 114 low-tension <glaucoma>LTG patients the mean peak trough and magnitude of the diurnal fluctuation of the intraocular pressure IOP determined over a period of 24 hours diurnal IOP were correlated with the IOPs recorded at the daytime office office IOP refraction extent of visual field loss age sex blood <pressure>}
{<glaucoma>,<LTG patients the mean peak trough and magnitude of the diurnal fluctuation of the intraocular pressure IOP determined over a period of 24 hours diurnal IOP were correlated with the IOPs recorded at the daytime office office IOP refraction extent of visual field loss age sex blood >,<pressure>
{with untreated normal-tension <glaucoma>were randomly assigned to a marked intraocular <pressure>}
{<glaucoma>,<were randomly assigned to a marked intraocular >,<pressure>
{function in early <glaucoma>after intraocular <pressure>}
{<glaucoma>,<after intraocular >,<pressure>
{ laterality of <glaucoma>presenting and highest diurnal intraocular <pressure>}
{<glaucoma>,<presenting and highest diurnal intraocular >,<pressure>
{family history of <glaucoma>systemic systolic channel blood <pressure>}
{<glaucoma>,<systemic systolic channel blood >,<pressure>
{ and low-tension <glaucoma>on the basis of intraocular <pressure>}
{<glaucoma>,<on the basis of intraocular >,<pressure>
{registry with normal-tension <glaucoma>NTG and 64 patients with primary open angle glaucoma pOAG as control group were performed with regard to activities respectively diseases causing intrathoracic or -abdominal <pressure>}
{<glaucoma>,<NTG and 64 patients with primary open angle glaucoma pOAG as control group were performed with regard to activities respectively diseases causing intrathoracic or -abdominal >,<pressure>
{patients attending for <glaucoma>assessment in a district general hospital to avoid misclassification resulting from the relationship between CCT and tonometric <pressure>}
{<glaucoma>,<assessment in a district general hospital to avoid misclassification resulting from the relationship between CCT and tonometric >,<pressure>
{contributes to aggravating <glaucoma>at a lower intraocular <pressure>}
{<glaucoma>,<at a lower intraocular >,<pressure>
{Patients with known <glaucoma>or with intraocular <pressure>}
{<glaucoma>,<or with intraocular >,<pressure>
{the absence of <glaucoma>but with intraocular <pressure>}
{<glaucoma>,<but with intraocular >,<pressure>
{eyes with open-angle <glaucoma>viscocanalostomy is less effective in reducing intraocular <pressure>}
{<glaucoma>,<viscocanalostomy is less effective in reducing intraocular >,<pressure>
{  and <glaucoma>surgery is an established method to control intraocular <pressure>}
{<glaucoma>,<surgery is an established method to control intraocular >,<pressure>
{In the secondary <glaucoma>groups the maximal intraocular <pressure>}
{<glaucoma>,<groups the maximal intraocular >,<pressure>
{common form of <glaucoma>is a slowly progressive atrophy of the optic nerve characterized by loss of peripheral visual function and is usually associated with elevated intraocular <pressure>}
{<glaucoma>,<is a slowly progressive atrophy of the optic nerve characterized by loss of peripheral visual function and is usually associated with elevated intraocular >,<pressure>
{for treatment of <glaucoma>not only because it reduces intraocular <pressure>}
{<glaucoma>,<not only because it reduces intraocular >,<pressure>
{duration of phacolytic <glaucoma>addition of a trabeculectomy to cataract surgery is safe prevents postoperative rise in intraocular <pressure>}
{<glaucoma>,<addition of a trabeculectomy to cataract surgery is safe prevents postoperative rise in intraocular >,<pressure>
{trabeculectomy in primary <glaucoma>a long-term intra-individual comparison of intra-ocular <pressure>}
{<glaucoma>,<a long-term intra-individual comparison of intra-ocular >,<pressure>
{Risk factors for <glaucoma>progression Where does intraocular <pressure>}
{<glaucoma>,<progression Where does intraocular >,<pressure>
{the objective of <glaucoma>surgery is an additional greater than or equal to 5 to 6 mm Hg reduction of intraocular <pressure>}
{<glaucoma>,<surgery is an additional greater than or equal to 5 to 6 mm Hg reduction of intraocular >,<pressure>
{administered in alpha-chymotrypsin-induced <glaucoma>rabbits for determining the lowering effect on intraocular <pressure>}
{<glaucoma>,<rabbits for determining the lowering effect on intraocular >,<pressure>
{in healthy and <glaucoma>subjects the effects of an angiotensin conversion enzyme inhibitor Captopril on intraocular pressure local tolerance influence on systemic circulation and to ascertain or suggest the mechanisms inducing this <pressure>}
{<glaucoma>,<subjects the effects of an angiotensin conversion enzyme inhibitor Captopril on intraocular pressure local tolerance influence on systemic circulation and to ascertain or suggest the mechanisms inducing this >,<pressure>
{ and low-tension <glaucoma>can be established by determining the tolerable <pressure>}
{<glaucoma>,<can be established by determining the tolerable >,<pressure>
{family history of <glaucoma>refraction intraocular <pressure>}
{<glaucoma>,<refraction intraocular >,<pressure>
{patients with low-tension <glaucoma>were excluded a high mean intraocular <pressure>}
{<glaucoma>,<were excluded a high mean intraocular >,<pressure>
{history of open-angle <glaucoma>high intraocular <pressure>}
{<glaucoma>,<high intraocular >,<pressure>
{cyclophotocoagulation for refractory <glaucoma>after penetrating keratoplasty on intraocular <pressure>}
{<glaucoma>,<after penetrating keratoplasty on intraocular >,<pressure>
{eyes with high-pressure <glaucoma>indicates that the development of the parapapillary atrophy may at least partially be independent of an elevation of intraocular <pressure>}
{<glaucoma>,<indicates that the development of the parapapillary atrophy may at least partially be independent of an elevation of intraocular >,<pressure>
{patients with low-tension <glaucoma>had APONs whereas 31 15% of the 232 patients with elevated <pressure>}
{<glaucoma>,<had APONs whereas 31 15% of the 232 patients with elevated >,<pressure>
{Pathogenetic mechanisms of <glaucoma>not related to intraocular <pressure>}
{<glaucoma>,<not related to intraocular >,<pressure>
{loss in normal-tension <glaucoma>there may be a possible benefit from therapeutic efforts to lower the <pressure>}
{<glaucoma>,<there may be a possible benefit from therapeutic efforts to lower the >,<pressure>
{whether in normal-pressure <glaucoma>the level of intraocular <pressure>}
{<glaucoma>,<the level of intraocular >,<pressure>
{at risk for <glaucoma>usually have one or more of the following characteristics advanced age diabetes myopia elevated intraocular <pressure>}
{<glaucoma>,<usually have one or more of the following characteristics advanced age diabetes myopia elevated intraocular >,<pressure>
{ Researches of <glaucoma>visual function damage hemorheology ocular rheography and other related multiplex factors with computed multifactorial stepwise regression analysis indicate that the elevation of intraocular <pressure>}
{<glaucoma>,<visual function damage hemorheology ocular rheography and other related multiplex factors with computed multifactorial stepwise regression analysis indicate that the elevation of intraocular >,<pressure>
{group consisted of <glaucoma>subjects with controlled intraocular <pressure>}
{<glaucoma>,<subjects with controlled intraocular >,<pressure>
{zero to two <glaucoma>medications than in patients with more difficult intraocular <pressure>}
{<glaucoma>,<medications than in patients with more difficult intraocular >,<pressure>
{lamina cribrosa of <glaucoma>eyes have a curled appearance when the tissue is fixed at atmospheric <pressure>}
{<glaucoma>,<eyes have a curled appearance when the tissue is fixed at atmospheric >,<pressure>
{ In capsular <glaucoma>laser treatment resulted in a significantly lower average <pressure>}
{<glaucoma>,<laser treatment resulted in a significantly lower average >,<pressure>
{patients with open-angle <glaucoma>was associated with a reduction of perfusion <pressure>}
{<glaucoma>,<was associated with a reduction of perfusion >,<pressure>
{beagle dogs with <glaucoma>were more resistant to the elevated intraocular <pressure>}
{<glaucoma>,<were more resistant to the elevated intraocular >,<pressure>
{of cataracts or <glaucoma>although there are anecdotal data on transient elevated intraocular <pressure>}
{<glaucoma>,<although there are anecdotal data on transient elevated intraocular >,<pressure>
{ In primary <glaucoma>an increased intraocular <pressure>}
{<glaucoma>,<an increased intraocular >,<pressure>
{  from <glaucoma>the adherence to treatment and the effects of stress on intraocular <pressure>}
{<glaucoma>,<the adherence to treatment and the effects of stress on intraocular >,<pressure>
{ In secondary <glaucoma>an increased intraocular <pressure>}
{<glaucoma>,<an increased intraocular >,<pressure>
{and may need <glaucoma>surgery to control high intraocular <pressure>}
{<glaucoma>,<surgery to control high intraocular >,<pressure>
{  Although <glaucoma>usually is characterized by chronically elevated intraocular <pressure>}
{<glaucoma>,<usually is characterized by chronically elevated intraocular >,<pressure>
{patients with EF <glaucoma>have a large initial reduction in intraocular <pressure>}
{<glaucoma>,<have a large initial reduction in intraocular >,<pressure>
{that in neovascular <glaucoma>the retinal blood vessels are not capable of autoregulation of calibre in response to changes in intraocular <pressure>}
{<glaucoma>,<the retinal blood vessels are not capable of autoregulation of calibre in response to changes in intraocular >,<pressure>
{a failing Ahmed <glaucoma>valve AGV implant and to identify predictors of long-term intraocular <pressure>}
{<glaucoma>,<valve AGV implant and to identify predictors of long-term intraocular >,<pressure>
{cent of these <glaucoma>patients have intraocular <pressure>}
{<glaucoma>,<patients have intraocular >,<pressure>
{primary goal of <glaucoma>treatment is to lower and control intraocular <pressure>}
{<glaucoma>,<treatment is to lower and control intraocular >,<pressure>
{and phaco plus <glaucoma>surgeries that lower intraocular <pressure>}
{<glaucoma>,<surgeries that lower intraocular >,<pressure>
{the severity of <glaucoma>albeit less strongly than with intraocular <pressure>}
{<glaucoma>,<albeit less strongly than with intraocular >,<pressure>
{the definition of <glaucoma>is rapidly evolving elevated intraocular <pressure>}
{<glaucoma>,<is rapidly evolving elevated intraocular >,<pressure>
{standard approach in <glaucoma>therapy is reduction of intraocular <pressure>}
{<glaucoma>,<therapy is reduction of intraocular >,<pressure>
{ to have <glaucoma>or started on treatment to lower the intra-ocular <pressure>}
{<glaucoma>,<or started on treatment to lower the intra-ocular >,<pressure>
{increased risk of <glaucoma>or elevated intraocular <pressure>}
{<glaucoma>,<or elevated intraocular >,<pressure>
{threshold in chronic <glaucoma>was found to correlate significantly with the initial intraocular <pressure>}
{<glaucoma>,<was found to correlate significantly with the initial intraocular >,<pressure>
{  Although <glaucoma>drops are proven to work well to lower intraocular <pressure>}
{<glaucoma>,<drops are proven to work well to lower intraocular >,<pressure>
{sex prior surgery <glaucoma>type number of medications intraocular <pressure>}
{<glaucoma>,<type number of medications intraocular >,<pressure>
{  When <glaucoma>medication fails to adequately control intraocular <pressure>}
{<glaucoma>,<medication fails to adequately control intraocular >,<pressure>
{RATIONALE Neovascular secondary <glaucoma>is a condition characterized by increased intraocular <pressure>}
{<glaucoma>,<is a condition characterized by increased intraocular >,<pressure>
{early-to-moderate chronic open-angle <glaucoma>COAG in whom reversal of glaucomatous disc cupping was documented by computerized image analysis Rodenstock Optic Nerve Head Analyzer after intraocular <pressure>}
{<glaucoma>,<COAG in whom reversal of glaucomatous disc cupping was documented by computerized image analysis Rodenstock Optic Nerve Head Analyzer after intraocular >,<pressure>
{into current available <glaucoma>medications new <pressure>}
{<glaucoma>,<medications new >,<pressure>
{  Therefore <glaucoma>follow-up means <pressure>}
{<glaucoma>,<follow-up means >,<pressure>
{the following terms <glaucoma>automated perimetry optic nerve imaging optical coherence tomography glaucoma structure and function intraocular <pressure>}
{<glaucoma>,<automated perimetry optic nerve imaging optical coherence tomography glaucoma structure and function intraocular >,<pressure>
{common types of <glaucoma>is an increased intra-ocular <pressure>}
{<glaucoma>,<is an increased intra-ocular >,<pressure>
{complete pathomechanism of <glaucoma>is not known and there is no treatment available except modification of intraocular <pressure>}
{<glaucoma>,<is not known and there is no treatment available except modification of intraocular >,<pressure>
{PURPOSE Ab interno <glaucoma>surgery such as trabecular aspiration or ab interno trabeculotomy has been introduced as an alternative non-filtering procedure to lower intraocular <pressure>}
{<glaucoma>,<surgery such as trabecular aspiration or ab interno trabeculotomy has been introduced as an alternative non-filtering procedure to lower intraocular >,<pressure>
{ INTRODUCTION Fixed-combination <glaucoma>medications are commonly used to achieve target intraocular <pressure>}
{<glaucoma>,<medications are commonly used to achieve target intraocular >,<pressure>
{ An Ahmed <glaucoma>valve model FP7 was implanted with the tube in the posterior chamber with adequate intraocular <pressure>}
{<glaucoma>,<valve model FP7 was implanted with the tube in the posterior chamber with adequate intraocular >,<pressure>
{patients with open-angle <glaucoma>were tested to see if and to what extent timolol and acetazolamide produced a supplementary reduction of intraocular <pressure>}
{<glaucoma>,<were tested to see if and to what extent timolol and acetazolamide produced a supplementary reduction of intraocular >,<pressure>
{patients with open-angle <glaucoma>were divided into 2 groups according to intraocular <pressure>}
{<glaucoma>,<were divided into 2 groups according to intraocular >,<pressure>
{eyes with open-angle <glaucoma>had an intraocular <pressure>}
{<glaucoma>,<had an intraocular >,<pressure>
{patient with open-angle <glaucoma>who underwent canaloplasty and subsequently maintained good intraocular <pressure>}
{<glaucoma>,<who underwent canaloplasty and subsequently maintained good intraocular >,<pressure>
{chronic simple open-angle <glaucoma>because of the occasional occurrence of a high rise of <pressure>}
{<glaucoma>,<because of the occasional occurrence of a high rise of >,<pressure>
{patients with open-angle <glaucoma>intra-ocular <pressure>}
{<glaucoma>,<intra-ocular >,<pressure>
{tafluprost for open-angle <glaucoma>patients assessed by home intraocular <pressure>}
{<glaucoma>,<patients assessed by home intraocular >,<pressure>
{with unilateral angle-recession <glaucoma>had an ipsilateral increased intraocular <pressure>}
{<glaucoma>,<had an ipsilateral increased intraocular >,<pressure>
{Surgical management of <glaucoma>secondary to idiopathic elevated episcleral venous <pressure>}
{<glaucoma>,<secondary to idiopathic elevated episcleral venous >,<pressure>
{eyes with open-angle <glaucoma>by means of one-drop curves diurnal <pressure>}
{<glaucoma>,<by means of one-drop curves diurnal >,<pressure>
{clinical management of <glaucoma>should not simply be about control of intraocular <pressure>}
{<glaucoma>,<should not simply be about control of intraocular >,<pressure>
{patients with open-angle <glaucoma>to ascertain the immediate intraocular <pressure>}
{<glaucoma>,<to ascertain the immediate intraocular >,<pressure>
glaucoma retinal artery occlusion,endophthalmitis
{   <glaucoma retinal artery occlusion>and <endophthalmitis>}
{<glaucoma retinal artery occlusion>,<and >,<endophthalmitis>
ocular hypertension,primary open angle glaucoma
{58 eyes with <ocular hypertension>OHT or <primary open angle glaucoma>}
{<ocular hypertension>,<OHT or >,<primary open angle glaucoma>
{ PURPOSE Glucocorticoid-induced <ocular hypertension>the steroid response may result in optic nerve damage that very closely mimics the pathologic course of <primary open angle glaucoma>}
{<ocular hypertension>,<the steroid response may result in optic nerve damage that very closely mimics the pathologic course of >,<primary open angle glaucoma>
{ Management of <ocular hypertension>and <primary open angle glaucoma>}
{<ocular hypertension>,<and >,<primary open angle glaucoma>
{17 eyes with <ocular hypertension>in 239 eyes with <primary open angle glaucoma>}
{<ocular hypertension>,<in 239 eyes with >,<primary open angle glaucoma>
{patients whereas the <ocular hypertension>patients had significantly higher central corneal thicknesses than the controls and the <primary open angle glaucoma>}
{<ocular hypertension>,<patients had significantly higher central corneal thicknesses than the controls and the >,<primary open angle glaucoma>
{patients 35 OHT <ocular hypertension>34 early POAG <primary open angle glaucoma>}
{<ocular hypertension>,<34 early POAG >,<primary open angle glaucoma>
{150 eyes of <ocular hypertension>and 132 eyes of <primary open angle glaucoma>}
{<ocular hypertension>,<and 132 eyes of >,<primary open angle glaucoma>
{polymorphisms in glucocorticoid-induced <ocular hypertension>and <primary open angle glaucoma>}
{<ocular hypertension>,<and >,<primary open angle glaucoma>
{the eyes with <ocular hypertension>greatly resembled the eyes with <primary open angle glaucoma>}
{<ocular hypertension>,<greatly resembled the eyes with >,<primary open angle glaucoma>
{angle glaucoma and <ocular hypertension>as a risk factor for <primary open angle glaucoma>}
{<ocular hypertension>,<as a risk factor for >,<primary open angle glaucoma>
Breast feeding,acute appendicitis
{   <Breast feeding>and <acute appendicitis>}
{<Breast feeding>,<and >,<acute appendicitis>
{  br <Breast feeding>stimulates a more tolerant lymphoid tissue at the base of the appendix and this could provide protection against <acute appendicitis>}
{<Breast feeding>,<stimulates a more tolerant lymphoid tissue at the base of the appendix and this could provide protection against >,<acute appendicitis>
brachydactyly,joint stiffness
{   <brachydactyly>and <joint stiffness>}
{<brachydactyly>,<and >,<joint stiffness>
sudden cardiac death pulmonary hypertension,valvular heart disease
{   <sudden cardiac death pulmonary hypertension>and <valvular heart disease>}
{<sudden cardiac death pulmonary hypertension>,<and >,<valvular heart disease>
glaucoma chemical burn,scleritis
{   <glaucoma chemical burn>and <scleritis>}
{<glaucoma chemical burn>,<and >,<scleritis>
Optic disc hemorrhages,glaucoma
{   <Optic disc hemorrhages>and <glaucoma>}
{<Optic disc hemorrhages>,<and >,<glaucoma>
{   <Optic disc hemorrhages>in a population with and without signs of <glaucoma>}
{<Optic disc hemorrhages>,<in a population with and without signs of >,<glaucoma>
Hypothyroidism,glaucoma
{   <Hypothyroidism>and <glaucoma>}
{<Hypothyroidism>,<and >,<glaucoma>
ileus small bowel obstruction,wound
{   <ileus small bowel obstruction>and <wound>}
{<ileus small bowel obstruction>,<and >,<wound>
disease,disease
{weaker in mild <disease>as some patients with early <disease>}
{<disease>,<as some patients with early >,<disease>
{contributes to the <disease>process or is secondary to pathological changes caused by the <disease>}
{<disease>,<process or is secondary to pathological changes caused by the >,<disease>
{patients with early-stage <disease>to $2511 per patient per year for patients with end-stage <disease>}
{<disease>,<to $2511 per patient per year for patients with end-stage >,<disease>
{such as Alzheimer <disease>and Parkinson <disease>}
{<disease>,<and Parkinson >,<disease>
{experience with the <disease>and the treatment interaction between the patient and the treatment and patient knowledge of the <disease>}
{<disease>,<and the treatment interaction between the patient and the treatment and patient knowledge of the >,<disease>
{is a multi-factorial <disease>with a devastating impact on the quality of life of the patient in the moderate and severe stages of the <disease>}
{<disease>,<with a devastating impact on the quality of life of the patient in the moderate and severe stages of the >,<disease>
{optic nerve head <disease>and in 127 subjects without optic nerve head <disease>}
{<disease>,<and in 127 subjects without optic nerve head >,<disease>
{course of the <disease>and may therefore account for some of the variability in the course of the <disease>}
{<disease>,<and may therefore account for some of the variability in the course of the >,<disease>
{or with recurrent <disease>not suitable for primary surgical treatment with no palliative chemotherapy or radiotherapy to the chest or immunotherapy or biologic therapy the presence of measurable <disease>}
{<disease>,<not suitable for primary surgical treatment with no palliative chemotherapy or radiotherapy to the chest or immunotherapy or biologic therapy the presence of measurable >,<disease>
{neurites in Parkinson's <disease>ballooned neurons in Creutzfeldt-Jakob <disease>}
{<disease>,<ballooned neurons in Creutzfeldt-Jakob >,<disease>
{neurites in Alzheimer's <disease>Lewy bodies and Lewy neurites in Parkinson's <disease>}
{<disease>,<Lewy bodies and Lewy neurites in Parkinson's >,<disease>
{glaucoma with vascular <disease>with 2 independent pathways the association of glaucoma with cardiovascular <disease>}
{<disease>,<with 2 independent pathways the association of glaucoma with cardiovascular >,<disease>
{  and <disease>severity <disease>}
{<disease>,<severity >,<disease>
{is a treatable <disease>with surgery being beneficial in a few cases and with chemotherapy radiotherapy and immunotherapy contributing to prolonged survival in patients with inoperable <disease>}
{<disease>,<with surgery being beneficial in a few cases and with chemotherapy radiotherapy and immunotherapy contributing to prolonged survival in patients with inoperable >,<disease>
{either to malignant <disease>or to treatment of the <disease>}
{<disease>,<or to treatment of the >,<disease>
{outlook for the <disease>remains poor primarily because of dissemination of <disease>}
{<disease>,<remains poor primarily because of dissemination of >,<disease>
{patients with local <disease>are cured by surgery in patients with metastatic <disease>}
{<disease>,<are cured by surgery in patients with metastatic >,<disease>
{therapy for this <disease>is the advent of multiple new chemotherapeutic agents such as the taxanes gemcitabine vinorelbine and the topoisomerase-I inhibitors which have activity in stage IV <disease>}
{<disease>,<is the advent of multiple new chemotherapeutic agents such as the taxanes gemcitabine vinorelbine and the topoisomerase-I inhibitors which have activity in stage IV >,<disease>
{ In limited <disease>median survival is about 12-16 months with 4-5% of long-term survivors in extensive <disease>}
{<disease>,<median survival is about 12-16 months with 4-5% of long-term survivors in extensive >,<disease>
{had no systemic <disease>dropped out than those with systemic <disease>}
{<disease>,<dropped out than those with systemic >,<disease>
{primarily a complex <disease>we examined the potential of coding single nucleotide polymorphisms cSNPs in the gene for association with the <disease>}
{<disease>,<we examined the potential of coding single nucleotide polymorphisms cSNPs in the gene for association with the >,<disease>
{knowledge about the <disease>in the general population and the active help of all general practitioners explaining their patients the insidious nature of the <disease>}
{<disease>,<in the general population and the active help of all general practitioners explaining their patients the insidious nature of the >,<disease>
{is a complex <disease>with a genetic architecture that can be simplified through the investigation of individual traits underlying <disease>}
{<disease>,<with a genetic architecture that can be simplified through the investigation of individual traits underlying >,<disease>
{these genes causes <disease>either directly or indirectly and the severity of the <disease>}
{<disease>,<either directly or indirectly and the severity of the >,<disease>
{classify them as <disease>but at the same time are not at a stage or level at which people can be declared entirely <disease>}
{<disease>,<but at the same time are not at a stage or level at which people can be declared entirely >,<disease>
{ stage worse <disease>were found to have statistically higher treatment costs compared with those at lower <disease>}
{<disease>,<were found to have statistically higher treatment costs compared with those at lower >,<disease>
{patients with initial <disease>in 48 7% of cases with advanced stage and in 50% of patients with the end stage of the <disease>}
{<disease>,<in 48 7% of cases with advanced stage and in 50% of patients with the end stage of the >,<disease>
{genes modulating the <disease>and increase knowledge of <disease>}
{<disease>,<and increase knowledge of >,<disease>
{eyes with advanced <disease>while its effects on secondary malignancies or trilateral <disease>}
{<disease>,<while its effects on secondary malignancies or trilateral >,<disease>
{presence of asymmetric <disease>it performed poorly in those with symmetric <disease>}
{<disease>,<it performed poorly in those with symmetric >,<disease>
{the corneal endothelium-advanced <disease>OD and presymptomatic <disease>}
{<disease>,<OD and presymptomatic >,<disease>
{stages of the <disease>process at the level of the corneal endothelium-advanced <disease>}
{<disease>,<process at the level of the corneal endothelium-advanced >,<disease>
{myocilin across the <disease>spectrum but the absence of myocilin does not cause <disease>}
{<disease>,<spectrum but the absence of myocilin does not cause >,<disease>
{is a multifactorial <disease>and multiple factors are likely to be involved in the <disease>}
{<disease>,<and multiple factors are likely to be involved in the >,<disease>
{for accelerated cardiovascular <disease>in CKD is facilitated by a few key features of this <disease>}
{<disease>,<in CKD is facilitated by a few key features of this >,<disease>
{increase in cardiovascular <disease>in end stage renal <disease>}
{<disease>,<in end stage renal >,<disease>
{treatment of this <disease>and serve as a roadmap to help educate adults as well as children with this <disease>}
{<disease>,<and serve as a roadmap to help educate adults as well as children with this >,<disease>
{diabetic nephropathy cardiac <disease>hypertension and VC may open new paths in the fight against CV <disease>}
{<disease>,<hypertension and VC may open new paths in the fight against CV >,<disease>
{effectively treated this <disease>invariably leads to end stage kidney <disease>}
{<disease>,<invariably leads to end stage kidney >,<disease>
{ Diabetic kidney <disease>DKD is a microvascular complication of type 1 and 2 diabetes with a devastating impact on individuals with the <disease>}
{<disease>,<DKD is a microvascular complication of type 1 and 2 diabetes with a devastating impact on individuals with the >,<disease>
{linked to cardiovascular <disease>and mortality in patients with CKD this review focuses only on uric acid as a potential therapeutic target to prevent kidney <disease>}
{<disease>,<and mortality in patients with CKD this review focuses only on uric acid as a potential therapeutic target to prevent kidney >,<disease>
{calcification in stenotic/occlusive <disease>or destruction of the extracellular matrix in aneurysmal <disease>}
{<disease>,<or destruction of the extracellular matrix in aneurysmal >,<disease>
{and chronic type <disease>there is in addition progressive neurodegenerative <disease>}
{<disease>,<there is in addition progressive neurodegenerative >,<disease>
{comorbid with cardiovascular <disease>hypertension kidney <disease>}
{<disease>,<hypertension kidney >,<disease>
{people with alcoholic <disease>in improving their prognosis of survival at any stage of their <disease>}
{<disease>,<in improving their prognosis of survival at any stage of their >,<disease>
{is a chronic <disease>that is often comorbid with cardiovascular <disease>}
{<disease>,<that is often comorbid with cardiovascular >,<disease>
{stage of the <disease>to prevent the <disease>}
{<disease>,<to prevent the >,<disease>
{is a chronic <disease>ocular complications can be prevented and sight may be preserved if the <disease>}
{<disease>,<ocular complications can be prevented and sight may be preserved if the >,<disease>
{means of distinguishing <disease>loci in large families with dominant <disease>}
{<disease>,<loci in large families with dominant >,<disease>
{clinical course of <disease>and response to treatment were similar to other families with this <disease>}
{<disease>,<and response to treatment were similar to other families with this >,<disease>
{families with this <disease>to determine if their <disease>}
{<disease>,<to determine if their >,<disease>
{patients with MÃ©niÃ¨re's <disease>may be significantly decreased 5-10 dB depending on the stage of <disease>}
{<disease>,<may be significantly decreased 5-10 dB depending on the stage of >,<disease>
{  Hirschsprung <disease>and Wilson <disease>}
{<disease>,<and Wilson >,<disease>
{risk of the <disease>in offspring for an efficient prophylaxis of the <disease>}
{<disease>,<in offspring for an efficient prophylaxis of the >,<disease>
{transmission of the <disease>to detect the carriers of pathological gene the heterozygotes to calculate the recurrence risk of the <disease>}
{<disease>,<to detect the carriers of pathological gene the heterozygotes to calculate the recurrence risk of the >,<disease>
{  This <disease>remains undetected in one half of the people with this <disease>}
{<disease>,<remains undetected in one half of the people with this >,<disease>
{patients with Alzheimer's <disease>and of 38 patients with Parkinson's <disease>}
{<disease>,<and of 38 patients with Parkinson's >,<disease>
{expression of the <disease>but weakened as the <disease>}
{<disease>,<but weakened as the >,<disease>
{patients 17% the <disease>was diagnosed on the basis of the ocular findings while in the remaining 107 patients 83% the period between the diagnosis of Behcet <disease>}
{<disease>,<was diagnosed on the basis of the ocular findings while in the remaining 107 patients 83% the period between the diagnosis of Behcet >,<disease>
{or other ocular <disease>likely to affect the visual field and 78 subjects with a diagnosis of glaucoma and no other ocular <disease>}
{<disease>,<likely to affect the visual field and 78 subjects with a diagnosis of glaucoma and no other ocular >,<disease>
{resulted in rapid <disease>progression whereas good IOP control usually only by means of filtration surgery could stabilize the <disease>}
{<disease>,<progression whereas good IOP control usually only by means of filtration surgery could stabilize the >,<disease>
{progression of renal <disease>indicating that a treatment for lipid abnormality might prevent the progression of renal <disease>}
{<disease>,<indicating that a treatment for lipid abnormality might prevent the progression of renal >,<disease>
{and chronic kidney <disease>are the expected outcomes of the <disease>}
{<disease>,<are the expected outcomes of the >,<disease>
{is an autoimmune <disease>characterised by an autoantibody to phospholipase A2 receptor 1 and the identification of two genes PLA2R1 and DQA1 which account for the genetic susceptibility to the <disease>}
{<disease>,<characterised by an autoantibody to phospholipase A2 receptor 1 and the identification of two genes PLA2R1 and DQA1 which account for the genetic susceptibility to the >,<disease>
{cause of foodborne <disease>yet global estimates of <disease>}
{<disease>,<yet global estimates of >,<disease>
{between diabetic kidney <disease>and various forms of cardiovascular <disease>}
{<disease>,<and various forms of cardiovascular >,<disease>
{or severe kidney <disease>or any other significantly <disease>}
{<disease>,<or any other significantly >,<disease>
{pre-existing unstable cardiovascular <disease>moderate or severe kidney <disease>}
{<disease>,<moderate or severe kidney >,<disease>
{to achieve comprehensive <disease>definition from a genomics perspective and identify shared molecular drivers of <disease>}
{<disease>,<definition from a genomics perspective and identify shared molecular drivers of >,<disease>
{extent of the <disease>as patients with vascular <disease>}
{<disease>,<as patients with vascular >,<disease>
{of cancer heart <disease>chronic obstructive pulmonary disease kidney <disease>}
{<disease>,<chronic obstructive pulmonary disease kidney >,<disease>
{renal and cardiovascular <disease>with poor <disease>}
{<disease>,<with poor >,<disease>
{risks of kidney <disease>progression cardiovascular <disease>}
{<disease>,<progression cardiovascular >,<disease>
{phosphorus metabolism and <disease>in CKD patients may clarify the potential role of excess dietary phosphorus as a risk factor for <disease>}
{<disease>,<in CKD patients may clarify the potential role of excess dietary phosphorus as a risk factor for >,<disease>
{bone and cardiovascular <disease>CVD in CKD patients as well as progression of kidney <disease>}
{<disease>,<CVD in CKD patients as well as progression of kidney >,<disease>
{patient with renal <disease>and then review recent and emerging research to suggest an approach to the management of patients with renal <disease>}
{<disease>,<and then review recent and emerging research to suggest an approach to the management of patients with renal >,<disease>
{of nondiabetic kidney <disease>in the focal segmental glomerulosclerosis spectrum of <disease>}
{<disease>,<in the focal segmental glomerulosclerosis spectrum of >,<disease>
{pathogenesis of this <disease>is being unraveled we are afforded new opportunities to develop novel biomarkers for early identification and prevention of <disease>}
{<disease>,<is being unraveled we are afforded new opportunities to develop novel biomarkers for early identification and prevention of >,<disease>
{liver and heart <disease>cancer Alzheimer and Parkinson <disease>}
{<disease>,<cancer Alzheimer and Parkinson >,<disease>
{to prevent kidney <disease>stroke and cardiovascular <disease>}
{<disease>,<stroke and cardiovascular >,<disease>
{and chronic renal <disease>is provided followed by a discussion of common therapies that have anti-inflammatory or immunosuppressive effects in the treatment of renal <disease>}
{<disease>,<is provided followed by a discussion of common therapies that have anti-inflammatory or immunosuppressive effects in the treatment of renal >,<disease>
{patient with kidney <disease>and in patients with extrarenal <disease>}
{<disease>,<and in patients with extrarenal >,<disease>
{progression of kidney <disease>through hemodynamic and direct cellular actions and that antagonists of aldosterone may retard the progression of kidney <disease>}
{<disease>,<through hemodynamic and direct cellular actions and that antagonists of aldosterone may retard the progression of kidney >,<disease>
{CKD associated cardiovascular <disease>and identify ActRIIA signaling as a therapeutic target in CKD that links progression of renal <disease>}
{<disease>,<and identify ActRIIA signaling as a therapeutic target in CKD that links progression of renal >,<disease>
{moderate chronic kidney <disease>and diabetic kidney <disease>}
{<disease>,<and diabetic kidney >,<disease>
{ hypertension cardiovascular <disease>cancer musculoskeletal disorders chronic kidney and pulmonary <disease>}
{<disease>,<cancer musculoskeletal disorders chronic kidney and pulmonary >,<disease>
{ In liver <disease>all creatinine-based estimates of GFR overestimate gold standard-measured GFR and the degree of overestimation is highest at lower measured GFR values and in more severe liver <disease>}
{<disease>,<all creatinine-based estimates of GFR overestimate gold standard-measured GFR and the degree of overestimation is highest at lower measured GFR values and in more severe liver >,<disease>
{prioritization in kidney <disease>and describe research priorities of patients with kidney <disease>}
{<disease>,<and describe research priorities of patients with kidney >,<disease>
{patients with kidney <disease>was performed by selecting those articles published between January 1 1990 and December 1 2014 using PubMed as a search engine with the keywords elderly kidney <disease>}
{<disease>,<was performed by selecting those articles published between January 1 1990 and December 1 2014 using PubMed as a search engine with the keywords elderly kidney >,<disease>
{detection of renal <disease>screening of CKD patients specific therapy slowing down <disease>}
{<disease>,<screening of CKD patients specific therapy slowing down >,<disease>
{of chronic kidney <disease>CKD patients and on the most common causes of the <disease>}
{<disease>,<CKD patients and on the most common causes of the >,<disease>
{prevention identification of <disease>management and subsequent chronic <disease>}
{<disease>,<management and subsequent chronic >,<disease>
{frequency of ulcer <disease>is higher in patients with kidney <disease>}
{<disease>,<is higher in patients with kidney >,<disease>
{an increasingly prevalent <disease>CKD together with consequent CV <disease>}
{<disease>,<CKD together with consequent CV >,<disease>
{guidelines for cardiovascular <disease>excluded patients with kidney <disease>}
{<disease>,<excluded patients with kidney >,<disease>
{circulating OxPLs and <disease>progression with particular emphasis on cardiovascular <disease>}
{<disease>,<progression with particular emphasis on cardiovascular >,<disease>
{progression of kidney <disease>the development or exacerbation of bone <disease>}
{<disease>,<the development or exacerbation of bone >,<disease>
{ are the <disease>and overall cystic burden measured by MRI as total kidney volume is being established as the best available biomarker of <disease>}
{<disease>,<and overall cystic burden measured by MRI as total kidney volume is being established as the best available biomarker of >,<disease>
{better understanding of <disease>mechanisms has been gained in recent years but the current management strategies are ineffective at preventing <disease>}
{<disease>,<mechanisms has been gained in recent years but the current management strategies are ineffective at preventing >,<disease>
{this increasingly prevalent <disease>that is likely to have an important future impact on the global burden of <disease>}
{<disease>,<that is likely to have an important future impact on the global burden of >,<disease>
{implicated in SLE <disease>progression because of the prevalence of the <disease>}
{<disease>,<progression because of the prevalence of the >,<disease>
{progression of liver <disease>but also reduce morbidity for cardiovascular <disease>}
{<disease>,<but also reduce morbidity for cardiovascular >,<disease>
{developed for binary <disease>staging in CHC continue to be refined for diagnostic use in other chronic liver <disease>}
{<disease>,<staging in CHC continue to be refined for diagnostic use in other chronic liver >,<disease>
{succumbing to disseminated <disease>while 1 patient developed extracutaneous nodal <disease>}
{<disease>,<while 1 patient developed extracutaneous nodal >,<disease>
{duration of the <disease>which didn't exceed 24 hours and in presence of less than 60 ml of exudate in the abdominal cavity the microirrigators were used in duration of the <disease>}
{<disease>,<which didn't exceed 24 hours and in presence of less than 60 ml of exudate in the abdominal cavity the microirrigators were used in duration of the >,<disease>
{died from their <disease>within 1 year and of the patients with small bowel carcinoid one died of the <disease>}
{<disease>,<within 1 year and of the patients with small bowel carcinoid one died of the >,<disease>
{onset of the <disease>and the patient's call for the doctor the dependence of the histologic findings in the examined removed vermiform processes on the duration of the <disease>}
{<disease>,<and the patient's call for the doctor the dependence of the histologic findings in the examined removed vermiform processes on the duration of the >,<disease>
{treatment of this <disease>including laparoscopy the possibilities for outpatient antibiotic therapy and the worrisome potential for a change in referral patterns as children with this <disease>}
{<disease>,<including laparoscopy the possibilities for outpatient antibiotic therapy and the worrisome potential for a change in referral patterns as children with this >,<disease>
{focuses on kidney <disease>in childhood and the antecedents of adult kidney <disease>}
{<disease>,<in childhood and the antecedents of adult kidney >,<disease>
{ In cardiovascular <disease>arterial hypertension diabetes migraine and Parkinson <disease>}
{<disease>,<arterial hypertension diabetes migraine and Parkinson >,<disease>
{severity of the <disease>markedly influenced the chemical composition of the peritoneum whereas the duration of the <disease>}
{<disease>,<markedly influenced the chemical composition of the peritoneum whereas the duration of the >,<disease>
{manifestations of the <disease>it is concluded that patients with Crohn's <disease>}
{<disease>,<it is concluded that patients with Crohn's >,<disease>
{children with gallbladder <disease>in Houston Texas there were an equal number of patients with and without hemolytic <disease>}
{<disease>,<in Houston Texas there were an equal number of patients with and without hemolytic >,<disease>
{pathogenesis driving cardiovascular <disease>burden such as altered bone metabolism and calcific vascular <disease>}
{<disease>,<burden such as altered bone metabolism and calcific vascular >,<disease>
{hypothesis that this <disease>entity is associated with IgG4-associated <disease>}
{<disease>,<entity is associated with IgG4-associated >,<disease>
{molecular-proteomic-lipidomic classification of <disease>should yield new information about the functional basis of <disease>}
{<disease>,<should yield new information about the functional basis of >,<disease>
{information regarding Gaucher <disease>from the history of the <disease>}
{<disease>,<from the history of the >,<disease>
{regulation in kidney <disease>is crucial to unravelling the pathophysiological relevance of coagulation regulators in renal <disease>}
{<disease>,<is crucial to unravelling the pathophysiological relevance of coagulation regulators in renal >,<disease>
{patients with celiac <disease>and it may predispose to a higher risk of infections by encapsulated bacteria and thromboembolic and autoimmune complications particularly when celiac patients have concomitant pre-malignant and malignant complications refractory celiac <disease>}
{<disease>,<and it may predispose to a higher risk of infections by encapsulated bacteria and thromboembolic and autoimmune complications particularly when celiac patients have concomitant pre-malignant and malignant complications refractory celiac >,<disease>
{patients with kidney <disease>examines key <disease>}
{<disease>,<examines key >,<disease>
{spread endemic parasitic <disease>may evolve to severe forms of the <disease>}
{<disease>,<may evolve to severe forms of the >,<disease>
{n=1 granulomatous liver <disease>n=1 and Werlhof <disease>}
{<disease>,<n=1 and Werlhof >,<disease>
{progression of liver <disease>and promising therapeutic targets to either prevent or halt the progression of liver <disease>}
{<disease>,<and promising therapeutic targets to either prevent or halt the progression of liver >,<disease>
{depending on the <disease>stage owing to differential risk of progression and the particularities of an individual's comorbid <disease>}
{<disease>,<stage owing to differential risk of progression and the particularities of an individual's comorbid >,<disease>
{cases of this <disease>are probably undiagnosed this review emphasizes the clinical manifestations of HNF1Î²-associated <disease>}
{<disease>,<are probably undiagnosed this review emphasizes the clinical manifestations of HNF1Î²-associated >,<disease>
{ Although the <disease>primarily affects the gut the clinical spectrum of CD is remarkably varied and the <disease>}
{<disease>,<primarily affects the gut the clinical spectrum of CD is remarkably varied and the >,<disease>
{PGE2 in kidney <disease>outcomes that accelerate cardiovascular <disease>}
{<disease>,<outcomes that accelerate cardiovascular >,<disease>
{of progression and <disease>outcome Although up to 25% of the general population are at risk of progressive <disease>}
{<disease>,<outcome Although up to 25% of the general population are at risk of progressive >,<disease>
{stage of vascular <disease>and diabetic kidney <disease>}
{<disease>,<and diabetic kidney >,<disease>
{related to cardiovascular <disease>and cancer and not to the progression of liver <disease>}
{<disease>,<and cancer and not to the progression of liver >,<disease>
{stage of vascular <disease>and diabetic kidney <disease>}
{<disease>,<and diabetic kidney >,<disease>
{human metabolism and <disease>the interplay between gene polymorphisms clinical phenotypes and <disease>}
{<disease>,<the interplay between gene polymorphisms clinical phenotypes and >,<disease>
{and poorly understood <disease>seen predominantly in end stage renal <disease>}
{<disease>,<seen predominantly in end stage renal >,<disease>
{treatment for resectable <disease>long-term outcomes are poor and recurrence rates are high with surgery alone in patients presenting with locally advanced <disease>}
{<disease>,<long-term outcomes are poor and recurrence rates are high with surgery alone in patients presenting with locally advanced >,<disease>
{small bowel Crohn's <disease>presents specific management issues not seen in patients with Crohn's <disease>}
{<disease>,<presents specific management issues not seen in patients with Crohn's >,<disease>
{ During the <disease>course strictures develop in the majority of patients with ileal <disease>}
{<disease>,<course strictures develop in the majority of patients with ileal >,<disease>
{patients with reflux <disease>but the efficacy and impact on the natural history of <disease>}
{<disease>,<but the efficacy and impact on the natural history of >,<disease>
{non-alcoholic fatty pancreatic <disease>is an independent risk factor for the development of metabolic <disease>}
{<disease>,<is an independent risk factor for the development of metabolic >,<disease>
{ Extranodal Rosai-Dorfman <disease>involving appendix and mesenteric nodes with a protracted course report of a rare case lacking relationship to IgG4-related <disease>}
{<disease>,<involving appendix and mesenteric nodes with a protracted course report of a rare case lacking relationship to IgG4-related >,<disease>
{G4 IgG4 -related <disease>also known as hyper-IgG4 <disease>}
{<disease>,<also known as hyper-IgG4 >,<disease>
{relapse with distant <disease>and therefore a systemic <disease>}
{<disease>,<and therefore a systemic >,<disease>
{treatment of Crohn <disease>have evolved to bowel conservation such as strictureplasty techniques and limited resection margins such practices by themselves are often not sufficient for the management of complex small bowel Crohn <disease>}
{<disease>,<have evolved to bowel conservation such as strictureplasty techniques and limited resection margins such practices by themselves are often not sufficient for the management of complex small bowel Crohn >,<disease>
{metastatic manifestations and <disease>patterns may aid in differentiating distant metastatic <disease>}
{<disease>,<patterns may aid in differentiating distant metastatic >,<disease>
{a marker of <disease>susceptibility should shed light on how to better tackle prevention early detection and treatment of this highly fatal <disease>}
{<disease>,<susceptibility should shed light on how to better tackle prevention early detection and treatment of this highly fatal >,<disease>
{characterizes a rare <disease>and increases awareness of the <disease>}
{<disease>,<and increases awareness of the >,<disease>
{treating inflammatory liver <disease>such as non-alcoholic steatohepatitis reducing the likelihood of <disease>}
{<disease>,<such as non-alcoholic steatohepatitis reducing the likelihood of >,<disease>
{is a multisystem <disease>and the factors that might determine interindividual variation in the development and progression of its major hepatic and extrahepatic manifestations principally type 2 diabetes mellitus and cardiovascular <disease>}
{<disease>,<and the factors that might determine interindividual variation in the development and progression of its major hepatic and extrahepatic manifestations principally type 2 diabetes mellitus and cardiovascular >,<disease>
{end stage liver <disease>increased worldwide and over 7000 patients die in each year due to liver <disease>}
{<disease>,<increased worldwide and over 7000 patients die in each year due to liver >,<disease>
{end-stages of the <disease>and the course of the <disease>}
{<disease>,<and the course of the >,<disease>
{To prevent advanced <disease>clinicians need to have simple markers that predict the onset of NAFLD so that interventions can be started at much earlier stages of <disease>}
{<disease>,<clinicians need to have simple markers that predict the onset of NAFLD so that interventions can be started at much earlier stages of >,<disease>
{age comorbidities and <disease>severity and if treatment should be continued lifelong to prevent <disease>}
{<disease>,<severity and if treatment should be continued lifelong to prevent >,<disease>
{potential both as <disease>indicators and for providing deeper insights into the <disease>}
{<disease>,<indicators and for providing deeper insights into the >,<disease>
{  However <disease>pathogenesis is complicated by the fact that AD can occur as a separate <disease>}
{<disease>,<pathogenesis is complicated by the fact that AD can occur as a separate >,<disease>
{NAFLD with cardiovascular <disease>reviewing the likely mechanisms underlying this association as well as summarizing from a cardiologist's perspective current and potential future treatment options for this increasingly prevalent <disease>}
{<disease>,<reviewing the likely mechanisms underlying this association as well as summarizing from a cardiologist's perspective current and potential future treatment options for this increasingly prevalent >,<disease>
{patients with T1N0M <disease>who may be treated with surgery alone and those with metastatic <disease>}
{<disease>,<who may be treated with surgery alone and those with metastatic >,<disease>
{spontaneously develop liver <disease>and the second one includes mice that acquire the <disease>}
{<disease>,<and the second one includes mice that acquire the >,<disease>
{  Kimura <disease>Castleman disease and immunoglobulin G4-related <disease>}
{<disease>,<Castleman disease and immunoglobulin G4-related >,<disease>
{risk factors for <disease>progression and the <disease>}
{<disease>,<progression and the >,<disease>
{  Kikuchi-Fujimoto <disease>Kimura <disease>}
{<disease>,<Kimura >,<disease>
{understanding of the <disease>where we need to go to understand the molecular triggers that set the process in motion and what emergent therapeutic approaches show promise for ameliorating <disease>}
{<disease>,<where we need to go to understand the molecular triggers that set the process in motion and what emergent therapeutic approaches show promise for ameliorating >,<disease>
{events associated with <disease>onset and progression through the study of animal models for Alport syndrome and have identified some potential therapeutic approaches that may serve to delay the onset or slow the progression of the <disease>}
{<disease>,<onset and progression through the study of animal models for Alport syndrome and have identified some potential therapeutic approaches that may serve to delay the onset or slow the progression of the >,<disease>
{Patiens with non-complicated <disease>could undergo programmed surgery without having a higher risk of complicated <disease>}
{<disease>,<could undergo programmed surgery without having a higher risk of complicated >,<disease>
{referents without coeliac <disease>identified through the Swedish National Registers 1964-2003 and conditional logistic regression to study the risk of coeliac <disease>}
{<disease>,<identified through the Swedish National Registers 1964-2003 and conditional logistic regression to study the risk of coeliac >,<disease>
{individuals with coeliac <disease>and 68 000 referents without coeliac <disease>}
{<disease>,<and 68 000 referents without coeliac >,<disease>
{ Preoperative concomitant <disease>was present in 31% of patients cardiac <disease>}
{<disease>,<was present in 31% of patients cardiac >,<disease>
{clinical presentation underlying <disease>process white blood cell count WBC and absolute neutrophil count ANC prior to the onset of the <disease>}
{<disease>,<process white blood cell count WBC and absolute neutrophil count ANC prior to the onset of the >,<disease>
{types of liver <disease>including alcoholic liver disease ALD and viral liver <disease>}
{<disease>,<including alcoholic liver disease ALD and viral liver >,<disease>
{and non-alcoholic liver <disease>and the role of excess iron in chronic <disease>}
{<disease>,<and the role of excess iron in chronic >,<disease>
{patients the underlying <disease>was juvenile idiopathic arthritis in 12 57% BehÃ§et <disease>}
{<disease>,<was juvenile idiopathic arthritis in 12 57% BehÃ§et >,<disease>
{  Alzheimer <disease>or to chronic cerebral vascular <disease>}
{<disease>,<or to chronic cerebral vascular >,<disease>
{is a devastating <disease>with a median survival of around 6 months for patients with stage IV <disease>}
{<disease>,<with a median survival of around 6 months for patients with stage IV >,<disease>
{is a challenging <disease>to treat with median overall survival times ranging between 9-17 months for all stages of <disease>}
{<disease>,<to treat with median overall survival times ranging between 9-17 months for all stages of >,<disease>
{have not experienced <disease>progression after first-line treatment has shown potential in improving the efficacy in patients with advanced <disease>}
{<disease>,<progression after first-line treatment has shown potential in improving the efficacy in patients with advanced >,<disease>
{pregnancy and vascular <disease>such as hypertension cardiovascular <disease>}
{<disease>,<such as hypertension cardiovascular >,<disease>
{a precursor of <disease>but not the <disease>}
{<disease>,<but not the >,<disease>
{Oxaluric renal stone <disease>and some cases of uric acid stone <disease>}
{<disease>,<and some cases of uric acid stone >,<disease>
{on the underlying <disease>duration of the <disease>}
{<disease>,<duration of the >,<disease>
{of Vogt-Koyanagi-Harada VKH <disease>in a retrospective chart review of all patients diagnosed with VKH <disease>}
{<disease>,<in a retrospective chart review of all patients diagnosed with VKH >,<disease>
{  The <disease>carries a cumulative risk of need of colectomy of 20-30% and an estimated cumulative risk of colorectal cancer of 18% after 30 years of <disease>}
{<disease>,<carries a cumulative risk of need of colectomy of 20-30% and an estimated cumulative risk of colorectal cancer of 18% after 30 years of >,<disease>
{modalities for this <disease>entity whereas Western researchers are more inclined to treat this <disease>}
{<disease>,<entity whereas Western researchers are more inclined to treat this >,<disease>
{adequately stage the <disease>and to consider suitable treatment modalities for this <disease>}
{<disease>,<and to consider suitable treatment modalities for this >,<disease>
{of this serious <disease>had been dismal but improvement in diagnosis a better understanding of the natural course of the <disease>}
{<disease>,<had been dismal but improvement in diagnosis a better understanding of the natural course of the >,<disease>
{treatment of different <disease>states in ophthalmology including early- and late-stage <disease>}
{<disease>,<states in ophthalmology including early- and late-stage >,<disease>
{in treating this <disease>much data have emerged from experimental research the world over suggesting various pathological processes involved in this <disease>}
{<disease>,<much data have emerged from experimental research the world over suggesting various pathological processes involved in this >,<disease>
{neuroprotectant in Huntington's <disease>and its taurine conjugate exhibits neuro-protective effects in vitro that may be relevant to Alzheimer's <disease>}
{<disease>,<and its taurine conjugate exhibits neuro-protective effects in vitro that may be relevant to Alzheimer's >,<disease>
{literature on Coats <disease>and provide a structured framework for differentiating challenging clinical features in Coats <disease>}
{<disease>,<and provide a structured framework for differentiating challenging clinical features in Coats >,<disease>
{factor in Crohn's <disease>while it positively interferes with the <disease>}
{<disease>,<while it positively interferes with the >,<disease>
{ Thus the <disease>progresses substantially before the patients seek treatment and is a major contributing factor to the severity of this <disease>}
{<disease>,<progresses substantially before the patients seek treatment and is a major contributing factor to the severity of this >,<disease>
neutropenia fever,abdominal pain
{   <neutropenia fever>and <abdominal pain>}
{<neutropenia fever>,<and >,<abdominal pain>
Rubella,acute appendicitis
{   <Rubella>and <acute appendicitis>}
{<Rubella>,<and >,<acute appendicitis>
undescended testicles abdominal abscess,gastroesophageal reflux
{   <undescended testicles abdominal abscess>and <gastroesophageal reflux>}
{<undescended testicles abdominal abscess>,<and >,<gastroesophageal reflux>
ocular hypertension,glaucoma
{the treatment of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{novel drugs against <ocular hypertension>and/or <glaucoma>}
{<ocular hypertension>,<and/or >,<glaucoma>
{disc pit and <ocular hypertension>misdiagnosed as <glaucoma>}
{<ocular hypertension>,<misdiagnosed as >,<glaucoma>
{been developed corticosteroid-induced <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{Early treatment of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{  The <ocular hypertension>is the most frequent manifestation of the evolution of <glaucoma>}
{<ocular hypertension>,<is the most frequent manifestation of the evolution of >,<glaucoma>
{further damages called <ocular hypertension>and only glaucomatous damages without high pressure called normal- or low-pressure <glaucoma>}
{<ocular hypertension>,<and only glaucomatous damages without high pressure called normal- or low-pressure >,<glaucoma>
{the eyes with <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{electrodes in early <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{in cases of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{  from <ocular hypertension>to advanced <glaucoma>}
{<ocular hypertension>,<to advanced >,<glaucoma>
{angle glaucoma POAG <ocular hypertension>OHT normal tension <glaucoma>}
{<ocular hypertension>,<OHT normal tension >,<glaucoma>
{risk of developing <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{  or <ocular hypertension>as they have a higher incidence of normal-tension <glaucoma>}
{<ocular hypertension>,<as they have a higher incidence of normal-tension >,<glaucoma>
{the treatment of <ocular hypertension>and chronic open-angle <glaucoma>}
{<ocular hypertension>,<and chronic open-angle >,<glaucoma>
{  NTG <ocular hypertension>OHT <glaucoma>}
{<ocular hypertension>,<OHT >,<glaucoma>
{  POAG <ocular hypertension>OHT low-tension <glaucoma>}
{<ocular hypertension>,<OHT low-tension >,<glaucoma>
{long-term management of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{Risk factors of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{risk factors of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{  POAG <ocular hypertension>OHT and normal tension <glaucoma>}
{<ocular hypertension>,<OHT and normal tension >,<glaucoma>
{In the suspected <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{  n <ocular hypertension>n = 66 normal tension <glaucoma>}
{<ocular hypertension>,<n = 66 normal tension >,<glaucoma>
{48 subjects with <ocular hypertension>63 patients with open-angle <glaucoma>}
{<ocular hypertension>,<63 patients with open-angle >,<glaucoma>
{  or <ocular hypertension>maintained in our <glaucoma>}
{<ocular hypertension>,<maintained in our >,<glaucoma>
{32 eyes with <ocular hypertension>and 21 patients 37 eyes with early chronic <glaucoma>}
{<ocular hypertension>,<and 21 patients 37 eyes with early chronic >,<glaucoma>
{ Diagnoses included <ocular hypertension>chronic open-angle <glaucoma>}
{<ocular hypertension>,<chronic open-angle >,<glaucoma>
{  or <ocular hypertension>who had taken no <glaucoma>}
{<ocular hypertension>,<who had taken no >,<glaucoma>
{responsible for glucocorticoid-induced <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{  or <ocular hypertension>POAG/OH 20 and 61 control subjects without glaucoma who presented with no risk factors for arteriosclerosis were extracted for further analysis of systemic arterial stiffness by <glaucoma>}
{<ocular hypertension>,<POAG/OH 20 and 61 control subjects without glaucoma who presented with no risk factors for arteriosclerosis were extracted for further analysis of systemic arterial stiffness by >,<glaucoma>
{other diagnoses included <ocular hypertension>normal tension glaucoma and pseudoexfoliation <glaucoma>}
{<ocular hypertension>,<normal tension glaucoma and pseudoexfoliation >,<glaucoma>
{  n <ocular hypertension>n=44 and normal tension <glaucoma>}
{<ocular hypertension>,<n=44 and normal tension >,<glaucoma>
{  POAG <ocular hypertension>OHT normal tension <glaucoma>}
{<ocular hypertension>,<OHT normal tension >,<glaucoma>
{of POAG and <ocular hypertension>OHT with that in subjects with no <glaucoma>}
{<ocular hypertension>,<OHT with that in subjects with no >,<glaucoma>
{diagnosed cases of <ocular hypertension>open-angle and normal tension <glaucoma>}
{<ocular hypertension>,<open-angle and normal tension >,<glaucoma>
{those with glaucoma <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{Fourteen eyes had <ocular hypertension>17 primary open-angle/normal-tension <glaucoma>}
{<ocular hypertension>,<17 primary open-angle/normal-tension >,<glaucoma>
{first-line therapy for <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{topical treatment of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{response ranging from <ocular hypertension>refractory to maximal medical therapy to the development of steroid-induced <glaucoma>}
{<ocular hypertension>,<refractory to maximal medical therapy to the development of steroid-induced >,<glaucoma>
{patients for persistent <ocular hypertension>especially in eyes with preexisting <glaucoma>}
{<ocular hypertension>,<especially in eyes with preexisting >,<glaucoma>
{131 eyes with <ocular hypertension>and medically controlled <glaucoma>}
{<ocular hypertension>,<and medically controlled >,<glaucoma>
{ eight with <ocular hypertension>and 11 as <glaucoma>}
{<ocular hypertension>,<and 11 as >,<glaucoma>
{  n <ocular hypertension>n = 1 or normal-tension <glaucoma>}
{<ocular hypertension>,<n = 1 or normal-tension >,<glaucoma>
{  NTG <ocular hypertension>OHT or physiologic cup PC or still remained as <glaucoma>}
{<ocular hypertension>,<OHT or physiologic cup PC or still remained as >,<glaucoma>
{altered early in <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{for management of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{available to treat <ocular hypertension>and/or <glaucoma>}
{<ocular hypertension>,<and/or >,<glaucoma>
{ Steroid induced <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{important in evaluating <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{field loss and <ocular hypertension>would usually be thought sufficient to diagnose <glaucoma>}
{<ocular hypertension>,<would usually be thought sufficient to diagnose >,<glaucoma>
{simple glaucoma or <ocular hypertension>suggests that the diagnosis of <glaucoma>}
{<ocular hypertension>,<suggests that the diagnosis of >,<glaucoma>
{The prevalence of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{ POAG n <ocular hypertension>OHT n = 16 and normal tension <glaucoma>}
{<ocular hypertension>,<OHT n = 16 and normal tension >,<glaucoma>
{OAG JOAG POAG <ocular hypertension>OHT or normal tension <glaucoma>}
{<ocular hypertension>,<OHT or normal tension >,<glaucoma>
{optic disc in <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{natural history of <ocular hypertension>and glaucoma and the effectiveness of available treatment modalities limit our ability to draw definitive conclusions concerning the cost-effectiveness of various <glaucoma>}
{<ocular hypertension>,<and glaucoma and the effectiveness of available treatment modalities limit our ability to draw definitive conclusions concerning the cost-effectiveness of various >,<glaucoma>
{the management of <ocular hypertension>and low-tension <glaucoma>}
{<ocular hypertension>,<and low-tension >,<glaucoma>
{to glaucoma and <ocular hypertension>checkerboard pattern reversal visual evoked potentials VEPs were recorded from 20 <glaucoma>}
{<ocular hypertension>,<checkerboard pattern reversal visual evoked potentials VEPs were recorded from 20 >,<glaucoma>
{the management of <ocular hypertension>and low-tension <glaucoma>}
{<ocular hypertension>,<and low-tension >,<glaucoma>
{open angle glaucoma <ocular hypertension>OH and low-tension <glaucoma>}
{<ocular hypertension>,<OH and low-tension >,<glaucoma>
{The prevalence of <ocular hypertension>in patients of an optometrist and the incidence of <glaucoma>}
{<ocular hypertension>,<in patients of an optometrist and the incidence of >,<glaucoma>
{  or <ocular hypertension>and 1 with closed-angle <glaucoma>}
{<ocular hypertension>,<and 1 with closed-angle >,<glaucoma>
{of cases of <ocular hypertension>and suspected glaucoma n = 31 chronic open-angle <glaucoma>}
{<ocular hypertension>,<and suspected glaucoma n = 31 chronic open-angle >,<glaucoma>
{studied 116 POAG <ocular hypertension>47 <glaucoma>}
{<ocular hypertension>,<47 >,<glaucoma>
{and timolol in <ocular hypertension>and chronic open-angle <glaucoma>}
{<ocular hypertension>,<and chronic open-angle >,<glaucoma>
{syndrome and either <ocular hypertension>of <glaucoma>}
{<ocular hypertension>,<of >,<glaucoma>
{effect of GC-induced <ocular hypertension>OHT and iatrogenic open-angle <glaucoma>}
{<ocular hypertension>,<OHT and iatrogenic open-angle >,<glaucoma>
{optic disc in <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{of progression of <ocular hypertension>OHT to primary <glaucoma>}
{<ocular hypertension>,<OHT to primary >,<glaucoma>
{and treat corticosteroid-induced <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{the management of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{the group with <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{ Steroid induced <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{of steroid induced <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{as normal NML <ocular hypertension>OH <glaucoma>}
{<ocular hypertension>,<OH >,<glaucoma>
{Structure-function relationship in <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{  or <ocular hypertension>at a hospital-based <glaucoma>}
{<ocular hypertension>,<at a hospital-based >,<glaucoma>
{  or <ocular hypertension>attending the <glaucoma>}
{<ocular hypertension>,<attending the >,<glaucoma>
{was present between <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{The incidence of <ocular hypertension>OHT after these injections was investigated with respect to the number of injections pre-existing open-angle <glaucoma>}
{<ocular hypertension>,<OHT after these injections was investigated with respect to the number of injections pre-existing open-angle >,<glaucoma>
{with glaucoma including <ocular hypertension>suspected glaucoma and/or chronic open-angle <glaucoma>}
{<ocular hypertension>,<suspected glaucoma and/or chronic open-angle >,<glaucoma>
{a group with <ocular hypertension>but without functional morphological damage and progression diagnosis of <glaucoma>}
{<ocular hypertension>,<but without functional morphological damage and progression diagnosis of >,<glaucoma>
{subjects 70 normal <ocular hypertension>and 70 <glaucoma>}
{<ocular hypertension>,<and 70 >,<glaucoma>
{developed model of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{for studying glucocorticoid-induced <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{be successful established <ocular hypertension>an abnormally concave iris base and absence of patent <glaucoma>}
{<ocular hypertension>,<an abnormally concave iris base and absence of patent >,<glaucoma>
{with glaucoma or <ocular hypertension>who needed additional IOP lowering or who were intolerant of other <glaucoma>}
{<ocular hypertension>,<who needed additional IOP lowering or who were intolerant of other >,<glaucoma>
{diagnoses of GS <ocular hypertension>pseudoexfoliative <glaucoma>}
{<ocular hypertension>,<pseudoexfoliative >,<glaucoma>
{damage is termed <ocular hypertension>a risk factor for <glaucoma>}
{<ocular hypertension>,<a risk factor for >,<glaucoma>
{performed to manage <ocular hypertension>due to pediatric <glaucoma>}
{<ocular hypertension>,<due to pediatric >,<glaucoma>
{005 diagnosis of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{ progression in <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{A diagnosis of <ocular hypertension>was made in 49 11% patients and <glaucoma>}
{<ocular hypertension>,<was made in 49 11% patients and >,<glaucoma>
{20 eyes with <ocular hypertension>and 22 eyes with <glaucoma>}
{<ocular hypertension>,<and 22 eyes with >,<glaucoma>
{appropriate treatment of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{angle glaucoma and <ocular hypertension>patients aged 20 years and older who underwent <glaucoma>}
{<ocular hypertension>,<patients aged 20 years and older who underwent >,<glaucoma>
{systemic hypertension diabetes <ocular hypertension>and early open-angle <glaucoma>}
{<ocular hypertension>,<and early open-angle >,<glaucoma>
{CONCLUSION In diagnosing <ocular hypertension>and its conversion to <glaucoma>}
{<ocular hypertension>,<and its conversion to >,<glaucoma>
{noncontact tonometry in <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{retinal function in <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{50 eyes with <ocular hypertension>and 60 eyes without <glaucoma>}
{<ocular hypertension>,<and 60 eyes without >,<glaucoma>
{alternatives for glaucoma <ocular hypertension>and even angle-closure <glaucoma>}
{<ocular hypertension>,<and even angle-closure >,<glaucoma>
{the conversion of <ocular hypertension>into <glaucoma>}
{<ocular hypertension>,<into >,<glaucoma>
{  or <ocular hypertension>all users of beta-blockers and G5 not sustaining arterial hypertension and also not suffering from either <glaucoma>}
{<ocular hypertension>,<all users of beta-blockers and G5 not sustaining arterial hypertension and also not suffering from either >,<glaucoma>
{ Management of <ocular hypertension>and chronic open-angle <glaucoma>}
{<ocular hypertension>,<and chronic open-angle >,<glaucoma>
{and eyes with <ocular hypertension>OH group C in order to assess the possible contribution of this correlation to the diagnosis or prognosis of <glaucoma>}
{<ocular hypertension>,<OH group C in order to assess the possible contribution of this correlation to the diagnosis or prognosis of >,<glaucoma>
{tomography to discriminate <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{of progression from <ocular hypertension>to glaucoma and <glaucoma>}
{<ocular hypertension>,<to glaucoma and >,<glaucoma>
{population-based studies of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
{the treatment of <ocular hypertension>and <glaucoma>}
{<ocular hypertension>,<and >,<glaucoma>
amyotrophic lateral sclerosis Parkinson's disease,glaucoma
{   <amyotrophic lateral sclerosis Parkinson's disease>and <glaucoma>}
{<amyotrophic lateral sclerosis Parkinson's disease>,<and >,<glaucoma>
Snoring,glaucoma
{   <Snoring>and <glaucoma>}
{<Snoring>,<and >,<glaucoma>
{   <Snoring>was observed in all <glaucoma>}
{<Snoring>,<was observed in all >,<glaucoma>
Ocular hypertension,glaucoma
{   <Ocular hypertension>and <glaucoma>}
{<Ocular hypertension>,<and >,<glaucoma>
{   <Ocular hypertension>and normal-tension <glaucoma>}
{<Ocular hypertension>,<and normal-tension >,<glaucoma>
{   <Ocular hypertension>and <glaucoma>}
{<Ocular hypertension>,<and >,<glaucoma>
{   <Ocular hypertension>OH was defined in the absence of <glaucoma>}
{<Ocular hypertension>,<OH was defined in the absence of >,<glaucoma>
{   <Ocular hypertension>and <glaucoma>}
{<Ocular hypertension>,<and >,<glaucoma>
torsade de pointes sustained ventricular fibrillation,bradyarrhythmia
{   <torsade de pointes sustained ventricular fibrillation>and <bradyarrhythmia>}
{<torsade de pointes sustained ventricular fibrillation>,<and >,<bradyarrhythmia>
open-angle glaucoma,diabetic retinopathy
{  AMD <open-angle glaucoma>and <diabetic retinopathy>}
{<open-angle glaucoma>,<and >,<diabetic retinopathy>
{with pre-operatively diagnosed <open-angle glaucoma>high myopia and <diabetic retinopathy>}
{<open-angle glaucoma>,<high myopia and >,<diabetic retinopathy>
{changes macular changes <open-angle glaucoma>and <diabetic retinopathy>}
{<open-angle glaucoma>,<and >,<diabetic retinopathy>
vitreous opacities cystoid macular edema,retinal neovascularization
{   <vitreous opacities cystoid macular edema>and <retinal neovascularization>}
{<vitreous opacities cystoid macular edema>,<and >,<retinal neovascularization>
Metabolic syndrome,chronic kidney disease
{   <Metabolic syndrome>and <chronic kidney disease>}
{<Metabolic syndrome>,<and >,<chronic kidney disease>
disease metabolic syndrome,atherosclerosis
{   <disease metabolic syndrome>and <atherosclerosis>}
{<disease metabolic syndrome>,<and >,<atherosclerosis>
growth hormone deficiency,hypercortisolism
{   <growth hormone deficiency>or <hypercortisolism>}
{<growth hormone deficiency>,<or >,<hypercortisolism>
Chronic kidney disease,vascular dementia
{   <Chronic kidney disease>and <vascular dementia>}
{<Chronic kidney disease>,<and >,<vascular dementia>
diabetes mellitus heart failure,peripheral vascular disease
{   <diabetes mellitus heart failure>and <peripheral vascular disease>}
{<diabetes mellitus heart failure>,<and >,<peripheral vascular disease>
epiploic appendagitis omental infarction,appendicitis
{   <epiploic appendagitis omental infarction>and <appendicitis>}
{<epiploic appendagitis omental infarction>,<and >,<appendicitis>
thrombocytopenia,portal hypertension
{the treatment of <thrombocytopenia>and <portal hypertension>}
{<thrombocytopenia>,<and >,<portal hypertension>
